id,label
HGNC:1777,CDK6
HGNC:5289,HTR1D
MONDO:0010796,"Parkinson disease, mitochondrial"
HP:0011149,Absence seizure with eyelid myoclonia
chembl:CHEMBL587849,CHEMBL587849
chembl:CHEMBL395915,CHEMBL395915
chembl:CHEMBL414804,OXALIPLATIN
chembl:CHEMBL190412,TEGLARINAD CHLORIDE
HGNC:7461,MT-ND5
chembl:CHEMBL1237132,CLEVIDIPINE
HGNC:5542,IGHMBP2
chembl:CHEMBL440,THIAMYLAL
chembl:CHEMBL504936,HERNANDEZINE
chembl:CHEMBL367149,DOCONEXENT
chembl:CHEMBL590643,CHEMBL590643
chembl:CHEMBL777,CLAVULANIC ACID
CHEBI:35720,enrofloxacin
HP:0000565,Esotropia
chembl:CHEMBL1089,PHENELZINE
MONDO:0012246,spinocerebellar ataxia type 26
HGNC:5244,HSPA9
chembl:CHEMBL27759,ENTINOSTAT
chembl:CHEMBL2107143,GLUFOSFAMIDE
chembl:CHEMBL284237,DIZOCILPINE
MONDO:0012204,familial pseudohyperkalemia
chembl:CHEMBL600747,CHEMBL600747
chembl:CHEMBL2435326,"(20S,21R)-FLUOROCAMPTOTHECIN"
chembl:CHEMBL485756,CHEMBL485756
chembl:CHEMBL1479,DANAZOL
chembl:CHEMBL578928,CHEMBL578928
HP:0002476,Primitive reflex
HGNC:6515,LATS2
chembl:CHEMBL388590,BENZBROMARONE
chembl:CHEMBL585966,CHEMBL585966
chembl:CHEMBL1743051,ONARTUZUMAB
MONDO:0003541,adult acute lymphoblastic leukemia
chembl:CHEMBL366861,FUMARPROTOCETRARIC ACID
chembl:CHEMBL586937,CHEMBL586937
chembl:CHEMBL3545135,NV-128
chembl:CHEMBL2204495,CHEMBL2204495
MONDO:0012684,arrhythmogenic right ventricular dysplasia 12
chembl:CHEMBL1498652,CHEMBL1498652
chembl:CHEMBL1529479,CHEMBL1529479
chembl:CHEMBL3989819,NAXIFYLLINE
chembl:CHEMBL1491455,CHEMBL1491455
MONDO:0005533,distal colitis
HP:0002395,Lower limb hyperreflexia
MONDO:0018531,carcinoma of liver and intrahepatic biliary tract
MONDO:0011658,autosomal recessive early-onset Parkinson disease 7
chembl:CHEMBL1200906,OXYPHENONIUM BROMIDE
chembl:CHEMBL91397,RUPATADINE
chembl:CHEMBL1561747,CHEMBL1561747
HGNC:18714,DCP1A
MONDO:0005053,ischemic disease
chembl:CHEMBL508494,DAPHNORETIN
HP:0010535,Sleep apnea
UPHENO:0081741,increased biological_process in pectoral complex
chembl:CHEMBL2396661,ALPELISIB
chembl:CHEMBL34412,LOMETREXOL
HGNC:30309,RER1
chembl:CHEMBL596802,PRIDOPIDINE
HGNC:21555,EYS
chembl:CHEMBL3188551,GSK-2636771
chembl:CHEMBL507361,PD-0325901
chembl:CHEMBL1403041,METHYL ROBUSTONE
chembl:CHEMBL38576,"ICI-199,441"
HGNC:30855,U2SURP
MGI:1351624,Abcg3
HP:0004298,Abnormality of the abdominal wall
chembl:CHEMBL24510,FUSARIC ACID
HP:0001396,Cholestasis
HGNC:9827,RAD9A
FB:FBgn0037643,ScsÎ²A
chembl:CHEMBL3674570,EDICOTINIB
HGNC:29012,KDM6B
chembl:CHEMBL980,GUAIFENESIN
MONDO:0020485,King-Denborough syndrome
chembl:CHEMBL203191,KRESOXIM-METHYL
HP:0002072,Chorea
HP:0002714,Downturned corners of mouth
chembl:CHEMBL1908342,PICROTOXIN
chembl:CHEMBL2109512,MCS-110
MONDO:0013062,long QT syndrome 12
CHEBI:145790,mupirocin(1-)
HP:0002539,Cortical dysplasia
chembl:CHEMBL1725279,SP-600125
chembl:CHEMBL336208,CHEMBL336208
chembl:CHEMBL462576,KEPONE
chembl:CHEMBL1229517,VEMURAFENIB
chembl:CHEMBL600778,CHEMBL600778
chembl:CHEMBL19954,CHEMBL19954
chembl:CHEMBL2109482,BI-505
chembl:CHEMBL1743083,TREGALIZUMAB
HP:0002756,Pathologic fracture
HP:0025097,Eyelid myoclonus
HGNC:8982,PIK3R4
chembl:CHEMBL4297954,FIBROBLAST GROWTH FACTOR-1
chembl:CHEMBL118678,CHEMBL118678
chembl:CHEMBL546531,CHEMBL546531
chembl:CHEMBL498485,ICARITIN
chembl:CHEMBL1200903,SECOBARBITAL SODIUM
RGD:1308416,Jph3
MONDO:0015002,"developmental and epileptic encephalopathy, 49"
HGNC:20947,TOMM20
MONDO:0013477,hypertrophic cardiomyopathy 20
wikidata:Q29006164,MEKINIST
chembl:CHEMBL956,SUPROFEN
HGNC:12036,TRAF6
chembl:CHEMBL1539,SULFADOXINE
chembl:CHEMBL111743,STROPHANTHIDIN
chembl:CHEMBL3545079,PLX-5622
MONDO:0013265,"autism, susceptibility to, 17"
HGNC:9262,PPIL3
GO:0016015,morphogen activity
NCBITaxon:1769,Mycobacterium leprae
HGNC:5129,HOXC8
HP:0002188,Delayed CNS myelination
MONDO:0020044,autosomal recessive metabolic cerebellar ataxia
HGNC:34528,TOMM6
HGNC:22140,FAM20C
HGNC:19280,METTL17
chembl:CHEMBL862,GUANFACINE
HGNC:9438,PRKRA
MONDO:0002090,eccrine sweat gland neoplasm
chembl:CHEMBL1405979,CHEMBL1405979
HGNC:19277,RNASE8
HP:0003759,Hypoplasia of lymphatic vessels
HP:0007340,Lower limb muscle weakness
MONDO:0004186,cranial nodular fasciitis
GO:0006367,transcription initiation at RNA polymerase II promoter
chembl:CHEMBL3707323,SOMAVARATAN
HGNC:21957,KCTD7
HP:0100297,Increased endomysial connective tissue
chembl:CHEMBL967,TEMAZEPAM
chembl:CHEMBL219410,ZOTAROLIMUS
chembl:CHEMBL4297299,KX2-361
chembl:CHEMBL578257,CHEMBL578257
chembl:CHEMBL360803,PI-CLONIDINE
HGNC:11185,SORL1
chembl:CHEMBL1256391,PIRFENIDONE
chembl:CHEMBL36654,ROEMERINE
NCBIGene:504769,CYP2B6
MONDO:0018155,lateral sclerosis
chembl:CHEMBL4297449,USL-311
CHEBI:47898,4'-epidoxorubicin
HGNC:12476,UBE2D3
chembl:CHEMBL272980,MOCETINOSTAT
chembl:CHEMBL1492,DIPHENYLPYRALINE
HGNC:28734,DCUN1D3
RGD:71047,Epm2a
HGNC:30500,PRRT2
HGNC:4061,SLC37A4
CHEBI:63607,linezolid
HGNC:6150,ITGAV
WB:WBGene00012967,kvs-4
MGI:1096574,Car4
chembl:CHEMBL602206,CHEMBL602206
HGNC:19391,SOCS3
chembl:CHEMBL184412,DRONEDARONE
chembl:CHEMBL1743068,SECUKINUMAB
HGNC:17284,POT1
HGNC:4585,GRIN2A
HGNC:427,ALK
chembl:CHEMBL1389,LEVONORGESTREL
chembl:CHEMBL583969,PHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER
HGNC:14888,DNAJB6
chembl:CHEMBL1782604,CONICASTEROL B
HGNC:9817,RAD51
MONDO:0010264,X-linked adrenal hypoplasia congenita
GO:0072748,cellular response to tacrolimus
MONDO:0005534,ileocolitis
wikidata:Q29005794,ENBREL
HGNC:11115,KDM5D
chembl:CHEMBL1095014,AESCULIOSIDE IIC
chembl:CHEMBL295337,CHEMBL295337
chembl:CHEMBL19612,SPERMIDINE
UBERON:0003454,small intestine Peyer's patch
chembl:CHEMBL1707,LOPERAMIDE HYDROCHLORIDE
chembl:CHEMBL1200399,BUSPIRONE HYDROCHLORIDE
HP:0011350,Mild receptive language delay
MONDO:0000942,corneal disorder
chembl:CHEMBL523073,CYCLOCITRINOL
GO:0010243,response to organonitrogen compound
HP:0003155,Elevated circulating alkaline phosphatase concentration
HP:0025268,Stuttering
chembl:CHEMBL600734,CHEMBL600734
chembl:CHEMBL1743009,EFUNGUMAB
HGNC:3263,AGO2
chembl:CHEMBL584668,CHEMBL584668
chembl:CHEMBL2108651,TALACTOFERRIN ALFA
HGNC:16993,SEC61B
HP:0045025,Narrow palpebral fissure
chembl:CHEMBL3187812,ILEPATRIL
HGNC:2482,CSTB
chembl:CHEMBL66279,CHEMBL66279
chembl:CHEMBL495852,CHEMBL495852
HGNC:7102,MINPP1
chembl:CHEMBL15972,BENZALDEHYDE
chembl:CHEMBL1332182,CHEMBL1332182
HP:0003401,Paresthesia
HGNC:12601,USH2A
chembl:CHEMBL346631,CEP-7055
chembl:CHEMBL600030,CHEMBL600030
chembl:CHEMBL58752,PIMONIDAZOLE
chembl:CHEMBL3039543,ULOCUPLUMAB
chembl:CHEMBL1201631,INSULIN
HP:0008767,Self-mutilation of tongue and lips due to involuntary movements
MONDO:0013977,combined oxidative phosphorylation defect type 13
chembl:CHEMBL476,DACARBAZINE
UBERON:0002106,spleen
MONDO:0033135,"Charcot-Marie-Tooth disease, demyelinating, type 1G"
chembl:CHEMBL2104926,CINOLAZEPAM
chembl:CHEMBL284028,"2,3-DIHYDROXY-6,7-DICHLOROQUINOXALINE"
chembl:CHEMBL586061,CHEMBL586061
HGNC:850,ATP5PO
chembl:CHEMBL104270,TOSUFLOXACIN TOSYLATE
chembl:CHEMBL1201113,CETIRIZINE HYDROCHLORIDE
chembl:CHEMBL1230607,PHA-793887
chembl:CHEMBL485803,CIMIPRONIDINE
MONDO:0015760,T-cell non-Hodgkin lymphoma
MONDO:0011057,cerebrovascular disorder
chembl:CHEMBL1795071,RUXOLITINIB PHOSPHATE
MONDO:0021063,malignant colon neoplasm
HP:0030051,Tip-toe gait
chembl:CHEMBL19980,BREFELDIN A
CHEBI:1722,3beta-hydroxy-Delta(5)-steroid
HGNC:12310,TRIP4
chembl:CHEMBL1480173,4-METHYLBENZOIC ACID METHYL ESTER
NCBIGene:478700,BPHL
NCBIGene:770757,DRD3
HGNC:9352,PRDX1
chembl:CHEMBL2142592,TALADEGIB
chembl:CHEMBL2374078,CHEMBL2374078
GO:0071407,cellular response to organic cyclic compound
HGNC:18484,DUSP18
chembl:CHEMBL1546223,CHEMBL1546223
HP:0007289,Limb fasciculations
chembl:CHEMBL2096642,INAMRINONE LACTATE
chembl:CHEMBL2110585,EZATIOSTAT
HGNC:4117,B4GALNT1
UPHENO:0079846,abnormal emotional behavior
HGNC:20823,DPP10
HGNC:10591,SCN4A
chembl:CHEMBL1194325,ACLIDINIUM
chembl:CHEMBL1303948,CHEMBL1303948
HGNC:11200,SOX4
chembl:CHEMBL348856,"4,4'-THIODIANILINE"
chembl:CHEMBL395091,ESKETAMINE
chembl:CHEMBL580381,CHEMBL580381
chembl:CHEMBL2018096,IPRAGLIFLOZIN
chembl:CHEMBL849,TRICLOSAN
NCBIGene:533445,ARNT2
HGNC:6881,MAPK8
chembl:CHEMBL42710,EUGENOL
HGNC:21111,BICRAL
HP:0000546,Retinal degeneration
HGNC:10760,SET
HGNC:21359,HMGCLL1
chembl:CHEMBL2103883,AVATROMBOPAG
HP:0000639,Nystagmus
chembl:CHEMBL8659,OLEIC ACID
chembl:CHEMBL522892,DOVITINIB
MONDO:0000565,infective endocarditis
MONDO:0045048,toxemia of pregnancy
chembl:CHEMBL580727,CHEMBL580727
HGNC:5246,HSPB1
HGNC:5300,HTR5A
chembl:CHEMBL445153,CHEMBL445153
WB:WBGene00012536,Y37A1A.3
chembl:CHEMBL3301627,TENAPANOR HYDROCHLORIDE
HGNC:30829,TUBB2B
chembl:CHEMBL686,MEFENAMIC ACID
HGNC:3010,DPP6
chembl:CHEMBL41140,6-NITROQUIPAZINE
HP:0007001,Loss of Purkinje cells in the cerebellar vermis
chembl:CHEMBL1743057,PEGSUNERCEPT
chembl:CHEMBL1651,DEXAMETHASONE ACETATE
chembl:CHEMBL1905010,PYRAFLUFEN-ETHYL
chembl:CHEMBL1522900,MENTHOFURAN
HGNC:10992,SLC25A6
HP:0003397,Generalized hypotonia due to defect at the neuromuscular junction
CHEBI:142549,ent-tamsulosin(1+)
chembl:CHEMBL582355,ETHACRIDINE LACTATE
HGNC:16937,ARL6IP5
MONDO:0000108,"bacteremia, susceptibility"
chembl:CHEMBL1371413,"2,3-DIHYDROXY-4-METHOXY-4'-ETHOXYBENZOPHENONE"
chembl:CHEMBL2109092,EPOETIN BETA
chembl:CHEMBL163238,PILSICAINIDE
HP:0002084,Encephalocele
HGNC:19365,PANK3
chembl:CHEMBL119385,NEFLAMAPIMOD
GO:0042995,cell projection
HGNC:17663,PITRM1
chembl:CHEMBL621,TRAZODONE
chembl:CHEMBL451,CHLORDIAZEPOXIDE
chembl:CHEMBL1489,AZACITIDINE
chembl:CHEMBL3039530,ABEDITEROL
chembl:CHEMBL4297278,E7107
Reactome:R-GGA-549127,Organic cation transport
chembl:CHEMBL1522984,CHEMBL1522984
CHEBI:16831,3-hydroxy-3-methylglutaric acid
chembl:CHEMBL673,PARGYLINE
chembl:CHEMBL602312,CHEMBL602312
chembl:CHEMBL337173,CHEMBL337173
MONDO:0020175,malignant tumor of palpebral epidermis
chembl:CHEMBL193240,ROFLUMILAST
HGNC:15598,HAMP
chembl:CHEMBL3039525,GOLVATINIB
HP:0009878,Cerebellar ataxia associated with quadrupedal gait
chembl:CHEMBL40275,ALOE-EMODIN
HGNC:1052,BIN1
chembl:CHEMBL1969664,AZD-1080
CHEBI:46848,N-arylpiperazine
chembl:CHEMBL14153,PD-170292
chembl:CHEMBL1201650,THYROGLOBULIN
chembl:CHEMBL1489662,DIFENPIRAMIDE
MONDO:0004538,endocervical type cervical mucinous adenocarcinoma
chembl:CHEMBL12948,SEMUSTINE
HP:0007153,Progressive extrapyramidal movement disorder
MONDO:0005071,nervous system disorder
chembl:CHEMBL2109557,MLN-591RL
MONDO:0013737,hereditary spastic paraplegia 46
CHEBI:17276,phloretin
chembl:CHEMBL1200617,RIMEXOLONE
HGNC:12505,UBL4A
HP:0002197,Generalized-onset seizure
chembl:CHEMBL1256878,BENZAMIL HYDROCHLORIDE
MONDO:0007080,glucocorticoid-remediable aldosteronism
chembl:CHEMBL591404,CHEMBL591404
HGNC:5270,DNAJB1
HP:0009928,Thick nasal alae
chembl:CHEMBL453818,CHEMBL453818
chembl:CHEMBL2103863,ABEXINOSTAT
chembl:CHEMBL1599768,PYRANTEL PAMOATE
MGI:1920958,Dppa3
HGNC:9509,PSEN2
MONDO:0024295,skin disease caused by bacterial infection
chembl:CHEMBL16807,5-HYDROXYFLAVONE
MONDO:0013928,dystonia 23
chembl:CHEMBL1306,TERCONAZOLE
CHEBI:16632,vanillate
CHEBI:5615,halothane
HGNC:18263,RAB21
HGNC:1144,BTRC
HGNC:10765,SF3A1
HGNC:9243,PPEF1
chembl:CHEMBL1201232,ISOPROPAMIDE
HGNC:7218,MPO
MONDO:0014741,DeSanto-Shinawi syndrome due to WAC point mutation
HP:0007354,Amyotrophic lateral sclerosis
chembl:CHEMBL878,METOLAZONE
chembl:CHEMBL323356,CHEMBL323356
chembl:CHEMBL592868,ESTROGEN
CHEBI:8871,risperidone
GO:0042802,identical protein binding
chembl:CHEMBL86304,MOCLOBEMIDE
HGNC:2150,CNGA3
chembl:CHEMBL1892201,MOFEBUTAZONE
chembl:CHEMBL1086397,CHEMBL1086397
MONDO:0004530,early invasive cervical adenocarcinoma
chembl:CHEMBL2171812,CHEMBL2171812
chembl:CHEMBL1367933,CHEMBL1367933
chembl:CHEMBL2435327,"(20S,21S)-FLUOROCAMPTOTHECIN"
chembl:CHEMBL569419,CHEMBL569419
HGNC:23067,TRAPPC5
HP:0002014,Diarrhea
chembl:CHEMBL1439833,CHEMBL1439833
chembl:CHEMBL1200757,PANCURONIUM BROMIDE
chembl:CHEMBL3989870,BERZOSERTIB
MONDO:0019791,recessive mitochondrial ataxia syndrome
HP:0000719,Inappropriate behavior
NCBIGene:769492,NDUFS8
HP:0000843,Hyperparathyroidism
MONDO:0007483,dyschromatosis symmetrica hereditaria
MONDO:0010156,Troyer syndrome
chembl:CHEMBL1567571,CHEMBL1567571
chembl:CHEMBL573339,PI-103
HGNC:7577,MYH7
HP:0002339,Abnormal caudate nucleus morphology
HP:0004691,2-3 toe syndactyly
chembl:CHEMBL1200911,QUETIAPINE FUMARATE
chembl:CHEMBL1276678,VTP-27999
chembl:CHEMBL594257,CHEMBL594257
HP:0002186,Apraxia
chembl:CHEMBL242011,HINOKININ
chembl:CHEMBL77675,CHEMBL77675
HGNC:1964,CHRNB4
chembl:CHEMBL45830,MILTIRONE
HGNC:4068,GABARAPL1
CHEBI:172923,fluorescein (acid form)
HGNC:9813,RAD23B
MGI:1919412,Dhx36
chembl:CHEMBL1547715,CHEMBL1547715
HGNC:28963,EMC2
chembl:CHEMBL129,ZIDOVUDINE
chembl:CHEMBL581910,CHEMBL581910
chembl:CHEMBL14249,ADENOSINE TRIPHOSPHATE
chembl:CHEMBL1829335,IRDABISANT
chembl:CHEMBL599098,CHEMBL599098
MONDO:0008943,autosomal recessive spinocerebellar ataxia 2
chembl:CHEMBL324053,CHEMBL324053
chembl:CHEMBL1513392,CHEMBL1513392
HGNC:9295,PPP1R7
chembl:CHEMBL1009,LEVODOPA
chembl:CHEMBL411,DIETHYLSTILBESTROL
HGNC:28906,G6PC2
HP:0000723,Restrictive behavior
HGNC:93,ACAT1
chembl:CHEMBL2331680,RG-7603
chembl:CHEMBL2028044,CHEMBL2028044
chembl:CHEMBL1869353,ACEQUINOCYL
chembl:CHEMBL93747,NETOGLITAZONE
chembl:CHEMBL132767,TRAPIDIL
MONDO:0005578,arthritic joint disease
MONDO:0024564,cerebroretinal microangiopathy with calcifications and cysts 1
HGNC:4433,GOT2
HGNC:8811,PDK3
MONDO:0016698,ependymoma
HGNC:4922,HK1
chembl:CHEMBL184074,CHEMBL184074
MONDO:0012414,neuronal ceroid lipofuscinosis 10
HGNC:8806,PDHA1
chembl:CHEMBL2108791,TENECTEPLASE
HGNC:2347,CREB3
RGD:619776,Pfkfb3
chembl:CHEMBL451226,CHEMBL451226
chembl:CHEMBL3545261,BRONTICTUZUMAB
chembl:CHEMBL558,MEXILETINE
chembl:CHEMBL12252,"5,7-DIHYDROXY-4-METHYLCOUMARIN"
chembl:CHEMBL267777,RITANSERIN
chembl:CHEMBL416526,BUFOTENINE
chembl:CHEMBL3544945,SAR-113945
chembl:CHEMBL1531222,CHEMBL1531222
chembl:CHEMBL467987,CHEMBL467987
MONDO:0010412,X-linked intellectual disability-craniofacioskeletal syndrome
MONDO:0018492,hereditary clear cell renal cell carcinoma
chembl:CHEMBL145,CAFFEIC ACID
MONDO:0003631,cervical serous adenocarcinoma
HP:0000193,Bifid uvula
RGD:621384,Kcne3
chembl:CHEMBL291536,CHEMBL291536
MONDO:0003122,striatonigral degeneration
HGNC:10548,ATXN1
HGNC:8729,PCNA
chembl:CHEMBL1610638,DIHYDRO-OBLIQUIN
UBERON:0003728,mediastinum
chembl:CHEMBL1642672,CHEMBL1642672
chembl:CHEMBL76903,OLVANIL
chembl:CHEMBL275391,CHRYSIN DIMETHYL ETHER
CHEBI:28001,vancomycin
chembl:CHEMBL738,THIOPENTAL SODIUM
HGNC:14906,NIN
HGNC:9713,PEX19
chembl:CHEMBL632,BETAMETHASONE
chembl:CHEMBL515252,CHEMBL515252
chembl:CHEMBL219553,GIGANTOL
HGNC:24280,PHF20L1
HGNC:21305,KCTD3
NCBITaxon:520,Bordetella pertussis
HP:0030810,Abnormal tongue physiology
HP:0000099,Glomerulonephritis
NCBIGene:428563,MTARC1
RGD:71027,Grik3
HGNC:4077,GABRA3
chembl:CHEMBL4298032,MEDI-4276
chembl:CHEMBL729,LOPINAVIR
chembl:CHEMBL1200682,SODIUM OXYBATE
CHEBI:27899,cisplatin
chembl:CHEMBL1201022,PHENAZOPYRIDINE HYDROCHLORIDE
chembl:CHEMBL3330650,RG-7420
CHEBI:85278,17beta-hydroxyandrostan-3-one
chembl:CHEMBL3990020,VADACABTAGENE LERALEUCEL
HP:0011110,Recurrent tonsillitis
HGNC:6374,KLRC1
chembl:CHEMBL587620,CHEMBL587620
chembl:CHEMBL1201222,LISDEXAMFETAMINE
UPHENO:0080957,absent social behavior
chembl:CHEMBL38288,CHEMBL38288
HGNC:5383,IDH2
chembl:CHEMBL324774,CHEMBL324774
chembl:CHEMBL1523964,EPHEDRINE SULFATE
MONDO:0013705,"intellectual disability, autosomal recessive 19"
HP:0001123,Visual field defect
chembl:CHEMBL48166,HOMIDIUM
HP:0000707,Abnormality of the nervous system
chembl:CHEMBL23293,SALIRASIB
chembl:CHEMBL4297747,ENDOSTATIN
chembl:CHEMBL684,DIETHYLCARBAMAZINE
GO:0014075,response to amine
chembl:CHEMBL1200841,PROCAINE HYDROCHLORIDE
MONDO:0012851,hypophosphatemic nephrolithiasis/osteoporosis 2
MGI:1098687,Aak1
chembl:CHEMBL412982,CHEMBL412982
chembl:CHEMBL1008,BEPRIDIL
chembl:CHEMBL1555467,ANAZOLENE
HGNC:1097,BRAF
HP:0033748,Hypoesthesia
HGNC:10585,SCN1A
chembl:CHEMBL1628227,DOXEPIN
chembl:CHEMBL374107,8-AZAGUANINE
RGD:1559857,Ahrr
chembl:CHEMBL106,FLUCONAZOLE
chembl:CHEMBL77098,"3-HYDROXY-3',4'-DIMETHOXYFLAVONE"
HGNC:2976,DNMT1
MONDO:0010709,early-onset parkinsonism-intellectual disability syndrome
HP:0012168,Head-banging
chembl:CHEMBL1201621,SOMATROPIN
MONDO:0014024,hereditary spastic paraplegia 43
chembl:CHEMBL4297529,RISUTEGANIB
chembl:CHEMBL408980,ANISOCOUMARIN H
chembl:CHEMBL1773683,EZUTROMID
MGI:1927133,Gmfb
CHEBI:46691,"2,3-dihydroxy-5-methyl-1,4-benzoquinone"
CHEBI:175901,gemcitabine
chembl:CHEMBL1405,ESTRONE
HP:0002448,Progressive encephalopathy
GO:0005576,extracellular region
HGNC:30213,ATP13A2
CHEBI:142677,triazinoindole
chembl:CHEMBL3833373,AVELUMAB
HP:0010869,Asynergia
MONDO:0003630,pancreatic serous cystadenocarcinoma
HGNC:17586,MTCH1
chembl:CHEMBL1719948,MORUSINOL
chembl:CHEMBL405355,NIGULDIPINE
chembl:CHEMBL814,FLUVOXAMINE
chembl:CHEMBL1614650,EXATECAN
chembl:CHEMBL3545168,IMD-1041
chembl:CHEMBL4297887,GSK-2586881
chembl:CHEMBL261454,CHEMBL261454
chembl:CHEMBL1277001,MIBAMPATOR
chembl:CHEMBL1098,BUPIVACAINE
chembl:CHEMBL2219421,RECILISIB
HP:0008000,Decreased corneal reflex
MONDO:0022736,occupational lung disease
chembl:CHEMBL206468,AFEGOSTAT
chembl:CHEMBL524930,CHEMBL524930
chembl:CHEMBL4297627,SELITRECTINIB
MONDO:0018901,left ventricular noncompaction
HP:0008404,Nail dystrophy
HGNC:7652,NBN
chembl:CHEMBL595227,CHEMBL595227
chembl:CHEMBL1379900,CHEMBL1379900
HGNC:30306,PHB2
HP:0001744,Splenomegaly
chembl:CHEMBL290624,CHLORACYZINE
chembl:CHEMBL106525,CHEMBL106525
chembl:CHEMBL1900528,TIOTROPIUM
HGNC:959,BAX
HGNC:4179,NIPSNAP2
chembl:CHEMBL544115,CHEMBL544115
chembl:CHEMBL1200337,METOPROLOL SUCCINATE
HGNC:7523,TRIM37
HGNC:21919,PARP12
MONDO:0002501,brain glioblastoma
MONDO:0005004,clear cell adenocarcinoma
HP:0033200,Triceps hyporeflexia
chembl:CHEMBL726,FLUPHENAZINE
chembl:CHEMBL493,BROMOCRIPTINE
chembl:CHEMBL1697766,PERAZINE
UBERON:0001156,ascending colon
chembl:CHEMBL34730,CHEMBL34730
chembl:CHEMBL2005186,CHEMBL2005186
chembl:CHEMBL190461,CANNABIDIOL
HP:0012080,Cerebellar granular layer atrophy
chembl:CHEMBL501680,BILIRUBIN
chembl:CHEMBL1910971,CHEMBL1910971
UBERON:0000451,prefrontal cortex
chembl:CHEMBL1650245,CHEMBL1650245
FB:FBgn0039358,Idh3g
wikidata:Q3143635,HYALURONAN
chembl:CHEMBL264374,BEZAFIBRATE
chembl:CHEMBL1405922,FENDILINE HYDROCHLORIDE
MONDO:0005020,intestinal disorder
MONDO:0012430,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2"
HGNC:21495,KIF12
chembl:CHEMBL1332032,TRIFLUSAL
chembl:CHEMBL513521,BL-1020
MONDO:0005229,bacterial infectious disease with sepsis
HP:0002751,Kyphoscoliosis
HGNC:5466,IGF2
UBERON:0013540,Brodmann (1909) area 9
HGNC:1689,CD59
CHEBI:40303,lovastatin
HGNC:5275,KAT5
chembl:CHEMBL1650317,"SODIUM 2,2-DIMETHYLBUTYRATE"
chembl:CHEMBL640,PROCAINAMIDE
chembl:CHEMBL1909354,GW459057A
HGNC:379,AKAP9
chembl:CHEMBL1336287,"3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN"
GO:0110165,cellular anatomical entity
chembl:CHEMBL465339,MUNDULONE
HP:0001427,Mitochondrial inheritance
chembl:CHEMBL591598,CHEMBL591598
wikidata:Q29005931,HERCEPTIN
chembl:CHEMBL601933,CHEMBL601933
chembl:CHEMBL1694,BENAZEPRIL HYDROCHLORIDE
HGNC:21645,CHCHD2
MONDO:0011439,spinocerebellar ataxia type 12
chembl:CHEMBL1334693,PROROXAN HYDROCHLORIDE
MONDO:0019794,autosomal dominant cerebellar ataxia type IV
HGNC:1918,CHD3
chembl:CHEMBL3039558,ETIRINOTECAN PEGOL
MONDO:0850283,acute asthma
HP:0006597,Diaphragmatic paralysis
HGNC:14652,PARVA
chembl:CHEMBL2219416,NALOXEGOL OXALATE
HGNC:3009,DPP4
chembl:CHEMBL3545163,AMP579
HGNC:13867,SH3KBP1
chembl:CHEMBL1769,PROPOXYCAINE HYDROCHLORIDE
HP:0000034,Hydrocele testis
HP:0002086,Abnormality of the respiratory system
HGNC:4635,GSTM3
chembl:CHEMBL3639788,TELAGLENASTAT
chembl:CHEMBL23094,CHEMBL23094
chembl:CHEMBL1088184,DIBUTYLDICHLOROSTANNANE
chembl:CHEMBL3544961,BI-853520
chembl:CHEMBL1782602,THEONELLASTEROL G
NCBIGene:487748,CBR3
HGNC:3465,ESD
chembl:CHEMBL591876,CHEMBL591876
MONDO:0100151,nephropathic cystinosis
CHEBI:16796,melatonin
chembl:CHEMBL346516,METHYL PARATHIONE
chembl:CHEMBL1688952,2-MERCAPTOPYRIMIDINE
HP:0012547,Abnormal involuntary eye movements
UBERON:0000159,anal canal
MONDO:0014620,myoclonic dystonia 26
chembl:CHEMBL2105664,TECARFARIN
chembl:CHEMBL1257065,STILONIUM IODIDE
chembl:CHEMBL249697,BMS-345541
HP:0000023,Inguinal hernia
chembl:CHEMBL1509115,TETRYDAMINE
HGNC:10362,RPL6
chembl:CHEMBL273103,CHEMBL273103
ZFIN:ZDB-GENE-040718-448,cox6b1
chembl:CHEMBL64925,MG-132
chembl:CHEMBL1595865,CHINOMETHIONAT
MONDO:0015247,opsoclonus-myoclonus syndrome
RGD:3713,Slc5a1
CHEBI:22160,acetamides
chembl:CHEMBL1080077,CHEMBL1080077
chembl:CHEMBL3349001,AVN-944
chembl:CHEMBL4297565,CERTOLIZUMAB
chembl:CHEMBL1079460,CHEMBL1079460
HP:0008181,Abetalipoproteinemia
MONDO:0003332,malignant struma ovarii
GO:0003700,DNA-binding transcription factor activity
MONDO:0011833,spinocerebellar ataxia type 21
chembl:CHEMBL1241951,LETERMOVIR
chembl:CHEMBL539843,VAPITADINE DIHYDROCHLORIDE
HGNC:4115,GALC
HGNC:9218,POU4F1
CHEBI:146260,spectinomycin(1+)
chembl:CHEMBL2064032,VONOPRAZAN FUMURATE
chembl:CHEMBL1436980,"4,4'-DIMETHOXYDALBERGIONE"
HGNC:21461,RC3H2
HGNC:12474,UBE2D1
HP:0031952,Neurogenic claudication
WB:WBGene00020932,dhod-1
HGNC:3058,DTNB
HP:0012462,Chin myoclonus
HGNC:13083,ZBTB21
chembl:CHEMBL242171,CHEMBL242171
chembl:CHEMBL34833,CETYLPYRIDINIUM CHLORIDE
chembl:CHEMBL459022,TOXYLOXANTHONE C
MONDO:0002423,rectosigmoid junction neoplasm
chembl:CHEMBL1255966,CHEMBL1255966
MONDO:0005561,aortic disorder
chembl:CHEMBL206452,CATECHIN
chembl:CHEMBL1200781,CITALOPRAM HYDROBROMIDE
chembl:CHEMBL1762,TOCAINIDE
chembl:CHEMBL521941,PEPEROMIN E
chembl:CHEMBL1289494,TIVOZANIB
MONDO:0010321,"autism, susceptibility to, X-linked 1"
GO:0006810,transport
NCBIGene:475428,NDUFA12
chembl:CHEMBL253551,FRAXIDIN METHYL ETHER
HP:0009894,Thickened ears
MONDO:0002238,ascending colon cancer
HGNC:13516,BIRC6
chembl:CHEMBL81782,CHEMBL81782
CHEBI:72588,semisynthetic derivative
chembl:CHEMBL65375,TIPIRACIL HYDROCHLORIDE
HGNC:26101,ACSF2
chembl:CHEMBL267476,LINOLEIC ACID
HGNC:29672,MICALL2
HGNC:977,BCAT2
chembl:CHEMBL602012,CHEMBL602012
GO:0055056,D-glucose transmembrane transporter activity
WB:WBGene00011559,umps-1
GO:0005362,low-affinity glucose:sodium symporter activity
chembl:CHEMBL481,IRINOTECAN
HGNC:160,ACTL6B
chembl:CHEMBL3545386,BI113823
chembl:CHEMBL1094966,PIRBUTEROL
MONDO:0014143,Noonan syndrome 8
ZFIN:ZDB-GENE-030131-3157,dhodh
chembl:CHEMBL1256783,CHEMBL1256783
NCBIGene:516036,CBR3
chembl:CHEMBL3693786,CITARINOSTAT
MONDO:0013208,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome
chembl:CHEMBL1743052,OPORTUZUMAB MONATOX
chembl:CHEMBL493646,CUCURBITACIN D
chembl:CHEMBL448741,DIHYDROSPINGOSINE
HP:0002007,Frontal bossing
HP:0000076,Vesicoureteral reflux
chembl:CHEMBL776,METAPROTERENOL
chembl:CHEMBL4117187,MASUPIRDINE
HGNC:25473,KANSL3
CHEBI:58007,streptomycin(3+)
chembl:CHEMBL932,DIPYRIDAMOLE
chembl:CHEMBL123904,CHEMBL123904
chembl:CHEMBL259633,CHEMBL259633
HGNC:11390,AURKB
chembl:CHEMBL1094,FELBAMATE
chembl:CHEMBL242112,SALICYLALDEHYDE THIOSEMICARBAZONE
chembl:CHEMBL2110372,RANITIDINE HYDROCHLORIDE
chembl:CHEMBL560303,N-METHYLCALOTHRIXIN B
chembl:CHEMBL1200984,AMLODIPINE MALEATE
chembl:CHEMBL367741,DIFFRACTAIC ACID
HP:0011834,Moyamoya phenomenon
HGNC:10805,SGCA
chembl:CHEMBL1873684,CHEMBL1873684
chembl:CHEMBL1520188,CLODRONATE DISODIUM
chembl:CHEMBL1256696,CARBETAPENTANE CITRATE
chembl:CHEMBL526763,CHEMBL526763
chembl:CHEMBL180682,AMMONIUM TRICHLOROTELLURATE
chembl:CHEMBL1201576,RITUXIMAB
chembl:CHEMBL1133,OXYBUTYNIN CHLORIDE
chembl:CHEMBL608862,CHEMBL608862
HGNC:3363,ENTPD1
chembl:CHEMBL465843,PIPLARTINE
chembl:CHEMBL1451116,IODOFORM
CHEBI:24031,ferulic acids
chembl:CHEMBL412262,IBIPINABANT
chembl:CHEMBL533542,CHEMBL533542
HGNC:7608,MYO9A
HGNC:23782,POLDIP3
HP:0025711,Convergence-retraction nystagmus
RGD:620119,Fntb
chembl:CHEMBL3545025,INSM-18
MONDO:0018256,acute myeloid leukemia with t(8;16)(p11;p13) translocation
CHEBI:33308,carboxylic ester
chembl:CHEMBL578,ENALAPRIL
HGNC:2891,DKK1
chembl:CHEMBL588,FENOLDOPAM
SGD:S000004636,ARP9
HGNC:20038,DDX52
chembl:CHEMBL41275,CHEMBL41275
HGNC:16501,PDLIM4
chembl:CHEMBL1412489,CHEMBL1412489
HP:0001789,Hydrops fetalis
chembl:CHEMBL2108302,SPRIFERMIN
chembl:CHEMBL582767,CHEMBL582767
chembl:CHEMBL1668773,TUBERATOLIDE A
chembl:CHEMBL253978,TELENZEPINE
GO:0140271,hexose import across plasma membrane
HGNC:1394,CACNA1G
chembl:CHEMBL176045,FANCHININ
chembl:CHEMBL585,TRIAMTERENE
RGD:621373,Tex101
chembl:CHEMBL3137351,ABRILUMAB
chembl:CHEMBL4297976,N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT
HGNC:8787,PDE6C
HGNC:30760,TMEM165
chembl:CHEMBL4296719,DUTOGLIPTIN
RGD:1310512,Mpv17
NCBIGene:476754,NDUFS7
chembl:CHEMBL18797,SULINDAC SULFIDE
MGI:106210,Dmbt1
chembl:CHEMBL3544963,DS-3078A
HGNC:938,BAG2
chembl:CHEMBL2141712,PALOMID-529
chembl:CHEMBL117447,PHENYL ISATIN
chembl:CHEMBL31741,CHEMBL31741
HP:0033044,Motor regression
chembl:CHEMBL18901,EFAPROXIRAL
HGNC:469,AMPD2
chembl:CHEMBL2338554,SYMPLOSTATIN 5
WB:WBGene00000066,act-4
chembl:CHEMBL2103855,TELOTRISTAT
chembl:CHEMBL2106003,CIPRALISANT MALEATE
HGNC:5004,HMGB3
WB:WBGene00022533,cutl-19
HP:0002817,Abnormality of the upper limb
GO:0006600,creatine metabolic process
CHEBI:59066,oxolinate
UBERON:0001626,left coronary artery
chembl:CHEMBL596839,CHEMBL596839
chembl:CHEMBL2103862,BAVISANT
chembl:CHEMBL578929,CHEMBL578929
WB:WBGene00002179,jph-1
chembl:CHEMBL3545252,DOCETAXEL
chembl:CHEMBL533577,CHEMBL533577
chembl:CHEMBL2392545,TAK-960
HP:0031844,Euphoria
chembl:CHEMBL3544935,XL-418
GO:0140877,mevastatin biosynthetic process
HGNC:830,ATP5F1B
chembl:CHEMBL16751,CHEMBL16751
HGNC:4422,GNS
HGNC:845,ATP5PD
chembl:CHEMBL4297494,GSK-3117391
HGNC:4136,GAMT
HGNC:7421,MT-CO2
chembl:CHEMBL1358662,DEXPROPRANOLOL HYDROCHLORIDE
chembl:CHEMBL599,MELOXICAM
chembl:CHEMBL267475,FPL-55712
HGNC:4135,GALT
chembl:CHEMBL1201198,PEMIROLAST
HGNC:4332,BICRA
HGNC:19181,KIF14
HGNC:18303,ATP6V1H
HP:0001284,Areflexia
CHEBI:63580,ribavirin
CHEBI:23359,colchicine
chembl:CHEMBL92708,CALPEPTIN
HGNC:11868,TRAPPC10
MONDO:0003518,mediastinum teratoma
chembl:CHEMBL3087515,MAVOGLURANT
chembl:CHEMBL258940,FALNIDAMOL
HP:0032860,Generalized non-convulsive status epilepticus without coma
UPHENO:0077857,abnormal lateral crico-arytenoid morphology
HGNC:15574,RB1CC1
chembl:CHEMBL603952,CHEMBL603952
HGNC:6601,LIG4
HP:0001371,Flexion contracture
HP:0003777,Pili torti
chembl:CHEMBL3545100,ASP7991
chembl:CHEMBL2105275,PROPYLHEXEDRINE
Reactome:R-HSA-9022535,Loss of phosphorylation of MECP2 at T308
chembl:CHEMBL100014,AN-9
chembl:CHEMBL2022241,CHEMBL2022241
MONDO:0006693,cerebral arterial disease
HGNC:4598,GRM6
chembl:CHEMBL312448,XYLOMETAZOLINE
MONDO:0018307,neurodegeneration with brain iron accumulation
MONDO:0011249,torsion dystonia with onset in infancy
GO:0016085,myoinhibitory hormone activity
HGNC:1554,CBX4
chembl:CHEMBL2107339,ESMIRTAZAPINE MALEATE
chembl:CHEMBL2178578,VERCIRNON
HP:0010936,Abnormality of the lower urinary tract
chembl:CHEMBL494083,XANTHOANGELOL
MONDO:0013874,glucocorticoid deficiency 4
chembl:CHEMBL103667,DORAMAPIMOD
CHEBI:133580,N-hexanoylglycinate
HP:0031964,Elevated circulating alanine aminotransferase concentration
UBERON:0001966,substantia nigra pars reticulata
chembl:CHEMBL165090,ROMAZARIT
HGNC:483,ANG
chembl:CHEMBL70418,CLOBAZAM
HGNC:17631,POLR1E
CHEBI:38777,azetidines
chembl:CHEMBL586033,CHEMBL586033
chembl:CHEMBL471498,MITIGLINIDE
chembl:CHEMBL1380,ABACAVIR
chembl:CHEMBL3039596,FOSINOPRIL SODIUM
chembl:CHEMBL1259,METOCURINE
HP:0100806,Sepsis
chembl:CHEMBL233194,CHEMBL233194
chembl:CHEMBL9225,MESO-HEXESTROL
chembl:CHEMBL570,TRIFLUPROMAZINE
chembl:CHEMBL91732,ALDICARB
CL:0000019,sperm
chembl:CHEMBL1372341,PIRENOXINE
chembl:CHEMBL94454,MIZOLASTINE
MONDO:0002277,arteriosclerosis disorder
HP:0000824,Decreased response to growth hormone stimulation test
HP:0034340,Pseudoautosomal dominant inheritance
chembl:CHEMBL1083390,INTEPIRDINE
chembl:CHEMBL864,CARBINOXAMINE
CHEBI:38582,difluorobenzene
HP:0002540,Inability to walk
MONDO:0002275,generalized atherosclerosis
chembl:CHEMBL406381,KRN-633
HGNC:30646,SND1
chembl:CHEMBL1201467,"SYNTHETIC CONJUGATED ESTROGENS, B"
chembl:CHEMBL509890,MAKALUVAMINE F
HGNC:18418,HYPK
chembl:CHEMBL64249,CLOROTEPINE
HP:0002530,Axial dystonia
chembl:CHEMBL1200943,MERSALYL
HGNC:7804,NFYA
HGNC:8048,NUDT1
chembl:CHEMBL1915270,CHEMBL1915270
CHEBI:35341,steroid
chembl:CHEMBL207538,BREXANOLONE
HP:0045037,Abnormality of jaw muscles
CHEBI:16015,L-glutamic acid
chembl:CHEMBL2146883,COBIMETINIB
HGNC:16828,SEC22C
CHEBI:27881,resveratrol
CHEBI:34995,teicoplanin A2-1
HP:0002548,Parkinsonism with favorable response to dopaminergic medication
chembl:CHEMBL220808,SARIZOTAN
HP:0003473,Fatigable weakness
chembl:CHEMBL74926,PHENSERINE
MONDO:0014233,early-onset Parkinson disease 20
chembl:CHEMBL127643,DIMETHISOQUIN
chembl:CHEMBL268368,STAUROSPORINE AGLYCON
chembl:CHEMBL111201,CHEMBL111201
chembl:CHEMBL2108739,PLACULUMAB
chembl:CHEMBL1628502,GABAPENTIN ENACARBIL
chembl:CHEMBL1201203,BENZTROPINE
chembl:CHEMBL753,PHENOXYBENZAMINE
chembl:CHEMBL3234237,JNJ-37822681
HP:0008722,Urethral diverticulum
MONDO:0005618,anxiety disorder
chembl:CHEMBL1094636,NIRAPARIB
chembl:CHEMBL2109623,STX-100
chembl:CHEMBL3545229,DWP05195
chembl:CHEMBL727,THIOGUANINE
HP:0025435,Increased circulating lactate dehydrogenase concentration
chembl:CHEMBL12831,IMAZODAN
chembl:CHEMBL2106406,DERSALAZINE
chembl:CHEMBL366603,DIALLYLDISULFIDE
HGNC:7605,MYO6
FB:FBgn0032129,jp
chembl:CHEMBL301265,PRAMIPEXOLE
chembl:CHEMBL3545072,LANDOGROZUMAB
GO:0140735,lovastatin biosynthetic process
chembl:CHEMBL2103882,TIVANTINIB
HP:0008640,Congenital macroorchidism
chembl:CHEMBL1024,IFOSFAMIDE
HGNC:8801,PDGFC
HP:0034585,Cochlear nerve hypoplasia
chembl:CHEMBL1201099,CODEINE PHOSPHATE
GO:0030424,axon
chembl:CHEMBL533074,CHEMBL533074
chembl:CHEMBL2062869,CHEMBL2062869
MONDO:0002093,acanthoma
chembl:CHEMBL398021,CHEMBL398021
HGNC:24824,FZR1
HGNC:28654,ZDHHC23
chembl:CHEMBL2108466,GINKGO
HGNC:33939,CLRN2
MGI:1345143,Pde10a
HGNC:6079,INPP5D
HP:0007185,Loss of consciousness
HGNC:19016,TRIM44
HGNC:17288,APOA5
NCBIGene:478577,NDUFB4
HGNC:14415,ELOVL4
HGNC:7197,MOG
chembl:CHEMBL601757,CHEMBL601757
chembl:CHEMBL3099551,CMX-2043
HGNC:12271,TRG
chembl:CHEMBL4297421,COH-29
chembl:CHEMBL1490,TRIHEXYPHENIDYL
MONDO:0024621,serous cystadenocarcinoma
HGNC:3012,DPYD
HP:0003209,Decreased pyruvate carboxylase activity
MONDO:0005278,serous adenocarcinoma
chembl:CHEMBL71851,SCOPOLETIN
chembl:CHEMBL272195,EPIANDROSTERONE
UBERON:0001052,rectum
chembl:CHEMBL1716,CYPROHEPTADINE HYDROCHLORIDE
HGNC:12565,UNC119
chembl:CHEMBL16117,PHILANTHOTOXIN 343
chembl:CHEMBL1328919,CLOROPHENE
GO:0035579,specific granule membrane
HGNC:17337,LCN6
chembl:CHEMBL1200667,ENCLOMIPHENE CITRATE
FB:FBgn0261955,Cs1
HP:0002340,Caudate atrophy
HP:0012758,Neurodevelopmental delay
chembl:CHEMBL1450486,THIPHENAMIL
HP:0002066,Gait ataxia
chembl:CHEMBL284092,GEPIRONE
chembl:CHEMBL710,FINASTERIDE
HGNC:12500,UBE4B
HGNC:10735,SEMA4G
chembl:CHEMBL588683,CHEMBL588683
chembl:CHEMBL442906,CHEMBL442906
HGNC:569,AP3M1
GO:0005356,glucose:proton symporter activity
CHEBI:15428,glycine
HP:0033755,Increased left ventricular end-diastolic volume
chembl:CHEMBL2028665,REMOGLIFLOZIN ETABONATE
CHEBI:87211,fluoroquinolone antibiotic
MONDO:0002492,acute kidney failure
GO:0031091,platelet alpha granule
chembl:CHEMBL43482,MITONAFIDE
GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding
chembl:CHEMBL521083,CHEMBL521083
chembl:CHEMBL1173655,AFATINIB
Reactome:R-MMU-211945,Phase I - Functionalization of compounds
MONDO:0012444,neurodegeneration with brain iron accumulation 2B
HGNC:17293,PRKD2
chembl:CHEMBL1095016,AESCULIOSIDE IID
HGNC:6893,MAPT
chembl:CHEMBL383824,ALVESPIMYCIN
chembl:CHEMBL3545008,SAR-260301
chembl:CHEMBL1766,DESOXIMETASONE
CHEBI:58017,5-O-phosphonato-alpha-D-ribofuranosyl diphosphate(5-)
chembl:CHEMBL399491,PYRROLIDINE DITHIOCARBAMATE
chembl:CHEMBL423081,CHEMBL423081
chembl:CHEMBL1607,TOPOTECAN HYDROCHLORIDE
chembl:CHEMBL106265,8-CYCLOPENTYLTHEOPHYLLINE
chembl:CHEMBL2135268,PHENETHYL PHENYLCARBAMATE
HGNC:17939,SLC45A1
chembl:CHEMBL48449,CANTHARIDIN
chembl:CHEMBL1261,CITRIC ACID
MONDO:0021427,squamous cell carcinoma of lip
HP:0003701,Proximal muscle weakness
chembl:CHEMBL1180725,PROPANTHELINE
HGNC:12587,UQCRFS1
chembl:CHEMBL484785,CRISABOROLE
HP:0002921,Abnormal cerebrospinal fluid morphology
HGNC:24664,PATE1
chembl:CHEMBL2105199,OCINAPLON
chembl:CHEMBL169300,DEHYDROXYMETHYLEPOXYQUINOMICIN
HGNC:3650,FEN1
NCBIGene:509995,LRPPRC
chembl:CHEMBL29188,LOMERIZINE
chembl:CHEMBL533082,CHEMBL533082
HGNC:2451,CSNK1A1
HGNC:6847,MAP2K7
chembl:CHEMBL498746,CHEMBL498746
chembl:CHEMBL289191,LUPEOL
chembl:CHEMBL1699,MEMANTINE HYDROCHLORIDE
MONDO:0030004,"autism, susceptibility to, 20"
MONDO:0003196,appendix carcinoma
chembl:CHEMBL201325,CHEMBL201325
chembl:CHEMBL42055,E-FLUPENTIXOL
HGNC:7696,NDUFB10
GO:1904659,glucose transmembrane transport
chembl:CHEMBL504323,BERBAMINE
HGNC:11208,SP3
MONDO:0023696,Marinesco-Sjogren-like syndrome
chembl:CHEMBL602158,CHEMBL602158
OBA:1000400,
NCBIGene:415752,UQCRFS1
MONDO:0013755,PYCR1-related de Barsy syndrome
chembl:CHEMBL2109384,DEMCIZUMAB
HGNC:12362,TSC1
chembl:CHEMBL1201014,PREDNISOLONE SODIUM PHOSPHATE
HGNC:3076,DUSP9
HGNC:4651,GTF2E2
HP:0002754,Osteomyelitis
HGNC:18133,TAOK3
chembl:CHEMBL128988,FRENTIZOLE
chembl:CHEMBL1908397,KW-2449
chembl:CHEMBL1420181,CHEMBL1420181
chembl:CHEMBL3137353,BIMAGRUMAB
chembl:CHEMBL1688556,CHEMBL1688556
HGNC:5341,IBSP
chembl:CHEMBL4297713,CABIRALIZUMAB
chembl:CHEMBL861,MEPHENYTOIN
GO:0103116,ABC-type D-galactofuranose transporter
CHEBI:16480,nitric oxide
MONDO:0003768,signet ring cell variant cervical mucinous adenocarcinoma
MONDO:0100057,food-dependent exercise-induced anaphylaxis
chembl:CHEMBL683,CLOFIBRIC ACID
MONDO:0018014,transient neonatal multiple acyl-CoA dehydrogenase deficiency
CHEBI:49167,anti-asthmatic drug
MONDO:0005341,skin basal cell carcinoma
MONDO:0003821,ovarian biphasic or triphasic teratoma
chembl:CHEMBL348436,CIRSIMARITIN
chembl:CHEMBL1256958,EPINEPHRINE BITARTRATE
GO:0150034,distal axon
chembl:CHEMBL8747,REV-5901
chembl:CHEMBL625,THIABENDAZOLE
chembl:CHEMBL1743043,MOXETUMOMAB PASUDOTOX
CHEBI:2682,amphotericin B
chembl:CHEMBL408653,CHEMBL408653
HGNC:8607,PRKN
chembl:CHEMBL2108463,GARLIC
chembl:CHEMBL3545225,INCB-047986
MONDO:0015067,"neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor"
chembl:CHEMBL452954,CHEMBL452954
MONDO:0011849,psoriatic arthritis
MONDO:0002940,anal margin basal cell carcinoma
chembl:CHEMBL1734,SOLIFENACIN
chembl:CHEMBL113150,CETRIMIDE
chembl:CHEMBL1503,OMEPRAZOLE
HGNC:4667,GTF3C4
MONDO:0850284,extrinsic asthma
HP:0003738,Exercise-induced myalgia
chembl:CHEMBL297304,CHEMBL297304
HGNC:1787,CDKN2A
chembl:CHEMBL4297469,LGD-6972
HP:0020036,Upper limb dysmetria
chembl:CHEMBL503990,CHEMBL503990
chembl:CHEMBL12318,CLODRONIC ACID
chembl:CHEMBL3545299,BMS-698769
chembl:CHEMBL2178596,CHEMBL2178596
chembl:CHEMBL49623,"(R,S)-IFENPRODIL"
HGNC:691,PHOX2A
chembl:CHEMBL253896,XANTHOHUMOL
UBERON:0000947,aorta
MONDO:0011240,megalencephaly-capillary malformation-polymicrogyria syndrome
chembl:CHEMBL4298097,ROMILKIMAB
chembl:CHEMBL497001,ALOIN
UBERON:0001255,urinary bladder
MONDO:0014601,autosomal recessive spinocerebellar ataxia 20
chembl:CHEMBL215645,RIVASTIGMINE TARTRATE
chembl:CHEMBL597251,CHEMBL597251
chembl:CHEMBL1427,HYPOXANTHINE
chembl:CHEMBL222556,CHEMBL222556
HGNC:14406,PTPN23
HGNC:29605,SH2B3
chembl:CHEMBL1201134,LUBIPROSTONE
chembl:CHEMBL505,CHLORPHENIRAMINE
MONDO:0018439,eosinophilic colitis
chembl:CHEMBL1222035,CHEMBL1222035
HGNC:5241,HSPA8
chembl:CHEMBL150894,CEP-5214
chembl:CHEMBL1869863,QUINOXYFEN
wikidata:Q47521502,DOXIL
WB:WBGene00044568,ntc-1
chembl:CHEMBL463574,RATANIAPHENOL II
chembl:CHEMBL152,CIDOFOVIR
HP:0000618,Blindness
chembl:CHEMBL599013,CHEMBL599013
chembl:CHEMBL72,DESIPRAMINE
HP:0033205,Biceps hyperreflexia
GO:0008017,microtubule binding
chembl:CHEMBL376897,METHSCOPOLAMINE
HP:0002653,Bone pain
chembl:CHEMBL509617,RESACTIN A
HGNC:24936,EEF1AKMT3
CHEBI:50851,hydrocortamate
chembl:CHEMBL579143,CHEMBL579143
MONDO:0018315,X-linked osteoporosis with fractures
HGNC:3434,ERCC2
MONDO:0011529,spinocerebellar ataxia type 13
chembl:CHEMBL1069,VALSARTAN
HGNC:18118,RSF1
chembl:CHEMBL220360,TARANABANT
chembl:CHEMBL334830,RANIRESTAT
chembl:CHEMBL398673,(R)-FLECAINIDE
MONDO:0024457,neurodegeneration with brain iron accumulation 2A
HGNC:1943,CHN1
chembl:CHEMBL1516,OLMESARTAN
chembl:CHEMBL4297327,SUVN-D4010
HP:0000753,Autism with high cognitive abilities
HGNC:2745,DDX3X
GO:0006836,neurotransmitter transport
chembl:CHEMBL580155,CHEMBL580155
chembl:CHEMBL100116,PENTAZOCINE
chembl:CHEMBL1255842,PRECLAMOL HYDROCHLORIDE
chembl:CHEMBL513994,PRX-08066
HGNC:492,ANK1
MONDO:0012188,neuronal ceroid lipofuscinosis 9
chembl:CHEMBL453805,PENTOSALEN
HGNC:6641,LMO1
chembl:CHEMBL1326164,CHEMBL1326164
HP:0010530,Palatal tremor
chembl:CHEMBL399043,THIOLACTOMYCIN
chembl:CHEMBL215152,AZD-1152-HQPA
chembl:CHEMBL1510,ELETRIPTAN
chembl:CHEMBL16685,CHEMBL16685
CHEBI:474053,cefazolin
chembl:CHEMBL2437368,LICOAGRODIN
chembl:CHEMBL2355051,CLOMIPHENE
HP:0001344,Absent speech
chembl:CHEMBL219586,GW590735
CHEBI:50249,anticoagulant
MONDO:0032781,"congenital hypotonia, epilepsy, developmental delay, and digital anomalies"
HGNC:5382,IDH1
HGNC:1725,CDC25A
HP:0034353,Appendicular spasticity
MONDO:0006732,drug-induced dyskinesia
chembl:CHEMBL521078,PORFIROMYCIN
chembl:CHEMBL1200543,ANILERIDINE PHOSPHATE
chembl:CHEMBL1200826,LITHIUM CARBONATE
HGNC:11969,TNRC6A
chembl:CHEMBL2178583,CHEMBL2178583
HGNC:21077,CMTR1
HGNC:1460,CAMK2A
HP:0006813,Focal hemiclonic seizure
chembl:CHEMBL285819,CHEMBL285819
CHEBI:16330,17beta-hydroxy-5alpha-androstan-3-one
CHEBI:65173,iloperidone
HP:0008763,No social interaction
HP:0001583,Rotary nystagmus
HGNC:17152,ACOT9
GO:0042908,xenobiotic transport
HGNC:13709,DEGS1
chembl:CHEMBL114283,DANIQUIDONE
chembl:CHEMBL259819,CHEMBL259819
HP:0006801,Hyperactive deep tendon reflexes
HGNC:24667,MAPK15
MONDO:0001391,indeterminate leprosy
HGNC:17095,LARS2
HP:0012745,Short palpebral fissure
HGNC:18423,DEPDC5
MONDO:0024607,congenital muscular dystrophy with cataracts and intellectual disability
WB:WBGene00000416,ced-2
chembl:CHEMBL292303,D-TRYPTOPHAN
chembl:CHEMBL1236936,CINACIGUAT
chembl:CHEMBL281594,VANOXERINE
chembl:CHEMBL260342,CHEMBL260342
chembl:CHEMBL3747513,CB-5083
HP:0012762,Cerebral white matter atrophy
HGNC:8809,PDK1
chembl:CHEMBL89295,SODIUM AZIDE
HGNC:29255,USP53
chembl:CHEMBL1972216,CHEMBL1972216
chembl:CHEMBL1375444,AZEPANE
MONDO:0007171,atrial standstill 1
HGNC:8881,PFN1
HP:0000550,Undetectable electroretinogram
HP:0007326,Progressive choreoathetosis
HGNC:2698,DBT
chembl:CHEMBL1672332,BUTYRYLHYDROXAMIC ACID
GO:0034614,cellular response to reactive oxygen species
MONDO:0014113,cardiofaciocutaneous syndrome 3
chembl:CHEMBL351585,PAPAVEROLINE
chembl:CHEMBL576982,QUIZARTINIB
chembl:CHEMBL463701,CHEMBL463701
HGNC:3072,DUSP6
GO:0033300,dehydroascorbic acid transmembrane transporter activity
chembl:CHEMBL3137346,PEGARGIMINASE
chembl:CHEMBL1201571,ALEFACEPT
chembl:CHEMBL539507,CLORGYLINE HYDROCHLORIDE
chembl:CHEMBL3707228,PLOZALIZUMAB
chembl:CHEMBL3545184,VELCALCETIDE
CHEBI:133610,N-isobutyrylglycinate
chembl:CHEMBL1451,TRIAMCINOLONE
HGNC:20305,SLC34A3
chembl:CHEMBL1200374,EXEMESTANE
chembl:CHEMBL4297855,TECHNETIUM TC-99M TROFOLASTAT CHLORIDE
chembl:CHEMBL31601,REMIKIREN
HP:0031722,Near esotropia
MONDO:0030505,"cholestasis, progressive familial intrahepatic, 8"
Reactome:R-CFA-611105,Respiratory electron transport
CHEBI:26191,polyol
chembl:CHEMBL118,CELECOXIB
chembl:CHEMBL2105864,LABRADIMIL
HGNC:13518,CLIC4
chembl:CHEMBL221300,CHEMBL221300
chembl:CHEMBL1944698,ZOTIRACICLIB
chembl:CHEMBL536008,CHEMBL536008
chembl:CHEMBL458765,CHEMBL458765
GO:0005789,endoplasmic reticulum membrane
chembl:CHEMBL577711,LY-2334737
chembl:CHEMBL152632,NIRIDAZOLE
chembl:CHEMBL127071,POZANICLINE
chembl:CHEMBL4298169,TROPIFEXOR
HP:0007164,Slowed slurred speech
chembl:CHEMBL578109,CHEMBL578109
chembl:CHEMBL589,ROPINIROLE
chembl:CHEMBL1097474,GANODERIC ACID TR
chembl:CHEMBL1332314,DISULFOTON
HGNC:4580,GRIK2
chembl:CHEMBL15193,LAPACHOL
chembl:CHEMBL1604,CEPHRADINE
chembl:CHEMBL961,DITIOCARB
HGNC:14004,ANO3
MONDO:0010444,X-linked dyserythropoetic anemia with abnormal platelets and neutropenia
chembl:CHEMBL220492,TOPIRAMATE
chembl:CHEMBL25236,BP-897
HGNC:9280,PPOX
chembl:CHEMBL252915,SESAMIN
chembl:CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE
NCBIGene:475322,NDUFS5
MONDO:1011336,"nervous system disorder, non-human animal"
MGI:1328362,Blm
HGNC:9532,PSMA3
chembl:CHEMBL454173,ZEARALENONE
chembl:CHEMBL578719,CHEMBL578719
chembl:CHEMBL566534,ARTEMETHER
chembl:CHEMBL579318,CHEMBL579318
chembl:CHEMBL155622,NIPRADILOL
chembl:CHEMBL1333953,PHENYLMERCURIC ACETATE
chembl:CHEMBL279898,ENPROFYLLINE
chembl:CHEMBL1597,DIMERCAPROL
MONDO:0004114,urinary bladder small cell neuroendocrine carcinoma
HGNC:51483,LINC02210-CRHR1
HGNC:3374,EPAS1
MGI:1923957,Clasp1
chembl:CHEMBL409450,6BIO
chembl:CHEMBL3545296,ARQ-736
HGNC:4600,GRM8
chembl:CHEMBL373742,VASOPRESSIN
chembl:CHEMBL1801204,AZD-8055
chembl:CHEMBL1630,AMODIAQUINE HYDROCHLORIDE
chembl:CHEMBL463065,DESACETYLBUFOTALIN
HGNC:1748,CDH1
chembl:CHEMBL1200495,HYDROCORTISONE SODIUM SUCCINATE
chembl:CHEMBL1256754,CHEMBL1256754
chembl:CHEMBL221047,CHEMBL221047
HGNC:2264,COX17
chembl:CHEMBL413,SIROLIMUS
MONDO:0009300,Perrault syndrome 1
chembl:CHEMBL267345,AMPHOTERICIN B
ZFIN:ZDB-GENE-050417-263,coq10b
HGNC:9602,PTGIR
chembl:CHEMBL1421,DASATINIB
MONDO:0020046,autosomal recessive degenerative and progressive cerebellar ataxia
chembl:CHEMBL3039540,ADUCANUMAB
GO:1901327,response to tacrolimus
chembl:CHEMBL387152,CHEMBL387152
HGNC:6663,LORICRIN
chembl:CHEMBL587772,CHEMBL587772
chembl:CHEMBL1232510,SOLITHROMYCIN
HGNC:9763,RAB2A
chembl:CHEMBL1697838,GLYMIDINE
chembl:CHEMBL482050,CHEMBL482050
chembl:CHEMBL3287218,PF-5190457
CHEBI:33295,diagnostic agent
NCBIGene:616109,UQCR10
MONDO:0001358,bronchial disorder
chembl:CHEMBL1569,AMANTADINE HYDROCHLORIDE
chembl:CHEMBL416288,(S)APOMORPHINE
chembl:CHEMBL286721,AMINOPURVALANOL
chembl:CHEMBL3183075,NIZATIDINE
CHEBI:26188,polyketide
chembl:CHEMBL303336,CHEMBL303336
chembl:CHEMBL289233,IODOMELATONIN
HGNC:1565,ACKR2
chembl:CHEMBL405130,WHI-P131
HGNC:17175,PLCE1
chembl:CHEMBL3545173,IRX4310
chembl:CHEMBL1532097,DIHYDRODAPHNODORIN B
HGNC:14405,KIF13B
HGNC:14342,C1QTNF7
HGNC:8912,PHB1
chembl:CHEMBL408500,CHEMBL408500
chembl:CHEMBL241608,CALYCOSIN
chembl:CHEMBL17350,TRAXOPRODIL
MONDO:0012265,preeclampsia/eclampsia 3
HGNC:592,XIAP
chembl:CHEMBL38508,CHEMBL38508
HGNC:445,SETX
chembl:CHEMBL175,DEXIBUPROFEN
chembl:CHEMBL589946,CHEMBL589946
chembl:CHEMBL288174,CHEMBL288174
HGNC:29944,TENM3
chembl:CHEMBL502835,NINTEDANIB
chembl:CHEMBL1232583,INDEGLITAZAR
chembl:CHEMBL58323,ERLOSAMIDE
HGNC:7060,MGP
chembl:CHEMBL3545106,TM30339
HGNC:21367,CGAS
wikidata:Q47521323,CASODEX
MONDO:0021465,benign neoplasm of appendix
MONDO:0015547,hereditary dementia
MGI:1351342,Grm5
chembl:CHEMBL46516,FLUSPIRILENE
chembl:CHEMBL1416084,PROPARGITE
chembl:CHEMBL1200805,DILTIAZEM MALATE
HP:0025682,Crouch gait
chembl:CHEMBL2171793,CHEMBL2171793
CL:0002255,stromal cell of endometrium
chembl:CHEMBL85194,CHEMBL85194
chembl:CHEMBL1200881,MINOCYCLINE HYDROCHLORIDE
chembl:CHEMBL1236854,XANTHOPTERIN
chembl:CHEMBL3545276,CP-778875
CHEBI:142517,tschimganine
HGNC:30035,PIK3R5
HGNC:1005,BCL7B
chembl:CHEMBL242580,CICLOPIROX OLAMINE
chembl:CHEMBL263664,CHEMBL263664
HGNC:1583,CCND2
chembl:CHEMBL4297310,ONC-201
chembl:CHEMBL1201124,KETOROLAC TROMETHAMINE
chembl:CHEMBL3545365,ALTIRATINIB
chembl:CHEMBL491473,CEDIRANIB
chembl:CHEMBL104264,CHEMBL104264
chembl:CHEMBL601743,CHEMBL601743
HGNC:7716,NDUFV1
chembl:CHEMBL31,GATIFLOXACIN
chembl:CHEMBL94007,ETHACRIDINE
chembl:CHEMBL2208197,CHEMBL2208197
chembl:CHEMBL578220,CHEMBL578220
HGNC:1473,CANX
chembl:CHEMBL28,APIGENIN
MGI:2148520,Vmn1r41
MGI:1095438,Slc2a2
GO:0009060,aerobic respiration
HP:0008984,Neck muscle hypoplasia
HGNC:1557,CBX7
chembl:CHEMBL1336,SORAFENIB
HP:0000488,Retinopathy
chembl:CHEMBL2062154,CI-988
chembl:CHEMBL650,METHYLPREDNISOLONE
HGNC:7479,MT-TE
MONDO:0030027,"tremor, hereditary essential, 6"
HGNC:1304,MRAP
chembl:CHEMBL2109617,HUMAX-IL8
MONDO:0006980,struma ovarii
HGNC:7720,NEB
chembl:CHEMBL1355965,DIENOCHLOR
ZFIN:ZDB-GENE-070524-2,drd1b
HGNC:1771,CDK2
HGNC:393,AKT3
ZFIN:ZDB-GENE-040426-1963,sucla2
HP:0007109,Periventricular cysts
HGNC:12463,UBB
chembl:CHEMBL261663,TETRANITROMETHANE
HP:0100738,Abnormal eating behavior
HP:0008770,Obsessive-compulsive trait
HGNC:32068,MICOS10
chembl:CHEMBL275006,GYKI-52466
chembl:CHEMBL2218872,VAPREOTIDE ACETATE
chembl:CHEMBL187216,CHEMBL187216
HP:0011856,Pica
GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding
chembl:CHEMBL13786,CHEMBL13786
chembl:CHEMBL2381408,SAR-405838
CHEBI:18420,magnesium(2+)
chembl:CHEMBL274654,ORANTINIB
chembl:CHEMBL3039516,GEMCITABINE ELAIDATE
HGNC:5384,IDH3A
HGNC:17274,TRIM29
chembl:CHEMBL3545176,DB959
CL:0000655,secondary oocyte
HGNC:9891,RBBP8
chembl:CHEMBL827,DEXMETHYLPHENIDATE
chembl:CHEMBL1416006,EVOXINE
chembl:CHEMBL528463,CHEMBL528463
chembl:CHEMBL312862,DEMECOLCINE
HGNC:8124,OGDH
HGNC:1789,CDKN2C
chembl:CHEMBL2109308,ONCOLYSIN B
ZFIN:ZDB-GENE-050417-274,ndufs3
chembl:CHEMBL585654,CHEMBL585654
chembl:CHEMBL17205,CYCLOVALONE
HGNC:6570,LGALS9
MONDO:0013866,neuronal ceroid lipofuscinosis 11
chembl:CHEMBL584520,CHEMBL584520
chembl:CHEMBL3545330,MSX-122
chembl:CHEMBL669,CYCLOBENZAPRINE
HP:0003713,Muscle fiber necrosis
chembl:CHEMBL583558,CHEMBL583558
chembl:CHEMBL2109159,PITRAKINRA
GO:0098674,extrinsic component of neuronal dense core vesicle membrane
UBERON:0000997,mammalian vulva
chembl:CHEMBL578502,CHEMBL578502
chembl:CHEMBL585686,CHEMBL585686
HP:0000188,Short upper lip
MGI:1917816,Abhd17b
HGNC:21146,ZMYND19
chembl:CHEMBL1374986,BISSALICYL FUMARATE
chembl:CHEMBL14193,4-HYDROXYBENZALDEHYDE
HGNC:1884,CFTR
UBERON:0001870,frontal cortex
chembl:CHEMBL517712,ATROPINE
wikidata:Q419808,SAPROPTERIN
chembl:CHEMBL1270169,CHEMBL1270169
HGNC:17170,TRUB2
HP:0031826,Abnormal reflex
HGNC:9051,PLAT
chembl:CHEMBL214154,MAYTANSINOL
HGNC:7125,MLF1
CHEBI:38166,organic heteropolycyclic compound
HGNC:23641,NIPSNAP3B
chembl:CHEMBL585591,CHEMBL585591
chembl:CHEMBL408,TROGLITAZONE
chembl:CHEMBL1200987,EPROSARTAN MESYLATE
HGNC:1161,CEP55
chembl:CHEMBL3646221,VADADUSTAT
MONDO:0006134,cervical adenosquamous carcinoma
chembl:CHEMBL587923,CHEMBL587923
chembl:CHEMBL37744,ZIMELDINE
HGNC:1541,CBL
CHEBI:16189,sulfate
GO:0036457,keratohyalin granule
chembl:CHEMBL568150,CHEMBL568150
HP:0006943,Diffuse spongiform leukoencephalopathy
HGNC:19737,TNS2
HGNC:1185,TIGAR
HP:0000742,Self-mutilation
chembl:CHEMBL1990783,CHEMBL1990783
HGNC:7127,MLH1
chembl:CHEMBL2109539,RG-7652
chembl:CHEMBL267160,CHEMBL267160
GO:0097232,lamellar body membrane
chembl:CHEMBL502529,NAKIJIQUINONES G
chembl:CHEMBL480477,GLABRIDIN
MONDO:0100118,hereditary skin disorder
chembl:CHEMBL23194,SPERMINE
chembl:CHEMBL54126,NEOSTIGMINE BROMIDE
chembl:CHEMBL2354444,PIRARUBICIN
HGNC:28321,ANKRD22
HGNC:167,ACTR1A
MONDO:0001613,vertebrobasilar insufficiency
MONDO:0015405,cerebrofacial arteriovenous metameric syndrome
HGNC:9621,TWF2
HGNC:8031,NTRK1
chembl:CHEMBL293030,BUNOLOL
chembl:CHEMBL303483,PHYLLODULCIN
HGNC:9232,PPARA
MONDO:0011687,Charcot-Marie-Tooth disease axonal type 2F
chembl:CHEMBL1650619,PYRITHIONE
chembl:CHEMBL1567328,OMEPRAZOLE MAGNESIUM
MONDO:0005306,ankylosing spondylitis
chembl:CHEMBL1200387,AMPHETAMINE ADIPATE
HP:0003546,Exercise intolerance
chembl:CHEMBL3545057,ACETYLDIGITOXIN
CHEBI:28748,doxorubicin
HGNC:2389,CRYAB
HGNC:5961,IKBKG
chembl:CHEMBL228511,DICOFOL
HGNC:8804,PDGFRB
chembl:CHEMBL151,LUTEOLIN
HGNC:84,ACACA
chembl:CHEMBL2109037,ILODECAKIN
chembl:CHEMBL24,ATENOLOL
HGNC:30959,ZC3H7A
HGNC:1773,CDK4
HGNC:21033,HACE1
chembl:CHEMBL456559,CHEMBL456559
chembl:CHEMBL4297526,REMIMAZOLAM
chembl:CHEMBL2104927,FIGOPITANT
chembl:CHEMBL2105705,LUNACALCIPOL
HGNC:16999,CLP1
HGNC:10421,RPS3A
MONDO:0016892,partial deletion of the short arm of chromosome 10
GO:0001221,transcription coregulator binding
chembl:CHEMBL98,VORINOSTAT
HGNC:20001,PCSK9
chembl:CHEMBL1200560,GUANABENZ ACETATE
MGI:2156687,Slc2a10
NCBIGene:474479,CYB5R3
chembl:CHEMBL3545074,LEO-15520
MONDO:0005265,inflammatory bowel disease
chembl:CHEMBL1200398,BUTOCONAZOLE NITRATE
HGNC:28270,R3HDM4
HGNC:7493,MT-TN
HP:0000066,Labial hypoplasia
MONDO:0011366,ovarian germ cell tumor
CHEBI:18946,delta-lactone
chembl:CHEMBL91,MICONAZOLE
UPHENO:0079834,abnormal irritability behavior
HGNC:4331,GLS
HP:0000741,Apathy
HP:0030186,Kinetic tremor
HGNC:783,ATF1
chembl:CHEMBL2109295,ASCRINVACUMAB
HGNC:7871,NONO
HP:0000097,Focal segmental glomerulosclerosis
FB:FBgn0010100,mAcon1
HP:0000341,Narrow forehead
chembl:CHEMBL115,INDINAVIR
chembl:CHEMBL1201486,QUINIDINE POLYGALACTURONATE
chembl:CHEMBL2110563,CYANOCOBALAMIN
chembl:CHEMBL1200408,PANTOPRAZOLE SODIUM
chembl:CHEMBL261237,CHEMBL261237
CHEBI:9948,verapamil
HGNC:21163,MDC1
HP:0002133,Status epilepticus
HP:0002062,Morphological abnormality of the pyramidal tract
HGNC:9179,POLG
MONDO:0004663,colon carcinoma in situ
chembl:CHEMBL1923502,ULIMORELIN HYDROCHLORIDE
GO:0005770,late endosome
chembl:CHEMBL566757,DAPORINAD
chembl:CHEMBL3545235,SIMOTINIB
HGNC:11076,NHERF2
chembl:CHEMBL220241,GSK-269962A
chembl:CHEMBL1213033,APRINDINE
HGNC:18572,HSDL2
MONDO:0000001,disease
MONDO:0007920,lymphatic malformation 5
chembl:CHEMBL135400,ZOPICLONE
CHEBI:26788,streptomycins
HP:0003072,Hypercalcemia
chembl:CHEMBL4297863,REMTOLUMAB
chembl:CHEMBL1632,CEPHALOTHIN SODIUM
chembl:CHEMBL607309,CHEMBL607309
HGNC:4398,GNB2
HGNC:16903,TNIP1
chembl:CHEMBL1946170,REGORAFENIB
chembl:CHEMBL78920,CHEMBL78920
chembl:CHEMBL313244,4-METHYLESCULETIN
chembl:CHEMBL3137342,DINUTUXIMAB
HGNC:17190,OLFM4
HGNC:2631,CYP2E1
chembl:CHEMBL648,CYCLIZINE
HGNC:26407,LSM12
HGNC:25250,ADPGK
MONDO:0016751,malignant perineurioma
HGNC:12612,USP14
HGNC:2431,CSE1L
HGNC:17359,NUP54
UPHENO:0081739,increased reflex in pectoral complex
chembl:CHEMBL1200825,METHADONE HYDROCHLORIDE
UPHENO:0026492,absent vestibular nerve in the vestibulocochlear nerve
chembl:CHEMBL1303,ROTIGOTINE
chembl:CHEMBL398338,ABT-102
HGNC:8062,NUP153
HGNC:3436,ERCC4
HGNC:29006,SEC16A
chembl:CHEMBL1200890,OXYCODONE HYDROCHLORIDE
chembl:CHEMBL275563,ISOVANILLIN
chembl:CHEMBL2108370,INOLIMOMAB
chembl:CHEMBL1242101,CHEMBL1242101
HP:0006844,Absent patellar reflexes
HP:0033206,Hyperactive Achilles reflex
MONDO:0800043,StÃ¼ve-Wiedemann syndrome 1
HGNC:4241,GFPT1
chembl:CHEMBL3545351,AV-101
chembl:CHEMBL2108715,EMEPEPIMUT-S
MONDO:0002066,breast adenomyoepithelioma
chembl:CHEMBL505670,CHEMBL505670
chembl:CHEMBL1233,CARISOPRODOL
CHEBI:26509,quinoline alkaloid
chembl:CHEMBL459769,TASOCITINIB
chembl:CHEMBL225230,R-N-PROPYLNORAPOMORPHINE
chembl:CHEMBL838,BENAZEPRIL
CHEBI:3766,clozapine
chembl:CHEMBL511142,BUPRENORPHINE
chembl:CHEMBL606166,CHEMBL606166
chembl:CHEMBL101690,CHEMBL101690
chembl:CHEMBL1200795,CLEMASTINE FUMARATE
HGNC:12669,VDAC1
MONDO:0004286,pancreatic intraductal papillary-mucinous neoplasm
HGNC:868,ATP6AP1
chembl:CHEMBL450449,TRABECTEDIN
chembl:CHEMBL456341,LENABASUM
MONDO:0012432,Joubert syndrome 5
HGNC:25519,ANO10
HGNC:19297,TNK2
MONDO:0002912,brainstem cancer
chembl:CHEMBL4297926,CJM-112
HGNC:24666,FAF2
UPHENO:0080582,abnormal sexual inhibition
HP:0100963,Hyperesthesia
chembl:CHEMBL530291,CHEMBL530291
chembl:CHEMBL3545161,LY545694
HGNC:6190,JAK1
HP:0000617,Abnormality of ocular smooth pursuit
HGNC:17851,REXO2
NCBIGene:770937,UQCR10
chembl:CHEMBL1518572,CHEMBL1518572
HGNC:3435,ERCC3
chembl:CHEMBL75978,5-DEMETHYLNOBILETIN
GO:0045893,positive regulation of DNA-templated transcription
chembl:CHEMBL410683,GUGGULSTERONE
chembl:CHEMBL600773,CHEMBL600773
chembl:CHEMBL524407,CHEMBL524407
chembl:CHEMBL1448292,CHEMBL1448292
chembl:CHEMBL562668,OTENABANT
chembl:CHEMBL3545339,FRUQUINTINIB
chembl:CHEMBL1783256,AZD6280
chembl:CHEMBL267458,BMS-182874
chembl:CHEMBL75435,DEXKETOPROFEN
chembl:CHEMBL395429,OXYTOCIN
chembl:CHEMBL591,ETHCHLORVYNOL
HGNC:18154,RNF115
chembl:CHEMBL1090771,AVAGACESTAT
ZFIN:ZDB-GENE-040426-874,sdha
chembl:CHEMBL121626,TOLFENAMIC ACID
HGNC:18025,COA6
chembl:CHEMBL52939,SARPOGRELATE
chembl:CHEMBL538104,CHEMBL538104
chembl:CHEMBL1201336,FOSPHENYTOIN
chembl:CHEMBL12856,INAMRINONE
chembl:CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE
chembl:CHEMBL981,FENOFIBRIC ACID
chembl:CHEMBL456807,PHENYLHYDRAZINE
HGNC:7530,MVK
chembl:CHEMBL457092,BESTATIN METHYL ESTER
chembl:CHEMBL70880,CHEMBL70880
chembl:CHEMBL296021,CHEMBL296021
chembl:CHEMBL1222038,SECRAMINE A
MONDO:0024613,bipolar depression
WB:WBGene00019760,calu-1
chembl:CHEMBL141,LAMIVUDINE
chembl:CHEMBL273453,ALDOSTERONE
chembl:CHEMBL1354502,KOPARIN
chembl:CHEMBL32749,FERULIC ACID
chembl:CHEMBL113262,METHOXYARACHIDONOYL FLUOROPHOSPHONATE
chembl:CHEMBL296588,PEPSTATIN
HGNC:3774,FMOD
HGNC:4812,HAP1
chembl:CHEMBL3544988,DAPRODUSTAT
chembl:CHEMBL39317,L-694247
HGNC:17146,ARL2BP
HGNC:1493,CARS1
MONDO:0005227,abscess
HGNC:4593,GRM1
HP:0007042,Focal white matter lesions
CHEBI:28304,heparin
chembl:CHEMBL2108308,TERTOMOTIDE
chembl:CHEMBL1195,PROPOXYCAINE
chembl:CHEMBL2108361,AMEDIPLASE
HP:0000708,Atypical behavior
HGNC:7455,MT-ND1
HP:0006977,Deficit in grammar
HP:0001156,Brachydactyly
HP:0007843,Attenuation of retinal blood vessels
HGNC:10474,RUVBL1
chembl:CHEMBL250892,(R)-MELPHALAN
chembl:CHEMBL15848,ANANDAMIDE
chembl:CHEMBL3545227,NGD-8243
HGNC:14351,CLEC2D
HGNC:6846,MAP2K6
chembl:CHEMBL3707294,DEPATUXIZUMAB
chembl:CHEMBL1237023,DENOSUMAB
HP:0000157,Abnormality of the tongue
chembl:CHEMBL230006,ENOXOLONE
Reactome:R-BTA-500753,Pyrimidine biosynthesis
HGNC:6199,JRK
chembl:CHEMBL1797159,CHEMBL1797159
chembl:CHEMBL259084,MLN-8054
chembl:CHEMBL2109193,GAVILIMOMAB
chembl:CHEMBL1565322,NIHYDRAZONE
chembl:CHEMBL65717,MEPINDOLOL
chembl:CHEMBL1504679,CHEMBL1504679
chembl:CHEMBL2333543,CHEMBL2333543
chembl:CHEMBL171699,CHEMBL171699
Xenbase:XB-GENE-982586,cln6
HP:0009004,Hypoplasia of the musculature
chembl:CHEMBL589717,CHEMBL589717
chembl:CHEMBL28564,ELIPRODIL
MONDO:0013258,"autism, susceptibility to, 16"
chembl:CHEMBL4297384,GSK-356278
CHEBI:61057,tacrolimus hydrate
chembl:CHEMBL1452868,SPHONDIN
chembl:CHEMBL176570,PSOROMIC ACID
chembl:CHEMBL111654,2-MERCAPTOBENZOTHIAZOLE
chembl:CHEMBL1172,DESLORATADINE
chembl:CHEMBL3545269,SAR425899
chembl:CHEMBL1750,CLOFARABINE
wikidata:Q3997863,ADO-TRASTUZUMAB EMTANSINE
chembl:CHEMBL528647,CHEMBL528647
HGNC:11443,STX8
GO:0031526,brush border membrane
HP:0010818,Generalized tonic seizure
chembl:CHEMBL3545272,LAS190792
chembl:CHEMBL1743047,NECITUMUMAB
chembl:CHEMBL448213,LINURON
MONDO:0100320,post-COVID-19 disorder
chembl:CHEMBL513108,DIPLAMINE B
MONDO:0016058,paroxysmal dystonia
GO:0007286,spermatid development
HGNC:5234,HSPA1L
HGNC:53924,NOTCH2NLC
HGNC:20093,ADSS1
chembl:CHEMBL590212,CHEMBL590212
CHEBI:64390,N-hexanoylglycine
HP:0001281,Tetany
chembl:CHEMBL1447476,BITHIONOLATE SODIUM
CHEBI:30839,orotate
HP:0007441,Hyperpigmented/hypopigmented macules
chembl:CHEMBL259421,CHEMBL259421
chembl:CHEMBL1200986,HALOPERIDOL DECANOATE
chembl:CHEMBL3545220,LY2590443
HGNC:543,ANXA5
HP:0010866,Abdominal wall defect
chembl:CHEMBL4084907,BIMIRALISIB
chembl:CHEMBL1456,MYCOPHENOLATE MOFETIL
HP:0001460,Aplasia/Hypoplasia involving the skeletal musculature
chembl:CHEMBL1199080,BRETYLIUM
chembl:CHEMBL1442660,BUTINOLINE
MONDO:0956977,near-fatal asthma
HP:0003552,Muscle stiffness
HGNC:7713,NDUFS6
MONDO:0011743,Alzheimer disease 4
chembl:CHEMBL34398,4'-METHOXYCHALCONE
chembl:CHEMBL1287853,FEDRATINIB
HGNC:15983,WNT3A
HP:0000176,Submucous cleft hard palate
chembl:CHEMBL1308,FOMEPIZOLE
chembl:CHEMBL197669,ST1535
HGNC:117,ACO1
HP:0000021,Megacystis
CHEBI:19168,17-oxo steroid
HGNC:28492,FAM76B
chembl:CHEMBL1082407,ENZALUTAMIDE
chembl:CHEMBL233929,GALUTEOLIN
HP:0006929,Hypoglycemic encephalopathy
chembl:CHEMBL1339265,CYCLIRAMINE MALEATE
chembl:CHEMBL1371125,BENZO[E]PYRENE
GO:0008361,regulation of cell size
chembl:CHEMBL1200377,AMPHETAMINE ASPARTATE
chembl:CHEMBL260028,CHEMBL260028
MONDO:0007533,elliptocytosis 2
HP:0001254,Lethargy
chembl:CHEMBL1334191,CHEMBL1334191
chembl:CHEMBL267431,ASOPRISNIL
RGD:621551,Cyb5b
chembl:CHEMBL4297348,"BRIMAPITIDE, C-TERMINAL ACID"
HP:0009591,Abnormality of the vestibulocochlear nerve
chembl:CHEMBL483302,CHEMBL483302
HGNC:12592,UROS
HGNC:10252,ROCK2
chembl:CHEMBL1201731,NEBIVOLOL HYDROCHLORIDE
chembl:CHEMBL244707,CHEMBL244707
chembl:CHEMBL2108324,OBLIMERSEN
HGNC:4092,GAD1
chembl:CHEMBL8946,ETICLOPRIDE
chembl:CHEMBL314639,CHEMBL314639
chembl:CHEMBL1200692,OLMESARTAN MEDOXOMIL
chembl:CHEMBL1704,TIROFIBAN HYDROCHLORIDE
chembl:CHEMBL1254771,SAFOTIBANT
chembl:CHEMBL1619528,PIPENZOLATE
chembl:CHEMBL3989951,NAVOXIMOD
MONDO:0005008,colorectal adenocarcinoma
chembl:CHEMBL548,DINOPROSTONE
chembl:CHEMBL491960,CAMBINOL
chembl:CHEMBL190333,RWJ-67657
HGNC:30077,REEP5
chembl:CHEMBL594426,PHOTOFRIN
chembl:CHEMBL1201746,PRALATREXATE
HP:0012672,Akinetic mutism
chembl:CHEMBL466465,CHEMBL466465
GO:0006287,"base-excision repair, gap-filling"
HGNC:11065,SLC7A7
chembl:CHEMBL2103858,NARONAPRIDE
chembl:CHEMBL3545029,ABT-288
MONDO:0005113,bacterial infectious disease
chembl:CHEMBL29757,D-ASPARTATE
UBERON:0000006,islet of Langerhans
chembl:CHEMBL1162,NORETHINDRONE
chembl:CHEMBL497392,CHEMBL497392
chembl:CHEMBL302795,TENOXICAM
HP:0002607,Bowel incontinence
CHEBI:529996,cytochalasin D
chembl:CHEMBL1200782,DEXTROAMPHETAMINE ADIPATE
HGNC:11986,TOP1
chembl:CHEMBL405914,CHEMBL405914
chembl:CHEMBL4298077,PRASINEZUMAB
chembl:CHEMBL379300,A-443654
chembl:CHEMBL1200474,DEMECLOCYCLINE HYDROCHLORIDE
HGNC:12666,VCP
Reactome:R-MMU-71288,Creatine metabolism
chembl:CHEMBL240773,QUINPIROLE
HGNC:6764,MAD2L2
HP:0001649,Tachycardia
Reactome:R-DME-549127,Organic cation transport
chembl:CHEMBL328250,ADINAZOLAM
HGNC:10588,SCN2A
HGNC:2603,CYP26A1
chembl:CHEMBL47,VITAMIN E
chembl:CHEMBL1092743,CHEMBL1092743
chembl:CHEMBL1989750,CHEMBL1989750
chembl:CHEMBL449063,CHEMBL449063
chembl:CHEMBL2108675,DUPILUMAB
GO:0019899,enzyme binding
chembl:CHEMBL502109,BENZALKONIUM CHLORIDE
wikidata:Q30314624,TISAGENLECLEUCEL
GO:0008333,endosome to lysosome transport
chembl:CHEMBL1230609,FORETINIB
wikidata:Q47521803,MARINOL
MONDO:0009131,Riley-Day syndrome
HP:0000768,Pectus carinatum
chembl:CHEMBL107498,DECANOIC ACID
chembl:CHEMBL2109602,IMC-3C5
HGNC:3312,ELAVL1
MONDO:0008769,neuronal ceroid lipofuscinosis 2
CHEBI:33019,diphosphate(3-)
HGNC:12691,EZR
HGNC:21690,GET4
HGNC:14256,BRPF3
CHEBI:37565,GTP(4-)
HP:0100034,Motor tics
HGNC:15455,MBTPS2
HP:0003477,Peripheral axonal neuropathy
chembl:CHEMBL1236469,DIOTYROSINE
chembl:CHEMBL270362,CALANOLIDE A
chembl:CHEMBL2103738,LITHIUM CITRATE
chembl:CHEMBL2205230,TAK-441
chembl:CHEMBL294264,PURPURIN
chembl:CHEMBL633,AMIODARONE
chembl:CHEMBL1794051,CHEMBL1794051
chembl:CHEMBL742,KETAMINE
chembl:CHEMBL431770,ISTRADEFYLLINE
HGNC:15517,XYLT2
HGNC:3356,ENPP1
CHEBI:27560,boron atom
MONDO:0012883,acute promyelocytic leukemia
chembl:CHEMBL271068,ROSABULIN
chembl:CHEMBL248564,CORONOPILIN
CHEBI:59137,(8xi)-cinchonan
chembl:CHEMBL1201192,ARMODAFINIL
CHEBI:48626,pyranoindolizinoquinoline
CHEBI:72564,temozolomide
chembl:CHEMBL541585,CHEMBL541585
HGNC:8599,PANX1
chembl:CHEMBL513000,EMETINE HYDROCHLORIDE
MONDO:0018242,autoimmune hypoparathyroidism
MONDO:0011151,exudative vitreoretinopathy 4
HGNC:16627,CHEK2
chembl:CHEMBL3963485,ROGARATINIB
chembl:CHEMBL1615438,LEVOCABASTINE
HP:0025352,Typically de novo
HGNC:1116,BSG
chembl:CHEMBL584235,CHEMBL584235
FB:FBgn0003257,r-l
HGNC:2024,CLCN6
HP:0100816,Lip hyperpigmentation
chembl:CHEMBL1513985,ANTHRACENE-9-CARBOXYLIC ACID
MONDO:0011858,"spastic paraplegia, ataxia, and intellectual disability"
HP:0031139,Frog-leg posture
HGNC:9670,PTPRF
MONDO:0010246,"developmental and epileptic encephalopathy, 9"
MONDO:0013888,"tremor, hereditary essential, 4"
HP:0033063,Shortened sleep cycle
NCBIGene:478981,NDUFS2
chembl:CHEMBL597248,CHEMBL597248
CHEBI:15971,L-histidine
MONDO:0030355,"facioscapulohumeral muscular dystrophy 4, digenic"
HGNC:25666,ATOSB
HGNC:5394,CFI
chembl:CHEMBL1256845,CHEMBL1256845
chembl:CHEMBL3545238,CS-8080
HGNC:29434,RC3H1
GO:0048471,perinuclear region of cytoplasm
MONDO:0032814,"microangiopathy and leukoencephalopathy, pontine, autosomal dominant"
MONDO:0024237,inherited neurodegenerative disorder
HGNC:20090,DNAJC1
MONDO:0018002,adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
HGNC:5295,HTR2C
HP:0100513,Decreased circulating vitamin E concentration
chembl:CHEMBL421215,CHEMBL421215
chembl:CHEMBL4297067,FLUORESCEIN
HGNC:7573,MYH3
chembl:CHEMBL445177,GINGKOLIC ACID
MONDO:0010080,familial infantile bilateral striatal necrosis
HGNC:11547,TAF15
chembl:CHEMBL480558,GSI-136
chembl:CHEMBL3545078,PF-03814735
MONDO:0005240,kidney disorder
chembl:CHEMBL268291,DIMETHYLFORMAMIDE
HP:0001941,Acidosis
chembl:CHEMBL24944,TRIBROMSALAN
NCBIGene:475739,COX7A2L
chembl:CHEMBL382300,ORTATAXEL
CHEBI:28757,fructose
chembl:CHEMBL1997854,VERMISTATIN
HGNC:4829,HBD
HP:0008959,Distal upper limb muscle weakness
chembl:CHEMBL240624,PRELADENANT
chembl:CHEMBL2171807,CHEMBL2171807
HGNC:14562,BET1
chembl:CHEMBL1200856,THIETHYLPERAZINE MALEATE
chembl:CHEMBL279785,MARIMASTAT
chembl:CHEMBL600107,CHEMBL600107
chembl:CHEMBL434394,NEBIVOLOL
chembl:CHEMBL1200491,EPINASTINE HYDROCHLORIDE
HGNC:2843,DGAT1
HGNC:17075,TAB2
chembl:CHEMBL477197,HEMATOXYLIN
MGI:1915271,Bphl
MONDO:0007915,systemic lupus erythematosus
chembl:CHEMBL1201002,CARTEOLOL HYDROCHLORIDE
HGNC:861,ATP6V0B
chembl:CHEMBL1201438,ALDESLEUKIN
HP:0011352,Severe receptive language delay
HGNC:9056,PLCB3
HGNC:23251,AWAT2
chembl:CHEMBL210574,PYROCATECHOL VIOLET
chembl:CHEMBL173530,STICTIC ACID
chembl:CHEMBL3286580,IDALOPIRDINE
chembl:CHEMBL525043,CASEARINONE A
HGNC:20692,TPH2
chembl:CHEMBL84472,CHEMBL84472
chembl:CHEMBL1520,VARDENAFIL
HP:3000013,Abnormal platysma muscle morphology
chembl:CHEMBL2107358,OBATOCLAX MESYLATE
chembl:CHEMBL189,MILRINONE
chembl:CHEMBL3818130,ADH-1
HP:0002691,Platybasia
HGNC:30064,PBRM1
chembl:CHEMBL1743086,VATELIZUMAB
MONDO:1010000,pythiosis
MONDO:0015674,late infantile neuronal ceroid lipofuscinosis
CHEBI:46842,sarcosinium
HGNC:1665,SCARB2
chembl:CHEMBL146,BUTYLATED HYDROXYTOLUENE
HGNC:16915,HAX1
chembl:CHEMBL1231101,ACIVICIN
GO:0009679,hexose:proton symporter activity
HP:0002586,Peritonitis
chembl:CHEMBL291962,LEUCINE
HGNC:11389,STK11
HGNC:2227,COMP
chembl:CHEMBL1381098,1-NAPHTHYLISOTHIOCYANATE
MONDO:0002543,adult oligodendroglioma
chembl:CHEMBL1200790,METHYPRYLON
chembl:CHEMBL2022560,APRATOXIN F
chembl:CHEMBL43048,MIDOMAFETAMINE
HP:0008311,Spinal cord posterior columns myelin loss
FB:FBgn0011582,Dop1R1
HP:0002024,Malabsorption
chembl:CHEMBL295124,BERBERINE
chembl:CHEMBL3348923,MLN-2480
HP:0003678,Rapidly progressive
HGNC:4415,GNMT
MONDO:0002852,mediastinum sarcoma
chembl:CHEMBL2108557,TELBERMIN
chembl:CHEMBL221733,CHEMBL221733
chembl:CHEMBL1614702,SCIO-323
HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
chembl:CHEMBL1624,LEVOTHYROXINE
chembl:CHEMBL2109474,TRX-1
chembl:CHEMBL790,CHLORHEXIDINE
chembl:CHEMBL1475,TRIOXSALEN
chembl:CHEMBL1077759,GRACILIN J
MONDO:0019383,acute disseminated encephalomyelitis
wikidata:Q29006714,ZALTRAP
HGNC:6186,IVD
chembl:CHEMBL1200515,DESERPIDINE
HGNC:12788,WNT8A
HGNC:35410,TSTD1
HP:0010863,Receptive language delay
chembl:CHEMBL1236475,TETRAHYDROURIDINE
chembl:CHEMBL1201087,CABERGOLINE
RGD:1311340,Vps13a
chembl:CHEMBL305380,BUPRANOLOL
chembl:CHEMBL493863,CHEMBL493863
HGNC:10484,RYR2
chembl:CHEMBL1186579,METHYLNALTREXONE
chembl:CHEMBL1200562,HYDROCORTISONE VALERATE
chembl:CHEMBL83527,PTEROSTILBENE
chembl:CHEMBL1541,CEFIXIME
MONDO:0016242,hemoglobin C disease
MONDO:0002831,non-keratinizing sinonasal squamous cell carcinoma
chembl:CHEMBL3545239,PF-05019702
HGNC:2079,CLN8
HGNC:25751,TRAPPC11
HP:0030217,Limb apraxia
MONDO:0002056,breast fibroadenoma
HGNC:7223,MPST
HGNC:6138,ITGA2B
NCBIGene:478619,CMBL
chembl:CHEMBL2108575,ASELIZUMAB
UPHENO:0013942,cerebellum atrophy
chembl:CHEMBL118417,CHEMBL118417
GO:0042581,specific granule
HGNC:2531,CTSF
HGNC:4283,GJB1
chembl:CHEMBL546576,CHEMBL546576
HGNC:122,ACP1
chembl:CHEMBL463175,CEPHALOCHROMIN
chembl:CHEMBL926,DOBUTAMINE
HP:0000044,Hypogonadotropic hypogonadism
chembl:CHEMBL1029,MIGLUSTAT
MONDO:0041751,multibacillary leprosy
HP:0001167,Abnormal finger morphology
HGNC:8975,PIK3CA
chembl:CHEMBL1487,ATORVASTATIN
HGNC:20145,GPR143
chembl:CHEMBL502774,CHEMBL502774
MONDO:0004784,allergic asthma
MONDO:0020482,myotonia permanens
GO:0017134,fibroblast growth factor binding
chembl:CHEMBL326967,CHLOROETHYLCLONIDINE
chembl:CHEMBL225257,CHEMBL225257
chembl:CHEMBL2147777,TENELIGLIPTIN
chembl:CHEMBL905,RIZATRIPTAN
chembl:CHEMBL434435,TETRAETHYLAMMONIUM CHLORIDE
HP:0002275,Poor motor coordination
chembl:CHEMBL1453126,CHEMBL1453126
chembl:CHEMBL1208572,SALINOMYCIN
HP:0031848,Cock-walk gait
HGNC:12590,UQCRH
HP:0001231,Abnormal fingernail morphology
chembl:CHEMBL1243244,CHEMBL1243244
chembl:CHEMBL515505,CHEMBL515505
chembl:CHEMBL2108045,PRITUMUMAB
chembl:CHEMBL309490,GALANGIN
chembl:CHEMBL441343,PARABEN
Xenbase:XB-GENE-5806009,cmbl
chembl:CHEMBL3545133,JNJ-26483327
chembl:CHEMBL1200402,AMLODIPINE BESYLATE
chembl:CHEMBL1235764,RIBAVIRIN MONOPHOSPHATE
chembl:CHEMBL1271,PENTOLINIUM
chembl:CHEMBL1094674,CHEMBL1094674
HGNC:11837,TLE1
chembl:CHEMBL1096435,RO-281675
chembl:CHEMBL534353,CHEMBL534353
chembl:CHEMBL499608,NAKIJIQUINONES H
GO:1901858,regulation of mitochondrial DNA metabolic process
MONDO:0100545,hereditary neurological disease
HGNC:17427,DPF3
chembl:CHEMBL708,ZIPRASIDONE
CHEBI:24436,guanidines
HP:0007123,Subcortical dementia
HGNC:11450,SUCLG2
HP:0012523,Oral aversion
MONDO:0011724,encephalopathy due to GLUT1 deficiency
HGNC:14661,EGLN3
chembl:CHEMBL1201745,CHOLINE FENOFIBRATE
MONDO:0012497,congenital stationary night blindness autosomal dominant 3
HP:0002019,Constipation
HGNC:27683,ALKAL2
chembl:CHEMBL3545257,MIROGABALIN BESYLATE
chembl:CHEMBL112302,SODIUM SELENITE
chembl:CHEMBL1256940,METHOXYVERAPAMIL HYDROCHLORIDE
MONDO:0018346,ferro-cerebro-cutaneous syndrome
chembl:CHEMBL385911,CHEMBL385911
chembl:CHEMBL522302,VOFOPITANT
HGNC:16524,RAB14
MONDO:0030702,autoimmune atherosclerosis
chembl:CHEMBL2058994,CHEMBL2058994
chembl:CHEMBL525826,CHEMBL525826
chembl:CHEMBL4297467,KPT-9274
chembl:CHEMBL8260,BAICALEIN
chembl:CHEMBL2017291,CHEMBL2017291
chembl:CHEMBL1201159,FENTANYL HYDROCHLORIDE
HP:0032011,Heterophoria
MONDO:0021444,benign neoplasm of large intestine
chembl:CHEMBL1201466,"ESTROGENS, CONJUGATED SYNTHETIC A"
chembl:CHEMBL412873,SPARTEINE
chembl:CHEMBL2109478,DAPIROLIZUMAB PEGOL
chembl:CHEMBL1372046,CHEMBL1372046
MONDO:0030323,"spinocerebellar ataxia, autosomal recessive 31"
HGNC:28844,FBXO38
UBERON:0002736,lateral nuclear group of thalamus
CHEBI:17810,1-O-(alk-1-enyl)-2-O-acyl-sn-glycero-3-phosphocholine
HGNC:2746,DDX5
MONDO:0010747,X-linked dystonia-parkinsonism
chembl:CHEMBL509256,GERALDOL
chembl:CHEMBL1743005,DACETUZUMAB
HP:0002180,Neurodegeneration
MONDO:0004695,liver lymphoma
chembl:CHEMBL2108680,PIDILIZUMAB
HGNC:23116,SENP2
HGNC:15852,ARFGAP1
chembl:CHEMBL29898,QUINALIZARIN
chembl:CHEMBL2103775,ALACEPRIL
chembl:CHEMBL3545179,AZD-7451
HP:0031375,Refractory
chembl:CHEMBL1374101,POTASSIUM DICHROMATE 
wikidata:Q29006769,ZYTIGA
chembl:CHEMBL144757,CHEMBL144757
HGNC:5237,HSPA4
MGI:2443220,Slc4a5
chembl:CHEMBL113,CAFFEINE
HP:0005110,Atrial fibrillation
chembl:CHEMBL87708,LOFEPRAMINE
chembl:CHEMBL3301626,BASIMGLURANT
GO:2000377,regulation of reactive oxygen species metabolic process
chembl:CHEMBL498770,IODOPHENPROPIT
HGNC:3052,DSP
chembl:CHEMBL1255582,FIPAMEZOLE
chembl:CHEMBL428880,CROMOLYN
HGNC:8983,PI4KA
HGNC:406,ALDH4A1
chembl:CHEMBL6966,VERAPAMIL
HGNC:14454,GABRQ
chembl:CHEMBL3545268,MLN3126
CHEBI:7735,olanzapine
NCBIGene:537713,SUCLG2
CHEBI:6636,magnesium dichloride
chembl:CHEMBL35493,ADOZELESIN
chembl:CHEMBL290916,EDARAVONE
chembl:CHEMBL282614,ELTOPRAZINE
CHEBI:176497,geroprotector
MONDO:0008727,congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
Reactome:R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
HP:5200068,Socially innappropriate questioning
chembl:CHEMBL547285,CHEMBL547285
chembl:CHEMBL970,HALAZEPAM
chembl:CHEMBL1201625,CHOLESTYRAMINE
MONDO:0054845,"developmental and epileptic encephalopathy, 66"
CHEBI:15377,water
chembl:CHEMBL645,BISOPROLOL
chembl:CHEMBL1087,MEPIVACAINE
HGNC:9716,PXMP2
HGNC:7526,MMUT
HGNC:4853,HDAC2
chembl:CHEMBL601547,CHEMBL601547
chembl:CHEMBL2364655,EVOLOCUMAB
HP:0003006,Neuroblastoma
GO:0090298,negative regulation of mitochondrial DNA replication
HP:0003355,Aminoaciduria
chembl:CHEMBL486386,PUERARIN
chembl:CHEMBL1201081,METHYLPREDNISOLONE SODIUM SUCCINATE
HP:0000711,Restlessness
MGI:88107,Atp1a3
MONDO:0004790,fatty liver disease
chembl:CHEMBL1727,CEPHALEXIN
MONDO:0007193,primary biliary cholangitis 1
CHEBI:27958,cocaine
HGNC:33280,SEPTIN14
chembl:CHEMBL582030,CHEMBL582030
chembl:CHEMBL4297527,REVAMILAST
HGNC:16629,RAPGEF3
chembl:CHEMBL2087361,ICOTINIB
chembl:CHEMBL3137331,DEFACTINIB
HGNC:9676,PTPRN
HGNC:29932,COASY
HGNC:7463,MTNR1A
HP:0002200,Pseudobulbar signs
chembl:CHEMBL525103,CHEMBL525103
HP:0011728,Elbow clonus
HGNC:11049,SLC6A3
chembl:CHEMBL531322,CHEMBL531322
chembl:CHEMBL17423,VESNARINONE
Reactome:R-CEL-390666,Serotonin receptors
Xenbase:XB-GENE-493040,hap1
HGNC:5348,ICAM5
chembl:CHEMBL2107729,ATACIGUAT
chembl:CHEMBL9324,TETRYLAMMONIUM
GO:0006613,cotranslational protein targeting to membrane
chembl:CHEMBL225304,PIMAGEDINE
chembl:CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE
chembl:CHEMBL89977,CHEMBL89977
CHEBI:33853,phenols
chembl:CHEMBL440084,SB-431542
HGNC:6255,KCNJ1
HGNC:5302,HTR7
HGNC:3606,FBP1
chembl:CHEMBL277062,BROMAZEPAM
chembl:CHEMBL134,CLONIDINE
CHEBI:132992,radiosensitizing agent
chembl:CHEMBL1337519,CHEMBL1337519
MONDO:0012639,hereditary spastic paraplegia 18
MONDO:0000510,synucleinopathy
HGNC:14135,PIGQ
HP:0008760,Violent behavior
MONDO:0014285,congenital dyserythropoietic anemia type type 1B
HP:0100295,Muscle fiber atrophy
chembl:CHEMBL1718,NALOXONE HYDROCHLORIDE
chembl:CHEMBL582478,CHEMBL582478
chembl:CHEMBL17329,CHEMBL17329
chembl:CHEMBL1568698,GANAXOLONE
chembl:CHEMBL1505,ALMOTRIPTAN
chembl:CHEMBL102714,SB-216763
chembl:CHEMBL1784528,TURNAGAINOLIDE B
chembl:CHEMBL1797709,CHEMBL1797709
chembl:CHEMBL1482,BETHANECHOL
UBERON:0002118,right ovary
HGNC:10879,STIL
HGNC:12849,YWHAB
chembl:CHEMBL1289110,TIANEPTINE
chembl:CHEMBL476833,CHEMBL476833
chembl:CHEMBL531710,CHEMBL531710
chembl:CHEMBL1693,DIETHYLPROPION HYDROCHLORIDE
chembl:CHEMBL382301,ATOSIBAN
chembl:CHEMBL1201180,DICLOFENAC EPOLAMINE
chembl:CHEMBL1743260,KARENITECIN
HGNC:1033,BDNF
HP:0030786,Photopsia
HP:0001538,Protuberant abdomen
chembl:CHEMBL448399,HYDROXYTOLUIC ACID
chembl:CHEMBL1897070,TEBUFENPYRAD
NCBIGene:420624,CYCS
chembl:CHEMBL2109177,ODULIMOMAB
MONDO:0002671,signet ring cell breast carcinoma
chembl:CHEMBL643,PROMETHAZINE
HP:0001395,Hepatic fibrosis
chembl:CHEMBL2059711,CHEMBL2059711
HP:0000020,Urinary incontinence
MGI:103262,Yap1
chembl:CHEMBL1554674,CHARTREUSIN
chembl:CHEMBL211502,PHENAMIL
chembl:CHEMBL1429,DESMOPRESSIN
HGNC:23576,HOOK3
chembl:CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE
chembl:CHEMBL119549,ANDOLAST
chembl:CHEMBL157946,CHEMBL157946
HP:0002527,Falls
chembl:CHEMBL13647,BMY-7378
CHEBI:38070,anti-arrhythmia drug
HP:0000217,Xerostomia
CHEBI:21760,N-methyl-amino acid
chembl:CHEMBL22062,CHEMBL22062
chembl:CHEMBL49338,DIFLUBENZURON
chembl:CHEMBL589723,CHEMBL589723
Reactome:R-DRE-611105,Respiratory electron transport
MONDO:0003852,ovarian solid teratoma
HGNC:601,APOA2
SGD:S000003963,VPS13
chembl:CHEMBL1676,FLUTICASONE FUROATE
chembl:CHEMBL536151,CHEMBL536151
chembl:CHEMBL273273,5-OH-DPAT
MONDO:0002939,skin pigmented basal cell carcinoma
chembl:CHEMBL576412,CHEMBL576412
chembl:CHEMBL6640,TRYPTAMINE
chembl:CHEMBL508676,ETHYL VANILLIN
HGNC:21148,RNF123
chembl:CHEMBL592676,ISOSILYBIN A
chembl:CHEMBL430893,(-)-ROLIPRAM
UBERON:0001882,nucleus accumbens
chembl:CHEMBL2109621,ABITUZUMAB
chembl:CHEMBL1895252,BENSULIDE
HGNC:2861,DHFR
chembl:CHEMBL1408759,GUAIAZULEN
HGNC:6176,ITPA
HP:0007034,Generalized hyperreflexia
chembl:CHEMBL1201864,DIENOGEST
chembl:CHEMBL1200804,DICLOFENAC POTASSIUM
HP:0009062,Infantile axial hypotonia
chembl:CHEMBL414890,PROTOAPIGENONE
MONDO:0013310,congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
CHEBI:192486,ciprofloxacin(1+)
chembl:CHEMBL53463,DOXORUBICIN
MONDO:0002286,renal artery disease
chembl:CHEMBL1098875,CHEMBL1098875
HGNC:3064,DUSP1
chembl:CHEMBL1683544,ERIBULIN MESYLATE
chembl:CHEMBL579956,CHEMBL579956
chembl:CHEMBL3707250,CP-601927
chembl:CHEMBL1256836,NALOXONE BENZOYLHYDRAZONE
chembl:CHEMBL150,KAEMPFEROL
chembl:CHEMBL431836,P-HYDROXYCINNAMALDEHYDE
UBERON:0015488,sural nerve
chembl:CHEMBL162358,TOMELUKAST
chembl:CHEMBL3833368,RUCAPARIB CAMSYLATE
MONDO:0016368,Rothmund-Thomson syndrome type 1
chembl:CHEMBL1385558,CHEMBL1385558
HGNC:16488,UNC119B
chembl:CHEMBL377300,BRIVANIB
CHEBI:26776,stilbenoid
HGNC:19305,SLC30A6
chembl:CHEMBL1980715,LAUROGUADINE
HP:0012735,Cough
chembl:CHEMBL416146,ETORICOXIB
HGNC:6874,MAPK12
chembl:CHEMBL601140,CHEMBL601140
chembl:CHEMBL3545345,UR-63325
chembl:CHEMBL4297851,XMT-1536
MONDO:0014889,"striatonigral degeneration, childhood-onset"
PATO:0002096,"neoplastic, non-malignant"
HGNC:13222,BCL11B
chembl:CHEMBL15177,MK-571
chembl:CHEMBL3544962,CT-1578
chembl:CHEMBL526981,CHEMBL526981
MONDO:0017721,"Sandhoff disease, infantile form"
HGNC:31369,TOMM5
chembl:CHEMBL1493986,METHYL ANTHRANILATE
HP:0034434,Abnormal communication
chembl:CHEMBL291278,N-METHYL-D-ASPARTIC ACID (NMDA)
chembl:CHEMBL2105743,OLODATEROL HYDROCHLORIDE
GO:0006874,intracellular calcium ion homeostasis
HGNC:18370,RAB1B
HGNC:20612,TDRD3
chembl:CHEMBL1237104,PROPOXYPHENE HYDROCHLORIDE
HGNC:18412,ZDHHC17
chembl:CHEMBL1716091,SDX-101
chembl:CHEMBL1201007,HYDROXYZINE HYDROCHLORIDE
HGNC:7007,RAB8A
chembl:CHEMBL1257005,LOBELINE HYDROCHLORIDE
chembl:CHEMBL1478,LITHOCHOLIC ACID
UBERON:0035827,right adrenal gland cortex
CHEBI:600520,micafungin
chembl:CHEMBL1491,AMLODIPINE
UPHENO:0084533,hypertrophic muscle of neck
GO:0001889,liver development
MONDO:0014544,osteogenesis imperfecta type 16
MONDO:0018044,idiopathic hypersomnia
HGNC:15514,PICALM
chembl:CHEMBL509186,MAKALUVAMINE E
CHEBI:48422,angiogenesis inhibitor
chembl:CHEMBL592123,CHEMBL592123
CHEBI:36785,carbobicyclic compound
HGNC:391,AKT1
HGNC:9302,PPP2R1A
chembl:CHEMBL2435339,"(20S,21S)-7-CYCLOHEXYLFLUOROCAMPTOTHECIN"
chembl:CHEMBL42126,PICLAMILAST
ZFIN:ZDB-GENE-030131-1390,aco2
HGNC:2554,CUL4A
MONDO:0100053,anaphylaxis
chembl:CHEMBL186720,PHENYLTOLOXAMINE
CHEBI:39447,pyrimidines
chembl:CHEMBL78257,TYRPHOSTIN 51
chembl:CHEMBL2325741,CAPIVASERTIB
chembl:CHEMBL585902,AMG-548
chembl:CHEMBL1201577,CETUXIMAB
HGNC:1919,CHD4
chembl:CHEMBL591126,CHEMBL591126
HGNC:11006,SLC2A2
HGNC:3377,EPB41
chembl:CHEMBL165,RESVERATROL
HGNC:646,ARAF
chembl:CHEMBL2096646,AMINOSALICYLATE SODIUM
chembl:CHEMBL149246,CHEMBL149246
HGNC:2535,CTSH
chembl:CHEMBL1201451,ALBUMIN HUMAN
chembl:CHEMBL2146110,SARIZOTAN HYDROCHLORIDE
chembl:CHEMBL476501,CHEMBL476501
HGNC:1464,CAMK4
chembl:CHEMBL1436860,DIMETHYL GAMBOGATE
chembl:CHEMBL1394756,ESOXYBUTYNIN
chembl:CHEMBL1527,CHEMBL1527
chembl:CHEMBL2106793,LUFIRONIL
HP:0002553,Highly arched eyebrow
chembl:CHEMBL4297416,PF-4191834
HP:0012678,Iron accumulation in substantia nigra
HP:0007649,Congenital hypertrophy of retinal pigment epithelium
MONDO:0002889,orbital cancer
chembl:CHEMBL495727,AT-9283
chembl:CHEMBL1528955,N-METHYLANTHRANILIC ACID
chembl:CHEMBL1533,DESOGESTREL
MGI:1336172,Tbl1x
chembl:CHEMBL2103841,CANAGLIFLOZIN
chembl:CHEMBL454803,4'-O-ACETYLPATENTIFLORIN B
HGNC:18676,DDX42
chembl:CHEMBL1939687,CHEMBL1939687
HGNC:7765,NF1
HGNC:1876,CFLAR
chembl:CHEMBL475536,"1R,9S-HYDRASTINE"
HGNC:7897,NPC1
HGNC:11787,THBS3
chembl:CHEMBL487187,THIOPHANATE METHYL
HP:0006886,Impaired distal vibration sensation
HGNC:652,ARF1
HGNC:4426,GOLGA3
chembl:CHEMBL361812,RAMATROBAN
chembl:CHEMBL3264610,SEVITERONEL
chembl:CHEMBL2028663,DABRAFENIB
chembl:CHEMBL71752,VINPOCETINE
HP:0002814,Abnormality of the lower limb
HP:0000480,Retinal coloboma
chembl:CHEMBL582857,NELIVAPTAN
chembl:CHEMBL1185,ZOLMITRIPTAN
chembl:CHEMBL1200772,WARFARIN POTASSIUM
chembl:CHEMBL3990030,EFIZONERIMOD ALFA
HP:0008339,Diaminoaciduria
HP:0000175,Cleft palate
HGNC:15840,KMT2B
ZFIN:ZDB-GENE-050522-377,ndufa2
chembl:CHEMBL417990,BICUCULLINE
chembl:CHEMBL31574,FISETIN
MONDO:0031040,"cholestasis, progressive familial intrahepatic, 12"
GO:0015370,solute:sodium symporter activity
MONDO:0018772,Joubert syndrome
chembl:CHEMBL345237,PICLOZOTAN
HGNC:7717,NDUFV2
chembl:CHEMBL1951071,ARFORMOTEROL TARTRATE
MONDO:0010915,autosomal dominant nonsyndromic hearing loss 4A
chembl:CHEMBL534,KETOTIFEN
MGI:1915008,Aadac
CHEBI:46640,diketone
chembl:CHEMBL852,MELPHALAN
chembl:CHEMBL8443,NITIDINE CHLORIDE
MONDO:0018369,immature ovarian teratoma
chembl:CHEMBL347610,CHEMBL347610
chembl:CHEMBL275665,ICRF-193
HP:0001761,Pes cavus
chembl:CHEMBL602365,CHEMBL602365
chembl:CHEMBL572,NITROFURANTOIN
GO:0005794,Golgi apparatus
HGNC:1720,CDC16
chembl:CHEMBL4298018,LY-3164530
chembl:CHEMBL43185,PIPERINE
chembl:CHEMBL4297451,XL-888
HGNC:8859,PEX6
HGNC:23287,ETHE1
MGI:1321161,Ppp2cb
chembl:CHEMBL530115,GUTHION
chembl:CHEMBL109,VALPROIC ACID
HP:0010747,Medial flaring of the eyebrow
MONDO:0001106,kidney failure
chembl:CHEMBL305187,IFENPRODIL
chembl:CHEMBL600342,CHEMBL600342
chembl:CHEMBL517986,5-(N-ETHYL-N-ISOPROPYL)AMILORIDE
chembl:CHEMBL600862,CHEMBL600862
HP:0025153,Transient
MONDO:0956975,T2-high asthma
Reactome:R-RNO-211945,Phase I - Functionalization of compounds
MONDO:0004948,B-cell chronic lymphocytic leukemia
HGNC:7943,NPR1
chembl:CHEMBL1086377,CHEMBL1086377
chembl:CHEMBL652,FLECAINIDE
chembl:CHEMBL1484251,CHLORHEXIDINE HYDROCHLORIDE
chembl:CHEMBL19439,IMETIT
HGNC:2422,CS
HGNC:10894,PRMT5
chembl:CHEMBL1784538,CYCLIC CRYPEVEIC
chembl:CHEMBL1509,DROSPIRENONE
chembl:CHEMBL2007641,PERTUZUMAB
chembl:CHEMBL63055,ALRESTATIN
HP:0001397,Hepatic steatosis
NCBIGene:420989,AHRR
chembl:CHEMBL1139,EPOPROSTENOL
MONDO:0016695,oligodendroglioma
chembl:CHEMBL888,GEMCITABINE
HP:0002141,Gait imbalance
chembl:CHEMBL1945287,CHEMBL1945287
HGNC:662,ARFRP1
HGNC:6858,MAP3K6
HP:0002286,Fair hair
HGNC:28727,APOO
chembl:CHEMBL580609,CHEMBL580609
chembl:CHEMBL289469,GRANISETRON
NCBIGene:424978,NDUFB5
chembl:CHEMBL56900,LERISETRON
HGNC:7667,NCL
chembl:CHEMBL1399124,SYROSINGOPINE
chembl:CHEMBL291143,CHEMBL291143
HGNC:12012,TPM3
chembl:CHEMBL1764,LEVOMEPROMAZINE
MONDO:0004993,carcinoma
chembl:CHEMBL1257069,NAFTOPIDIL DIHYDROCHLORIDE
chembl:CHEMBL87333,CIS-RESVERATROL
MONDO:0000771,allergic respiratory disease
MGI:2145977,Dip2b
HP:0003077,Hyperlipidemia
chembl:CHEMBL66089,CHEMBL66089
HGNC:9557,PSMD12
chembl:CHEMBL3039504,NINTEDANIB ESYLATE
chembl:CHEMBL18824,L-NOREPINEPHRINE
HGNC:16844,CREB5
HP:0001266,Choreoathetosis
HP:0000085,Horseshoe kidney
HGNC:1759,CDH2
HP:0031765,Partially accomodative esotropia
NCBIGene:514472,TRAP1
MONDO:0002280,anemia
chembl:CHEMBL434750,ERGOSTEROL PEROXIDE
chembl:CHEMBL170405,ROBINETIN
chembl:CHEMBL272682,CHEMBL272682
MONDO:0001627,dementia
chembl:CHEMBL1543865,CHEMBL1543865
HP:0031760,Non-accomodative esotropia
chembl:CHEMBL1459149,CHEMBL1459149
chembl:CHEMBL271227,ABIRATERONE ACETATE
chembl:CHEMBL271220,CORT 108297
HP:0002071,Abnormality of extrapyramidal motor function
chembl:CHEMBL1683590,ERIBULIN
chembl:CHEMBL404108,LUMIRACOXIB
HP:0031422,Abnormal cerebellar cortex morphology
chembl:CHEMBL105060,DNK333
chembl:CHEMBL521686,OLAPARIB
HGNC:24358,TSPYL2
chembl:CHEMBL1201217,DYCLONINE
chembl:CHEMBL1668777,(R)-SARGACHROMENOL
chembl:CHEMBL1230165,SILMITASERTIB
chembl:CHEMBL2204435,CHEMBL2204435
HGNC:1006,BCL7C
MONDO:0044299,"myasthenic syndrome, congenital, 22"
HGNC:10741,SEMA7A
HP:0003677,Slowly progressive
chembl:CHEMBL275260,CHEMBL275260
chembl:CHEMBL29097,CHEMBL29097
chembl:CHEMBL4297668,MILCICLIB MALEATE
chembl:CHEMBL158,AZTREONAM
chembl:CHEMBL111,RIMONABANT
HGNC:1594,CCNH
MONDO:0009667,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3"
HGNC:9884,RB1
HGNC:13055,ZMYM4
chembl:CHEMBL1004,DOXYLAMINE
MONDO:0002742,cervical mucinous adenocarcinoma
HGNC:4573,GRIA3
HGNC:7458,MT-ND3
chembl:CHEMBL3989977,EMAPALUMAB
CHEBI:26125,phytosterols
HGNC:1616,CCT3
CHEBI:46195,paracetamol
GO:0001578,microtubule bundle formation
chembl:CHEMBL1200341,INDECAINIDE HYDROCHLORIDE
GO:0005355,glucose transmembrane transporter activity
MONDO:0010128,thyrocerebrorenal syndrome
chembl:CHEMBL227529,ALOGLIPTIN BENZOATE
chembl:CHEMBL372629,CHEMBL372629
chembl:CHEMBL1194287,CHLOROPYRAMINE
HGNC:4944,HLA-DQB1
chembl:CHEMBL3545011,GS-9667
chembl:CHEMBL116955,CONGO RED
chembl:CHEMBL3039537,SEBELIPASE ALFA
HP:0000746,Delusions
HP:0033683,Jaw hyperreflexia
chembl:CHEMBL953,ENTACAPONE
chembl:CHEMBL914,FEXOFENADINE
chembl:CHEMBL4206119,UPAMOSTAT
chembl:CHEMBL239559,ISOORIENTIN
chembl:CHEMBL1386434,CHEMBL1386434
HGNC:4740,MACROH2A1
HGNC:706,ARPC3
chembl:CHEMBL3990042,GOSURANEMAB
NCBIGene:428525,LOC428525
chembl:CHEMBL1200819,ARTICAINE HYDROCHLORIDE
MONDO:0005260,autism
HGNC:7566,MYF6
chembl:CHEMBL366460,ISOFLAVONE
chembl:CHEMBL2108489,KELIXIMAB
chembl:CHEMBL423,BETAXOLOL
CHEBI:3647,chlorpromazine
HP:0003141,Increased LDL cholesterol concentration
chembl:CHEMBL590706,CHEMBL590706
HGNC:8788,PDE6D
HGNC:6291,KCNN2
chembl:CHEMBL335741,CHEMBL335741
HGNC:20073,SNX27
HP:0033201,Biceps hyporeflexia
chembl:CHEMBL589583,DELAPRIL
MONDO:0016702,oligoastrocytoma
chembl:CHEMBL501701,"N,N-HEXAMETHYLENEAMILORIDE"
UBERON:0000399,jejunal mucosa
chembl:CHEMBL74415,CANNABINOL
HGNC:12854,YWHAQ
chembl:CHEMBL226345,ADENINE
chembl:CHEMBL601351,CHEMBL601351
chembl:CHEMBL2087337,VELUSETRAG
MONDO:0002463,lacrimal gland carcinoma
HGNC:23720,CREB3L2
GO:0008516,hexose uniporter activity
chembl:CHEMBL412309,AR-67
HGNC:18756,RHOBTB2
chembl:CHEMBL535730,CHEMBL535730
chembl:CHEMBL25230,CHEMBL25230
GO:0042592,homeostatic process
chembl:CHEMBL927,CEFDINIR
NCBIGene:482814,HTR5A
chembl:CHEMBL562,GRISEOFULVIN
chembl:CHEMBL63507,S-NITROSOGLUTATHIONE
HGNC:14247,ATP5MG
MONDO:0000903,myoclonus-dystonia syndrome
HGNC:13667,AP1M1
HP:0002380,Fasciculations
CHEBI:29806,fumarate(2-)
HP:0002425,Anarthria
HGNC:9251,CTSA
chembl:CHEMBL1201129,DECITABINE
HGNC:10912,SLC12A3
CHEBI:83403,monochlorobenzenes
chembl:CHEMBL3545006,PWT-33587
chembl:CHEMBL1201174,SITAGLIPTIN PHOSPHATE
chembl:CHEMBL2104981,RILAPLADIB
chembl:CHEMBL139000,(R)-PIA
chembl:CHEMBL1833984,CHEMBL1833984
chembl:CHEMBL589444,CHEMBL589444
WB:WBGene00019979,R09B5.11
HGNC:7821,NID1
chembl:CHEMBL1320798,CHEMBL1320798
HP:0002335,Agenesis of cerebellar vermis
HGNC:1623,CCT8
ZFIN:ZDB-GENE-030910-2,drd2b
MONDO:0002420,tic disorder
chembl:CHEMBL1350,TILUDRONIC ACID
chembl:CHEMBL972,SELEGILINE
HGNC:2468,SMC3
GO:0070530,K63-linked polyubiquitin modification-dependent protein binding
HP:0031466,Impairment in personality functioning
chembl:CHEMBL9960,AZD-7624
HP:0031762,Distance esotropia
MONDO:0007088,Alzheimer disease type 1
chembl:CHEMBL77705,GARDENIN
HGNC:29918,NDUFAF3
MONDO:0003337,acute hemorrhagic encephalitis
chembl:CHEMBL1339,VARDENAFIL HYDROCHLORIDE
HGNC:7200,MOV10
CHEBI:25698,ether
MONDO:0019942,distal arthrogryposis
chembl:CHEMBL494826,METHYLCURCUMIN
MONDO:0014503,autosomal recessive spinocerebellar ataxia 17
MGI:1923322,Rnf183
NCBIGene:509751,AOC1
chembl:CHEMBL572881,MOTESANIB
HGNC:2148,CNGA1
chembl:CHEMBL469,KETOROLAC
chembl:CHEMBL2109613,PF-04236921
MONDO:0016865,Kleefstra syndrome due to a point mutation
HGNC:10047,RNASE4
chembl:CHEMBL592374,AMITIFADINE
chembl:CHEMBL2108465,GINGER
HGNC:12585,UQCRC1
chembl:CHEMBL2094573,CHEMBL2094573
MONDO:0010493,Diamond-Blackfan anemia 14 with mandibulofacial dysostosis
chembl:CHEMBL562318,MARDEPODECT
chembl:CHEMBL127579,CHEMBL127579
chembl:CHEMBL122972,2-ARACHIDONOYLGLYCEROL
HGNC:6930,MC2R
chembl:CHEMBL618,4-CHLORO-BENZOIC ACID
chembl:CHEMBL1523974,CHEMBL1523974
chembl:CHEMBL258994,DIGERANYL BISPHOSPHONATE
MONDO:0011264,torsion dystonia 6
FB:FBgn0050169,Brca2
HP:0031761,Infantile constant esotropia
CHEBI:24318,glutamine family amino acid
chembl:CHEMBL3545083,RGB-286638
chembl:CHEMBL1200323,LABETALOL HYDROCHLORIDE
chembl:CHEMBL533,IBUTILIDE
MONDO:0018935,hairy cell leukemia
MGI:108554,Dab1
HP:0001129,Large central visual field defect
chembl:CHEMBL4297475,PEN-866
HP:0003326,Myalgia
MONDO:0007488,Lewy body dementia
NCBIGene:510767,CYCS
chembl:CHEMBL512649,CHEMBL512649
chembl:CHEMBL50588,EMETINE
chembl:CHEMBL2106767,LINTOPRIDE
HGNC:5299,HTR4
chembl:CHEMBL2109498,IPH-2101
chembl:CHEMBL75267,"7,8-DIHYDROXYFLAVONE"
HP:0000544,External ophthalmoplegia
chembl:CHEMBL603130,CHEMBL603130
HGNC:29955,SLC51A
MGI:1919599,Dusp3
chembl:CHEMBL275875,CL-329167
HGNC:1034,BECN1
chembl:CHEMBL1256179,ALPRENOLOL HYDROCHLORIDE
GO:0004087,carbamoyl-phosphate synthase (ammonia) activity
chembl:CHEMBL257662,ZD-6126
CHEBI:7809,oxacillin
HGNC:6947,MCM4
chembl:CHEMBL2109377,PAMREVLUMAB
HGNC:2362,CRK
NCBIGene:615506,MTARC2
chembl:CHEMBL444929,SQUALAMINE
MONDO:0005298,osteoporosis
chembl:CHEMBL1200862,METYROSINE
HGNC:30291,G3BP2
HGNC:7703,NDUFB8
chembl:CHEMBL68738,N6-CYCLOPENTYLADENOSINE
HP:0001028,Hemangioma
MONDO:0044637,infantile-onset generalized dyskinesia with orofacial involvement
HGNC:10982,SLC25A12
HGNC:48955,UMAD1
MONDO:0019064,hereditary spastic paraplegia
chembl:CHEMBL1393,SPIRONOLACTONE
GO:0016029,subrhabdomeral cisterna
chembl:CHEMBL1201575,EFALIZUMAB
chembl:CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE
HGNC:3725,FKBP9
chembl:CHEMBL505807,CHEMBL505807
chembl:CHEMBL1200444,PIRBUTEROL ACETATE
MONDO:0018198,acute encephalopathy with biphasic seizures and late reduced diffusion
chembl:CHEMBL1200830,FERROUS SULFATE
HGNC:12420,TUFM
chembl:CHEMBL488025,EXISULIND
HP:0002705,"High, narrow palate"
chembl:CHEMBL602127,CHEMBL602127
HGNC:52297,STRIT1
HGNC:10979,SLC25A1
chembl:CHEMBL1201748,CABAZITAXEL
CHEBI:35352,organonitrogen compound
chembl:CHEMBL1399,ANASTROZOLE
FB:FBgn0004573,5-HT7
CHEBI:63598,levofloxacin
HP:0001374,Congenital hip dislocation
chembl:CHEMBL3544971,DEXTROAMPHETAMINE SULFATE
MONDO:0000133,immunodeficiency-centromeric instability-facial anomalies syndrome
chembl:CHEMBL1433292,QUINALDINE BLUE
chembl:CHEMBL1255647,CHEMBL1255647
chembl:CHEMBL4298016,FROVOCIMAB
chembl:CHEMBL1574420,CHEMBL1574420
chembl:CHEMBL1094358,CHEMBL1094358
HGNC:12488,UBE2L3
chembl:CHEMBL1425,MERCAPTOPURINE
HP:0003687,Centrally nucleated skeletal muscle fibers
chembl:CHEMBL2028056,CHEMBL2028056
chembl:CHEMBL2103953,DELTIBANT
chembl:CHEMBL1501,FLUOCINONIDE
chembl:CHEMBL1201614,CALCITONIN HUMAN
chembl:CHEMBL602923,CHEMBL602923
chembl:CHEMBL23236,BETULIN
HP:0001321,Cerebellar hypoplasia
HP:0012378,Fatigue
chembl:CHEMBL36506,NOVOBIOCIN
UBERON:0001154,vermiform appendix
HGNC:24723,ACSS3
HP:0007811,Horizontal pendular nystagmus
chembl:CHEMBL3545065,VEROSUDIL
chembl:CHEMBL896,HYDROXYZINE
HGNC:7010,MEN1
chembl:CHEMBL2103815,LARAZOTIDE ACETATE
chembl:CHEMBL508338,THIMEROSAL
CHEBI:15356,cysteine
chembl:CHEMBL188762,CHEMBL188762
chembl:CHEMBL197655,MANSONONE F
chembl:CHEMBL2105754,TRELAGLIPTIN SUCCINATE
MONDO:0004107,splenic manifestation of leukemia
chembl:CHEMBL313972,MASOPROCOL
wikidata:Q6457467,LCZ696
HGNC:2020,CLCN2
chembl:CHEMBL257704,EPLIVANSERIN
chembl:CHEMBL1200534,MOEXIPRIL HYDROCHLORIDE
chembl:CHEMBL2105719,DACOMITINIB
chembl:CHEMBL83154,2-AMINOANTHRACENE
HGNC:10069,RNF6
HP:0000421,Epistaxis
chembl:CHEMBL1200951,FLUPHENAZINE ENANTHATE
chembl:CHEMBL1200660,ISOSORBIDE
chembl:CHEMBL822,TERBINAFINE
chembl:CHEMBL77,ARTEMISIN
HP:0011966,Elevated plasma citrulline
HGNC:2228,COMT
chembl:CHEMBL272621,HYODEOXYCHOLIC_ACID
HGNC:5031,HNRNPA1
chembl:CHEMBL136689,CHEMBL136689
chembl:CHEMBL569713,SCOPOLAMINE
chembl:CHEMBL4297816,PX-478
chembl:CHEMBL114112,CHEMBL114112
chembl:CHEMBL30432,GW282974X
CHEBI:24026,fatty alcohol
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific"
chembl:CHEMBL312487,CHEMBL312487
chembl:CHEMBL2088730,CHEMBL2088730
chembl:CHEMBL1201338,CYCLOPENTOLATE
chembl:CHEMBL601167,CHEMBL601167
HGNC:779,ATCAY
HGNC:29652,WDR77
HGNC:7234,MRRF
HGNC:15879,CTNNBL1
UBERON:0004533,left testis
chembl:CHEMBL547269,CHEMBL547269
HGNC:365,AK5
chembl:CHEMBL2103876,MAPRACORAT
chembl:CHEMBL283552,FLUOROSALAN
chembl:CHEMBL1201536,NICOTINE POLACRILEX
MGI:1932872,Ctns
chembl:CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE
MGI:1923442,Abhd12
chembl:CHEMBL401565,CHEMBL401565
chembl:CHEMBL450970,MAKALUVAMINE C TFA SALT
HGNC:494,ANK3
HP:0031007,Orofacial action-specific dystonia induced by speech
NCBIGene:513552,TMEM186
HGNC:21652,OSTM1
chembl:CHEMBL83747,PSAMMAPLIN A
chembl:CHEMBL1275,PERGOLIDE MESYLATE
MONDO:0012627,"epilepsy, idiopathic generalized, susceptibility to, 13"
chembl:CHEMBL1476898,CADMIUM ACETATE
HGNC:5962,IL10
chembl:CHEMBL585628,CHEMBL585628
HGNC:10628,CCL3L1
chembl:CHEMBL317364,CHEMBL317364
NCBIGene:403980,CAV1
chembl:CHEMBL1094690,AESCULIOSIDE IIIA
HGNC:29148,FBXO45
GO:0070837,dehydroascorbic acid transport
chembl:CHEMBL4298120,FUTIBATINIB
chembl:CHEMBL1237021,LURASIDONE
HGNC:17818,NT5C1B
UPHENO:0088436,abnormality of tarsal region physiology
chembl:CHEMBL93,ZILEUTON
chembl:CHEMBL1940832,MILVETEROL
HGNC:3098,TOR1A
HP:0025269,Panic attack
HGNC:29534,ESYT1
chembl:CHEMBL3137320,TALAZOPARIB
chembl:CHEMBL11458,CHEMBL11458
chembl:CHEMBL28626,MORIN
CHEBI:194135,"9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid"
HGNC:4855,HDC
HGNC:3026,DRD5
chembl:CHEMBL1333512,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE"
chembl:CHEMBL533965,CHEMBL533965
chembl:CHEMBL3545157,TIDEGLUSIB
chembl:CHEMBL2108165,VALERIAN
chembl:CHEMBL579028,CHEMBL579028
chembl:CHEMBL333121,CHEMBL333121
HGNC:11019,SLC34A1
HGNC:4647,GTF2A2
HGNC:20182,SLC39A9
chembl:CHEMBL400777,ROBUSTIC ACID
RGD:62058,Aoc3
RGD:631440,Aadac
chembl:CHEMBL2364628,RICOLINOSTAT
chembl:CHEMBL3545377,LY-2606368
GO:0000002,mitochondrial genome maintenance
MONDO:0000200,Zimmermann-Laband syndrome
chembl:CHEMBL1334033,PERHEXILINE MALEATE
chembl:CHEMBL1224785,MADOLIN A
MONDO:0002475,lacrimal gland adenocarcinoma
chembl:CHEMBL63323,NIFLUMIC ACID
HGNC:10943,SLC1A5
chembl:CHEMBL76688,SIVELESTAT
HGNC:4114,GAL
chembl:CHEMBL2000716,CARICOTAMIDE
chembl:CHEMBL15766,LY-255283
GO:0060170,ciliary membrane
HGNC:4661,GTF2IRD1
HP:0006913,Frontal cortical atrophy
HGNC:13448,SLC38A2
chembl:CHEMBL261641,CHEMBL261641
HGNC:20665,SCN3B
MONDO:0006162,colorectal neuroendocrine tumor G1
chembl:CHEMBL1615372,LURASIDONE HYDROCHLORIDE
chembl:CHEMBL284671,CODEINE SULFATE
MONDO:0005101,ulcerative colitis
MONDO:0016239,cystinosis
HGNC:28487,GOT1L1
HP:0025668,Abnormal neck morphology
chembl:CHEMBL1519374,CHEMBL1519374
HP:0002333,Motor deterioration
chembl:CHEMBL576981,TEBIPENEM
chembl:CHEMBL1078000,CHEMBL1078000
HGNC:9834,RAI1
chembl:CHEMBL457091,KASANOSIN B
HGNC:4019,FUT8
HGNC:853,ATP6V1B1
chembl:CHEMBL503,LOVASTATIN
chembl:CHEMBL520897,TRIADIMEFON
MONDO:0002086,clear cell acanthoma
HGNC:758,ASS1
CHEBI:24995,lactam
chembl:CHEMBL2036124,CHEMBL2036124
UBERON:0001637,artery
chembl:CHEMBL4297187,DERAZANTINIB
HGNC:24316,TACO1
WB:WBGene00012330,zip-3
CHEBI:68508,diethyl maleate
CHEBI:26518,quinuclidines
HGNC:9154,PNKP
MGI:1261831,Hap1
chembl:CHEMBL1094689,AESCULIOSIDE IIK
chembl:CHEMBL420762,MOZAVAPTAN
HGNC:10983,SLC25A13
chembl:CHEMBL502496,CHEMBL502496
HGNC:11875,TMPO
HGNC:7014,MEOX2
chembl:CHEMBL762,OXYMETAZOLINE
chembl:CHEMBL3545143,SR-13668
MONDO:0021313,eyelid cancer
HGNC:10405,RPS20
MONDO:0010375,"developmental and epileptic encephalopathy, 8"
MONDO:0021166,inflammatory disease
MONDO:0000079,"nephrolithiasis/osteoporosis, hypophosphatemic"
PomBase:SPBC21C3.01c,vps1301
HP:0003396,Syringomyelia
chembl:CHEMBL1093369,CHEMBL1093369
chembl:CHEMBL565612,SOTRASTAURIN
HGNC:2295,CP
chembl:CHEMBL502620,ACLARUBICIN
chembl:CHEMBL1064,SIMVASTATIN
chembl:CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE
chembl:CHEMBL21396,SKIMMIANINE
chembl:CHEMBL1329029,TETROQUINONE
chembl:CHEMBL528712,CHEMBL528712
chembl:CHEMBL458855,CHEMBL458855
chembl:CHEMBL3623004,AZD-9496
HP:0011951,Aspiration pneumonia
HGNC:610,APOC3
HGNC:22407,TMEM106B
chembl:CHEMBL244888,NIFUROXAZIDE
chembl:CHEMBL258844,CHEMBL258844
MONDO:0014682,"thyroid cancer, nonmedullary, 5"
chembl:CHEMBL1456870,GARCINOLIC ACID
chembl:CHEMBL353764,CHEMBL353764
MONDO:0014667,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3"
wikidata:Q47522319,XELJANZ
HGNC:13533,ATP8A2
HGNC:14561,ARHGEF9
chembl:CHEMBL1204337,NYLIDRIN HYDROCHLORIDE
HGNC:7714,NDUFS7
chembl:CHEMBL1200879,WARFARIN SODIUM
chembl:CHEMBL2108326,ALICAFORSEN
chembl:CHEMBL410063,PAXILLINE
HGNC:4075,GABRA1
chembl:CHEMBL1697,DILTIAZEM HYDROCHLORIDE
chembl:CHEMBL63857,PHENOLPHTHALEIN
chembl:CHEMBL73711,CHEMBL73711
chembl:CHEMBL1200585,OXYMETHOLONE
chembl:CHEMBL1200561,DOXAZOSIN MESYLATE
chembl:CHEMBL2108569,INSULIN PEGLISPRO
chembl:CHEMBL501849,SIMEPREVIR
HGNC:8782,PDE4C
HP:0002757,Recurrent fractures
HGNC:11572,TARS1
chembl:CHEMBL1729,CISAPRIDE
chembl:CHEMBL1236107,SGX-523
chembl:CHEMBL339587,CHEMBL339587
chembl:CHEMBL1200758,AMPICILLIN SODIUM
chembl:CHEMBL2105717,CABOZANTINIB
chembl:CHEMBL1200483,PHENMETRAZINE HYDROCHLORIDE
chembl:CHEMBL3301578,EMIBETUZUMAB
MONDO:0016759,pontocerebellar hypoplasia type 2
chembl:CHEMBL3544940,G1T28-1
HGNC:23038,LMBRD1
HGNC:7984,NR5A2
HGNC:6053,IMPDH2
Reactome:R-XTR-211945,Phase I - Functionalization of compounds
HGNC:8994,PIP5K1A
HGNC:12392,DNAJC7
chembl:CHEMBL415,CLOMIPRAMINE
HGNC:14412,AGXT2
HGNC:16767,GRIN3A
chembl:CHEMBL1200977,MILRINONE LACTATE
HGNC:6925,MBP
chembl:CHEMBL546797,CHEMBL546797
HGNC:9644,PTPN11
HP:0002039,Anorexia
chembl:CHEMBL417,EPIRUBICIN
CHEBI:71392,tetracycline(1-)
HP:0001273,Abnormal corpus callosum morphology
chembl:CHEMBL1230222,CHLOROCRESOL
chembl:CHEMBL89445,TERPYRIDINE
chembl:CHEMBL3894860,TRILACICLIB
chembl:CHEMBL3545408,NALTALIMIDE
chembl:CHEMBL399530,CHEMBL399530
HP:0001151,Impaired horizontal smooth pursuit
MONDO:0054794,"hydrocephalus, congenital, 3, with brain anomalies"
UBERON:0001872,parietal lobe
chembl:CHEMBL1521174,2-MERCAPTONICOTINIC ACID
chembl:CHEMBL3545270,LY2969822
chembl:CHEMBL2386889,SCH-900776
HGNC:25419,ARL13B
chembl:CHEMBL642,ACEBUTOLOL
chembl:CHEMBL2107772,RIMACALIB
UBERON:0004359,corpus epididymis
HGNC:10561,ATXN8OS
MONDO:0002666,pancreatic signet ring cell adenocarcinoma
chembl:CHEMBL428789,CHEMBL428789
chembl:CHEMBL1488393,"5,7-DIHYDROXYISOFLAVONE"
chembl:CHEMBL3545209,NKTR-171
CHEBI:15816,D-arginine
MONDO:0018370,KLHL9-related early-onset distal myopathy
NCBIGene:417157,SURF1
MONDO:0018083,transient tyrosinemia of the newborn
HGNC:11460,SUOX
MONDO:0003735,central nervous system immature teratoma
chembl:CHEMBL458178,KASANOSIN A
chembl:CHEMBL423192,ANISOMYCIN
chembl:CHEMBL1525298,DIETHYLSTILBESTROL DIPROPIONATE
HP:0007448,Hyperkeratosis over edematous areas
NCBIGene:475251,AHR
chembl:CHEMBL1200694,SEVOFLURANE
GO:0043197,dendritic spine
chembl:CHEMBL1078442,BERGAMOTTIN
HGNC:9758,RAB1A
HGNC:6177,ITPK1
chembl:CHEMBL3545216,FX-005
chembl:CHEMBL602927,CHEMBL602927
HP:0033229,Brachioradialis areflexia
HGNC:6140,ITGA4
HGNC:27924,LINC01139
chembl:CHEMBL1726,NISOLDIPINE
HGNC:4879,HEXB
HP:5200024,Abnormal relationship
PATO:0001863,chronic
chembl:CHEMBL1200479,DICYCLOMINE HYDROCHLORIDE
chembl:CHEMBL1200596,CHLOROXINE
chembl:CHEMBL261692,CHEMBL261692
HGNC:396,ALAS1
chembl:CHEMBL146710,CHEMBL146710
chembl:CHEMBL3989967,LOTAMILAST
chembl:CHEMBL1372,OXIGLUTATIONE
GO:0005528,FK506 binding
HGNC:4799,HADH
chembl:CHEMBL1950553,SONEDENOSON
chembl:CHEMBL2103784,COSYNTROPIN
HGNC:8856,PEX14
chembl:CHEMBL161598,ANISALDEHYDE
chembl:CHEMBL1200974,CARBINOXAMINE MALEATE
HGNC:992,BCL2L1
HGNC:12852,YWHAG
HP:0008278,Cerebellar cortical atrophy
chembl:CHEMBL61511,PERFOSFAMIDE
chembl:CHEMBL1200368,BENTIROMIDE
chembl:CHEMBL3544984,TRADIPITANT
MONDO:0005525,T-cell leukemia
chembl:CHEMBL1434057,2-BENZOYL-5-METHOXYBENZOQUINONE
Reactome:R-BTA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL2364624,PRADIGASTAT
chembl:CHEMBL78010,PECTOLINARIGENIN
chembl:CHEMBL2108027,DULAGLUTIDE
MONDO:0002483,breast myoepithelial tumor
MGI:95757,Slc2a3
chembl:CHEMBL1952329,SGI-1776
HGNC:30826,NT5DC3
FB:FBgn0034756,Cyp6d2
chembl:CHEMBL1287983,CHEMBL1287983
CHEBI:2637,amikacin
dictyBase:DDB_G0286725,vps13A
HGNC:14339,PLEKHA4
Reactome:R-CFA-211945,Phase I - Functionalization of compounds
HP:0032588,Hand apraxia
HP:0000658,Eyelid apraxia
chembl:CHEMBL1726814,CHEMBL1726814
HGNC:20774,TUBB4A
HGNC:7972,NR2C2
CHEBI:16347,(R)-carnitine
CHEBI:57774,2-acetyllactate
GO:0016020,membrane
chembl:CHEMBL1713082,TRIMEPRAZINE TARTRATE
HP:0010542,Vestibular nystagmus
HGNC:2711,DCTN1
HGNC:16098,PHF20
chembl:CHEMBL301982,CELASTROL
GO:0030175,filopodium
HGNC:8851,PEX10
chembl:CHEMBL313493,METHANESULFONIC ACID METHYL ESTER
HGNC:1112,NCAPH
chembl:CHEMBL3301607,FILGOTINIB
chembl:CHEMBL3133037,LEQ506
chembl:CHEMBL2347630,CHEMBL2347630
HP:0007052,Multifocal cerebral white matter abnormalities
CHR:9606-chr10p11.21-p12.31,
MONDO:0054835,classic dopamine transporter deficiency syndrome
HGNC:13353,MAP1LC3C
chembl:CHEMBL369075,VAPITADINE
chembl:CHEMBL1431115,CHEMBL1431115
CHEBI:58349,NADP(3-)
HP:0000083,Renal insufficiency
chembl:CHEMBL1626570,HEXOCYCLIUM METHYLSULFATE
MONDO:0002060,intraductal papilloma
HGNC:8896,PGK1
HGNC:10682,SDHC
HP:0000732,Inflexible adherence to routines
chembl:CHEMBL7301,FENRETINIDE
chembl:CHEMBL525486,CHEMBL525486
MONDO:0011214,progressive familial intrahepatic cholestasis type 3
chembl:CHEMBL530733,CHEMBL530733
chembl:CHEMBL1705,CLONIDINE HYDROCHLORIDE
MONDO:0006715,coronary stenosis
CHEBI:9398,tamsulosin
chembl:CHEMBL1201210,PROPIOMAZINE
HP:0000577,Exotropia
chembl:CHEMBL2107856,IMETELSTAT
CHEBI:17287,N-phosphocreatine
CHEBI:17759,"cholesta-5,7-dien-3beta-ol"
MONDO:0008294,acute intermittent porphyria
HP:0000154,Wide mouth
chembl:CHEMBL2141296,IXAZOMIB
chembl:CHEMBL3545154,POZIOTINIB
MONDO:0019209,Japanese encephalitis
chembl:CHEMBL2105857,AFELETECAN
HGNC:10418,RPS28
chembl:CHEMBL580324,CHEMBL580324
HP:0011468,Facial tics
chembl:CHEMBL357995,BOPINDOLOL
GO:0097386,glial cell projection
chembl:CHEMBL303958,CHEMBL303958
HP:0006986,Upper limb spasticity
chembl:CHEMBL536166,CHEMBL536166
chembl:CHEMBL4297771,INTERLEUKIN-10
chembl:CHEMBL1185568,DITHIAZANINE
HP:0025613,Focal emotional seizure
GO:0071897,DNA biosynthetic process
HP:0012443,Abnormality of brain morphology
PR:000007496,fibroblast growth factor 5
HGNC:1078,BMPR2
HGNC:25610,FGGY
chembl:CHEMBL2437367,LICOAGRONE
GO:0006366,transcription by RNA polymerase II
CHEBI:47724,vancomycin aglycone
chembl:CHEMBL487465,DEFERITAZOLE
GO:0005179,hormone activity
HGNC:14006,TRPV6
chembl:CHEMBL1466186,CHEMBL1466186
HP:0007311,Short stepped shuffling gait
chembl:CHEMBL3661115,TAS-116
HP:0007083,Hyperactive patellar reflex
chembl:CHEMBL2062259,VARENICLINE TARTRATE
chembl:CHEMBL412010,DERRUBONE
chembl:CHEMBL549880,O-METHYLCALOTHRIXIN A
chembl:CHEMBL31965,CANERTINIB
chembl:CHEMBL146346,CHEMBL146346
chembl:CHEMBL1452696,FEPRAZONE
HP:0009879,Simplified gyral pattern
HGNC:91,ACADSB
MONDO:0006659,arteriosclerosis obliterans
chembl:CHEMBL169233,CHEMBL169233
chembl:CHEMBL238624,CHEMBL238624
HGNC:16926,KRTAP9-2
CHEBI:7035,muscimol
HP:0025253,Claustrophobia
chembl:CHEMBL2104538,APAXIFYLLINE
NCBIGene:613899,UQCRH
chembl:CHEMBL1773343,CHEMBL1773343
chembl:CHEMBL538943,VINORELBINE TARTRATE
chembl:CHEMBL1480,FELODIPINE
GO:0007417,central nervous system development
wikidata:Q47521453,DEPAKOTE
HGNC:4627,GSTA2
HGNC:1551,CBX1
chembl:CHEMBL2103991,BALAGLITAZONE
HP:0000268,Dolichocephaly
chembl:CHEMBL7568,QUINACRINE
CHEBI:23765,quinolone
HGNC:257,ADK
chembl:CHEMBL2105759,BARICITINIB
HGNC:12974,RNF113A
HGNC:27265,UBXN2A
chembl:CHEMBL1186581,RTI-336
chembl:CHEMBL1112,ARIPIPRAZOLE
HGNC:22652,NOMO2
chembl:CHEMBL1256759,5-NITRO-2-PHENYLPROPYLAMINOBENZOIC ACID [NPPB]
HP:0002750,Delayed skeletal maturation
chembl:CHEMBL1077259,BISLEUCONOTHINE A
chembl:CHEMBL651,METHADONE
HGNC:28196,TMEM79
GO:0120082,smooth endoplasmic reticulum cisterna
MONDO:0004277,gonorrhea
chembl:CHEMBL1288831,PESUDOGINSENOSIDE RP1 METHYL ESTER
MONDO:0014937,aniridia 2
chembl:CHEMBL490355,SULFURETIN
CHEBI:64618,phosphagen
MONDO:0009026,Costello syndrome
MONDO:0011408,hereditary spastic paraplegia 10
chembl:CHEMBL606,MISOPROSTOL
MONDO:0100352,episodic kinesigenic dyskinesia 1
MGI:97828,Pygb
RGD:3763,Sstr2
chembl:CHEMBL256705,OCHROMYCINONE
chembl:CHEMBL119443,ERGONOVINE
chembl:CHEMBL2062868,CHEMBL2062868
chembl:CHEMBL1242210,CHEMBL1242210
MONDO:0958234,Bethlem myopathy 1C
HGNC:26404,NADK2
chembl:CHEMBL1200430,ESTRADIOL ACETATE
HGNC:4798,HABP2
chembl:CHEMBL430266,CALYCULIN A
chembl:CHEMBL486817,HARMOL
HGNC:7500,MT-TV
chembl:CHEMBL919,FOSPHENYTOIN SODIUM
HP:0002266,Focal clonic seizure
chembl:CHEMBL193,NIFEDIPINE
HGNC:6525,LCN1
MONDO:0007829,"cholestasis, intrahepatic, of pregnancy, 1"
MONDO:0005405,childhood onset asthma
chembl:CHEMBL499808,CASPOFUNGIN
HGNC:14934,SIRT6
MONDO:0015004,"dystonia 28, childhood-onset"
chembl:CHEMBL250450,ISOQUERCETIN
MONDO:0032613,"mitochondrial complex 1 deficiency, nuclear type 8"
CHEBI:36699,corticosteroid hormone
GO:0005764,lysosome
HGNC:6233,KCNC1
chembl:CHEMBL1889303,CHEMBL1889303
MONDO:0018511,epithelial tumor of the appendix
chembl:CHEMBL285848,MANUMYCIN A
HP:0011449,Knee clonus
CHEBI:15866,2-deoxy-D-glucose
WB:WBGene00013074,hmit-1.2
MONDO:0012166,autosomal dominant sensory ataxia 1
HGNC:9279,PDP1
chembl:CHEMBL1467165,CHEMBL1467165
chembl:CHEMBL592105,METHYLROSANILINE
chembl:CHEMBL224145,GUAIACOL HYDROCHLORIDE
chembl:CHEMBL1743054,OZORALIZUMAB
CHEBI:27656,camptothecin
HP:0001954,Recurrent fever
chembl:CHEMBL182066,RADIPRODIL
chembl:CHEMBL2336666,CHEMBL2336666
HGNC:6442,KRT5
chembl:CHEMBL286452,ALFATRADIOL
HGNC:4831,HBG1
chembl:CHEMBL532504,CHEMBL532504
chembl:CHEMBL217894,DECYLUBIQUINONE
HP:0000590,Progressive external ophthalmoplegia
HGNC:2372,MED23
chembl:CHEMBL485253,METHYSERGIDE
chembl:CHEMBL1908373,ONAPRISTONE
CHEBI:138856,oxolinic acid
HGNC:28862,NIPBL
HGNC:971,BCAR1
HGNC:8876,PFKL
MGI:1313136,Clip2
chembl:CHEMBL3545427,CM-082
HGNC:13532,TLX3
chembl:CHEMBL1256851,CHEMBL1256851
HGNC:13586,FBXO7
chembl:CHEMBL1598450,AROFYLLINE
MONDO:0957819,"arthrogryposis, distal, type 12"
HGNC:949,BAK1
UPHENO:0086129,non-functional eyelid
chembl:CHEMBL84010,CHEMBL84010
chembl:CHEMBL1201323,BETAZOLE
HGNC:3388,EPHA4
chembl:CHEMBL4297899,AZD-0156
HGNC:9719,PEX5
HP:0003584,Late onset
chembl:CHEMBL704,MESALAMINE
GO:0008514,organic anion transmembrane transporter activity
chembl:CHEMBL92,DOCETAXEL
HGNC:30688,CAND1
HGNC:10332,RPL3
CHEBI:50995,secondary amino compound
HGNC:32930,IGFL3
HGNC:3771,FMO3
chembl:CHEMBL1235966,SCOULERINE
HGNC:9143,PHOX2B
chembl:CHEMBL531269,CHEMBL531269
chembl:CHEMBL266481,GLUCAGON
chembl:CHEMBL1200613,TOLMETIN SODIUM
chembl:CHEMBL2109662,DALANTERCEPT
chembl:CHEMBL355001,SULFAMIDE
chembl:CHEMBL550348,DEFERASIROX
HP:0020216,Visually-induced seizure
HGNC:1530,MICU1
chembl:CHEMBL3545271,PBF-999
HP:0002361,Psychomotor deterioration
chembl:CHEMBL338314,CHEMBL338314
HGNC:6257,KCNJ11
chembl:CHEMBL464637,CHEMBL464637
chembl:CHEMBL434,ISOPROTERENOL
chembl:CHEMBL498,CHLORPROPAMIDE
chembl:CHEMBL3249110,13-DEOXYDOXORUBICIN
UPHENO:0071136,absent reflex in pectoral complex
chembl:CHEMBL136344,CHEMBL136344
UBERON:0001711,eyelid
chembl:CHEMBL1452227,CHEMBL1452227
HGNC:4165,GAS1
HGNC:11448,SUCLA2
HGNC:1820,CEACAM8
WB:WBGene00004978,spg-7
HGNC:6246,KCNF1
chembl:CHEMBL3707297,CG250 177LU
chembl:CHEMBL513116,N-AMINOHEXYL-5-CHLORO-1-NAPTHALENESULFONAMIDE HYDROCHLORIDE
HP:0001561,Polyhydramnios
chembl:CHEMBL3545367,LEMBOREXANT
HGNC:29600,MED19
MONDO:0015134,constitutional neutropenia
MONDO:0016696,anaplastic oligodendroglioma
chembl:CHEMBL585243,CHEMBL585243
chembl:CHEMBL1743036,LEXATUMUMAB
HGNC:17082,MLC1
chembl:CHEMBL3545210,SR16234
CHEBI:47519,ketoconazole
HGNC:3942,MTOR
chembl:CHEMBL1224755,CHEMBL1224755
chembl:CHEMBL585444,CHEMBL585444
GO:0005775,vacuolar lumen
chembl:CHEMBL3989756,TALC
CHEBI:20265,lanostane
HGNC:11289,SREBF1
chembl:CHEMBL2360079,ACETOPHENAZINE MALEATE
HGNC:13780,GFM1
chembl:CHEMBL1679,LEUCOVORIN
HGNC:5144,HPCA
chembl:CHEMBL125044,CHEMBL125044
chembl:CHEMBL579224,METHYSTICIN
chembl:CHEMBL56337,EPALRESTAT
chembl:CHEMBL2105737,SONIDEGIB
HP:0009748,Large earlobe
chembl:CHEMBL1201766,FOSPROPOFOL
chembl:CHEMBL254348,GRAMINE
WB:WBGene00020838,trak-1
chembl:CHEMBL454580,GARCINONE E
HGNC:15518,DCTN4
HGNC:6484,LAMA4
HGNC:10345,RPL35A
UPHENO:0080594,abnormal social behavior
chembl:CHEMBL1556958,STROBOPININ
HGNC:10120,RNU1-1
chembl:CHEMBL497939,CYTISINICLINE
chembl:CHEMBL580183,CHEMBL580183
chembl:CHEMBL2218861,QUINAGOLIDE
GO:0061486,high-affinity fructose transmembrane transporter activity
HP:0002659,Increased susceptibility to fractures
chembl:CHEMBL28079,ZAPRINAST
CHEBI:28262,dimethyl sulfoxide
HGNC:17929,AADAT
chembl:CHEMBL1672054,CASOPITANT
GO:1990539,fructose import across plasma membrane
HGNC:2151,CNGB1
RGD:69264,Shank3
chembl:CHEMBL601385,CHEMBL601385
chembl:CHEMBL1278,NARATRIPTAN
chembl:CHEMBL4297757,GDC-0077
chembl:CHEMBL2103852,CROLIBULIN
chembl:CHEMBL2108239,CILMOSTIM
chembl:CHEMBL1201026,ALBUTEROL SULFATE
chembl:CHEMBL604608,FRUCTOSE
chembl:CHEMBL1934283,OPHIOBOLIN O
HGNC:5042,HNRNPH2
chembl:CHEMBL177809,CHEMBL177809
chembl:CHEMBL26320,CHEMBL26320
HP:0100786,Hypersomnia
chembl:CHEMBL48802,SULFORAPHANE
HP:0008768,Inappropriate sexual behavior
chembl:CHEMBL1170047,INIPARIB
chembl:CHEMBL338115,CHEMBL338115
chembl:CHEMBL1201380,DIFLORASONE
MONDO:0000211,"striatal degeneration, autosomal dominant"
HGNC:7691,NDUFA7
chembl:CHEMBL1410004,CHEMBL1410004
chembl:CHEMBL456,ETHACRYNIC ACID
HGNC:590,BIRC2
chembl:CHEMBL1526240,DIHYDROGAMBOGIC ACID
chembl:CHEMBL424133,LY-518674
MONDO:0011970,rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome
MONDO:0003544,spinal cord cancer
HGNC:3046,PIGP
CHEBI:140325,secondary carboxamide
chembl:CHEMBL3545119,BMS-794833
chembl:CHEMBL100259,URIDINE
HGNC:6188,JAG1
chembl:CHEMBL1201782,FOSAPREPITANT DIMEGLUMINE
chembl:CHEMBL193093,CHEMBL193093
HGNC:12428,TWIST1
chembl:CHEMBL1201013,OLSALAZINE SODIUM
MONDO:0010397,severe neonatal-onset encephalopathy with microcephaly
chembl:CHEMBL3545292,QBW251
chembl:CHEMBL1198857,VILANTEROL
HGNC:1189,AHSA1
chembl:CHEMBL1257106,AMPEROZIDE HYDROCHLORIDE
chembl:CHEMBL490417,CHEMBL490417
HP:0025392,Nodular pattern on pulmonary HRCT
chembl:CHEMBL182150,CHEMBL182150
chembl:CHEMBL1868702,GESTRINONE
chembl:CHEMBL2103879,GANETESPIB
Reactome:R-HSA-1660499,Synthesis of PIPs at the plasma membrane
HGNC:343,AHCY
chembl:CHEMBL188921,BUFLOMEDIL
chembl:CHEMBL172439,SLAZINIC ACID
chembl:CHEMBL1201216,DAPIPRAZOLE
chembl:CHEMBL20377,CHEMBL20377
chembl:CHEMBL276727,IODOACETAMIDE
chembl:CHEMBL1685,DEZOCINE
HGNC:939,BAG3
chembl:CHEMBL2068724,ACAMPROSATE CALCIUM
chembl:CHEMBL243580,CARBAZOLE
chembl:CHEMBL1201102,TRIFLUPROMAZINE HYDROCHLORIDE
HP:0010935,Abnormality of the upper urinary tract
GO:0007595,lactation
chembl:CHEMBL310555,OXYQUINOLINE
chembl:CHEMBL601135,CHEMBL601135
chembl:CHEMBL2181040,CHEMBL2181040
HP:0002718,Recurrent bacterial infections
chembl:CHEMBL2094789,CHEMBL2094789
chembl:CHEMBL92129,CRYPTOLEPINE HYDROCHLORIDE
chembl:CHEMBL2108583,CINTREDEKIN BESUDOTOX
chembl:CHEMBL602,CYSTEAMINE
chembl:CHEMBL406931,CHEMBL406931
chembl:CHEMBL1256186,CHEMBL1256186
HGNC:17860,SERBP1
chembl:CHEMBL2106351,DOCARPAMINE
HGNC:1455,CALR
HP:0040202,Abnormal consumption behavior
chembl:CHEMBL58033,(-)-U-50488
chembl:CHEMBL1221986,WITHAFERIN A
HGNC:250,ADH1B
HGNC:17341,TRNT1
CHEBI:35757,monocarboxylic acid anion
HGNC:4587,GRIN2C
chembl:CHEMBL15137,MICHLER'S KETONE
CHEBI:77906,minocycline zwitterion
chembl:CHEMBL587092,CHEMBL587092
HGNC:603,APOB
chembl:CHEMBL317869,CHEMBL317869
chembl:CHEMBL146095,GLAFENINE
chembl:CHEMBL49642,INDIBULIN
GO:0046323,glucose import
HGNC:3185,EEA1
HGNC:10432,RPS6KA3
HGNC:4394,GNAT2
MGI:102675,Crym
chembl:CHEMBL1410006,"6,4'-DIMETHOXYFLAVONE"
chembl:CHEMBL3544916,GUADECITABINE
chembl:CHEMBL314437,MEPTAZINOL
CHEBI:606565,N-benzoylglycinate
HGNC:5218,HSD3B2
HGNC:16763,ZBTB32
UBERON:0004262,upper leg skin
HGNC:2092,CLTC
chembl:CHEMBL1200908,HALOBETASOL PROPIONATE
chembl:CHEMBL89250,CHEMBL89250
chembl:CHEMBL591370,CHEMBL591370
HGNC:6972,MDK
HP:0007668,Impaired pursuit initiation and maintenance
chembl:CHEMBL1342336,CHEMBL1342336
chembl:CHEMBL1292,CLOFAZIMINE
chembl:CHEMBL259209,MILNACIPRAN
HGNC:20407,CALR3
chembl:CHEMBL24924,FLUINDIONE
chembl:CHEMBL2107863,RINDOPEPIMUT
HP:0100785,Insomnia
chembl:CHEMBL2108228,BECTUMOMAB
chembl:CHEMBL1082723,CIPARGAMIN
chembl:CHEMBL8327,DEMETHYL-CANTHARIDIN
MONDO:0016547,Beckwith-Wiedemann syndrome due to NSD1 mutation
chembl:CHEMBL1067,LICARBAZEPINE
HGNC:17007,DUSP14
HGNC:25539,RFWD3
HGNC:29623,MAN2B2
CHEBI:16526,carbon dioxide
chembl:CHEMBL592344,CHEMBL592344
chembl:CHEMBL581187,CHEMBL581187
Xenbase:XB-GENE-964419,slc6a17
HGNC:4037,FYN
MONDO:0044740,salivary gland squamous cell carcinoma
chembl:CHEMBL1967878,CENISERTIB
HGNC:28962,SPCS2
HGNC:9117,PMP2
HGNC:30677,GPKOW
HP:0007936,Restrictive external ophthalmoplegia
ZFIN:ZDB-GENE-070508-3,drd4b
MONDO:0003414,skin pilomatrix carcinoma
chembl:CHEMBL711,PHENINDIONE
chembl:CHEMBL1564,DIPHENYLPYRALINE HYDROCHLORIDE
chembl:CHEMBL460574,LEVISOPRENALINE
HP:0006932,Transient psychotic episodes
chembl:CHEMBL1201304,INDOCYANINE GREEN
HGNC:29990,NUPR1
PomBase:SPAC630.03,arp3
MONDO:0007574,spinocerebellar ataxia type 34
chembl:CHEMBL1233528,VOLASERTIB
chembl:CHEMBL3185958,CLOMIPHENE CITRATE
chembl:CHEMBL1200904,SELEGILINE HYDROCHLORIDE
GO:0035577,azurophil granule membrane
MONDO:0044332,childhood-onset benign chorea with striatal involvement
UBERON:0004991,mucosa of transverse colon
chembl:CHEMBL9843,CHEMBL9843
chembl:CHEMBL2103832,PARDOPRUNOX
chembl:CHEMBL298406,ECOPIPAM
HP:0004209,Clinodactyly of the 5th finger
HGNC:7685,NDUFA2
chembl:CHEMBL559147,Y-27632
MONDO:0012850,hypophosphatemic nephrolithiasis/osteoporosis 1
CHEBI:35348,3beta-sterol
chembl:CHEMBL3545358,4SC-203
MONDO:0030805,spinocerebellar ataxia 49
chembl:CHEMBL1185260,NITROBLUE TETRAZOLIUM
chembl:CHEMBL305660,EBASTINE
HP:0012046,Areflexia of upper limbs
MGI:105053,Hsph1
HGNC:2666,DAG1
chembl:CHEMBL1997335,CHEMBL1997335
chembl:CHEMBL1097456,"N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)"
chembl:CHEMBL148674,VARESPLADIB
HGNC:3953,NCS1
HGNC:7715,NDUFS8
HGNC:9636,PTP4A3
HP:0011346,Mild expressive language delay
HGNC:11329,SST
chembl:CHEMBL43184,AMINACRINE
chembl:CHEMBL2387080,TASELISIB
chembl:CHEMBL4298102,VUNAKIZUMAB
MONDO:0021042,glioma
chembl:CHEMBL1201142,RASAGILINE MESYLATE
chembl:CHEMBL289228,TIPIFARNIB
chembl:CHEMBL478791,GERONTOXANTHONE I
chembl:CHEMBL598270,CHEMBL598270
CHEBI:22984,calcium atom
CHEBI:28694,copper atom
HGNC:6664,LOX
chembl:CHEMBL165064,ISOKAEMPFERIDE
chembl:CHEMBL1908841,LEVOLEUCOVORIN
chembl:CHEMBL829,METHYLPROMAZINE
chembl:CHEMBL1508,ESCITALOPRAM
chembl:CHEMBL71191,CHEMBL71191
HGNC:7994,NRCAM
chembl:CHEMBL871,ETIDRONIC ACID
chembl:CHEMBL83294,COUMARIN-3-CARBOXYLIC ACID
chembl:CHEMBL1908394,GSK-461364
HGNC:18002,TOMM22
chembl:CHEMBL649,NADOLOL
chembl:CHEMBL2105467,TEZACITABINE
chembl:CHEMBL526034,CHEMBL526034
HGNC:289,GRK2
chembl:CHEMBL592054,IMIGLITAZAR
chembl:CHEMBL2177349,HALICLONADIAMINE
chembl:CHEMBL22870,L-732138
HP:0001513,Obesity
chembl:CHEMBL1201489,SERACTIDE ACETATE
HGNC:7587,MYL6
HGNC:976,BCAT1
chembl:CHEMBL61,PODOFILOX
HGNC:20246,RAB2B
chembl:CHEMBL592561,CHEMBL592561
chembl:CHEMBL66693,D-ALANINE
HGNC:29450,GLIS2
chembl:CHEMBL159,VINBLASTINE
chembl:CHEMBL1205,NELFINAVIR MESYLATE
chembl:CHEMBL1160160,ROSE BENGAL
chembl:CHEMBL589238,CHEMBL589238
chembl:CHEMBL281948,K-252A
MONDO:0009698,Unverricht-Lundborg syndrome
HGNC:119,ACOX1
NCBIGene:403741,HTR1B
HP:0011877,Increased mean platelet volume
chembl:CHEMBL474376,TRIPHENYLSTANNYL ACETATE
HGNC:8800,PDGFB
NCBIGene:424256,UMPS
HP:0001258,Spastic paraplegia
HP:0005157,Concentric hypertrophic cardiomyopathy
CHEBI:142544,tamsulosin(1+)
chembl:CHEMBL3545419,TELISOTUZUMAB
chembl:CHEMBL545315,CANERTINIB DIHYDROCHLORIDE
MONDO:0014419,ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
chembl:CHEMBL2203843,CHEMBL2203843
chembl:CHEMBL1476858,PHENTHOATE
HP:0002566,Intestinal malrotation
chembl:CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE
chembl:CHEMBL116548,CHEMBL116548
GO:0019621,creatinine catabolic process to formate
chembl:CHEMBL305695,CHEMBL305695
CHEBI:71365,rifampicin zwitterion
chembl:CHEMBL554,LAPATINIB
HGNC:14215,TRIM55
chembl:CHEMBL562095,CHEMBL562095
HP:0001319,Neonatal hypotonia
HP:0010828,Hemifacial spasm
CHEBI:33570,benzenediols
HP:0012126,Stomach cancer
HGNC:8041,NUBP1
MONDO:0009620,Say-Barber-Miller syndrome
HGNC:7467,MTTP
HGNC:25443,C19orf12
CHEBI:50267,protective agent
chembl:CHEMBL1200392,DOXYLAMINE SUCCINATE
chembl:CHEMBL578515,CHEMBL578515
HGNC:3148,TYMP
HP:0008935,Generalized neonatal hypotonia
MONDO:0018763,tubulinopathy-associated dysgyria
chembl:CHEMBL700,SULFAPYRIDINE
chembl:CHEMBL1479195,CHEMBL1479195
chembl:CHEMBL1200391,TROMETHAMINE
chembl:CHEMBL19236,MOXONIDINE
HGNC:11161,SNRPE
HP:0003232,Mitochondrial malic enzyme reduced
HP:0006785,Limb-girdle muscular dystrophy
chembl:CHEMBL60550,TERLAKIREN
chembl:CHEMBL1490332,CHEMBL1490332
chembl:CHEMBL188,WIN-552122
HGNC:4657,GTF2H3
chembl:CHEMBL500468,GHRELIN
HGNC:10046,RNASE3
GO:0003723,RNA binding
chembl:CHEMBL40,PHENOBARBITAL
chembl:CHEMBL1578,ANISOTROPINE METHYLBROMIDE
chembl:CHEMBL644,TRIMIPRAMINE
chembl:CHEMBL4297787,MONALIZUMAB
chembl:CHEMBL1200635,HYDROCORTAMATE HYDROCHLORIDE
HP:0007350,Hyperreflexia in upper limbs
HGNC:28091,ATP6AP1L
HGNC:16077,DUSP22
HP:0010994,Abnormal corpus striatum morphology
chembl:CHEMBL578504,CHEMBL578504
HP:0012154,Anhedonia
chembl:CHEMBL3545381,PLX-7486
HGNC:9935,RCN2
HP:0002172,Postural instability
chembl:CHEMBL466659,PENTAERYTHRITOL TETRANITRATE
chembl:CHEMBL117785,TETRABENAZINE
chembl:CHEMBL605708,CHEMBL605708
chembl:CHEMBL15901,BENZIDINE
chembl:CHEMBL537708,DAZOXIBEN HYDROCHLORIDE
GO:0015267,channel activity
chembl:CHEMBL278751,CHEMBL278751
chembl:CHEMBL1559418,"2-METHYL-5,7,8-TRIMETHOXYISOFLAVONE"
HP:0012675,Iron accumulation in brain
chembl:CHEMBL1412710,CHEMBL1412710
chembl:CHEMBL1782605,CONICASTEROL D
chembl:CHEMBL1201260,BETHANIDINE
HGNC:857,ATP6V1E1
HGNC:12338,TRPC6
chembl:CHEMBL3545103,AZD3199
chembl:CHEMBL456881,DEOXYVASICINONE
HP:0002591,Polyphagia
HGNC:8803,PDGFRA
chembl:CHEMBL1545045,VALERENIC ACID
chembl:CHEMBL537087,CHEMBL537087
UBERON:0001245,anus
chembl:CHEMBL1956069,CHEMBL1956069
chembl:CHEMBL262075,INDIPLON
MONDO:0020835,"methemoglobinemia, alpha type"
HGNC:3701,FHIT
chembl:CHEMBL261557,CHEMBL261557
chembl:CHEMBL1077108,FUROSPONGOLIDE
chembl:CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE
HGNC:16889,PSMD14
chembl:CHEMBL3545397,ACALISIB
chembl:CHEMBL1440,TETRACYCLINE
MONDO:0012399,complex cortical dysplasia with other brain malformations 7
chembl:CHEMBL1201584,ABCIXIMAB
chembl:CHEMBL1200975,CLOCORTOLONE PIVALATE
HGNC:12712,VPS33B
chembl:CHEMBL186366,PINOSYLVIN METHYL ETHER
HGNC:11179,SOD1
chembl:CHEMBL2024517,CARIPRAZINE HYDROCHLORIDE
chembl:CHEMBL221959,TOFACITINIB
chembl:CHEMBL487194,AILANTHINONE
chembl:CHEMBL4297189,CERALASERTIB
HGNC:25198,SLC25A46
HP:0002268,Paroxysmal dystonia
MONDO:0020179,palpebral nevus
HP:0011098,Speech apraxia
NCBITaxon:747,Pasteurella multocida
chembl:CHEMBL137498,CHEMBL137498
Reactome:R-DRE-549127,Organic cation transport
chembl:CHEMBL585030,CHEMBL585030
chembl:CHEMBL375270,CHEMBL375270
chembl:CHEMBL368700,DITHIOLETHIONE
chembl:CHEMBL1201178,LISDEXAMFETAMINE DIMESYLATE
HGNC:11153,SNRPB
MONDO:0021135,rare or common
chembl:CHEMBL3137309,VENETOCLAX
HGNC:29812,DCPS
CHEBI:10119,ziprasidone
HGNC:6062,ING1
HGNC:11577,TAFAZZIN
chembl:CHEMBL258805,SU-9516
HGNC:9888,RBBP5
chembl:CHEMBL1201354,TRIDIHEXETHYL
CHEBI:26893,tetracyclic triterpenoid
chembl:CHEMBL578636,CHEMBL578636
chembl:CHEMBL88272,CHEMBL88272
chembl:CHEMBL1633,KETOTIFEN FUMARATE
chembl:CHEMBL1201716,MECASERMIN
HGNC:14203,JPH3
MONDO:0011339,hereditary spastic paraplegia 8
HGNC:11276,SPTBN2
HGNC:11926,TNFSF11
chembl:CHEMBL576409,CHEMBL576409
GO:0032127,dense core granule membrane
chembl:CHEMBL136478,SODIUM NITROPRUSSIDE
HGNC:12693,VIP
HGNC:9479,LONP1
CHEBI:18089,N-benzoylglycine
GO:0048741,skeletal muscle fiber development
chembl:CHEMBL940,GABAPENTIN
chembl:CHEMBL373822,CHEMBL373822
HGNC:1867,CETN2
chembl:CHEMBL402456,CHEMBL402456
GO:0005178,integrin binding
HGNC:21197,FA2H
chembl:CHEMBL1414826,TRITIOZINE
HGNC:29168,RPGRIP1L
HGNC:26261,LRRC31
chembl:CHEMBL2333445,CHEMBL2333445
chembl:CHEMBL1422,SITAGLIPTIN
HGNC:738,ASCL1
chembl:CHEMBL3990021,VADASTUXIMAB TALIRINE
HGNC:23302,HKDC1
CHEBI:83813,proteinogenic amino acid
HP:0002058,Myopathic facies
MONDO:0014986,Fanconi anemia complementation group R
chembl:CHEMBL1254682,LEVALLORPHAN
FB:FBgn0025682,scf
HGNC:6266,KCNJ5
HGNC:4776,H3C2
chembl:CHEMBL577851,CHEMBL577851
chembl:CHEMBL1395610,PROROXAN
HGNC:10388,RPS15
chembl:CHEMBL487402,EUPATORIN
HP:0000773,Short ribs
HP:0008665,Clitoral hypertrophy
chembl:CHEMBL249448,CHEMBL249448
HGNC:21735,LHX6
chembl:CHEMBL205596,CHOLIC ACID
chembl:CHEMBL33859,CHEMBL33859
HP:0001955,Unexplained fevers
chembl:CHEMBL198759,CHEMBL198759
HGNC:21479,DCBLD1
chembl:CHEMBL537,HYDROQUINONE
MONDO:0006702,chronic inflammatory demyelinating polyradiculoneuropathy
MONDO:0002853,rectum rhabdomyosarcoma
chembl:CHEMBL362863,CHEMBL362863
MONDO:0018851,familial keratoacanthoma
GO:0020016,ciliary pocket
NCBIGene:426488,NDUFV2
chembl:CHEMBL1719,OLOPATADINE HYDROCHLORIDE
HP:0001265,Hyporeflexia
HGNC:18157,TAB1
chembl:CHEMBL113897,CHEMBL113897
HP:0001419,X-linked recessive inheritance
HGNC:18445,CALML4
chembl:CHEMBL77030,TYRPHOSTIN 47
chembl:CHEMBL592314,CHEMBL592314
HGNC:6047,IMMT
chembl:CHEMBL1236962,OMIPALISIB
chembl:CHEMBL3597971,SELTOREXANT
chembl:CHEMBL3301675,LINACLOTIDE
HP:0006937,Impaired distal tactile sensation
HGNC:658,ARF5
chembl:CHEMBL14376,ILOPERIDONE
HP:0010852,EEG with photoparoxysmal response
HP:0004326,Cachexia
chembl:CHEMBL1095515,SCLEROTIORIN
chembl:CHEMBL454893,AMBUNOL
HGNC:11003,SLC29A1
MONDO:0100038,complex neurodevelopmental disorder
chembl:CHEMBL63329,CHEMBL63329
chembl:CHEMBL486133,LEPTOMYCIN B
CHEBI:26355,heme b
chembl:CHEMBL2105704,LENVATINIB MESYLATE
HGNC:833,ATP5F1C
HP:0000727,Frontal lobe dementia
chembl:CHEMBL603031,CHEMBL603031
chembl:CHEMBL597035,CHEMBL597035
chembl:CHEMBL2079588,TELATINIB
MONDO:0006658,arteriolosclerosis
HGNC:26010,SPDL1
chembl:CHEMBL1171754,JNJ-39220675
HGNC:17042,PUF60
chembl:CHEMBL3833320,EPTINEZUMAB
chembl:CHEMBL454,BUTALBITAL
chembl:CHEMBL320497,SUBEROHYDROXAMIC ACID
wikidata:Q4767903,ANNAMYCIN
HGNC:7113,MKRN2
HGNC:12635,UTRN
HGNC:4800,HSD17B10
chembl:CHEMBL316796,CHEMBL316796
MONDO:0002542,spinal cord glioma
Reactome:R-BTA-71403,Citric acid cycle (TCA cycle)
CHEBI:36885,20-oxo steroid
MONDO:0001406,peripheral nervous system neoplasm
chembl:CHEMBL2171782,CHEMBL2171782
chembl:CHEMBL320341,QUAZINONE
HP:0001974,Leukocytosis
HGNC:9604,PTGS1
RGD:1308810,Blm
HGNC:10941,SLC1A3
HP:0012452,Restless legs
HP:0002374,Diminished movement
chembl:CHEMBL591834,CHEMBL591834
MONDO:0003090,extrahepatic bile duct carcinoma
HGNC:1537,CBFA2T3
HGNC:61,ABCD1
HGNC:10295,RPGR
GO:0001164,RNA polymerase I core promoter sequence-specific DNA binding
HGNC:11752,TFE3
chembl:CHEMBL1099168,CHEMBL1099168
MONDO:0957545,"cardiomyopathy, dilated, 2I"
chembl:CHEMBL3989958,IVOSIDENIB
FB:FBgn0004168,5-HT1A
HP:0006859,Posterior leukoencephalopathy
HGNC:9533,PSMA4
MONDO:0001756,frontal sinus cancer
MONDO:0002254,syndromic disease
GO:0043195,terminal bouton
chembl:CHEMBL1743079,TEPROTUMUMAB
chembl:CHEMBL4298172,SOTICLESTAT
chembl:CHEMBL409225,CHEMBL409225
chembl:CHEMBL451532,NARINGIN
HGNC:7103,MIP
chembl:CHEMBL984,MIVACURIUM CHLORIDE
chembl:CHEMBL4298061,LEXAPTEPID PEGOL
chembl:CHEMBL472940,CHEMBL472940
chembl:CHEMBL2103822,TASIMELTEON
chembl:CHEMBL1256663,CHEMBL1256663
MONDO:0100191,inherited kidney disorder
chembl:CHEMBL1623028,CHEMBL1623028
chembl:CHEMBL3707374,AMISELIMOD HYDROCHLORIDE
chembl:CHEMBL1406948,CHEMBL1406948
GO:0055085,transmembrane transport
chembl:CHEMBL429023,ROTENONE
chembl:CHEMBL1242194,CYCLOSTREPTIN
HP:0002155,Hypertriglyceridemia
MONDO:0002032,colon carcinoma
chembl:CHEMBL275516,CANTHARIDIC_ACID
MONDO:0030268,developmental and epileptic encephalopathy 6B
chembl:CHEMBL1201120,REMIFENTANIL HYDROCHLORIDE
chembl:CHEMBL528271,PARBENDAZOLE
chembl:CHEMBL436774,AR9281
HGNC:18407,AGMAT
HP:0100660,Dyskinesia
chembl:CHEMBL417799,SANGUINARIUM
chembl:CHEMBL1201160,RITODRINE HYDROCHLORIDE
HGNC:4506,GPR50
chembl:CHEMBL4297760,GIVOSIRAN
CHEBI:17002,cholesteryl ester
HGNC:11543,TAF10
chembl:CHEMBL3137316,FOSDAGROCORAT
MONDO:0017998,PLA2G6-associated neurodegeneration
HP:0032113,Semidominant inheritance
chembl:CHEMBL1103,FURAZOLIDONE
HGNC:6349,KLF5
chembl:CHEMBL222645,FLOXACILLIN
chembl:CHEMBL220087,CHEMBL220087
chembl:CHEMBL1522,ESZOPICLONE
CHEBI:57288,acetyl-CoA(4-)
HGNC:14559,STOML2
HP:0002795,Abnormal respiratory system physiology
HGNC:7579,MYH9
HP:0001642,Pulmonic stenosis
chembl:CHEMBL512578,MORACIN M
HGNC:9402,PRKCG
HGNC:17789,LIN7C
ZFIN:ZDB-GENE-000329-3,actb2
MONDO:0013216,Diamond-Blackfan anemia 9
chembl:CHEMBL1200794,OXYMORPHONE HYDROCHLORIDE
chembl:CHEMBL155265,DNQX
chembl:CHEMBL274921,CHEMBL274921
CHEBI:7782,oripavine
chembl:CHEMBL1606,CHEMBL1606
chembl:CHEMBL222660,5-METHOXYISATIN
chembl:CHEMBL1800955,OMECAMTIV MECARBIL
chembl:CHEMBL269538,HARMINE
chembl:CHEMBL275742,DEXPROPRANOLOL
HP:0001285,Spastic tetraparesis
HGNC:7808,NGF
HP:0003549,Abnormality of connective tissue
chembl:CHEMBL3894518,AZD-8835
chembl:CHEMBL4298013,ELGEMTUMAB
chembl:CHEMBL2068623,LOBAPLATIN
chembl:CHEMBL93268,SODIUM NITRITE
chembl:CHEMBL441687,GLYCYRRHIZIN
chembl:CHEMBL2109637,HUHMFG1
HP:5200029,Social disinhibition
HGNC:30075,POLR3G
HP:0010821,Focal emotional seizure with laughing
chembl:CHEMBL1207745,BERAPROST
chembl:CHEMBL1201067,BIPERIDEN LACTATE
MGI:88031,Anxa7
UBERON:0001155,colon
MONDO:0004582,rheumatic myocarditis
HGNC:11107,SMARCD2
MONDO:0012050,major depressive disorder 1
HGNC:9283,PPP1CC
chembl:CHEMBL6995,PRACTOLOL
chembl:CHEMBL240681,ISO-IANTHERAN A
HP:0011805,Abnormal skeletal muscle morphology
HGNC:694,ARL3
HGNC:7876,NOS3
HP:0010521,Gait apraxia
HP:0032012,Heterotropia
HGNC:9381,PRKACB
HGNC:7179,ALDH6A1
CHEBI:35441,antiinfective agent
chembl:CHEMBL39677,ACRIDINE
chembl:CHEMBL771,CYCLOSERINE
MONDO:0025556,isocyanate induced asthma
chembl:CHEMBL1431,METFORMIN
chembl:CHEMBL1096885,VALRUBICIN
chembl:CHEMBL1927684,CHEMBL1927684
chembl:CHEMBL744,RILUZOLE
chembl:CHEMBL803,CYTARABINE
chembl:CHEMBL1423,PIMOZIDE
chembl:CHEMBL2105694,TELAPRISTONE ACETATE
chembl:CHEMBL487805,SCUTELLARIN
HGNC:25222,ERLEC1
chembl:CHEMBL41194,PRATOSARTAN
HP:0007000,Morning myoclonic jerks
HGNC:6638,LMNB2
UPHENO:0080598,abnormal emotional behavior
HGNC:34,ABCA4
HP:0000467,Neck muscle weakness
chembl:CHEMBL398707,HYDROMORPHONE
chembl:CHEMBL593570,CHEMBL593570
MONDO:0024491,"tumor grade 1, general grading system"
HGNC:4847,HCRT
HGNC:28217,TMEM203
chembl:CHEMBL1201776,TAPENTADOL
HGNC:12307,TRIP13
chembl:CHEMBL1201585,TRASTUZUMAB
HP:0006528,Chronic lung disease
chembl:CHEMBL321585,CHEMBL321585
HP:0031258,Delirium
chembl:CHEMBL18331,PIRENPERONE
chembl:CHEMBL898,DIFLUNISAL
NCBIGene:512098,CES1
MONDO:0010787,Kearns-Sayre syndrome
CHEBI:16113,cholesterol
HGNC:24525,MMACHC
UBERON:0002661,superior frontal gyrus
chembl:CHEMBL472656,CHEMBL472656
chembl:CHEMBL3545089,IMD-0354
MONDO:0005165,benign neoplasm
HP:0500153,Hyperargininemia
chembl:CHEMBL2165620,PF-04991532
chembl:CHEMBL119604,DIETHANOLAMINE
HGNC:4848,HCRTR1
chembl:CHEMBL1743064,ROBATUMUMAB
CHR:9606-chr11q22.2-q22.3,
HGNC:7978,NR3C1
HGNC:11010,SLC2A5
HGNC:12442,TYR
HP:0031986,Polyminimyoclonus
chembl:CHEMBL429910,DAPAGLIFLOZIN
chembl:CHEMBL2109393,RG-7160
HGNC:8156,OPRM1
chembl:CHEMBL3545134,LY-2780301
MONDO:0006133,cervical adenoid cystic carcinoma
chembl:CHEMBL4297312,ORM-12741
HP:0020217,Focal aware motor seizure
chembl:CHEMBL49429,LIXIVAPTAN
chembl:CHEMBL1101,BIPERIDEN
HGNC:3597,FAU
MONDO:0009240,formiminoglutamic aciduria
chembl:CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE
chembl:CHEMBL65675,GALLIC ACID METHYL ESTER
chembl:CHEMBL1232076,CHEMBL1232076
chembl:CHEMBL263094,CARMINIC ACID
chembl:CHEMBL1440119,IRIGINOL HEXAACEATATE
chembl:CHEMBL1373255,CHEMBL1373255
HGNC:4827,HBB
chembl:CHEMBL1091,HYDROCORTISONE ACETATE
chembl:CHEMBL3545159,R-333
chembl:CHEMBL30816,DICHLOROISOPROTERENOL
chembl:CHEMBL75967,PENTACHLOROPHENOL
GO:0031088,platelet dense granule membrane
HP:0003763,Bruxism
wikidata:Q29006438,RHUCIN
HGNC:10706,SEC24D
CHEBI:35358,sulfonamide
chembl:CHEMBL477936,CHEMBL477936
chembl:CHEMBL1371770,PIRIBEDIL
chembl:CHEMBL1255589,LORGLUMIDE SODIUM
HP:0003550,Predominantly lower limb lymphedema
chembl:CHEMBL1374360,MERCURIC CHLORIDE
chembl:CHEMBL522782,PROCHLORAZ
chembl:CHEMBL1500913,CHEMBL1500913
HGNC:8512,OTC
chembl:CHEMBL4297477,BREPOCITINIB
chembl:CHEMBL2010601,IVACAFTOR
chembl:CHEMBL587892,CHEMBL587892
HP:0012651,Abasia
MONDO:0002381,sweat gland neoplasm
chembl:CHEMBL918,PHENACEMIDE
chembl:CHEMBL1200771,TRIDIHEXETHYL CHLORIDE
chembl:CHEMBL278255,CLINAFLOXACIN
chembl:CHEMBL487253,BENDAMUSTINE
MONDO:0000707,diversion colitis
chembl:CHEMBL2110371,CHEMBL2110371
HGNC:22800,GNAT3
MONDO:0021178,injury
CHEBI:37941,clopidogrel
HP:0001308,Tongue fasciculations
chembl:CHEMBL363614,BENZOFURAN
HGNC:12475,UBE2D2
chembl:CHEMBL3707397,MR-1817
chembl:CHEMBL1550879,MECETRONIUM
HGNC:24539,NECAP1
chembl:CHEMBL1950649,APADENOSON
chembl:CHEMBL1529817,ALPHAPRODINE HYDROCHLORIDE
chembl:CHEMBL573,NIACIN
MONDO:0008725,congenital lipoid adrenal hyperplasia due to STAR deficency
MONDO:0002936,scrotum basal cell carcinoma
HGNC:4408,GNG5
CHEBI:57433,sarcosine zwitterion
chembl:CHEMBL72628,2-PICOLINIC ACID
HGNC:3569,ACSL1
CHEBI:23618,deoxycortisol
GO:0005615,extracellular space
HGNC:38606,BECN2
chembl:CHEMBL259820,CHEMBL259820
HGNC:11530,TACSTD2
HGNC:144,ACTG1
MONDO:0859201,neurodevelopmental disorder with impaired language and ataxia and with or without seizures
chembl:CHEMBL86,METOCLOPRAMIDE
chembl:CHEMBL2108869,TIPLIMOTIDE
chembl:CHEMBL279998,ISONIPECOTIC ACID
chembl:CHEMBL588501,CHEMBL588501
UBERON:0000397,colonic epithelium
chembl:CHEMBL586,SALICYLURIC ACID
chembl:CHEMBL55285,BENZYL ISOTHIOCYANATE
chembl:CHEMBL60824,"4-AMINO-[1,2]NAPHTHOQUINONE"
HGNC:11715,TEAD2
CHEBI:15551,prostaglandin E2
UPHENO:0001005,abnormal phenotype by ontology source
HGNC:263,ADORA2A
MONDO:0850286,exercise-induced bronchoconstriction
chembl:CHEMBL1200885,ALOSETRON HYDROCHLORIDE
chembl:CHEMBL2313445,CHEMBL2313445
chembl:CHEMBL2104262,FADOLMIDINE
HGNC:8540,P2RY11
chembl:CHEMBL1643,RIBAVIRIN
HGNC:12252,TRD
chembl:CHEMBL4297298,KW-2478
chembl:CHEMBL2105643,FOSBRETABULIN TROMETHAMINE
HGNC:20157,HECTD1
chembl:CHEMBL590660,CHEMBL590660
HP:0001263,Global developmental delay
HP:0000358,Posteriorly rotated ears
chembl:CHEMBL1088752,LOSMAPIMOD
chembl:CHEMBL2426136,NAMOLINE
HP:0012323,Sleep myoclonus
chembl:CHEMBL1046,AMINOCAPROIC ACID
HGNC:9717,PEX2
HGNC:14889,DNAJB11
HP:0003744,Genetic anticipation with paternal anticipation bias
CHEBI:27666,actinomycin D
MONDO:0011038,cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
HP:0006829,Severe muscular hypotonia
chembl:CHEMBL370805,COCAINE
chembl:CHEMBL2063687,CHEMBL2063687
chembl:CHEMBL540445,PARTHENOLIDE
chembl:CHEMBL3990037,DUVORTUXIZUMAB
HP:0034339,Pseudoautosomal inheritance
HGNC:17697,SARS2
chembl:CHEMBL1161520,CHEMBL1161520
chembl:CHEMBL498513,CHEMBL498513
chembl:CHEMBL579725,CHEMBL579725
chembl:CHEMBL31400,ELINAFIDE
HGNC:2000,CKS2
MONDO:0009049,Cushing syndrome due to macronodular adrenal hyperplasia
GO:0098796,membrane protein complex
HGNC:17563,METTL3
HGNC:10258,RORA
chembl:CHEMBL1200406,DIMENHYDRINATE
HP:0002305,Athetosis
HP:0025357,Erratic myoclonus
MONDO:0005005,clear cell renal carcinoma
chembl:CHEMBL3545085,XL-228
chembl:CHEMBL4297577,BELAPECTIN
chembl:CHEMBL1961797,SR9011
MONDO:0014231,juvenile onset Parkinson disease 19A
chembl:CHEMBL796,METHYLPHENIDATE
chembl:CHEMBL2108144,TENELIXIMAB
HGNC:11151,SNRPA
HGNC:1499,CASP1
HP:0000750,Delayed speech and language development
HP:0003774,Stage 5 chronic kidney disease
chembl:CHEMBL589469,CHEMBL589469
chembl:CHEMBL1200328,DULOXETINE HYDROCHLORIDE
MONDO:0800330,"myoclonic epilepsy, juvenile, 2"
HP:0000570,Abnormal saccadic eye movements
chembl:CHEMBL76589,CHEMBL76589
HGNC:26709,SCAI
chembl:CHEMBL590947,CHEMBL590947
HP:0010544,Vertical nystagmus
MONDO:0009469,benign recurrent intrahepatic cholestasis type 1
chembl:CHEMBL2111286,RANITIDINE BISMUTH CITRATE
chembl:CHEMBL200102,PU-H71
NCBIGene:506370,CYB5B
CHEBI:17754,glycerol
MONDO:0007624,Flynn-Aird syndrome
chembl:CHEMBL1235252,PROSTAGLANDIN D2
chembl:CHEMBL1090090,VX-702
chembl:CHEMBL1223641,GLISOFLAVONE
chembl:CHEMBL1222039,SECRAMINE B
HP:0002018,Nausea
MONDO:0859214,Marbach-Schaaf neurodevelopmental syndrome
chembl:CHEMBL463,AMINOHIPPURIC ACID
chembl:CHEMBL54440,MEVASTATIN
chembl:CHEMBL22148,CHEMBL22148
HGNC:1780,CDK9
CHEBI:38940,sunitinib
HP:0030082,Abnormal drinking behavior
chembl:CHEMBL413552,QUERCETAGETIN
chembl:CHEMBL64119,CHEMBL64119
HGNC:2704,DCK
CHEBI:35346,11beta-hydroxy steroid
HP:0004325,Decreased body weight
chembl:CHEMBL1390716,CHEMBL1390716
HGNC:11257,SPR
HGNC:5331,NOD2
chembl:CHEMBL1915540,PF-03893787
MONDO:0010953,Fanconi anemia complementation group E
MONDO:0003516,adult teratoma
HGNC:17327,WAC
chembl:CHEMBL16,PHENYTOIN
chembl:CHEMBL3301574,TISAGENLECLEUCEL
GO:0001046,core promoter sequence-specific DNA binding
HGNC:12023,TPTE
chembl:CHEMBL1765740,CHEMBL1765740
chembl:CHEMBL24955,BEXLOSTERIDE
HP:0001298,Encephalopathy
chembl:CHEMBL452715,ALANOSINE
HP:0000405,Conductive hearing impairment
chembl:CHEMBL1223740,CRYPTOCHINONE A
chembl:CHEMBL1397,POSACONAZOLE
HGNC:1864,CES2
chembl:CHEMBL464651,CHEMBL464651
UBERON:0004810,nephron tubule epithelium
chembl:CHEMBL486696,DOMIPHEN BROMIDE
HGNC:6076,INPP5A
chembl:CHEMBL356918,ENILCONAZOLE
chembl:CHEMBL963,OXYMORPHONE
chembl:CHEMBL3545097,SAPANISERTIB
chembl:CHEMBL526776,CHEMBL526776
CHEBI:8028,perphenazine
MONDO:0008062,narcolepsy 1
chembl:CHEMBL2107819,BELNACASAN
HP:0007364,Aplasia/Hypoplasia of the cerebrum
chembl:CHEMBL1291,METIPRANOLOL
chembl:CHEMBL584248,CHEMBL584248
chembl:CHEMBL1454,LEVAMISOLE
chembl:CHEMBL2109545,TB-403
chembl:CHEMBL464381,PALINURIN
HP:0003828,Variable expressivity
chembl:CHEMBL453,SULFISOXAZOLE
HP:0002876,Episodic tachypnea
chembl:CHEMBL1521,ZALEPLON
HGNC:25095,DCAF15
HP:0002353,EEG abnormality
chembl:CHEMBL259615,CHEMBL259615
chembl:CHEMBL494081,CHEMBL494081
chembl:CHEMBL1795737,CHEMBL1795737
MONDO:0005127,lepromatous leprosy
HP:0009942,Duplication of thumb phalanx
chembl:CHEMBL315795,CLOMETHIAZOLE
HGNC:4204,GCNT2
CHEBI:51323,cinchona alkaloid
chembl:CHEMBL1472895,FENBUTATIN OXIDE
chembl:CHEMBL1256472,CYTARABINE HYDROCHLORIDE
HGNC:4250,GGT1
chembl:CHEMBL1257039,TRIFLUPERIDOL HYDROCHLORIDE
chembl:CHEMBL4297874,AFM-11
chembl:CHEMBL1201328,CARPHENAZINE
HGNC:28300,NT5C3B
chembl:CHEMBL467590,GETIACAULEIN
chembl:CHEMBL505251,KERACYANIN
chembl:CHEMBL204021,DARAPLADIB
HP:0002478,Progressive spastic quadriplegia
HP:0010529,Echolalia
HGNC:90,ACADS
chembl:CHEMBL1223742,7-O-METHYLCRYPTOCHINONE A
chembl:CHEMBL255863,NILOTINIB
HGNC:3373,EP300
HGNC:19743,POMT2
chembl:CHEMBL100473,U-0126
HGNC:11142,SIK1
chembl:CHEMBL318743,TETRAHYDROCURCUMIN
chembl:CHEMBL349803,PIRETANIDE
NCBIGene:421447,EPHX1L
chembl:CHEMBL1651906,STREPTOZOCIN
chembl:CHEMBL1255834,CHEMBL1255834
MONDO:0958012,neurodegeneration with brain iron accumulation 9
HGNC:16971,FRS2
chembl:CHEMBL750,ZONISAMIDE
MONDO:0004986,urinary bladder carcinoma
chembl:CHEMBL2110727,CENICRIVIROC
chembl:CHEMBL23731,AMIDATE
chembl:CHEMBL1243178,LACTOFEN
GO:0043209,myelin sheath
chembl:CHEMBL416,METHOXSALEN
chembl:CHEMBL253989,CHEMBL253989
HP:0003144,Increased serum serotonin
chembl:CHEMBL492399,VERUBULIN
ZFIN:ZDB-GENE-050320-87,ndufc2
chembl:CHEMBL1702181,CHEMBL1702181
HGNC:30424,SPPL3
HGNC:13176,IKZF1
HP:0007359,Focal-onset seizure
HGNC:17158,PLD3
HGNC:1622,CCT7
chembl:CHEMBL534535,CHEMBL534535
chembl:CHEMBL598477,CHEMBL598477
chembl:CHEMBL576809,CHEMBL576809
chembl:CHEMBL1489254,TRIACETIN
chembl:CHEMBL3707402,PF-06372865
FB:FBgn0262559,Mdh2
HGNC:30313,UBR4
chembl:CHEMBL360328,LORCASERIN
CHEBI:192484,ciprofloxacin zwitterion
HGNC:16636,KIF1B
MONDO:0009745,neuronal ceroid lipofuscinosis 5
HGNC:11098,SMARCA2
MONDO:0015068,"neuroendocrine tumor of rectum, well differentiated, low or intermediate grade"
HGNC:7827,NIPSNAP1
CHEBI:11814,3-hydroxy-3-methylglutaryl-CoA
CHEBI:18344,kynurenic acid
HP:0002166,Impaired vibration sensation in the lower limbs
chembl:CHEMBL1200745,OXPRENOLOL HYDROCHLORIDE
NCBIGene:476735,NDUFA11
chembl:CHEMBL709,ALFUZOSIN
HGNC:11427,STUB1
HP:0031691,Severe viral infection
HGNC:583,APC
HGNC:18194,ZNF365
MONDO:0014157,mandibular hypoplasia-deafness-progeroid syndrome
chembl:CHEMBL443095,E163
WB:WBGene00000417,ced-3
chembl:CHEMBL7917,TYRPHOSTIN AG-1478
HGNC:7045,MGAT2
chembl:CHEMBL273862,HYDROXYCAMPTOTHECIN
chembl:CHEMBL1589,ACETOHEXAMIDE
chembl:CHEMBL224325,CHLORQUINALDOL
chembl:CHEMBL1494650,CHEMBL1494650
chembl:CHEMBL108,CARBAMAZEPINE
chembl:CHEMBL3039507,SOTAGLIFLOZIN
chembl:CHEMBL88147,CHEMBL88147
UBERON:0010414,omental fat pad
HP:0000736,Short attention span
chembl:CHEMBL582180,CHEMBL582180
chembl:CHEMBL1255743,TRANYLCYPROMINE HYDROCHLORIDE
chembl:CHEMBL1892429,FLUORODIFEN
chembl:CHEMBL601142,CHEMBL601142
chembl:CHEMBL1075790,PERUVOSIDE
chembl:CHEMBL449520,ATRACTYLENOLIDE I
HP:0006855,Cerebellar vermis atrophy
HGNC:15714,LRPPRC
chembl:CHEMBL2105755,NALDEMEDINE
HGNC:11169,SNTB2
MONDO:0006029,cecum carcinoma
MONDO:0002378,dermoid cyst
HP:0000640,Gaze-evoked nystagmus
HGNC:17072,ERC1
chembl:CHEMBL3707355,AZD8108
CHEBI:29035,manganese(2+)
MONDO:0005602,ovarian teratoma
chembl:CHEMBL581152,CHEMBL581152
chembl:CHEMBL1761,PROCYCLIDINE HYDROCHLORIDE
HGNC:4076,GABRA2
UPHENO:0009339,absent vestibular nerve
chembl:CHEMBL431701,SILYBIN A
MONDO:0018326,transient neonatal myasthenia gravis
CHEBI:27644,chlortetracycline
HP:0002791,Hypoventilation
chembl:CHEMBL406291,BRADYKININ
chembl:CHEMBL2304041,SAGOPILONE
chembl:CHEMBL449905,MAKALUVAMINE A
NCBIGene:520260,FH
CHEBI:36421,phenanthridine
GO:0005829,cytosol
chembl:CHEMBL2105741,TRAMETINIB DIMETHYL SULFOXIDE
chembl:CHEMBL1201587,ALEMTUZUMAB
MONDO:0006210,fibrolamellar hepatocellular carcinoma
chembl:CHEMBL232201,BENZIODARONE
HP:0040064,Abnormality of limbs
HGNC:124,ACP5
chembl:CHEMBL782,TOLBUTAMIDE
GO:0072757,cellular response to camptothecin
chembl:CHEMBL3545236,BPI-9016
chembl:CHEMBL1201421,PEGAPTANIB SODIUM
HGNC:8808,PDHB
CHEBI:35337,central nervous system stimulant
chembl:CHEMBL498230,OLEANDEROLIDE
Reactome:R-HSA-9022699,MECP2 regulates neuronal receptors and channels
chembl:CHEMBL276815,(S)-AMPA
GO:0015755,fructose transmembrane transport
HGNC:565,AP2S1
chembl:CHEMBL2449003,ENDO-ATROPINE
HGNC:7683,NDUFA1
chembl:CHEMBL2057864,CHEMBL2057864
GO:0008503,benzodiazepine receptor activity
HGNC:542,ANXA4
chembl:CHEMBL607308,CHEMBL607308
chembl:CHEMBL3928407,GS-9901
chembl:CHEMBL1241268,CHEMBL1241268
chembl:CHEMBL4297523,PIROMELATINE
MONDO:0001429,transient arthropathy
chembl:CHEMBL4101807,VOXELOTOR
chembl:CHEMBL4297261,APTO-253
chembl:CHEMBL229430,AMG-517
CHEBI:51454,cyclopropanes
chembl:CHEMBL399249,(R)-PINOCEMBRIN
chembl:CHEMBL3545021,ANLOTINIB
MONDO:0000709,Crohn ileitis
HGNC:4688,GUCY2C
chembl:CHEMBL1201753,PITAVASTATIN
chembl:CHEMBL1201770,METHYLNALTREXONE BROMIDE
HGNC:20776,TUBB6
chembl:CHEMBL528451,CHEMBL528451
chembl:CHEMBL1200854,FLUPHENAZINE DECANOATE
chembl:CHEMBL1198855,RONACALERET
chembl:CHEMBL4297399,LY-2608204
chembl:CHEMBL280074,OLOMOUCINE
MONDO:0018213,hereditary sensory and autonomic neuropathy type 1
HP:0002493,Upper motor neuron dysfunction
chembl:CHEMBL57895,EFAROXAN
chembl:CHEMBL1233714,E1501
HGNC:16711,TLR6
chembl:CHEMBL2333541,ARISTOYUNNOLIN A
chembl:CHEMBL602135,CHEMBL602135
chembl:CHEMBL1221944,CHEMBL1221944
MONDO:0013764,Joubert syndrome 16
chembl:CHEMBL91153,"3',4'-DIMETHOXYFLAVONE"
HP:0007366,Atrophy/Degeneration affecting the brainstem
chembl:CHEMBL590686,CHEMBL590686
chembl:CHEMBL1333049,CHEMBL1333049
chembl:CHEMBL2103881,DEXMECAMYLAMINE
HP:0100835,Benign neoplasm of the central nervous system
chembl:CHEMBL1208973,CUPRESSUFLAVONE
chembl:CHEMBL585265,CHEMBL585265
chembl:CHEMBL573107,CHEMBL573107
chembl:CHEMBL288943,LEUKOTRIENE D4
chembl:CHEMBL6246,ELLAGIC ACID
UBERON:0012336,perianal skin
chembl:CHEMBL1078178,MOMELOTINIB
CHEBI:15414,S-adenosyl-L-methionine
chembl:CHEMBL484640,CHEMBL484640
chembl:CHEMBL1579,PARAMETHASONE
chembl:CHEMBL721,ACROLEIN
MONDO:0000090,progressive external ophthalmoplegia with mitochondrial DNA deletions
chembl:CHEMBL1200940,METOCLOPRAMIDE HYDROCHLORIDE
UBERON:0009834,dorsolateral prefrontal cortex
chembl:CHEMBL35084,CANDOXATRIL
MONDO:0015026,cerebroretinal microangiopathy with calcifications and cysts 2
chembl:CHEMBL212948,DAMNACANTHAL
chembl:CHEMBL197672,EMRICASAN
MONDO:0011834,spinocerebellar ataxia type 18
HGNC:8546,P4HA1
chembl:CHEMBL174,AMPICILLIN
HGNC:786,ATF4
GO:0006457,protein folding
chembl:CHEMBL53628,DESMOSDUMOTIN C
chembl:CHEMBL564,PROMAZINE
chembl:CHEMBL601764,CHEMBL601764
HGNC:6616,LIMS1
chembl:CHEMBL2109352,BL22
chembl:CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE
HGNC:854,ATP6V1B2
chembl:CHEMBL2108713,IODINE I 124 GIRENTUXIMAB
chembl:CHEMBL1739,METOCURINE IODIDE
chembl:CHEMBL1200809,AZELASTINE HYDROCHLORIDE
MONDO:0036511,childhood malignant kidney neoplasm
chembl:CHEMBL532909,CHEMBL532909
NCBIGene:526221,DRD5
chembl:CHEMBL580516,CHEMBL580516
chembl:CHEMBL46917,CARBARIL
chembl:CHEMBL607534,CHEMBL607534
HGNC:9957,RELN
chembl:CHEMBL3544917,RAPASTINEL
HGNC:23456,ASAH2B
chembl:CHEMBL97858,CHEMBL97858
HP:0002483,Bulbar signs
chembl:CHEMBL2036277,SEIMATOPOLIDE A
chembl:CHEMBL238071,VINDESINE
MONDO:0001751,cholestasis
chembl:CHEMBL449317,HESPERIDIN
chembl:CHEMBL4297328,SUVN-G3031
chembl:CHEMBL319111,LINOPIRDINE
MONDO:0007182,Machado-Joseph disease
UBERON:0000988,pons
chembl:CHEMBL1310701,CHEMBL1310701
HGNC:9777,RAB3A
HGNC:20150,RAB15
chembl:CHEMBL1743058,PONEZUMAB
HGNC:9229,PLPP3
HGNC:4387,GNAI3
chembl:CHEMBL152231,AMOSULALOL
chembl:CHEMBL1822792,MK-2461
HGNC:3432,ERBB4
chembl:CHEMBL917,FLOXURIDINE
HP:0000762,Decreased nerve conduction velocity
chembl:CHEMBL1284,"3,4-DIHYDROXYPHENYLACETIC ACID "
chembl:CHEMBL4297701,BIO-11006
chembl:CHEMBL170,QUININE
chembl:CHEMBL404505,CHEMBL404505
chembl:CHEMBL8211,N-ETHYLMALEIMIDE
MONDO:0008728,classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
chembl:CHEMBL123349,CHEMBL123349
HGNC:3689,FGFR2
HP:0001238,Slender finger
MONDO:0000473,arterial disorder
chembl:CHEMBL1200500,BECLOMETHASONE DIPROPIONATE
chembl:CHEMBL1201020,DISOPYRAMIDE PHOSPHATE
HP:0000365,Hearing impairment
chembl:CHEMBL2218917,CEVIMELINE HYDROCHLORIDE
chembl:CHEMBL3545355,CHF4227
chembl:CHEMBL583555,CHEMBL583555
chembl:CHEMBL2356023,DIHYDROTACHYSTEROL
chembl:CHEMBL1201508,GLUCAGON HYDROCHLORIDE RECOMBINANT
chembl:CHEMBL1456848,CHEMBL1456848
chembl:CHEMBL3545240,CLX-0921
chembl:CHEMBL2107890,TAPLITUMOMAB PAPTOX
chembl:CHEMBL3182444,MK-5108
chembl:CHEMBL1200806,NAPROXEN SODIUM
HGNC:5301,HTR6
chembl:CHEMBL264373,METOPRINE
chembl:CHEMBL2109447,LYM-1
chembl:CHEMBL384441,CHEMBL384441
HGNC:11408,STK4
GO:0015371,galactose:sodium symporter activity
NCBIGene:423763,NDUFB8
chembl:CHEMBL294018,PATULIN
chembl:CHEMBL605846,OLODATEROL
chembl:CHEMBL2111112,VERNAKALANT
chembl:CHEMBL105350,BISDEMETHOXYCURCUMIN
MGI:2159324,Cln6
HP:0001347,Hyperreflexia
chembl:CHEMBL428690,ALVOCIDIB
HGNC:6879,MAPK6
chembl:CHEMBL1171829,BITOPERTIN
chembl:CHEMBL108829,2-PHENYLPHENOL
chembl:CHEMBL552439,CHEMBL552439
HP:0031856,Hobby horse gait
chembl:CHEMBL485833,FLUDIOXONIL
HGNC:11447,STYX
MONDO:0016703,anaplastic oligoastrocytoma
chembl:CHEMBL2178575,GSK-2239633
chembl:CHEMBL3542340,ISOSILYBIN B
GO:0017124,SH3 domain binding
HP:0008151,Prolonged prothrombin time
chembl:CHEMBL601768,CHEMBL601768
HGNC:8805,PDGFRL
HGNC:29333,ANKRD36B
MONDO:0019262,juvenile neuronal ceroid lipofuscinosis
CHEBI:35933,cinchonan
chembl:CHEMBL415879,PHENANTHROLINE
chembl:CHEMBL1481974,CHEMBL1481974
chembl:CHEMBL1784750,NOBILAMIDE B
MGI:1928369,Slc2a5
HP:0011344,Severe global developmental delay
MONDO:0017763,disorder of iron metabolism and transport
chembl:CHEMBL577014,CHEMBL577014
HGNC:9986,RFX5
chembl:CHEMBL1411979,METHAPYRILENE
HGNC:7694,NDUFAB1
chembl:CHEMBL1486366,CHEMBL1486366
chembl:CHEMBL4297184,CIFORADENANT
HGNC:8949,SERPINB5
MONDO:0011025,Cayman type cerebellar ataxia
HGNC:171,ACVR1
chembl:CHEMBL271663,PIPERONAL
UBERON:0001303,left uterine tube
chembl:CHEMBL371523,DIBENZOYLMETHANE
HP:0007076,Extrapyramidal muscular rigidity
MONDO:0014464,progressive encephalopathy with leukodystrophy due to DECR deficiency
HP:0002299,Brittle hair
HGNC:2291,COX7B
MONDO:0020172,palpebral epidermal tumor
NCBIGene:477115,AADAC
GO:0016913,follicle-stimulating hormone activity
chembl:CHEMBL296586,KENPAULLONE
chembl:CHEMBL4297604,ACEBILUSTAT
HP:0012622,Chronic kidney disease
MONDO:0018908,non-Hodgkin lymphoma
HGNC:12022,TPT1
chembl:CHEMBL510650,ECHINOMYCIN
HP:0002194,Delayed gross motor development
MONDO:0009397,neonatal severe primary hyperparathyroidism
MONDO:0033369,"developmental and epileptic encephalopathy, 60"
CHEBI:35623,anticonvulsant
MONDO:0018117,"disorder of phospholipids, sphingolipids and fatty acids biosynthesis"
MONDO:0009287,glycogen storage disease due to glucose-6-phosphatase deficiency type IA
chembl:CHEMBL2110666,DENAGLIPTIN
chembl:CHEMBL3545059,ALISKIREN FUMARATE
chembl:CHEMBL3092650,GSK239512
chembl:CHEMBL1201572,ETANERCEPT
HGNC:9407,PRKD1
chembl:CHEMBL444186,RAZOXANE
chembl:CHEMBL1237065,TRAMADOL HYDROCHLORIDE
chembl:CHEMBL1201661,CALCITONIN SALMON RECOMBINANT
chembl:CHEMBL282042,SAQUINAVIR MESYLATE
HGNC:7029,MET
chembl:CHEMBL399705,(S)-ONDANSETRON
chembl:CHEMBL602552,CHEMBL602552
chembl:CHEMBL1200538,BETAMETHASONE ACETATE
MONDO:0014475,spinocerebellar ataxia type 40
chembl:CHEMBL1182210,BENZETHONIUM
chembl:CHEMBL591178,CHEMBL591178
HGNC:9476,HTRA1
chembl:CHEMBL109480,TANESPIMYCIN
chembl:CHEMBL2062863,CHEMBL2062863
HGNC:20454,POLR1B
HGNC:4574,GRIA4
chembl:CHEMBL2103868,CABOZANTINIB S-MALATE
chembl:CHEMBL34259,METHOTREXATE
HP:0000006,Autosomal dominant inheritance
MONDO:0016705,angiocentric glioma
chembl:CHEMBL549208,CHEMBL549208
NCBIGene:100141309,RAD51
HGNC:7711,NDUFS4
GO:0019194,sorbose transmembrane transporter activity
chembl:CHEMBL1343544,CEFSULODIN SODIUM
HGNC:11190,SOX10
chembl:CHEMBL1889140,ROPIVACAINE HYDROCHLORIDE
chembl:CHEMBL223360,LINIFANIB
chembl:CHEMBL2386881,CAPROSPINOL
chembl:CHEMBL1607517,BENZANTHRONE
chembl:CHEMBL118841,PYRAZOLOACRIDINE
chembl:CHEMBL578420,CHEMBL578420
chembl:CHEMBL589245,CHEMBL589245
HP:0034335,Inheritance qualifier
chembl:CHEMBL1939433,CHEMBL1939433
MONDO:0010183,methylmalonic aciduria and homocystinuria type cblF
chembl:CHEMBL275938,AURINTRICARBOXYLIC ACID
ZFIN:ZDB-GENE-050706-62,rcn2
UBERON:0002115,jejunum
MONDO:0000328,hyperphosphatemia
CHEBI:25681,omega-3 fatty acid
HGNC:4916,HIRA
HP:0200085,Limb tremor
chembl:CHEMBL1023,BEXAROTENE
HGNC:6117,IRF2
MONDO:0011559,benign recurrent intrahepatic cholestasis type 2
CHEBI:3749,clofazimine
chembl:CHEMBL3545285,XL-999
chembl:CHEMBL20730,VESAMICOL
chembl:CHEMBL408563,CHEMBL408563
chembl:CHEMBL1276138,FARAMPATOR
chembl:CHEMBL529984,CHEMBL529984
chembl:CHEMBL582699,CHEMBL582699
GO:0042827,platelet dense granule
chembl:CHEMBL1162521,CHEMBL1162521
chembl:CHEMBL258893,CHELERYTHRINE CHLORIDE
HGNC:3670,FGF13
HP:5200045,Reduced impulse control
chembl:CHEMBL1256796,CHEMBL1256796
chembl:CHEMBL4297188,MIRANSERTIB
chembl:CHEMBL687,ACETYLSULFANILAMIDE
chembl:CHEMBL1200601,NARATRIPTAN HYDROCHLORIDE
HGNC:3402,EPHX2
chembl:CHEMBL1770248,ERTUGLIFLOZIN
chembl:CHEMBL2107188,PANCOPRIDE
chembl:CHEMBL1201825,RANIBIZUMAB
RGD:68327,Hap1
chembl:CHEMBL1584,PIPERACETAZINE
chembl:CHEMBL189724,CHEMBL189724
WB:WBGene00000403,casy-1
chembl:CHEMBL112,ACETAMINOPHEN
chembl:CHEMBL46403,STEARIC ACID
HP:0006879,Pontocerebellar atrophy
HGNC:1383,CA9
chembl:CHEMBL472437,KAMEBANIN
MONDO:0800301,Friedreich ataxia with retained reflexes
chembl:CHEMBL2108400,EMFILERMIN
HGNC:2159,CNR1
HGNC:7872,NOS1
chembl:CHEMBL602970,CHEMBL602970
chembl:CHEMBL589670,CHEMBL589670
chembl:CHEMBL2208211,ISOPROPYL ISOTHIOCYANATE
chembl:CHEMBL105442,CI-1040
chembl:CHEMBL599100,CHEMBL599100
HGNC:15456,MBTPS1
MONDO:0013968,PGM1-congenital disorder of glycosylation
HP:0100851,Abnormal emotion/affect behavior
GO:0005768,endosome
UBERON:0001898,hypothalamus
chembl:CHEMBL1927670,CHEMBL1927670
WB:WBGene00012067,sqst-3
HP:0010553,Oculogyric crisis
HP:0030220,Socially inappropriate behavior
chembl:CHEMBL67,COMBRETASTATIN A4
chembl:CHEMBL577,ENALAPRILAT
chembl:CHEMBL2109391,MDX-447
chembl:CHEMBL602126,CHEMBL602126
chembl:CHEMBL594379,CHEMBL594379
chembl:CHEMBL1372368,MUNDULONE ACETATE
chembl:CHEMBL445304,CHEMBL445304
chembl:CHEMBL3989767,CALCITONIN
chembl:CHEMBL309339,SALICYLHYDROXAMIC ACID
MONDO:0014084,ataxia with oculomotor apraxia type 3
HGNC:25490,NTAQ1
MONDO:0002531,skin neoplasm
MGI:2388633,Cltc
chembl:CHEMBL2218893,BEDORADRINE SULFATE
HP:0006849,Hypodysplasia of the corpus callosum
HP:0003380,Decreased number of peripheral myelinated nerve fibers
chembl:CHEMBL1762621,BARDOXOLONE METHYL
HGNC:707,ARPC4
HGNC:7525,MUSK
MP:0003312,abnormal locomotor coordination
RGD:71024,Actr3
chembl:CHEMBL224214,CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE
MONDO:0009141,torsion dystonia 2
chembl:CHEMBL76370,TEGASEROD
chembl:CHEMBL141530,ECHINATIN
Reactome:R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC
MONDO:0016810,autosomal recessive progressive external ophthalmoplegia
chembl:CHEMBL1200773,TOCAINIDE HYDROCHLORIDE
chembl:CHEMBL10284,SB-222200
chembl:CHEMBL3621988,TUCIDINOSTAT
HP:0000643,Blepharospasm
chembl:CHEMBL460273,CHEMBL460273
chembl:CHEMBL590914,CHEMBL590914
chembl:CHEMBL249447,CHEMBL249447
chembl:CHEMBL252920,BERKELEYACETAL A
MONDO:0011785,hereditary spastic paraplegia 19
HGNC:9382,PRKACG
chembl:CHEMBL3545151,CC-223
MONDO:0014638,Fanconi anemia complementation group T
GO:0006601,creatine biosynthetic process
Reactome:R-HSA-432047,Passive transport by Aquaporins
chembl:CHEMBL485629,MK-0873
chembl:CHEMBL563553,MULBERROFURAN H
HP:0001300,Parkinsonism
HP:0001288,Gait disturbance
chembl:CHEMBL343002,CHEMBL343002
chembl:CHEMBL577365,CHEMBL577365
chembl:CHEMBL1224528,DIHYDROXIDINE
UBERON:0014890,right hemisphere of cerebellum
MONDO:0016689,gemistocytic astrocytoma
chembl:CHEMBL191334,NUTLIN-3
chembl:CHEMBL1201827,PANITUMUMAB
HGNC:26483,GLT1D1
chembl:CHEMBL13960,DICHLOROACETIC ACID
MGI:1927091,Myo1g
chembl:CHEMBL530664,CHEMBL530664
chembl:CHEMBL231068,FLIBANSERIN
chembl:CHEMBL3039597,GENTAMICIN
HGNC:2355,CRH
GO:0007026,negative regulation of microtubule depolymerization
UBERON:0002483,trabecular bone tissue
chembl:CHEMBL1579130,CHEMBL1579130
chembl:CHEMBL25554,CHEMBL25554
HGNC:6913,MAX
chembl:CHEMBL1363249,CHEMBL1363249
HP:0001155,Abnormality of the hand
MONDO:0100062,developmental and epileptic encephalopathy
chembl:CHEMBL2108129,SARUPLASE
chembl:CHEMBL1514569,DALBERGIONE
chembl:CHEMBL3707266,RIBOCICLIB SUCCINATE
chembl:CHEMBL532412,CHEMBL532412
NCBIGene:515773,CYB5R3
chembl:CHEMBL408850,CHEMBL408850
chembl:CHEMBL2104986,TEDATIOXETINE
HGNC:14977,SNX14
chembl:CHEMBL1622,FOLIC ACID
MONDO:0005154,liver disorder
HGNC:17819,NT5C1A
MONDO:0015306,Lemierre syndrome
HGNC:28079,ZNF598
HGNC:11919,CD40
HP:0001623,Breech presentation
CHEBI:57248,echinocandin
chembl:CHEMBL1173140,CHEMBL1173140
chembl:CHEMBL2152922,PF-04995274
HP:0030216,Inertia
chembl:CHEMBL23832,FENAMIC ACID 
chembl:CHEMBL1623,MECLIZINE
chembl:CHEMBL507026,THIOLUTIN
HGNC:1014,BCR
chembl:CHEMBL576383,OLIVOMYCIN I
HGNC:7698,NDUFB3
chembl:CHEMBL3655081,ABROCITINIB
HP:0002174,Postural tremor
chembl:CHEMBL3544959,ARRY-382
HGNC:637,AQP4
HGNC:6396,KPNA3
chembl:CHEMBL1593717,CHEMBL1593717
HP:0000508,Ptosis
HGNC:130,ACTA2
NCBIGene:326346,NDUFA11
CHEBI:456215,adenosine 5'-monophosphate(2-)
chembl:CHEMBL1201319,METARAMINOL
MGI:1333889,Bub1b
dictyBase:DDB_G0287055,vps13F
chembl:CHEMBL243596,IMINOSTILBENE
GO:0004089,carbonate dehydratase activity
HGNC:2709,DCT
HGNC:2696,DBNL
chembl:CHEMBL418509,NITROBENZYLMERCAPTOPURINE RIBONUCLEOSIDE
HP:0002105,Hemoptysis
MONDO:0020753,Orthocoronavirinae infectious disease
NCBIGene:538821,COQ10A
chembl:CHEMBL1368322,PARAROSANILINE
chembl:CHEMBL843,ROSIGLITAZONE MALEATE
HGNC:6843,MAP2K3
chembl:CHEMBL267014,L-745870
HP:0003557,Increased variability in muscle fiber diameter
chembl:CHEMBL1692,IMIPRAMINE HYDROCHLORIDE
chembl:CHEMBL3545195,LY-3009120
chembl:CHEMBL2367706,SUCRALFATE
chembl:CHEMBL2109388,FUTUXIMAB
chembl:CHEMBL508649,5-METHOXYCANTHINONE
MONDO:0030800,"cholestasis, progressive familial intrahepatic, 9"
HGNC:4403,GNG11
HP:0031589,Suicidal ideation
chembl:CHEMBL611494,SALAGEN
MONDO:0044787,nasal cavity and paranasal sinus squamous cell carcinoma
GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific"
chembl:CHEMBL2108724,SEMAGLUTIDE
chembl:CHEMBL1164975,CHEMBL1164975
chembl:CHEMBL479533,HERBIMYCIN
HGNC:7516,MUC5B
HGNC:12449,TYROBP
HGNC:21869,AGK
GO:0017045,corticotropin-releasing hormone activity
chembl:CHEMBL1020,TOLMETIN
chembl:CHEMBL533602,CHEMBL533602
chembl:CHEMBL1330352,CHEMBL1330352
chembl:CHEMBL24441,BETAHISTINE
chembl:CHEMBL388757,N6-BENZYLADENOSINE
HGNC:10702,SEC23B
HGNC:4401,GNB5
chembl:CHEMBL383634,GLIQUIDONE
HP:0002488,Acute leukemia
MONDO:0003334,demyelinating polyneuropathy
chembl:CHEMBL274318,FLAVANONE
chembl:CHEMBL12131,CLOSANTEL
CHEBI:6076,itraconazole
chembl:CHEMBL260980,CHEMBL260980
HP:0001928,Abnormality of coagulation
chembl:CHEMBL4297392,IOWH-032
NCBIGene:281597,ACTR3
chembl:CHEMBL4297857,AB-928
CHEBI:61313,C21-steroid
chembl:CHEMBL253998,GLABRANIN
MONDO:0013188,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3"
chembl:CHEMBL2109540,ALIROCUMAB
chembl:CHEMBL3545387,SAD448
HP:0000520,Proptosis
chembl:CHEMBL1321401,CHEMBL1321401
chembl:CHEMBL1045,PHTHALIC ACID
chembl:CHEMBL1670,MITOTANE
chembl:CHEMBL2105022,INDELOXAZINE
HP:0025237,Confusional arousal
WB:WBGene00013132,strd-1
chembl:CHEMBL418995,AMINEPTINE
HGNC:29021,CEP290
HGNC:6446,KRT8
HGNC:4637,GSTM5
chembl:CHEMBL156075,CHEMBL156075
chembl:CHEMBL3707248,VALBENAZINE TOSYLATE
HGNC:2938,DMXL2
chembl:CHEMBL406,INDAPAMIDE
chembl:CHEMBL261123,CHEMBL261123
chembl:CHEMBL599552,INDIGO
chembl:CHEMBL1529,DIPHENIDOL HYDROCHLORIDE
chembl:CHEMBL35337,AMFONELIC ACID
HGNC:4908,HIBCH
chembl:CHEMBL3187723,BINIMETINIB
chembl:CHEMBL3585580,LOBEGLITAZONE
chembl:CHEMBL1439099,NAFRONYL OXALATE
chembl:CHEMBL299613,2-METHOXYESTRADIOL
chembl:CHEMBL1558498,BUTYL 2-AMINOBENZOATE
chembl:CHEMBL1173055,RUCAPARIB
chembl:CHEMBL68055,ACOLBIFENE
MONDO:0008845,atonic-astatic syndrome of Foerster
MONDO:0021534,rectal neuroendocrine tumor G1
chembl:CHEMBL9298,FADROZOLE
chembl:CHEMBL1201685,ENOXAPARIN
HGNC:589,ATG5
CHEBI:17263,estrone
UBERON:0004534,right testis
chembl:CHEMBL1742995,BRIAKINUMAB
chembl:CHEMBL415324,TRANILAST
CHEBI:57947,creatine zwitterion
chembl:CHEMBL596847,CHEMBL596847
HGNC:25790,FASTKD5
HGNC:2888,DISC1
HP:0002355,Difficulty walking
HGNC:362,AK2
chembl:CHEMBL1374610,CHEMBL1374610
chembl:CHEMBL3545431,HMN-214
chembl:CHEMBL191083,METHYLENE BLUE
HGNC:8740,CHMP1A
HP:0007089,Facial-lingual fasciculations
chembl:CHEMBL4297624,BISEGLIPTIN
MGI:2444552,Actbl2
chembl:CHEMBL3545141,RP-6530
chembl:CHEMBL396848,MACROCARPAL B
HGNC:4271,GIPR
chembl:CHEMBL613,PYRAZINOIC ACID
chembl:CHEMBL3545156,KW-2450
HGNC:6923,MBNL1
chembl:CHEMBL591618,CHEMBL591618
chembl:CHEMBL508102,CARBIMAZOLE
chembl:CHEMBL42355,CHEMBL42355
chembl:CHEMBL1196228,INDIMITECAN
chembl:CHEMBL1528531,PHOSALONE
HGNC:26087,HEATR3
chembl:CHEMBL483847,CHEMBL483847
GO:0047496,vesicle transport along microtubule
MONDO:0010476,neurodegeneration with brain iron accumulation 5
HP:0031954,Dystonic gait
chembl:CHEMBL558752,RAF-265
chembl:CHEMBL88553,CHEMBL88553
chembl:CHEMBL1409,FLUVOXAMINE MALEATE
chembl:CHEMBL2206292,PF-03654764
HGNC:8609,PARN
chembl:CHEMBL1255781,CHEMBL1255781
HP:0100518,Dysuria
chembl:CHEMBL659,GALANTAMINE
chembl:CHEMBL540956,CINNAMTANNIN B1
chembl:CHEMBL3544967,GSK-2256098
HGNC:3430,ERBB2
HP:0030903,Grasp reflex
chembl:CHEMBL866,MYCOPHENOLIC ACID
HGNC:4837,HCCS
HGNC:10064,TRIM3
chembl:CHEMBL455136,ALMOREXANT
CHEBI:27641,cycloheximide
RGD:1587185,Slc6a17
chembl:CHEMBL443684,NAVITOCLAX
HP:0009588,Vestibular schwannoma
chembl:CHEMBL1200512,IRINOTECAN HYDROCHLORIDE HYDRATE
chembl:CHEMBL393417,DEGUELIN
chembl:CHEMBL4297264,BENZODIAZEPINE
HGNC:20604,DIS3
CHEBI:39442,fluorescent probe
HGNC:8780,PDE4A
chembl:CHEMBL1528011,PRIDINOL METHANESULFONATE
MONDO:0859224,intellectual disability and myopathy syndrome
chembl:CHEMBL1770916,NIROGACESTAT
HGNC:3189,EEF1A1
chembl:CHEMBL2332127,CHEMBL2332127
MGI:2147616,Otub1
chembl:CHEMBL77517,INDISULAM
chembl:CHEMBL203135,BERBERRUBINE
chembl:CHEMBL600457,GLABRONE
MONDO:0020380,autosomal dominant cerebellar ataxia
chembl:CHEMBL1084617,TEMANOGREL
chembl:CHEMBL362919,METHOXYCHLOR
CHEBI:65191,second generation antipsychotic
HGNC:8636,PC
chembl:CHEMBL598663,CHEMBL598663
chembl:CHEMBL489079,MOFEGILINE
HP:3000067,Abnormal lateral cricoarytenoid muscle morphology
chembl:CHEMBL585622,CHEMBL585622
chembl:CHEMBL1743034,IXEKIZUMAB
chembl:CHEMBL1224483,CHEMBL1224483
chembl:CHEMBL1026,FENOLDOPAM MESYLATE
UBERON:0008971,left colon
HGNC:11905,TNFRSF10B
chembl:CHEMBL602561,CHEMBL602561
chembl:CHEMBL548286,CHEMBL548286
HP:0002346,Head tremor
chembl:CHEMBL1200788,CISAPRIDE
chembl:CHEMBL13045,CHELERYTHRINE
CHEBI:131619,C27-steroid
HGNC:17635,CD274
HP:0005943,Respiratory arrest
chembl:CHEMBL254218,DESMETHOXYYANGONIN
HP:0000648,Optic atrophy
HGNC:713,ARSA
HP:0011362,Abnormal hair quantity
HP:0002179,Opisthotonus
GO:0097180,serine protease inhibitor complex
HGNC:67,ABCD3
MONDO:0012435,3-methylglutaconic aciduria type 5
HGNC:9326,PPT2
HGNC:3214,EEF2
HGNC:2073,TPP1
chembl:CHEMBL63,ROLIPRAM
chembl:CHEMBL501,AMPHETAMINE SULFATE
chembl:CHEMBL1257031,CHEMBL1257031
chembl:CHEMBL128,SUMATRIPTAN
chembl:CHEMBL101815,CHEMBL101815
chembl:CHEMBL578607,KAVAIN
chembl:CHEMBL1237255,CHEMBL1237255
chembl:CHEMBL1200843,METHYLERGONOVINE MALEATE
MONDO:0003997,colon Kaposi sarcoma
chembl:CHEMBL2333550,MADOLIN T
MONDO:0008947,bilateral striopallidodentate calcinosis
chembl:CHEMBL942,BISACODYL
chembl:CHEMBL584655,CHEMBL584655
chembl:CHEMBL51628,UMBELLIFERONE
HGNC:12558,ULK1
MONDO:0005359,drug-induced liver injury
chembl:CHEMBL2364649,MARGETUXIMAB
chembl:CHEMBL1171837,PONATINIB
chembl:CHEMBL1513237,(-)-U-50488 METHANE SULFONATE
chembl:CHEMBL513,CARMUSTINE
chembl:CHEMBL464433,"4',7-DIMETHOXY-5-HYDROXYGENISTEIN"
HGNC:10468,RTN2
chembl:CHEMBL1371,CHLORZOXAZONE
chembl:CHEMBL1200666,CALCIPOTRIENE
chembl:CHEMBL300049,ALEMCINAL
chembl:CHEMBL129795,ISOLIQUIRITIGENIN
chembl:CHEMBL3833333,NABIXIMOLS
chembl:CHEMBL712,ANISINDIONE
CHEBI:35476,antipsychotic agent
HGNC:1069,BMP2
chembl:CHEMBL685,MEBENDAZOLE
HGNC:8157,SIGMAR1
MONDO:0006893,Pasteurella hemorrhagic septicemia
HGNC:15586,LRRC4
chembl:CHEMBL4297689,ALT-801
MONDO:0001824,polyneuropathy
HGNC:11133,SNAP29
HP:0032894,Seizure precipitated by febrile infection
chembl:CHEMBL600738,CHEMBL600738
chembl:CHEMBL1707907,CHEMBL1707907
chembl:CHEMBL3545039,AZD1386
chembl:CHEMBL1201831,CERTOLIZUMAB PEGOL
HGNC:11117,SMN1
HP:0000153,Abnormality of the mouth
CHEBI:545959,homovanillic acid
CHEBI:146295,pyranobenzodioxin
HGNC:3350,ENO1
HP:0002300,Mutism
chembl:CHEMBL344127,CHEMBL344127
chembl:CHEMBL1201463,CODEINE POLISTIREX
chembl:CHEMBL1474900,OLPRINONE
MGI:1277962,Hus1
Reactome:R-CEL-390651,Dopamine receptors
HGNC:11037,SLC5A2
HGNC:11524,TACC3
chembl:CHEMBL1214407,CHEMBL1214407
HGNC:25008,BABAM1
HGNC:5959,ELP1
HP:0000518,Cataract
chembl:CHEMBL1081326,CHEMBL1081326
MONDO:0008585,HELLP syndrome
chembl:CHEMBL471,SOTALOL
chembl:CHEMBL1481721,CHEMBL1481721
chembl:CHEMBL1170485,CHEMBL1170485
wikidata:Q29006728,ZELBORAF
CHEBI:16551,"alpha,alpha-trehalose"
HGNC:6871,MAPK1
UBERON:0001621,coronary artery
chembl:CHEMBL1908391,MASITINIB
HGNC:1686,CD53
HGNC:6215,KARS1
MONDO:0008083,"ceroid lipofuscinosis, neuronal, 4 (Kufs type)"
chembl:CHEMBL486231,CHEMBL486231
HGNC:961,BAZ1B
chembl:CHEMBL1741,CLARITHROMYCIN
chembl:CHEMBL593430,ATAGABALIN
chembl:CHEMBL1512580,XALIPRODEN
HGNC:3749,FLI1
chembl:CHEMBL464,ETRETINATE
HGNC:7545,MYB
HGNC:7745,NEK2
chembl:CHEMBL13209,NITRAZEPAM
chembl:CHEMBL235191,TACEDINALINE
chembl:CHEMBL2103825,CETILISTAT
MONDO:0100232,"psoriatic arthritis, susceptibility to"
MGI:1913677,Cyb5b
GO:0019463,glycine catabolic process to creatine
chembl:CHEMBL278819,MINAPRINE
NCBIGene:327673,NDUFA1
MONDO:0012048,endogenous depression
GO:0042803,protein homodimerization activity
chembl:CHEMBL450895,NYSTATIN
chembl:CHEMBL35228,PYRONARIDINE
chembl:CHEMBL453207,LYNGBYABELLIN A
chembl:CHEMBL1201777,TAPENTADOL HYDROCHLORIDE
chembl:CHEMBL508779,CAULIBUGULONE B
HGNC:4199,GCN1
UBERON:0001231,nephron tubule
GO:0000774,adenyl-nucleotide exchange factor activity
chembl:CHEMBL44657,ETOPOSIDE
chembl:CHEMBL398765,CHEMBL398765
chembl:CHEMBL105712,PHENACYL CHLORIDE
CHEBI:23527,cytochalasin B
chembl:CHEMBL1743080,TIGATUZUMAB
chembl:CHEMBL2107771,RALFINAMIDE
chembl:CHEMBL1256971,METAPHIT METHANESULFONATE
MONDO:0007485,"dyskeratosis congenita, autosomal dominant 1"
MONDO:0017884,papillary renal cell carcinoma
chembl:CHEMBL19215,METERGOLINE
HGNC:28125,NAA11
chembl:CHEMBL459008,BUTYLPARABEN
chembl:CHEMBL1201569,BOTULINUM TOXIN TYPE B
chembl:CHEMBL49120,PD-0166285
chembl:CHEMBL1743013,ENSITUXIMAB
MONDO:0011781,spinocerebellar ataxia type 17
HP:0007979,Gaze-evoked horizontal nystagmus
HGNC:3775,FMR1
chembl:CHEMBL8320,BENZOQUINONE
chembl:CHEMBL216913,MITOGUAZONE
chembl:CHEMBL4297300,LB-100
chembl:CHEMBL173929,LUTEIN
HGNC:4766,H3C1
MONDO:0003978,colon small cell neuroendocrine carcinoma
HGNC:402,ALDH1A1
HGNC:81,ABR
GO:0022857,transmembrane transporter activity
chembl:CHEMBL2146123,METHACYCLINE HYDROCHLORIDE
chembl:CHEMBL565893,CHEMBL565893
WB:WBGene00010698,K08H10.6
chembl:CHEMBL373114,LAMELLARIN D
chembl:CHEMBL250785,CINOBUFAGIN
chembl:CHEMBL580,LORAZEPAM
chembl:CHEMBL53,APOMORPHINE
chembl:CHEMBL37161,FENBENDAZOLE
chembl:CHEMBL620,CLIDINIUM
chembl:CHEMBL1782601,THEONELLASTEROL E
MONDO:0016778,iatrogenic botulism
HGNC:25230,AHDC1
chembl:CHEMBL402548,DANUSERTIB
chembl:CHEMBL71294,CHEMBL71294
chembl:CHEMBL194400,HEPTACHLOR
HP:0009088,Speech articulation difficulties
NCBITaxon:480418,Mycobacterium lepromatosis
chembl:CHEMBL601367,CHEMBL601367
HGNC:4751,H2BC3
HGNC:11317,SSBP1
CHEBI:7731,ofloxacin
chembl:CHEMBL496266,CHEMBL496266
HGNC:1509,CASP8
HGNC:24138,DNAJC5B
HP:0002359,Frequent falls
MONDO:0100148,X-linked complex neurodevelopmental disorder
MONDO:0013541,complex cortical dysplasia with other brain malformations 1
chembl:CHEMBL1200371,FROVATRIPTAN SUCCINATE
chembl:CHEMBL506048,CHEMBL506048
HGNC:21050,CDKAL1
chembl:CHEMBL415893,CHEMBL415893
HP:0001426,Non-Mendelian inheritance
HP:0003826,Stillbirth
chembl:CHEMBL3545000,MK-2201
chembl:CHEMBL2107832,PIMASERTIB
chembl:CHEMBL175247,ORLISTAT
HGNC:7881,NOTCH1
HP:0001873,Thrombocytopenia
chembl:CHEMBL306946,TRYPTANTHRIN
wikidata:Q20707748,ATEZOLIZUMAB
CL:0000738,leukocyte
MONDO:0007492,early-onset generalized limb-onset dystonia
chembl:CHEMBL3301606,SOLCITINIB
MONDO:0042965,Machado-Joseph disease type 5
chembl:CHEMBL81,RALOXIFENE
HGNC:14974,SNX10
chembl:CHEMBL590900,CHEMBL590900
chembl:CHEMBL1587,POLYTHIAZIDE
chembl:CHEMBL2332132,SECAUBRYOLIDE
chembl:CHEMBL518292,ISOVELLERAL
GO:0043005,neuron projection
chembl:CHEMBL75756,2-PHENYL-1H-INDOLE
chembl:CHEMBL1200464,PROPARACAINE HYDROCHLORIDE
chembl:CHEMBL120563,THIRAM
chembl:CHEMBL231813,TELAPREVIR
chembl:CHEMBL2332126,CHEMBL2332126
HP:0010851,EEG with burst suppression
HGNC:2194,COL17A1
chembl:CHEMBL1201581,INFLIXIMAB
chembl:CHEMBL484663,CHEMBL484663
chembl:CHEMBL3707183,QUINIDINE SULFATE
HGNC:11782,TH
chembl:CHEMBL600694,CHEMBL600694
chembl:CHEMBL486005,ISOCEPHAELINE
chembl:CHEMBL2171794,CHEMBL2171794
chembl:CHEMBL2093999,ISTAROXIME
chembl:CHEMBL2103975,VAPREOTIDE
CHEBI:27369,zwitterion
chembl:CHEMBL1200527,ATRACURIUM BESYLATE
MONDO:0850001,congenital neuronal ceroid lipofuscinosis
HGNC:2084,CLPP
HGNC:118,ACO2
chembl:CHEMBL807,MEMANTINE
chembl:CHEMBL388560,DIMPYLATE
chembl:CHEMBL4297287,HT-0712
Reactome:R-DRE-71403,Citric acid cycle (TCA cycle)
HGNC:28100,MMGT1
MONDO:0054748,"Fanconi anemia, complementation group S"
CHEBI:41922,diethylstilbestrol
chembl:CHEMBL2364609,ESKETAMINE HYDROCHLORIDE
chembl:CHEMBL164660,PSORALEN
chembl:CHEMBL728,PROCHLORPERAZINE
chembl:CHEMBL135,ESTRADIOL
chembl:CHEMBL1915269,CHEMBL1915269
MONDO:0002765,plantar verrucous skin carcinoma
HP:0004373,Focal dystonia
chembl:CHEMBL1569545,CRIDANIMOD
chembl:CHEMBL1201039,BENZTHIAZIDE
HGNC:14884,DNAJA2
HGNC:22932,GMPPB
chembl:CHEMBL579882,CHEMBL579882
chembl:CHEMBL1201293,ACAMPROSATE
chembl:CHEMBL1200949,BETAZOLE HYDROCHLORIDE
chembl:CHEMBL463981,BEGACESTAT
chembl:CHEMBL2110579,ANAMORELIN
HGNC:1802,CDSN
chembl:CHEMBL471004,CHEMBL471004
chembl:CHEMBL589924,CHEMBL589924
CHEBI:32695,argininate
MONDO:0004958,oral cavity squamous cell carcinoma
GO:0004674,protein serine/threonine kinase activity
chembl:CHEMBL260451,CHEMBL260451
chembl:CHEMBL2036119,CHEMBL2036119
MONDO:0008049,"myopathy, distal, infantile-onset"
CHEBI:15741,succinic acid
chembl:CHEMBL887,RASAGILINE
HGNC:3353,ENO2
MONDO:0013120,"46,XY sex reversal 5"
HP:0001161,Hand polydactyly
MONDO:0017357,transient hyperammonemia of the newborn
MONDO:0019643,transient pseudohypoaldosteronism
chembl:CHEMBL2103743,TOFACITINIB CITRATE
FB:FBgn0036316,nebu
chembl:CHEMBL2,PRAZOSIN
chembl:CHEMBL1374535,"3,5-DIPHENYLISOXAZOLE"
HGNC:4982,HMBS
MONDO:0006973,skin appendage carcinoma
chembl:CHEMBL574431,SULFOBROMOPHTHALEIN
GO:0003674,molecular_function
MONDO:0020525,transient neonatal diabetes mellitus
MONDO:0002966,splenic manifestation of prolymphocytic leukemia
MONDO:0016429,Marburg acute multiple sclerosis
chembl:CHEMBL146855,(S)-MEXILETINE
HGNC:12586,UQCRC2
HGNC:9801,RAC1
NCBIGene:512590,RECQL5
GO:0001784,phosphotyrosine residue binding
chembl:CHEMBL517140,GSK189254
HGNC:11641,TCF7L2
HGNC:3522,EYA4
chembl:CHEMBL516,CYPROHEPTADINE
HP:0007200,Episodic hypersomnia
chembl:CHEMBL1329349,CHEMBL1329349
MONDO:0011968,autosomal recessive limb-girdle muscular dystrophy type 2D
chembl:CHEMBL1956820,GS-9256
chembl:CHEMBL3186011,APR-246
chembl:CHEMBL1094675,CHEMBL1094675
MONDO:0032817,"neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies"
chembl:CHEMBL507974,TETRODOTOXIN
HP:0000549,Abnormal conjugate eye movement
chembl:CHEMBL1740,RACEPINEPHRINE
chembl:CHEMBL238188,OSAJIN
HGNC:11562,TANK
chembl:CHEMBL885,EMTRICITABINE
chembl:CHEMBL1559,MICONAZOLE NITRATE
HGNC:12692,VIM
MONDO:0019588,"hearing loss, autosomal recessive"
chembl:CHEMBL1276308,MIFEPRISTONE
GO:0030425,dendrite
HGNC:11340,SS18
GO:0042584,chromaffin granule membrane
UPHENO:0081742,increased reflex in patella
HP:0041051,Ageusia
chembl:CHEMBL175266,CHEMBL175266
CHEBI:600103,daptomycin
chembl:CHEMBL230011,TG100-115
MONDO:0003864,chronic lymphocytic leukemia/small lymphocytic lymphoma
HGNC:7690,NDUFA6
chembl:CHEMBL2109334,INEBILIZUMAB
Reactome:R-DME-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL1790041,RANITIDINE
HP:0007675,Progressive night blindness
chembl:CHEMBL264938,GALLOCATECHIN GALLATE
chembl:CHEMBL88055,RIMITEROL
chembl:CHEMBL1824581,SOPHORIDINE
CHEBI:149548,emetine(2+)
chembl:CHEMBL461522,DIPYRONE
CHEBI:59676,nystatins
chembl:CHEMBL3545147,IMD-2560
MGI:107678,Slc5a1
MONDO:0002548,cellular schwannoma
chembl:CHEMBL1096,AMLEXANOX
chembl:CHEMBL960,LEFLUNOMIDE
chembl:CHEMBL2107372,SIMOTAXEL
HP:0007440,Generalized hyperpigmentation
chembl:CHEMBL3544933,VS-4718
chembl:CHEMBL3182621,AZD-8330
MONDO:0021736,proctosigmoiditis
chembl:CHEMBL1095,ETHOTOIN
chembl:CHEMBL1201190,LEVOCETIRIZINE DIHYDROCHLORIDE
chembl:CHEMBL68500,ALLOXAZINE
chembl:CHEMBL42336,METHIONINE
NCBIGene:428252,DRD2
HGNC:16916,CLEC10A
chembl:CHEMBL1376091,CHEMBL1376091
HGNC:6254,KCNH5
chembl:CHEMBL2107725,ANATIBANT
chembl:CHEMBL4297886,ASUNERCEPT
UPHENO:0077907,decreased reflex in pectoral complex
HGNC:10593,SCN5A
MONDO:0012565,Fanconi anemia complementation group N
chembl:CHEMBL2103831,NAPROXCINOD
MONDO:0018467,nephropathic infantile cystinosis
chembl:CHEMBL13,METOPROLOL
WB:WBGene00013344,ebp-1
MONDO:0040998,Pasteurella multocida infectious disease
chembl:CHEMBL180917,CHEMBL180917
chembl:CHEMBL809,SERTRALINE
chembl:CHEMBL485832,GUANIDINONALTRINDOLE
chembl:CHEMBL1200848,HYDROXYPROGESTERONE CAPROATE
chembl:CHEMBL580353,CHEMBL580353
Reactome:R-CEL-549127,Organic cation transport
MONDO:0014017,intellectual developmental disorder with autism and macrocephaly
chembl:CHEMBL4297366,CG-200745
HGNC:6178,ITPKA
chembl:CHEMBL1269809,BENZOPHENONE-THIOSEMICARBAZONE
MONDO:0002815,acute myocarditis
Reactome:R-GGA-71288,Creatine metabolism
UPHENO:0088329,abnormally decreased number of neuron in the basal ganglion
HGNC:5456,IFRD1
MGI:1923038,Smurf1
chembl:CHEMBL1146,CEFAMANDOLE
chembl:CHEMBL1200891,OXYPHENCYCLIMINE HYDROCHLORIDE
MONDO:0002740,uterine ligament mucinous adenocarcinoma
chembl:CHEMBL1200759,ANAGRELIDE HYDROCHLORIDE
chembl:CHEMBL971,PENTOBARBITAL SODIUM
chembl:CHEMBL1408594,ALVERINE CITRATE
HGNC:11553,TAGLN
GO:0006423,cysteinyl-tRNA aminoacylation
chembl:CHEMBL1512,FLUNISOLIDE
MONDO:0010848,spinocerebellar ataxia type 5
chembl:CHEMBL1742408,OSEMOZOTAN
HP:0007207,Photosensitive tonic-clonic seizure
chembl:CHEMBL2051955,LEVOSIMENDAN
HGNC:315,AFG3L2
HP:0001967,Diffuse mesangial sclerosis
MONDO:0005116,Whipple disease
chembl:CHEMBL1223,PENICILLIN G POTASSIUM
chembl:CHEMBL293492,CINNAMALDEHYDE
HGNC:19140,TTBK1
chembl:CHEMBL1200983,GALLIUM NITRATE
MONDO:0018804,MYO5B-related progressive familial intrahepatic cholestasis
chembl:CHEMBL3301595,DASOTRALINE
chembl:CHEMBL394883,CHEMBL394883
MONDO:0800302,glycogen storage disease Id
chembl:CHEMBL1420059,TECNAZENE
CHEBI:63726,neuroprotective agent
MONDO:0957993,"progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6"
HGNC:12729,WARS1
HGNC:19700,CNKSR1
MONDO:0002379,cystic teratoma
HGNC:17731,CLASRP
HGNC:550,AOC3
chembl:CHEMBL1397886,LORECLEZOLE
HGNC:18071,EMSY
chembl:CHEMBL1201003,ELETRIPTAN HYDROBROMIDE
MONDO:0006694,cerebral atherosclerosis
CHEBI:28793,beta-D-glucan
chembl:CHEMBL4297806,PF-06747143
GO:0015937,coenzyme A biosynthetic process
HGNC:11588,TBP
chembl:CHEMBL1200521,ALMOTRIPTAN MALATE
MONDO:0009502,pyruvate dehydrogenase E2 deficiency
MONDO:0004586,rheumatoid lung disease
chembl:CHEMBL1697771,REBAMIPIDE
chembl:CHEMBL531611,CHEMBL531611
MONDO:0006971,sigmoid neoplasm
MONDO:0002487,breast granular cell tumor
HGNC:4402,GNG10
CHEBI:50402,androstanoid
chembl:CHEMBL1509103,CHEMBL1509103
chembl:CHEMBL2402737,IDASANUTLIN
HP:0031723,Secondary esotropia
HGNC:13740,SNTG1
HP:0012082,Cerebellar Purkinje layer atrophy
CHEBI:73693,ketone body
GO:0098743,cell aggregation
chembl:CHEMBL602363,CHEMBL602363
chembl:CHEMBL1200432,METHYLDOPATE HYDROCHLORIDE
HP:0001269,Hemiparesis
HGNC:8620,PAX6
HGNC:3438,ERCC6
chembl:CHEMBL1935538,CHEMBL1935538
chembl:CHEMBL3989476,PEGAMOTECAN
MGI:102773,Ces3a
chembl:CHEMBL296468,BMS-387032
HGNC:946,MAGI1
HGNC:16704,SLC17A7
HGNC:11005,SLC2A1
chembl:CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE
GO:0070527,platelet aggregation
HP:0001765,Hammertoe
chembl:CHEMBL446567,CHEMBL446567
MONDO:0021136,rare
chembl:CHEMBL587856,CHEMBL587856
chembl:CHEMBL1561148,PROSTAGLANDIN B1
chembl:CHEMBL341898,"(R,S)-INDATRALINE"
HGNC:3508,EWSR1
chembl:CHEMBL3039564,IRINOTECAN SUCROSOFATE
chembl:CHEMBL1290347,RETUSIN 7-METHYL ETHER
chembl:CHEMBL23393,SODIUM LAURYL SULFATE
HP:0010850,EEG with spike-wave complexes
HGNC:2852,DGKE
chembl:CHEMBL2181041,CHEMBL2181041
MONDO:0013886,cerebellar dysfunction with variable cognitive and behavioral abnormalities
chembl:CHEMBL2109555,MDX-070
HGNC:29969,MGARP
HP:0006962,"Gait instability, worse in the dark"
HP:0001626,Abnormality of the cardiovascular system
chembl:CHEMBL718,METHYLDOPA (RACEMIC)
HGNC:344,AHCYL1
HGNC:9385,PRKAG1
MONDO:0014559,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome
chembl:CHEMBL56331,CHEMBL56331
chembl:CHEMBL1789985,BRILLIANT GREEN OXALATE
MONDO:0005752,epidural abscess
WB:WBGene00000289,cam-1
MONDO:0004481,pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma
HGNC:17376,AK3
FB:FBgn0029663,CG10804
chembl:CHEMBL206834,BAFETINIB
chembl:CHEMBL1201049,ECONAZOLE NITRATE
chembl:CHEMBL587259,CHEMBL587259
chembl:CHEMBL1200348,SULCONAZOLE NITRATE
chembl:CHEMBL1701,MEPERIDINE HYDROCHLORIDE
chembl:CHEMBL396778,SAFINAMIDE
CHEBI:59163,biomarker
chembl:CHEMBL1201139,MEGESTROL ACETATE
MONDO:0006025,autosomal recessive disease
chembl:CHEMBL549216,CHEMBL549216
chembl:CHEMBL101168,CHEMBL101168
chembl:CHEMBL285802,ZOTEPINE
FB:FBgn0262476,CG43066
HGNC:15446,PRPF31
chembl:CHEMBL552212,LEXIBULIN
HGNC:12563,UMPS
HP:0000737,Irritability
chembl:CHEMBL2153191,AZD-4017
chembl:CHEMBL3544998,LY-3007113
HP:0030319,Weakness of facial musculature
chembl:CHEMBL1200463,OXAPROZIN POTASSIUM
HGNC:6081,INS
chembl:CHEMBL304818,DOCEBENONE
HGNC:3413,EPM2A
HP:0003745,Sporadic
NCBIGene:476659,NDUFA13
chembl:CHEMBL1401091,CHEMBL1401091
HGNC:4570,GRHPR
HGNC:703,ARPC1A
HP:0002344,Progressive neurologic deterioration
chembl:CHEMBL180920,MAGNOLOL
HP:0000519,Developmental cataract
chembl:CHEMBL3622820,ITACITINIB
chembl:CHEMBL1200480,OCTREOTIDE ACETATE
chembl:CHEMBL2144069,CHEMBL2144069
chembl:CHEMBL2094456,CHEMBL2094456
chembl:CHEMBL3545371,DENINTUZUMAB MAFODOTIN
chembl:CHEMBL1241,TRIPELENNAMINE
HGNC:10477,RXRA
chembl:CHEMBL530049,CHEMBL530049
chembl:CHEMBL585999,CHEMBL585999
chembl:CHEMBL2095212,MIRABEGRON
chembl:CHEMBL1200426,METHIXENE HYDROCHLORIDE
HGNC:4727,H2AC14
chembl:CHEMBL1392244,CHEMBL1392244
HGNC:4392,GNAS
HGNC:15472,ALDH1A2
chembl:CHEMBL275787,PRODIGIOSIN
chembl:CHEMBL1201497,INSULIN GLARGINE
HP:0002002,Deep philtrum
MONDO:0030689,"Charcot-Marie-Tooth disease, demyelinating, IIA 1H"
chembl:CHEMBL285932,CHEMBL285932
chembl:CHEMBL231884,DIOSMIN
FB:FBgn0029118,ScsÎ²G
HGNC:9955,RELA
HGNC:1615,CCT2
chembl:CHEMBL34241,ROTTLERIN
MONDO:0004583,transient retinal arterial occlusion
chembl:CHEMBL3545073,AMA0076
chembl:CHEMBL1201335,GLYCOPYRRONIUM
chembl:CHEMBL242385,CHEMBL242385
HP:0002283,Global brain atrophy
Xenbase:XB-GENE-1007450,cyp2a6.9
HGNC:1769,CDIPT
HGNC:682,ARHGEF2
HGNC:11159,SNRPD2
chembl:CHEMBL1908843,GADOFOSVESET
CHEBI:15379,dioxygen
chembl:CHEMBL269277,BETULINIC ACID
chembl:CHEMBL578741,CHEMBL578741
chembl:CHEMBL410484,CHEMBL410484
chembl:CHEMBL601192,CHEMBL601192
HP:0002414,Spina bifida
chembl:CHEMBL1200395,ORPHENADRINE CITRATE
chembl:CHEMBL1201610,CORTICOTROPIN
HGNC:17821,DDX39A
chembl:CHEMBL609606,CHEMBL609606
chembl:CHEMBL3545420,AG-24322
chembl:CHEMBL4297866,ABIVERTINIB MALEATE
chembl:CHEMBL409,BICALUTAMIDE
chembl:CHEMBL261849,GW632580X
chembl:CHEMBL253969,OSI-632
UPHENO:0014081,cerebellar vermis atrophy
chembl:CHEMBL1957038,IDRONOXIL
chembl:CHEMBL38380,FASUDIL
chembl:CHEMBL515606,CILAZAPRIL
HGNC:8038,NTS
HP:0007737,Bone spicule pigmentation of the retina
chembl:CHEMBL467,HYDROXYUREA
chembl:CHEMBL598263,CHEMBL598263
chembl:CHEMBL1201589,OMALIZUMAB
HGNC:3519,EYA1
HGNC:3188,EED
chembl:CHEMBL3545354,CAFUSERTIB
chembl:CHEMBL467399,BIIB021
HGNC:10937,SLC19A1
chembl:CHEMBL3544952,RG3487
chembl:CHEMBL1317506,CHEMBL1317506
chembl:CHEMBL481958,AMRUBICIN HYDROCHLORIDE
chembl:CHEMBL180672,CHEMBL180672
HP:0025149,Atrophic muscularis propria
MONDO:0018939,muscle-eye-brain disease
chembl:CHEMBL414883,RADICICOL
HP:0010868,Ocular dyssynergia
MONDO:0003539,T-cell adult acute lymphocytic leukemia
HP:0005202,Helicobacter pylori infection
chembl:CHEMBL82970,SALICYLANILIDE
chembl:CHEMBL296407,CHEMBL296407
HGNC:25358,RNF170
chembl:CHEMBL1481,GLIMEPIRIDE
chembl:CHEMBL1200927,DEXCHLORPHENIRAMINE MALEATE
HP:0006460,Increased laxity of ankles
chembl:CHEMBL1113,AMOXAPINE
ZFIN:ZDB-GENE-050828-1,ndufa12
WB:WBGene00012716,Y39E4B.5
chembl:CHEMBL588028,CHEMBL588028
HP:0007179,Absent smooth pursuit
HGNC:7441,MTIF2
chembl:CHEMBL577660,CHEMBL577660
HGNC:4055,XRCC6
chembl:CHEMBL123040,ALLITRIDIN
HGNC:2743,DDX20
HGNC:11538,TAF4B
HGNC:1791,CDKN3
chembl:CHEMBL2029988,CEP-32496
chembl:CHEMBL3544964,RAVOXERTINIB
chembl:CHEMBL121,ROSIGLITAZONE
MONDO:0005055,Kaposi's sarcoma
chembl:CHEMBL185,FLUOROURACIL
MONDO:0006424,soft tissue neoplasm
chembl:CHEMBL1900921,DEMETON S
HGNC:667,RHOA
chembl:CHEMBL2208196,CHEMBL2208196
MONDO:0859305,neurodevelopmental disorder with eye movement abnormalities and ataxia
HGNC:30531,C11orf52
chembl:CHEMBL1319047,ANTIAROL
chembl:CHEMBL20835,ACECLIDINE
GO:0032839,dendrite cytoplasm
chembl:CHEMBL1743076,TADOCIZUMAB
chembl:CHEMBL597246,CHEMBL597246
Reactome:R-HSA-190861,Gap junction assembly
HGNC:1101,BRCA2
chembl:CHEMBL1201163,SUFENTANIL CITRATE
chembl:CHEMBL2105720,LESINURAD
chembl:CHEMBL289480,RILMENIDINE
HGNC:9210,POU1F1
HGNC:21168,RHOT1
HGNC:11920,FAS
UBERON:0007808,adipose tissue of abdominal region
HGNC:30004,SULT1A4
chembl:CHEMBL3397300,CHEMBL3397300
chembl:CHEMBL293776,HISPIDULIN
chembl:CHEMBL1659,CHLORPHENIRAMINE MALEATE
Reactome:R-CFA-390666,Serotonin receptors
chembl:CHEMBL129198,JNJ-7777120
UBERON:0003074,mesonephric duct
HGNC:6499,LAMP1
GO:0098708,glucose import across plasma membrane
CHEBI:47881,3-oxo monocarboxylic acid
HP:0001251,Ataxia
HGNC:11585,TBL1X
HGNC:26661,RNF168
HP:0012001,EEG with generalized polyspikes
HGNC:4341,GLUL
chembl:CHEMBL1889436,OUABAIN
chembl:CHEMBL334255,CETYLPYRIDINIUM BROMIDE
chembl:CHEMBL2146146,ATROPINE SULFATE
MONDO:0014737,dehydrated hereditary stomatocytosis 2
HP:0045084,Limb myoclonus
chembl:CHEMBL22778,CHEMBL22778
chembl:CHEMBL393136,POMIFERIN
HP:0007074,Thick corpus callosum
chembl:CHEMBL1328,PENTAGASTRIN
chembl:CHEMBL1551,URSODIOL
chembl:CHEMBL502775,CHEMBL502775
HGNC:25229,LYRM2
HGNC:9894,RBL2
chembl:CHEMBL244800,SULPHADOXINE
wikidata:Q27077026,DEUTETRABENAZINE
chembl:CHEMBL1616,APOMORPHINE HYDROCHLORIDE
HP:0002099,Asthma
chembl:CHEMBL285123,(D)-SERINE
chembl:CHEMBL1789941,RUXOLITINIB
chembl:CHEMBL26260,BETA-NAPHTHOFLAVONE
HGNC:4318,GLI2
WB:WBGene00013177,rsy-1
MONDO:0010283,syndromic X-linked intellectual disability Lubs type
chembl:CHEMBL1567041,CHEMBL1567041
chembl:CHEMBL4297848,VOFATAMAB
HGNC:2867,DHODH
CHEBI:145565,macrolide lactam
HGNC:7527,MUTYH
MGI:101757,Cfl1
chembl:CHEMBL1200996,MEPHENTERMINE SULFATE
MGI:1277186,Atg5
chembl:CHEMBL1453,DIGITOXIGENIN
HGNC:11917,TNFRSF1B
chembl:CHEMBL181633,CHEMBL181633
HP:0002871,Central apnea
UBERON:0003128,cranium
HP:0034341,Pseudoautosomal recessive inheritance
chembl:CHEMBL529177,CHEMBL529177
chembl:CHEMBL269105,CHEMBL269105
HGNC:4854,HDAC3
chembl:CHEMBL1432305,CHEMBL1432305
chembl:CHEMBL586031,CHEMBL586031
HGNC:2928,DMD
HGNC:4425,GOLGA2
CHEBI:139590,primary alpha-hydroxy ketone
MONDO:0017174,Machado-Joseph disease type 1
chembl:CHEMBL284733,DICLAZURIL
chembl:CHEMBL548615,CHEMBL548615
HGNC:12412,TUBB2A
MONDO:0018905,diffuse large B-cell lymphoma
chembl:CHEMBL84685,CHEMBL84685
MONDO:0956976,T2-low asthma
MONDO:0002679,cerebral infarction
HGNC:15469,DNAJC6
chembl:CHEMBL217092,SARACATINIB
chembl:CHEMBL455004,CHEMBL455004
HGNC:3065,DUSP10
chembl:CHEMBL2332279,CHEMBL2332279
chembl:CHEMBL188462,ISPRONICLINE
MONDO:0011561,Alzheimer disease 6
chembl:CHEMBL1459280,CHEMBL1459280
chembl:CHEMBL1201131,PIPERONYL BUTOXIDE
chembl:CHEMBL51,KETANSERIN
chembl:CHEMBL2107572,TECALCET HYDROCHLORIDE
chembl:CHEMBL1200384,BETAMETHASONE DIPROPIONATE
chembl:CHEMBL68131,CHEMBL68131
chembl:CHEMBL1200468,MALATHION
MONDO:0044871,"dystonia, focal, task-specific"
chembl:CHEMBL226512,GARDENIN B
chembl:CHEMBL608846,CHEMBL608846
MONDO:0009804,osteogenesis imperfecta type 3
chembl:CHEMBL538867,PATIDEGIB
chembl:CHEMBL3544906,BENZPHETAMINE HYDROCHLORIDE
chembl:CHEMBL1371493,DENATONIUM BENZOATE
GO:0005884,actin filament
chembl:CHEMBL585279,CHEMBL585279
HP:0012170,Nail-biting
MONDO:0013674,neurodegeneration with brain iron accumulation 4
HGNC:9205,PON2
chembl:CHEMBL634,ALFENTANIL
chembl:CHEMBL4297632,OXYCODEGOL
chembl:CHEMBL41306,CNS-5161
chembl:CHEMBL1136,TELITHROMYCIN
chembl:CHEMBL460293,CHEMBL460293
chembl:CHEMBL1265,ADAPALENE
HGNC:17992,TRPM3
chembl:CHEMBL15192,LAPACHONE
HP:0012167,Hair-pulling
HGNC:329,AGRN
MONDO:0002466,eye carcinoma
MONDO:0007628,foveal hypoplasia 1
GO:0019904,protein domain specific binding
chembl:CHEMBL329785,CHEMBL329785
MONDO:0003513,gastric teratoma
chembl:CHEMBL1200553,CUPRIC CHLORIDE
CL:0000182,hepatocyte
chembl:CHEMBL486193,RETINYL ACETATE
Reactome:R-HSA-5620924,Intraflagellar transport
chembl:CHEMBL1258517,PKI-179
chembl:CHEMBL4298128,ELEXACAFTOR
HGNC:3364,ENTPD2
HP:0007338,Hypermetric saccades
MONDO:0015140,early-onset autosomal dominant Alzheimer disease
chembl:CHEMBL371405,MARIZOMIB
chembl:CHEMBL3301609,TOREFORANT
HP:0002509,Limb hypertonia
GO:0007565,female pregnancy
Reactome:R-DDI-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
chembl:CHEMBL471036,LITOXETINE
HGNC:18281,PECR
Reactome:R-HSA-71288,Creatine metabolism
MONDO:0005074,papillary cystadenocarcinoma
MONDO:0002168,rectum sarcoma
chembl:CHEMBL40583,3-METHYLCHOLANTHRENE
HGNC:2593,CYP17A1
chembl:CHEMBL494107,CHEMBL494107
chembl:CHEMBL96926,THAPSIGARGIN
chembl:CHEMBL221190,DIPHYLLIN
chembl:CHEMBL3786343,OLMUTINIB
chembl:CHEMBL1077,BROMFENAC
HGNC:12674,VDAC3
chembl:CHEMBL4297676,PIMASERTIB HYDROCHLORIDE
chembl:CHEMBL2108989,ASPARAGINASE
chembl:CHEMBL1255936,CHEMBL1255936
chembl:CHEMBL501617,IONOMYCIN
HGNC:2240,COPS5
HGNC:10729,SEMA4A
chembl:CHEMBL273264,NAFAMOSTAT
HGNC:13209,ARHGEF5
CHEBI:20156,3-oxo-Delta(1) steroid
HGNC:126,ACR
chembl:CHEMBL1657,TAZAROTENE
chembl:CHEMBL1923521,CHEMBL1923521
chembl:CHEMBL3623290,AZD-3759
HP:0001945,Fever
chembl:CHEMBL4297489,CXD-101
UBERON:0001760,frontal sinus
CHEBI:139592,tertiary alpha-hydroxy ketone
HGNC:29269,MARCHF4
HGNC:2342,CRAT
wikidata:Q47520887,ADRIAMYCIN
chembl:CHEMBL1369257,PHENYLSTIBONIC ACID
chembl:CHEMBL1200549,RAPACURONIUM BROMIDE
chembl:CHEMBL1593867,HARMINE HYDROCHLORIDE
MONDO:0010456,"renal cell carcinoma, Xp11-associated"
chembl:CHEMBL1200959,METHDILAZINE
chembl:CHEMBL578905,CHEMBL578905
chembl:CHEMBL1668778,(S)-SARGACHROMENOL
chembl:CHEMBL277498,NIPECOTIC ACID
chembl:CHEMBL13883,VANILLIN
MONDO:0007462,"multiple sclerosis, susceptibility to"
chembl:CHEMBL1689,TOLAZOLINE HYDROCHLORIDE
chembl:CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE
chembl:CHEMBL39879,DIPYRIDYL
chembl:CHEMBL592124,CHEMBL592124
HGNC:18732,KLHL9
chembl:CHEMBL1415851,CHEMBL1415851
chembl:CHEMBL42583,SAMPATRILAT
HGNC:3778,FN1
HGNC:8125,OGG1
chembl:CHEMBL935,PENTAMIDINE ISETHIONATE
chembl:CHEMBL512908,CHEMBL512908
chembl:CHEMBL228132,CHEMBL228132
HP:0001137,Alternating esotropia
MONDO:0043512,traumatic encephalopathy
chembl:CHEMBL590522,MAHANINE
chembl:CHEMBL1329957,RICININE
HGNC:18884,TDP1
chembl:CHEMBL1200833,DIPIVEFRIN HYDROCHLORIDE
chembl:CHEMBL312443,GABOXADOL
HGNC:4285,GJB3
HGNC:2062,CLIC1
chembl:CHEMBL605084,CHEMBL605084
MONDO:0018614,undetermined early-onset epileptic encephalopathy
chembl:CHEMBL48582,SAFINAMIDE MESYLATE
UBERON:0003027,cingulate cortex
chembl:CHEMBL430497,TEBANICLINE
MONDO:0006857,middle cerebral artery infarction
FB:FBgn0003189,r
chembl:CHEMBL3545428,CHIAURANIB
HGNC:23664,SH3PXD2A
WB:WBGene00006411,octr-1
HP:0001363,Craniosynostosis
HGNC:30262,PYCR2
chembl:CHEMBL228281,NORSTICTIC ACID
chembl:CHEMBL3545248,DS-7423
chembl:CHEMBL1200807,NORELGESTROMIN
HP:0031960,Arm dystonia
chembl:CHEMBL444376,CHEMBL444376
chembl:CHEMBL4298048,MP-0250
HP:0012343,Decreased circulating ferritin concentration
chembl:CHEMBL2109323,IMC-CS4
chembl:CHEMBL2108674,RAMATERCEPT
chembl:CHEMBL2137046,AFIMOXIFENE
chembl:CHEMBL1097999,E-6201
HGNC:16667,TMEM30A
HP:0002317,Unsteady gait
chembl:CHEMBL1200556,DESMOPRESSIN ACETATE
chembl:CHEMBL223643,VALINOMYCIN
HP:0000739,Anxiety
HP:0006919,"Abnormal aggressive, impulsive or violent behavior"
chembl:CHEMBL300389,CHEMBL300389
GO:0017166,vinculin binding
chembl:CHEMBL3545415,SMC021
MONDO:0021275,papilloma of eyelid
chembl:CHEMBL1201439,BASILIXIMAB
HGNC:11233,SPAST
HP:0006994,Diffuse leukoencephalopathy
HGNC:7744,NEK1
chembl:CHEMBL1096896,UK432097
MONDO:0024536,glucocorticoid deficiency 1
HGNC:8823,PECAM1
HP:0001644,Dilated cardiomyopathy
HP:0031392,Abnormal proportion of CD4-positive T cells
HP:0100617,Testicular seminoma
chembl:CHEMBL1448,NICLOSAMIDE
chembl:CHEMBL802,MINOXIDIL
GO:0036464,cytoplasmic ribonucleoprotein granule
MGI:106913,Abi2
chembl:CHEMBL4228250,SOR-C13
chembl:CHEMBL3545185,SELINEXOR
chembl:CHEMBL207456,PITTSBURGH COMPOUND B
chembl:CHEMBL1731432,CHEMBL1731432
MONDO:0014557,ataxia - oculomotor apraxia type 4
HGNC:4801,HADHA
CHEBI:164200,triclosan
chembl:CHEMBL1385840,ERGOCORNINE
chembl:CHEMBL253467,ISOBAVACHALCONE
HGNC:3229,EGF
chembl:CHEMBL362223,CHEMBL362223
CHEBI:2955,azithromycin
HGNC:11648,TCL1A
chembl:CHEMBL1609016,CHEMBL1609016
chembl:CHEMBL2109475,PG-102
chembl:CHEMBL222808,CHEMBL222808
HGNC:11393,AURKA
HP:0031766,Convergence excess esotropia
GO:0097305,response to alcohol
chembl:CHEMBL1086654,PHANTASMIDINE
ECTO:0001108,
chembl:CHEMBL635,PREDNISONE
GO:0042088,T-helper 1 type immune response
chembl:CHEMBL1590,PSEUDOEPHEDRINE
GO:0015284,fructose uniporter activity
chembl:CHEMBL2103849,UDENAFIL
HP:0031473,Hostility
HGNC:11906,TNFRSF10C
HP:0001315,Reduced tendon reflexes
HP:0001476,Delayed closure of the anterior fontanelle
HP:0010831,Impaired proprioception
chembl:CHEMBL1683024,CHEMBL1683024
HGNC:1549,CBR3
chembl:CHEMBL2028045,CHEMBL2028045
chembl:CHEMBL2137530,SERDEMETAN
RGD:727803,Cd2ap
chembl:CHEMBL210208,PYROGALLOL RED
chembl:CHEMBL28509,EDELFOSINE
HGNC:4385,GNAI2
HP:0006812,White mater abnormalities in the posterior periventricular region
HP:0002960,Autoimmunity
CHEBI:17154,nicotinamide
chembl:CHEMBL371197,TRIDOLGOSIR
HGNC:3767,FLT4
chembl:CHEMBL21241,GW7647
chembl:CHEMBL1169388,CHEMBL1169388
chembl:CHEMBL2105683,NAPROXEN ETEMESIL
MGI:1924834,Spidr
HGNC:18165,STYXL1
ZFIN:ZDB-GENE-050417-60,cox16
HGNC:4734,H2AC4
chembl:CHEMBL4297930,CYC-065
CL:0000788,naive B cell
chembl:CHEMBL252164,LUMINESPIB
HP:0002721,Immunodeficiency
HP:0031955,Antalgic gait
chembl:CHEMBL4301492,ALTROPANE
chembl:CHEMBL1346946,"DIBENZ[A,H]ANTHRACENE"
chembl:CHEMBL1255656,CHEMBL1255656
chembl:CHEMBL1522743,CHEMBL1522743
chembl:CHEMBL419667,RELCOVAPTAN
chembl:CHEMBL592332,CHEMBL592332
chembl:CHEMBL86537,SPLITOMICIN
chembl:CHEMBL1312,REVERSETRIIODOTHYRONINE
chembl:CHEMBL3545037,STX107
chembl:CHEMBL572346,CHEMBL572346
HP:0002070,Limb ataxia
HGNC:6083,INSIG1
HGNC:9206,PON3
MONDO:0001815,extrapyramidal and movement disease
chembl:CHEMBL1403281,ERGOCRYPTINE
GO:0031133,regulation of axon diameter
chembl:CHEMBL2110670,VABICASERIN
HGNC:3765,FLT3
chembl:CHEMBL1201668,NESIRITIDE
chembl:CHEMBL2104988,TIPELUKAST
MONDO:0009288,glycogen storage disease Ib
chembl:CHEMBL361506,PENTAMIDINE ISETHIONATE
HGNC:11290,SREBF2
HGNC:410,ALDH3B1
chembl:CHEMBL325109,CLEBOPRIDE
chembl:CHEMBL43452,POMALIDOMIDE
MONDO:0043377,juvenile spondyloarthropathy
chembl:CHEMBL582073,CHEMBL582073
chembl:CHEMBL1879463,DACTOLISIB
chembl:CHEMBL428647,PACLITAXEL
chembl:CHEMBL363387,LIDORESTAT
chembl:CHEMBL1200624,ETHYNODIOL DIACETATE
MONDO:0002764,urethra squamous cell carcinoma
chembl:CHEMBL833,TICLOPIDINE
chembl:CHEMBL2002849,CHEMBL2002849
chembl:CHEMBL1256746,CHEMBL1256746
chembl:CHEMBL1094785,CARMOTEROL
chembl:CHEMBL1163,ATAZANAVIR
chembl:CHEMBL73151,TERGURIDE
chembl:CHEMBL2219773,CUSTIRSEN SODIUM
chembl:CHEMBL1492017,CHEMBL1492017
RGD:1309728,Cbr3
chembl:CHEMBL580207,CHEMBL580207
MONDO:0002816,adrenal cortex disorder
HGNC:21602,TBC1D22B
chembl:CHEMBL1201089,DIPHENHYDRAMINE CITRATE
NCBIGene:514749,RAD51
NCBIGene:327696,SDHC
chembl:CHEMBL4297509,ELACESTRANT
HGNC:3823,FOXP1
chembl:CHEMBL587723,AEE-788
HGNC:18664,FAM3C
HGNC:5269,HSPE1
chembl:CHEMBL3545426,CC-115
HP:0500018,Abnormal cardiac exercise stress test
chembl:CHEMBL3545164,AZD2066
chembl:CHEMBL3989872,APIMOSTINEL
HGNC:11323,SSR1
chembl:CHEMBL297453,EPIGALOCATECHIN GALLATE
MONDO:0002541,spinal cord oligodendroglioma
chembl:CHEMBL2104955,BECOCALCIDIOL
chembl:CHEMBL1486690,PYRONIN Y
chembl:CHEMBL1514715,ETHAMSYLATE
chembl:CHEMBL254219,DIGITOXIN
chembl:CHEMBL1723657,6-CHLORONICOTINIC ACID
RGD:3548,Rcn2
chembl:CHEMBL391997,CAPSAZEPINE
chembl:CHEMBL133576,ACID BLUE 129
chembl:CHEMBL302449,GO-6976
chembl:CHEMBL2103875,TRAMETINIB
chembl:CHEMBL13791,PHENYL BIGUANIDE
HGNC:9126,GIGYF1
GO:0004638,phosphoribosylaminoimidazole carboxylase activity
chembl:CHEMBL1240,PROPANTHELINE BROMIDE
HGNC:7059,MGMT
MONDO:0003331,ovarian monodermal teratoma
chembl:CHEMBL419296,ZOLANTIDINE
chembl:CHEMBL45349,CHEMBL45349
HGNC:143,ACTC1
MONDO:0054695,"myopathy, centronuclear, 6, with fiber-type disproportion"
HGNC:1985,CIT
chembl:CHEMBL564085,TROLEANDOMYCIN
CHEBI:28593,quinidine
MONDO:0008767,neuronal ceroid lipofuscinosis 3
HGNC:16666,KIF9
HP:0100275,Diffuse cerebellar atrophy
chembl:CHEMBL336095,CHEMBL336095
HGNC:8630,PEBP1
HGNC:43984,HELLPAR
HGNC:12027,TRA
HGNC:12705,VNN1
HP:0040081,Abnormal circulating creatine kinase concentration
chembl:CHEMBL1201082,FLUOXETINE HYDROCHLORIDE
chembl:CHEMBL1743027,GIRENTUXIMAB
chembl:CHEMBL600614,TORMENTIC ACID METHYL ESTER
chembl:CHEMBL4298213,VOLAGIDEMAB
chembl:CHEMBL1194666,DIETHYLPROPION
HP:0011446,Abnormality of mental function
chembl:CHEMBL1531,ETONOGESTREL
MGI:2442535,Slc6a17
chembl:CHEMBL595354,CHEMBL595354
GO:0070335,aspartate binding
HGNC:11038,SLC5A3
HGNC:5182,HRH1
HGNC:10720,SELL
chembl:CHEMBL313006,DALCETRAPIB
chembl:CHEMBL277863,CHEMBL277863
Reactome:R-GGA-211945,Phase I - Functionalization of compounds
HGNC:16262,YAP1
chembl:CHEMBL1871992,CHEMBL1871992
chembl:CHEMBL477989,SB590885
chembl:CHEMBL2103795,AZILSARTAN KAMEDOXOMIL
HGNC:16815,PHOSPHO1
chembl:CHEMBL3969876,IMARIKIREN HYDROCHLORIDE
chembl:CHEMBL2103827,DROXIDOPA
HGNC:20662,SLC25A24
HGNC:26258,C1orf54
HGNC:12482,UBE2G1
HP:0000597,Ophthalmoparesis
chembl:CHEMBL510966,CHEMBL510966
chembl:CHEMBL1256797,CHEMBL1256797
HGNC:1426,CADPS
chembl:CHEMBL1201528,VASOPRESSIN TANNATE
chembl:CHEMBL1518369,CUMENE HYDROPEROXIDE
HGNC:13733,CDH23
MONDO:0020173,benign tumor of palpebral epidermis
chembl:CHEMBL1164992,TRICIFEROL
chembl:CHEMBL3545284,CERDULATINIB
FB:FBgn0263933,ebi
chembl:CHEMBL16687,CGS-15943
Reactome:R-BTA-390651,Dopamine receptors
HGNC:45,ABCB4
chembl:CHEMBL4290141,BRANAPLAM
CHEBI:29347,monocarboxylic acid amide
HGNC:6251,KCNH2
HGNC:9153,PNKD
chembl:CHEMBL331237,TRICIRIBINE
chembl:CHEMBL3935857,SERABELISIB
chembl:CHEMBL538921,SAPONARIN
chembl:CHEMBL3544931,TAK-659
chembl:CHEMBL585443,CHEMBL585443
chembl:CHEMBL1333798,CHEMBL1333798
chembl:CHEMBL46469,ANTHRALIN
HGNC:11480,SVIL
HGNC:18116,KHDRBS1
HGNC:8923,PHGDH
HGNC:7154,MME
chembl:CHEMBL325041,BORTEZOMIB
chembl:CHEMBL447876,CAULIBUGULONE D
chembl:CHEMBL574003,CHEMBL574003
HGNC:626,APRT
MONDO:0100002,food protein-induced allergic proctocolitis
chembl:CHEMBL290106,BITHIONOL
CHEBI:17650,cortisol
chembl:CHEMBL3402762,TEPOTINIB
HGNC:8638,KAT2B
CHEBI:6827,methicillin
chembl:CHEMBL1323699,PADIMATE O
chembl:CHEMBL2103744,MORPHINE SULFATE
chembl:CHEMBL1569213,CHEMBL1569213
GO:0005524,ATP binding
chembl:CHEMBL548540,CHEMBL548540
HP:0031874,Late chronotype
chembl:CHEMBL2094499,CHEMBL2094499
chembl:CHEMBL541758,FASITIBANT CHLORIDE
Reactome:R-CEL-500753,Pyrimidine biosynthesis
chembl:CHEMBL723,CARVEDILOL
chembl:CHEMBL49732,HERNIARIN
Reactome:R-DME-390666,Serotonin receptors
HGNC:2896,DLAT
chembl:CHEMBL533399,CHEMBL533399
chembl:CHEMBL2107779,SEMAPIMOD
chembl:CHEMBL1392894,CHEMBL1392894
chembl:CHEMBL1288106,CHEMBL1288106
chembl:CHEMBL1078983,AZD-2014
chembl:CHEMBL1625,OXYBENZONE
HGNC:30747,COPS2
chembl:CHEMBL1200376,BETAMETHASONE BENZOATE
HGNC:5184,HRH3
chembl:CHEMBL1237102,LEVOCABASTINE HYDROCHLORIDE
MONDO:0005395,movement disorder
chembl:CHEMBL247378,7-NITROINDAZOLE
CHEBI:9150,simvastatin
chembl:CHEMBL583,GREPAFLOXACIN
chembl:CHEMBL609027,CHEMBL609027
chembl:CHEMBL1096339,CHEMBL1096339
HGNC:16507,SYNPR
chembl:CHEMBL141305,CYCLOFENIL
chembl:CHEMBL4297595,LISAVANBULIN
chembl:CHEMBL1256753,BUTACLAMOL HYDROCHLORIDE
NCBIGene:537043,DRD3
chembl:CHEMBL2107821,EMIXUSTAT
HGNC:32,ABCA2
chembl:CHEMBL2107861,ZALUTUMUMAB
CHEBI:16828,L-tryptophan
chembl:CHEMBL1487183,ALEXIDINE HYDROCHLORIDE
chembl:CHEMBL457,GEMFIBROZIL
chembl:CHEMBL507674,CEFOPERAZONE
HGNC:16626,RAPGEF4
chembl:CHEMBL1083659,SUVOREXANT
HP:0020035,Lower limb dysmetria
HP:0000745,Diminished motivation
chembl:CHEMBL581929,CHEMBL581929
HP:0002555,Absent pubic hair
HP:0001140,Limbal dermoid
GO:0031100,animal organ regeneration
NCBIGene:789307,SAO
chembl:CHEMBL1367935,CHEMBL1367935
MONDO:0958095,"Nodal T-follicular helper cell lymphoma, follicular type"
chembl:CHEMBL105,MITOMYCIN
MONDO:0003644,cavernous hemangioma of colon
chembl:CHEMBL354541,LOMITAPIDE
MONDO:0100340,Friedreich ataxia 1
chembl:CHEMBL1434,MINOCYCLINE
chembl:CHEMBL219557,CHEMBL219557
chembl:CHEMBL1201454,ALSEROXYLON
chembl:CHEMBL303846,XANTHYLETIN
chembl:CHEMBL1079905,PROPENTOFYLLINE
chembl:CHEMBL1095341,AESCULIOSIDE IIIC
HGNC:2263,COX15
chembl:CHEMBL598369,CHEMBL598369
chembl:CHEMBL3545289,AZD2207
chembl:CHEMBL492591,CHEMBL492591
HGNC:1160,TWNK
chembl:CHEMBL1173475,QUERCETIN DIHYDRATE
chembl:CHEMBL103,PROGESTERONE
chembl:CHEMBL549473,DIPYRITHIONE
HGNC:15719,OBSCN
chembl:CHEMBL3545153,DE-104
HGNC:7967,NR1H4
HGNC:17097,EXOSC2
HP:0006896,Hypnopompic hallucinations
chembl:CHEMBL16073,PHENACETIN
chembl:CHEMBL1506226,CHEMBL1506226
HGNC:23246,MYPN
chembl:CHEMBL493737,METHYLINOSITOL
HGNC:4027,FXYD3
chembl:CHEMBL894,BUPROPION
HGNC:26025,MARCHF5
chembl:CHEMBL1201747,ALCAFTADINE
chembl:CHEMBL237347,GW559768X
chembl:CHEMBL473074,CYCLOASPEPTIDE A
CHEBI:17698,chloramphenicol
HP:0010522,Dyslexia
chembl:CHEMBL392068,CHEMBL392068
chembl:CHEMBL1980391,RG-1530
HGNC:11387,STIP1
HP:0005957,Breathing dysregulation
chembl:CHEMBL2028068,CHEMBL2028068
HGNC:25705,KCTD17
HGNC:6692,LRP1
HP:0031467,Negative affectivity
chembl:CHEMBL1628569,ROBALZOTAN
HGNC:5036,HNRNPD
MONDO:0012015,"nystagmus 3, congenital, autosomal dominant"
chembl:CHEMBL1117,IDARUBICIN
HGNC:23595,VPS13D
chembl:CHEMBL493682,DENOPAMINE
HGNC:4659,GTF2I
HP:0011150,Myoclonic absence seizure
CHEBI:171741,cerulenin
chembl:CHEMBL983,SUCCINYLCHOLINE CHLORIDE
chembl:CHEMBL1698,BUPROPION HYDROCHLORIDE
chembl:CHEMBL279085,TALIPEXOLE
chembl:CHEMBL1115,PYRIDOSTIGMINE
chembl:CHEMBL1743023,FULRANUMAB
HGNC:18278,RAD18
chembl:CHEMBL3813873,PEXIDARTINIB
chembl:CHEMBL603469,LESTAURTINIB
HGNC:6954,MCPH1
MONDO:0002503,adult astrocytic tumor
chembl:CHEMBL309848,CHEMBL309848
chembl:CHEMBL4208229,ASCIMINIB
HGNC:10018,RING1
chembl:CHEMBL1387,NORETHYNODREL
chembl:CHEMBL451197,OXIDOPAMINE HYDROCHLORIDE
chembl:CHEMBL1213456,NEMONOXACIN
HGNC:6929,MC1R
MONDO:0012651,spastic ataxia 2
MONDO:0002169,rectum adenocarcinoma
HGNC:6465,KSR1
chembl:CHEMBL3040192,TIGAPOTIDE
chembl:CHEMBL408995,TALAROFLAVONE
chembl:CHEMBL461903,(-)-USNIC ACID
CHEBI:59779,cyclic ketal
WB:WBGene00004779,ser-4
chembl:CHEMBL153057,CHEMBL153057
HP:0002550,Absent facial hair
chembl:CHEMBL504760,CAMPHOR
chembl:CHEMBL4298104,CBS-9106
HGNC:15528,CGRRF1
chembl:CHEMBL1256661,PROPIONYLPROMAZINE HYDROCHLORIDE
GO:0033282,protein C inhibitor-acrosin complex
HP:0001927,Acanthocytosis
HGNC:17810,AMOT
chembl:CHEMBL1017,TELMISARTAN
chembl:CHEMBL580918,CHEMBL580918
chembl:CHEMBL1312050,CHEMBL1312050
chembl:CHEMBL31184,BENZO[DEF]CHRYSENE
chembl:CHEMBL179512,DEMETHOXYCURCUMIN
CHEBI:133930,"5alpha-androst-1-ene-3,17-dione"
chembl:CHEMBL504567,ZEBULARINE
CHEBI:16236,ethanol
chembl:CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE
HP:0011665,Takotsubo cardiomyopathy
NCBIGene:418118,NDUFB2
FB:FBgn0014028,SdhB
HGNC:5291,HTR1E
chembl:CHEMBL228862,6-BENZYLAMINOPURINE
CHEBI:31927,nystatin A3
CHEBI:16610,spermidine
chembl:CHEMBL3545281,AKN-028
HGNC:11809,TIE1
chembl:CHEMBL77287,CHEMBL77287
MONDO:0019268,epidermal disease
chembl:CHEMBL4298024,M-7824
HGNC:12698,VLDLR
HGNC:17787,LIN7A
HGNC:10853,SHOX
HGNC:9200,POLRMT
chembl:CHEMBL602718,CHEMBL602718
HGNC:51504,CYP3A7-CYP3A51P
chembl:CHEMBL1201213,ISOETHARINE
chembl:CHEMBL2103736,FENOPROFEN CALCIUM
chembl:CHEMBL381625,CHEMBL381625
chembl:CHEMBL267633,NEUROPEPTIDE-Y
chembl:CHEMBL327919,BENOMYL
chembl:CHEMBL514499,GW843682X
HGNC:16090,PGRMC1
chembl:CHEMBL1950810,CONICASTEROL E
HP:0000718,Aggressive behavior
HGNC:9585,PTCH1
chembl:CHEMBL278041,SB-202190
MONDO:0010622,recessive X-linked ichthyosis
HGNC:4948,HLA-DRB1
chembl:CHEMBL56543,CHEMBL56543
chembl:CHEMBL600103,CHEMBL600103
HGNC:7128,MLH3
NCBIGene:515757,AFG3L2
chembl:CHEMBL253570,GOSSYPETIN
chembl:CHEMBL1730,CEFOTAXIME
HP:0002301,Hemiplegia
wikidata:Q6460439,GATAPARSEN
MONDO:0011497,hereditary North American Indian childhood cirrhosis
chembl:CHEMBL509523,IOXYNIL
chembl:CHEMBL308688,"5,7-DIMETHOXYISOFLAVONE"
chembl:CHEMBL589922,CHEMBL589922
HGNC:14582,LAMP3
HP:0002323,Anencephaly
chembl:CHEMBL1333653,OBTUSAQUINONE
chembl:CHEMBL226507,SINENSETIN
WB:WBGene00018779,F53H8.3
chembl:CHEMBL316040,TEPOXALIN
chembl:CHEMBL268697,HEMICHOLINIUM-3
UPHENO:0080041,increased reflex in independent continuant
chembl:CHEMBL600313,CHEMBL600313
HGNC:6220,KCNA2
HGNC:11278,SPTLC2
chembl:CHEMBL1200449,TRIAMCINOLONE DIACETATE
chembl:CHEMBL487387,STEPHOLIDINE
HGNC:9547,PSMC1
chembl:CHEMBL384467,DEXAMETHASONE
MGI:1916154,Abhd13
HGNC:2498,CTDP1
CHEBI:25696,organic anion
MONDO:0000568,autoimmune disorder of central nervous system
GO:0032869,cellular response to insulin stimulus
chembl:CHEMBL508112,BENZOTHIAZYL DISULFIDE
chembl:CHEMBL1305,ANTAZOLINE
chembl:CHEMBL7303,ARECOLINE
CHEBI:16810,2-oxoglutarate(2-)
HGNC:4025,FXYD1
chembl:CHEMBL1465049,CHEMBL1465049
GO:0070293,renal absorption
HP:0002436,Occipital meningocele
chembl:CHEMBL585240,CHEMBL585240
chembl:CHEMBL554475,CHEMBL554475
chembl:CHEMBL564829,MILCICLIB
HP:0005547,Myeloproliferative disorder
chembl:CHEMBL79280,BATABULIN
CHEBI:36054,benzoate ester
ZFIN:ZDB-GENE-050320-17,ndufa5
HP:0000545,Myopia
chembl:CHEMBL1200813,ACEBUTOLOL HYDROCHLORIDE
MONDO:0011144,"ceroid lipofuscinosis, neuronal, 6A"
HP:0030765,Sleep terror
chembl:CHEMBL399680,BUFALIN
chembl:CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE
HP:0010545,Downbeat nystagmus
MONDO:0014864,hypermanganesemia with dystonia 2
MONDO:0019261,infantile neuronal ceroid lipofuscinosis
chembl:CHEMBL418971,BISPHENOL A
chembl:CHEMBL1214185,ROXITHROMYCIN
HGNC:2345,CREB1
chembl:CHEMBL139,DICLOFENAC
HP:0009023,Abdominal wall muscle weakness
HP:0001178,Ulnar claw
chembl:CHEMBL142635,NAFTOPIDIL
MONDO:0011892,"epilepsy, idiopathic generalized, susceptibility to, 9"
HGNC:30953,ZBTB10
HP:0003657,Vascular granular osmiophilic material deposition
UPHENO:0078629,abnormal drinking behavior
HGNC:9674,PTPRK
chembl:CHEMBL546344,CHEMBL546344
chembl:CHEMBL275707,RIMCAZOLE
chembl:CHEMBL1089321,CHEMBL1089321
HGNC:1814,CEACAM1
HGNC:3806,FOXE1
chembl:CHEMBL1162414,CHEMBL1162414
chembl:CHEMBL592786,CHEMBL592786
SGD:S000003826,ARP3
MONDO:0015152,autosomal recessive limb-girdle muscular dystrophy
chembl:CHEMBL546649,CHEMBL546649
MONDO:0010983,dystonia 9
GO:0070887,cellular response to chemical stimulus
MONDO:0036193,parkinsonism with polyneuropathy
CHEBI:28260,galactose
HGNC:14076,CERS2
HP:0003241,External genital hypoplasia
chembl:CHEMBL1051,LATANOPROST
chembl:CHEMBL3545150,AZM-475271
NCBIGene:508586,SCO1
HGNC:11403,STK24
chembl:CHEMBL164,MYRICETIN
chembl:CHEMBL485,CODEINE
chembl:CHEMBL456340,ARACHIDONOYL GABA
HGNC:23064,GSTO2
chembl:CHEMBL3187365,ASENAPINE
chembl:CHEMBL602969,CHEMBL602969
CHEBI:17076,streptomycin
chembl:CHEMBL4297720,CDX-1135
HGNC:16290,TRIM33
ZFIN:ZDB-GENE-040625-180,cox5ba
chembl:CHEMBL1200342,PARAMETHASONE ACETATE
CHEBI:36816,oxime O-ether
chembl:CHEMBL1200437,QUINIDINE GLUCONATE
chembl:CHEMBL225519,CHEMBL225519
CHEBI:18409,(2S)-2-hydroxy-2-methyl-3-oxobutanoic acid
HGNC:14601,ECI2
GO:0031000,response to caffeine
chembl:CHEMBL469424,ASTERRIC ACID
HGNC:6759,MARCKS
chembl:CHEMBL441765,U-50488 METHANE SULFONATE
chembl:CHEMBL3545165,AFACIFENACIN
MGI:2429635,Hrh4
chembl:CHEMBL1201182,TEMSIROLIMUS
MONDO:0010130,dihydropyrimidine dehydrogenase deficiency
NCBIGene:420337,NDUFB9
HGNC:18159,VCX3A
HGNC:17722,SPRED2
MONDO:0014020,hereditary spastic paraplegia 55
chembl:CHEMBL536375,CHEMBL536375
chembl:CHEMBL1230245,RONOPTERIN
chembl:CHEMBL578883,CHEMBL578883
HP:0031931,Ocular flutter
chembl:CHEMBL171637,PHYSODIC ACID
chembl:CHEMBL3545048,AMG-319
chembl:CHEMBL162598,DICYCLOHEXYLCARBODIIMIDE
chembl:CHEMBL1201074,THIETHYLPERAZINE MALATE
RGD:1563603,Rad51
chembl:CHEMBL1087126,2'-METHOXYFORMONETIN
chembl:CHEMBL530149,CHEMBL530149
HGNC:17113,HIF1AN
HGNC:29898,C15orf48
HGNC:28781,MDP1
MONDO:0004970,adenocarcinoma
chembl:CHEMBL17201,CHEMBL17201
HP:0010867,Dyssynergia
HP:0031849,Sleep-wake inversion
chembl:CHEMBL1851943,PRACINOSTAT
MONDO:0013995,"cholestasis, intrahepatic, of pregnancy, 3"
MONDO:0012996,AGAT deficiency
chembl:CHEMBL379975,CHEMBL379975
HGNC:29685,IARS2
CHEBI:26255,prenylquinone
HP:0001305,Dandy-Walker malformation
chembl:CHEMBL54976,TRYPTOPHAN
HGNC:10483,RYR1
HP:0031908,Micrographia
RGD:68434,Pde10a
HGNC:28875,DNASE2B
HGNC:15578,REPS1
HP:0002384,Focal impaired awareness seizure
chembl:CHEMBL519873,PYRACLOSTROBIN
HGNC:11647,TCIRG1
HGNC:8727,PCM1
UPHENO:0079831,abnormal visual pursuit
CHEBI:28201,rotenone
chembl:CHEMBL458347,GLAUCARUBINONE
MONDO:0003281,ovarian cystic teratoma
chembl:CHEMBL1088750,ARRY-797
HGNC:11164,SNRPN
chembl:CHEMBL3545244,ALLITINIB
chembl:CHEMBL26424,TESMILIFENE
chembl:CHEMBL153479,AMBROXOL
chembl:CHEMBL451039,RETINYLRETINOATE
CHEBI:142546,5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide
HP:0001423,X-linked dominant inheritance
chembl:CHEMBL8145,DAIDZEIN
chembl:CHEMBL1200675,TOREMIFENE CITRATE
HGNC:4195,GCK
MONDO:0014147,neuronal ceroid lipofuscinosis 13
NCBIGene:476004,NDUFV1
chembl:CHEMBL428064,CHEMBL428064
chembl:CHEMBL1201288,DANTROLENE
chembl:CHEMBL47050,PENFLURIDOL
HGNC:12367,TSFM
HGNC:3358,ENPP3
HGNC:17018,SEC23IP
MONDO:0015792,transient congenital hypothyroidism
HGNC:28852,SYCE1
chembl:CHEMBL2332128,CHEMBL2332128
HP:0010952,Mild fetal ventriculomegaly
chembl:CHEMBL2109593,FGI-101-1A6
chembl:CHEMBL90983,TERAMEPROCOL
chembl:CHEMBL3686884,E-7090
HGNC:24124,ACTL6A
HP:0025233,Sleep paralysis
MONDO:0009723,Leigh syndrome
chembl:CHEMBL3545022,ULIXERTINIB
HGNC:3706,ATP8B1
chembl:CHEMBL1534,RIBOFLAVIN
chembl:CHEMBL2347958,CHEMBL2347958
chembl:CHEMBL60718,TPCK
chembl:CHEMBL230686,CHEMBL230686
chembl:CHEMBL2109399,T-DM1
HGNC:172,ACVR1B
HP:0007301,Oromotor apraxia
MONDO:0005694,cecal neoplasm
HGNC:5261,HSPD1
MONDO:0019792,autosomal dominant cerebellar ataxia type I
CHEBI:86324,quinolone antibiotic
chembl:CHEMBL497296,NEOCYCLOCITRINOL B
chembl:CHEMBL1098427,HIPPURISTANOL
chembl:CHEMBL3989869,UMBRALISIB TOSYLATE
MONDO:0012205,autosomal dominant striatal neurodegeneration type 1
chembl:CHEMBL1266,TETRAHYDROZOLINE
chembl:CHEMBL533293,CHEMBL533293
HP:0001009,Telangiectasia
chembl:CHEMBL362573,CALOTHRIXIN B
ECTO:0000509,
chembl:CHEMBL247471,CHEMBL247471
chembl:CHEMBL1669042,TERPESTACIN
MONDO:0054763,neurodegeneration with brain iron accumulation 7
HP:0030213,Emotional blunting
chembl:CHEMBL467084,LANICEMINE
chembl:CHEMBL174588,CHEMBL174588
HP:0006191,Deep palmar crease
MONDO:0030318,"spinocerebellar ataxia, autosomal recessive 30"
chembl:CHEMBL15927,OLEAMIDE
chembl:CHEMBL7492,PIRITREXIM
chembl:CHEMBL1382627,"SULFADIAZINE, SILVER"
MONDO:0014100,dilated cardiomyopathy 1KK
chembl:CHEMBL1085765,MECLIZINE DIHCL
chembl:CHEMBL45627,CERULENIN
chembl:CHEMBL325424,ALEPLASININ
chembl:CHEMBL1614707,MUBRITINIB
chembl:CHEMBL445,NORTRIPTYLINE
HGNC:163,ACTN1
MONDO:0002269,gastroenteritis
chembl:CHEMBL483,TENOFOVIR
chembl:CHEMBL2347632,CHEMBL2347632
chembl:CHEMBL1306556,CHEMBL1306556
chembl:CHEMBL4297578,PEGBELFERMIN
HGNC:1875,CFL2
HGNC:1908,VPS13A
CHEBI:133011,oxytetracycline zwitterion
MONDO:0008097,linear nevus sebaceous syndrome
chembl:CHEMBL556667,CHEMBL556667
chembl:CHEMBL168276,"3,5-DINITROCATECHOL (OR-486)"
HP:0001608,Abnormality of the voice
chembl:CHEMBL569,PROCAINE
chembl:CHEMBL429876,CILENGITIDE
HP:0007470,Periarticular subcutaneous nodules
chembl:CHEMBL2103851,AMUVATINIB
chembl:CHEMBL1201165,QUINESTROL
MONDO:0011510,Bohring-Opitz syndrome
chembl:CHEMBL576362,CHEMBL576362
chembl:CHEMBL1525,PERMETHRIN
MONDO:0013257,"leprosy, susceptibility to, 6"
chembl:CHEMBL271165,CHEMBL271165
chembl:CHEMBL600173,CHEMBL600173
chembl:CHEMBL1200659,ENALAPRIL MALEATE
chembl:CHEMBL3137308,PEFICITINIB
HGNC:7576,MYH6
chembl:CHEMBL284328,HOMIDIUM BROMIDE
CHEBI:34996,teicoplanin A2-3
GO:0032433,filopodium tip
HGNC:6763,MAD2L1
chembl:CHEMBL456237,LXR-623
chembl:CHEMBL571,KETOPROFEN
chembl:CHEMBL908,CHLORPROTHIXENE
chembl:CHEMBL1200654,BENOXINATE HYDROCHLORIDE
HP:0012077,Histrionic personality disorder
chembl:CHEMBL1554,DACTINOMYCIN
chembl:CHEMBL12089,BERBERINE CHLORIDE
chembl:CHEMBL383015,RADANAMYCIN
CHEBI:17303,morphine
UBERON:0002810,right frontal lobe
Reactome:R-HSA-5617833,Cilium Assembly
chembl:CHEMBL421,SULFASALAZINE
chembl:CHEMBL2109458,AMG-108
chembl:CHEMBL1228,OXYPHENBUTAZONE
MONDO:0002848,skeletal muscle neoplasm
chembl:CHEMBL457041,PENICILLIOL A
chembl:CHEMBL612,DEXTROAMPHETAMINE
chembl:CHEMBL61350,CYSTAMINE
HP:0033694,Tactile hallucination
chembl:CHEMBL1201356,METHYLERGONOVINE
Reactome:R-GGA-419469,Pyrimidine metabolism: de novo synthesis of UMP
MONDO:0002057,breast leiomyoma
MONDO:0003009,hyperaldosteronism
HGNC:7864,EMC8
HP:0034345,Mendelian inheritance
chembl:CHEMBL421701,DITHIAZANINE IODIDE
chembl:CHEMBL258767,CHEMBL258767
chembl:CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL259327,CHEMBL259327
HGNC:2661,DAB1
chembl:CHEMBL52333,ROLOFYLLINE
chembl:CHEMBL3218576,COPANLISIB
HGNC:32486,RTP2
CHEBI:75885,2-pyranones
MONDO:0010184,methylmalonic aciduria and homocystinuria type cblC
GO:0030027,lamellipodium
HGNC:13723,CTCF
chembl:CHEMBL1201659,CHLORPHENIRAMINE POLISTIREX
chembl:CHEMBL3990028,BLESELUMAB
HGNC:18649,GULP1
HGNC:5273,HSPG2
GO:0004348,glucosylceramidase activity
chembl:CHEMBL455876,DESMOSTEROL
chembl:CHEMBL271023,CHEMBL271023
HGNC:2363,CRKL
HGNC:2459,CSNK2A2
HP:0007346,Subcortical white matter calcifications
chembl:CHEMBL1201605,DACLIZUMAB
HGNC:17597,NCDN
chembl:CHEMBL646,TRIAZOLAM
chembl:CHEMBL4297687,ACP-001
HGNC:18039,KDM5B
chembl:CHEMBL475534,NITRENDIPINE
CHEBI:38763,chromanone
MONDO:0009092,polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly
HP:0000790,Hematuria
chembl:CHEMBL1223741,CRYPTOCHINONE B
chembl:CHEMBL2108061,VOLOCIXIMAB
UPHENO:0081703,paralysed facial muscle
NCBIGene:512500,CYC1
HP:0000748,Inappropriate laughter
HP:0030047,Abnormal lateral ventricle morphology
HGNC:3211,EEF1D
chembl:CHEMBL210287,BROMOPYROGALLOL RED
HGNC:6323,KIF5A
HGNC:16731,FBXO32
CHEBI:18243,dopamine
chembl:CHEMBL583578,CHEMBL583578
HGNC:12502,SUMO1
HGNC:3638,FDX1
chembl:CHEMBL254609,(R)-FELODIPINE
HGNC:9498,PSAP
CHEBI:29991,L-aspartate(1-)
chembl:CHEMBL221721,CHEMBL221721
chembl:CHEMBL1308677,CHEMBL1308677
HGNC:6501,LAMP2
chembl:CHEMBL3545402,XL-820
HGNC:18860,ASAH2
chembl:CHEMBL1392,"2,4-DIHYDROXYBENZOPHENONE"
MONDO:0014265,Alzheimer disease 18
chembl:CHEMBL389621,HYDROCORTISONE
CHEBI:50919,antiemetic
HGNC:21024,CUL7
chembl:CHEMBL606460,CHEMBL606460
chembl:CHEMBL3545366,VOXTALISIB
chembl:CHEMBL2105613,DIVALPROEX SODIUM
GO:0016251,RNA polymerase II general transcription initiation factor activity
HGNC:14897,ITPKC
HP:0007078,Decreased amplitude of sensory action potentials
HP:0012163,Carotid artery dilatation
HGNC:9343,PRCC
chembl:CHEMBL2109460,SCH-708980
chembl:CHEMBL316589,CHEMBL316589
MONDO:0033115,"spinocerebellar ataxia, autosomal recessive 25"
HGNC:4553,GPX1
FB:FBgn0024994,Ugalt
HGNC:11449,SUCLG1
chembl:CHEMBL2094567,CHEMBL2094567
chembl:CHEMBL500996,METHOCTRAMINE HYDROCHLORIDE
chembl:CHEMBL1915271,CHEMBL1915271
NCBIGene:771510,NDUFS5
HGNC:10819,SGTA
HGNC:30321,MPRIP
HP:0007058,Generalized cerebral atrophy/hypoplasia
HGNC:6395,KPNA2
HP:0031126,Impaired clot retraction
CHEBI:57865,uridine 5'-monophosphate(2-)
HGNC:21698,RNF216
chembl:CHEMBL1510164,CHEMBL1510164
CHEBI:15738,staurosporine
MONDO:0005264,transient ischemic attack
HGNC:4638,GSTP1
HGNC:3621,FCGRT
MONDO:0008730,congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency
MONDO:0100231,"psoriatic arthritis, susceptibility to, 1"
CHEBI:50852,glycinyl ester
chembl:CHEMBL90039,BENZOPHENONE
chembl:CHEMBL361497,ARTESUNATE
chembl:CHEMBL2063681,CHEMBL2063681
HP:0012391,Hyporeflexia of upper limbs
HGNC:7960,NR0B1
HGNC:4410,GNG7
HP:0004626,Lumbar scoliosis
chembl:CHEMBL601605,CHEMBL601605
chembl:CHEMBL32503,GABAZINE
HP:0002789,Tachypnea
chembl:CHEMBL1123,DICYCLOMINE
chembl:CHEMBL3545199,RG-7741
chembl:CHEMBL968,FLURAZEPAM
HGNC:21219,CILK1
chembl:CHEMBL1200853,DYDROGESTERONE
HGNC:5014,HMOX2
HGNC:7061,MGST1
HGNC:9645,PTPN12
HP:0002360,Sleep disturbance
CHEBI:38104,oxacycle
UPHENO:0078005,decreased reflex in jaw muscle
chembl:CHEMBL1257013,CHEMBL1257013
chembl:CHEMBL270190,ALVIMOPAN
chembl:CHEMBL249420,DEXPRAMIPEXOLE
MONDO:0020043,autosomal recessive congenital cerebellar ataxia
chembl:CHEMBL537045,CHEMBL537045
HGNC:8891,PGD
Reactome:R-CFA-549127,Organic cation transport
chembl:CHEMBL452157,CHEMBL452157
chembl:CHEMBL591363,CHEMBL591363
chembl:CHEMBL55814,ATHRAQUINONES A
chembl:CHEMBL284838,K-134
chembl:CHEMBL482811,U-50488 METHANE SULFONATE
chembl:CHEMBL4209157,LIFIRAFENIB
chembl:CHEMBL1200874,"TOLBUTAMIDE SODIUM, STERILE"
CHEBI:46577,dextrofloxacin
HP:0006101,Finger syndactyly
chembl:CHEMBL276711,SEMAXANIB
chembl:CHEMBL1201580,ADALIMUMAB
HGNC:7,A2M
HP:0002185,Neurofibrillary tangles
HGNC:799,ATP1A1
chembl:CHEMBL3581693,BRILANESTRANT
MONDO:0100342,malignant glioma
HP:0001350,Slurred speech
chembl:CHEMBL60889,MOSAPRIDE
chembl:CHEMBL602987,CHEMBL602987
chembl:CHEMBL556,DEFEROXAMINE
chembl:CHEMBL324547,NETAZEPIDE
chembl:CHEMBL1648,ISRADIPINE
chembl:CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE
MONDO:0014410,spinocerebellar ataxia type 37
CHEBI:37325,alloxazine
chembl:CHEMBL160145,ORTHO-PHTHALALDEHYDE
HGNC:3608,FCAR
HP:0011400,Abnormal CNS myelination
HP:0002059,Cerebral atrophy
chembl:CHEMBL1200641,CISATRACURIUM BESYLATE
chembl:CHEMBL2220442,FLUVASTATIN
chembl:CHEMBL1528359,CHEMBL1528359
chembl:CHEMBL579640,CHEMBL579640
chembl:CHEMBL592044,CHEMBL592044
CHEBI:16385,organic sulfide
MONDO:0003011,mucinous tubular and spindle renal cell carcinoma
HGNC:6149,ITGAM
chembl:CHEMBL7976,CHALCONE
chembl:CHEMBL597,PHENTOLAMINE
chembl:CHEMBL203567,RO-3201195
ZFIN:ZDB-GENE-040625-168,ndufa1
HGNC:6984,ME2
CHEBI:16134,ammonia
chembl:CHEMBL1976040,ADAVOSERTIB
chembl:CHEMBL3707351,ADOMEGLIVANT
HGNC:28496,POGLUT3
chembl:CHEMBL1200873,PHENTOLAMINE MESYLATE
HGNC:18745,DYNC1LI1
HGNC:13546,POLE3
chembl:CHEMBL127421,CHEMBL127421
HP:0000301,Abnormality of facial musculature
chembl:CHEMBL294878,CHEMBL294878
chembl:CHEMBL1709259,CHEMBL1709259
HGNC:10026,RLN1
chembl:CHEMBL2107354,MIFAMURTIDE
chembl:CHEMBL112750,CHEMBL112750
HGNC:1356,ERLIN2
HGNC:9950,RECQL5
chembl:CHEMBL1615025,TAK-733
HGNC:24500,VIRMA
HP:0001336,Myoclonus
HGNC:15911,NOP56
MONDO:0011156,progressive familial intrahepatic cholestasis type 2
chembl:CHEMBL1878267,FLUAZINAM
HP:0011448,Ankle clonus
chembl:CHEMBL320295,"O,O'-DIMETHYLCAFFEIC ACID"
chembl:CHEMBL539423,SPARSENTAN
MONDO:0025691,dystonia 30
MONDO:0018130,brain dopamine-serotonin vesicular transport disease
GO:0015517,galactose:proton symporter activity
Reactome:R-MMU-549127,Organic cation transport
chembl:CHEMBL117487,CHEMBL117487
chembl:CHEMBL2171781,CHEMBL2171781
chembl:CHEMBL1092,TRIHEXYPHENIDYL HYDROCHLORIDE
chembl:CHEMBL142588,COLCHICEINE
chembl:CHEMBL468,THALIDOMIDE
chembl:CHEMBL567,PERPHENAZINE
HP:0000009,Functional abnormality of the bladder
chembl:CHEMBL581257,CHEMBL581257
chembl:CHEMBL1410877,ARASERTACONAZOLE
HGNC:28985,LPGAT1
chembl:CHEMBL586962,CHEMBL586962
chembl:CHEMBL1200721,ESTRAMUSTINE PHOSPHATE SODIUM
chembl:CHEMBL1095870,1-HYDROXY-6-(4-HYDROXY-PHENYL)-1-PHENYL-HEXAN-3-ONE (ENANTIOMERIC MIX)
chembl:CHEMBL338474,HELENALIN
chembl:CHEMBL600334,CHEMBL600334
chembl:CHEMBL314010,BEVANTOLOL
chembl:CHEMBL297812,YONDELIS
HGNC:9537,PSMB1
CHEBI:133598,chlortetracycline(1-)
HGNC:26467,CHCHD4
chembl:CHEMBL760,ANAGRELIDE
chembl:CHEMBL244743,ESCULETIN
chembl:CHEMBL83899,CHEMBL83899
WB:WBGene00019550,K09C4.5
chembl:CHEMBL431,SPIRAPRIL
chembl:CHEMBL1687979,CHEMBL1687979
chembl:CHEMBL334491,BUDIPINE
HP:0002495,Impaired vibratory sensation
HP:0031475,Status epilepticus without prominent motor symptoms
chembl:CHEMBL1341,METHOXYFLURANE
HGNC:4781,H4C1
chembl:CHEMBL483254,PANOBINOSTAT
chembl:CHEMBL73930,TANGERETIN
chembl:CHEMBL2109528,FASINUMAB
CHEBI:34998,teicoplanin A2-5
HP:0003808,Abnormal muscle tone
chembl:CHEMBL3545053,EMD-1204831
chembl:CHEMBL1743041,MOGAMULIZUMAB
chembl:CHEMBL1321398,METHYLBENZETHONIUM CHLORIDE
wikidata:Q29006539,TAXOTERE
chembl:CHEMBL168,OLEANOLIC_ACID
chembl:CHEMBL2103762,AMBAZONE
chembl:CHEMBL2023733,CHEMBL2023733
MGI:1914344,Abhd2
HGNC:8066,NUP62
HGNC:16877,MFN2
UBERON:0018303,adrenal tissue
GO:0009433,"bacterial-type flagellum basal body, C ring"
chembl:CHEMBL107,COLCHICINE
chembl:CHEMBL483206,CHEMBL483206
chembl:CHEMBL578294,CHEMBL578294
chembl:CHEMBL238804,SELEXIPAG
chembl:CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE
chembl:CHEMBL2071606,CYPATE
HGNC:8794,PDE8B
chembl:CHEMBL1998001,CHEMBL1998001
MONDO:0035646,congenital-onset Steinert myotonic dystrophy
HP:0006858,Impaired distal proprioception
HGNC:17598,UBE2J1
HGNC:24565,KANSL1
chembl:CHEMBL1950554,BINODENOSON
HP:0030842,Choking episodes
chembl:CHEMBL3545405,BAY1067197
chembl:CHEMBL2158051,AT-406
HGNC:7137,AFDN
HP:0002354,Memory impairment
MONDO:0005188,iatrogenic Kaposi's sarcoma
chembl:CHEMBL1351571,4-BENZYLOXYANILINE
chembl:CHEMBL431367,ROXINDOLE
HGNC:1620,CCT6A
MONDO:0014835,"striatal degeneration, autosomal dominant 2"
chembl:CHEMBL479650,HEXAHYDROCURCUMIN
chembl:CHEMBL1287980,CHEMBL1287980
chembl:CHEMBL17784,CHEMBL17784
chembl:CHEMBL1257083,CHEMBL1257083
MONDO:0002744,fallopian tube mucinous adenocarcinoma
chembl:CHEMBL1321,PROCARBAZINE
HGNC:6953,CD46
MGI:1277959,Dlg4
HP:0001345,Psychotic mentation
HP:0002453,Abnormal globus pallidus morphology
MONDO:0016910,partial deletion of the long arm of chromosome 11
MONDO:0019216,inborn disorder of amino acid transport
chembl:CHEMBL2105866,PROTOPORPHYRIN DISODIUM
HGNC:864,ATP6V1G1
MONDO:0008201,Perry syndrome
chembl:CHEMBL1256742,PREGNENOLONE SULFATE SODIUM
HGNC:29679,PAM16
Reactome:R-HSA-9022537,Loss of MECP2 binding ability to the NCoR/SMRT complex
MONDO:0013776,spastic ataxia 5
chembl:CHEMBL23812,AZIETOMIDATE
chembl:CHEMBL384304,RG-547
chembl:CHEMBL2109589,L19TNFA
HP:0001181,Adducted thumb
MONDO:0004104,splenic manifestation of hairy cell leukemia
chembl:CHEMBL315985,ESLICARBAZEPINE
HP:0025401,Staring gaze
MONDO:0015129,chronic primary adrenal insufficiency
chembl:CHEMBL463783,CHEMBL463783
chembl:CHEMBL3137313,AXELOPRAN
chembl:CHEMBL421115,PODOCARIC ACID
HGNC:558,AP1M2
HGNC:2457,CSNK2A1
HP:0002401,Stroke-like episode
CHEBI:350546,serotonin(1+)
HGNC:5346,ICAM3
HGNC:29796,LAMTOR2
chembl:CHEMBL2393130,APABETALONE
chembl:CHEMBL1420457,CHEMBL1420457
chembl:CHEMBL3545087,GSK159802
chembl:CHEMBL1082,AMOXICILLIN
chembl:CHEMBL284642,BIZELESIN
chembl:CHEMBL584854,CHEMBL584854
chembl:CHEMBL1077896,ROPIVACAINE
HP:0032105,Macrosaccadic oscillations
MONDO:0014144,autosomal recessive limb-girdle muscular dystrophy type R18
HP:0004322,Short stature
chembl:CHEMBL1592,QUINAPRIL
chembl:CHEMBL482968,ENMD-2076
HGNC:19089,SLC30A5
HGNC:291,ADSL
HP:0012166,Skin-picking
HGNC:18669,PALS1
chembl:CHEMBL1200976,IDARUBICIN HYDROCHLORIDE
chembl:CHEMBL386115,ABT-510
MONDO:0021327,carcinoma of urethra
chembl:CHEMBL278703,ERTEBEREL
chembl:CHEMBL3544957,CORT 125134
chembl:CHEMBL582666,CHEMBL582666
MONDO:0021137,not rare
GO:0020018,ciliary pocket membrane
HGNC:7450,MTMR2
HP:0031354,Sleep onset insomnia
CHEBI:39270,naphthofuran
chembl:CHEMBL593254,CHEMBL593254
chembl:CHEMBL2068839,RISLENEMDAZ
chembl:CHEMBL3039556,APATORSEN
wikidata:Q415571,BLEOMYCIN
HP:5200017,Abnormal movements of face and head
Reactome:R-DDI-611105,Respiratory electron transport
chembl:CHEMBL13280,FLUNITRAZEPAM
MONDO:0032750,"arthrogryposis, distal, type 2B2"
HGNC:188,ADAM10
HP:0007747,Monocular horizontal nystagmus
MONDO:0005355,coronary restenosis
HP:0007332,Focal hemifacial clonic seizure
chembl:CHEMBL473721,CHEMBL473721
chembl:CHEMBL4297163,MUPARFOSTAT
chembl:CHEMBL3545396,BMS-690514
MONDO:0005062,lymphoma
chembl:CHEMBL1485,ARGININE
chembl:CHEMBL602580,CHEMBL602580
chembl:CHEMBL377559,RETASPIMYCIN HYDROCHLORIDE
HGNC:358,AIP
MONDO:0025699,Coffin-Siris syndrome 12
HGNC:7708,NDUFS2
HGNC:4861,HELLS
MONDO:0019303,premature aging syndrome
HGNC:10896,SKI
HGNC:11431,STX16
HGNC:2444,CSK
HGNC:3721,FKBP5
chembl:CHEMBL717,MEDROXYPROGESTERONE ACETATE
chembl:CHEMBL232943,MK0686
MGI:1917428,Abhd17c
HGNC:9449,PRNP
chembl:CHEMBL4297850,XENTUZUMAB
CHEBI:32600,tetracene
MONDO:0014613,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3"
MONDO:0001343,impaired renal function disease
HGNC:17382,SRGAP1
HGNC:6882,MAPK8IP1
chembl:CHEMBL599943,CHEMBL599943
CHEBI:17203,L-proline
chembl:CHEMBL528807,CHEMBL528807
chembl:CHEMBL2094652,CHEMBL2094652
HGNC:10996,SLC27A2
chembl:CHEMBL1412002,CHEMBL1412002
GO:0006602,creatinine catabolic process
chembl:CHEMBL11417,STREPTONIGRIN
MONDO:0020127,hereditary peripheral neuropathy
HGNC:3331,EMD
chembl:CHEMBL1256400,XYLOMETAZOLINE HYDROCHLORIDE
CHEBI:55346,anidulafungin
CHEBI:29016,arginine
MONDO:0007495,dystonia 5
chembl:CHEMBL1201314,VALGANCICLOVIR
NCBIGene:416571,NDUFAB1
chembl:CHEMBL3707379,PF-04958242
chembl:CHEMBL580851,CHEMBL580851
chembl:CHEMBL92401,IPRONIAZID
chembl:CHEMBL658,SUFENTANIL
chembl:CHEMBL58547,IPAMORELIN
HGNC:886,ATRX
UPHENO:0047459,dysgenesis of the corpus callosum
MONDO:0002615,xanthomatosis
chembl:CHEMBL500,PINDOLOL
HGNC:20390,SQOR
chembl:CHEMBL1646,INDOCYANINE GREEN
chembl:CHEMBL16300,BENZOHYDROXAMATE
chembl:CHEMBL120806,CHEMBL120806
chembl:CHEMBL3989496,TEZACITABINE
ZFIN:ZDB-GENE-030131-4257,trap1
MONDO:0007187,nevoid basal cell carcinoma syndrome
CHEBI:24261,glucocorticoid
chembl:CHEMBL533921,CHEMBL533921
HGNC:12003,TP73
chembl:CHEMBL53904,ZUCLOPENTHIXOL
Reactome:R-XTR-71288,Creatine metabolism
chembl:CHEMBL1200997,ZIPRASIDONE MESYLATE
chembl:CHEMBL3989512,SOBLIDOTIN
HGNC:7583,MYL2
chembl:CHEMBL405845,FURAFYLLINE
chembl:CHEMBL1197051,ISOXSUPRINE
chembl:CHEMBL8565,CHEMBL8565
HP:0005415,Decreased proportion of CD8-positive T cells
HGNC:744,ASH2L
HGNC:6296,KCNQ2
chembl:CHEMBL403664,BLEOMYCIN
chembl:CHEMBL65,CAMPTOTHECIN
GO:0015152,glucose-6-phosphate transmembrane transporter activity
chembl:CHEMBL8514,BUTACLAMOL
HGNC:18986,GBA2
HGNC:16283,TRIM14
chembl:CHEMBL505209,CHEMBL505209
MONDO:0019496,neuroendocrine neoplasm
chembl:CHEMBL427526,(R)-IBUPROPHEN
HGNC:11697,DYNLT1
MONDO:0005929,postpartum depression
chembl:CHEMBL123292,CYCLOHEXIMIDE
chembl:CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE
HGNC:16463,PRPF40A
chembl:CHEMBL279115,PHORBOL MYRISTATE ACETATE
chembl:CHEMBL26886,CHEMBL26886
HGNC:307,TLE5
GO:0070821,tertiary granule membrane
chembl:CHEMBL56731,CHEMBL56731
HGNC:2202,COL4A1
chembl:CHEMBL90568,DIOSMETIN
chembl:CHEMBL679,EPINEPHRINE
GO:0016028,rhabdomere
chembl:CHEMBL1417470,CHEMBL1417470
HGNC:2605,CYP27A1
HGNC:6239,KCND3
chembl:CHEMBL3545286,CCX140
HP:0030147,Truncal titubation
chembl:CHEMBL134561,ICLAPRIM
MONDO:0100087,familial Alzheimer disease
chembl:CHEMBL54044,CHEMBL54044
HGNC:7710,NDUFS3
HGNC:6912,MATR3
HGNC:6204,JUN
MGI:96067,Htt
chembl:CHEMBL482581,ESCULIN
MONDO:0011426,aceruloplasminemia
HP:0006955,Olivopontocerebellar hypoplasia
HGNC:17194,NDUFA13
HGNC:1516,CAT
chembl:CHEMBL295416,PIRINIXIC ACID
HGNC:1659,CD33
chembl:CHEMBL2104585,ECABET
HGNC:4093,GAD2
chembl:CHEMBL3545279,EFATUTAZONE HYDROCHLORIDE
chembl:CHEMBL1201743,SAXAGLIPTIN HYDROCHLORIDE
HGNC:17379,APBB1IP
HGNC:7559,MYCN
chembl:CHEMBL59986,CHEMBL59986
chembl:CHEMBL292687,DINITROCHLOROBENZENE
HGNC:28984,WASHC5
chembl:CHEMBL264931,(R)-INDOPROFEN
HP:0100022,Abnormality of movement
chembl:CHEMBL1715,PIOGLITAZONE HYDROCHLORIDE
chembl:CHEMBL2109530,ASK-8007
chembl:CHEMBL1823787,CHEMBL1823787
chembl:CHEMBL1586,BECLOMETHASONE
HP:0000506,Telecanthus
MONDO:0020143,cerebral lipidosis with dementia
chembl:CHEMBL192,SILDENAFIL
ZFIN:ZDB-GENE-040912-101,suclg1
chembl:CHEMBL1536,ERGOCALCIFEROL
MONDO:0100339,Friedreich ataxia
PomBase:SPAC1071.06,arp9
HGNC:7501,MT-TW
HP:0001370,Rheumatoid arthritis
chembl:CHEMBL2108058,VANUTIDE CRIDIFICAR
CHEBI:37143,organofluorine compound
GO:0051082,unfolded protein binding
chembl:CHEMBL1096380,PLINABULIN
chembl:CHEMBL1256737,METHIOTHEPIN MESYLATE
chembl:CHEMBL195008,NECROSTATIN
HGNC:3498,MECOM
HGNC:11537,TAF4
HGNC:11551,BRF1
MONDO:0007493,torsion dystonia 4
HP:0003324,Generalized muscle weakness
HGNC:25228,SGSM3
HGNC:2025,CLCN7
GO:0005788,endoplasmic reticulum lumen
chembl:CHEMBL106562,"2-METHOXY-1,4-NAPHTHOQUINONE"
chembl:CHEMBL1311,ISOSORBIDE MONONITRATE
HGNC:24862,MOGS
chembl:CHEMBL1479114,CHEMBL1479114
HGNC:11804,TIAL1
chembl:CHEMBL2171117,CHEMBL2171117
CHEBI:58432,histaminium
chembl:CHEMBL3545104,MODIMELANOTIDE
chembl:CHEMBL550495,METHYLENE BLUE
NCBIGene:417112,NDUFA8
CHEBI:28498,acadesine
chembl:CHEMBL416038,CHEMBL416038
chembl:CHEMBL34124,OLODANRIGAN
chembl:CHEMBL1614725,TAK-285
chembl:CHEMBL1737,SILDENAFIL CITRATE
MONDO:0011811,autosomal recessive cerebellar ataxia-saccadic intrusion syndrome
chembl:CHEMBL2062257,BRIMONIDINE TARTRATE
chembl:CHEMBL1395447,NITROVIN
HGNC:6407,KRAS
CL:0000084,T cell
chembl:CHEMBL1574,PHENTERMINE
chembl:CHEMBL895,NALBUPHINE
chembl:CHEMBL1519327,ZIRAM
HGNC:2623,CYP2C9
chembl:CHEMBL1182997,GANTACURIUM
chembl:CHEMBL1983268,ENTRECTINIB
chembl:CHEMBL92484,APTIGANEL
chembl:CHEMBL7549,PRECLAMOL
MONDO:0037847,vertebral joint disorder
chembl:CHEMBL88,CYCLOPHOSPHAMIDE
chembl:CHEMBL210618,CHEMBL210618
HGNC:29427,SH3TC2
HGNC:9016,PKHD1
MONDO:0100054,idiopathic anaphylaxis
HGNC:10431,RPS6KA2
HP:0100543,Cognitive impairment
HGNC:5386,IDH3G
HP:0003073,Hypoalbuminemia
HGNC:9461,PRPH
HGNC:26442,NUDT16
MONDO:0012895,torsion dystonia 17
CHEBI:133744,homovanillate
chembl:CHEMBL2106468,TRICETAMIDE
chembl:CHEMBL3545017,GTX-758
chembl:CHEMBL130,CHLORAMPHENICOL
chembl:CHEMBL3545096,BGT-226
HGNC:659,ARF6
HP:0003387,Decreased number of large peripheral myelinated nerve fibers
NCBIGene:613338,IDH3B
HP:0010819,Atonic seizure
chembl:CHEMBL1002,LEVOSALBUTAMOL
MONDO:0030810,"cholestasis, progressive familial intrahepatic, 10"
HP:0001256,"Intellectual disability, mild"
UBERON:0001765,mammary duct
chembl:CHEMBL1235478,PLATINUM
MONDO:0001631,vertebral artery insufficiency
RGD:1359613,Creb3l1
HGNC:672,RHOG
HP:0001763,Pes planus
HP:0000407,Sensorineural hearing impairment
chembl:CHEMBL3545388,SERIDOPIDINE
chembl:CHEMBL23507,5-FLUOROINDOLE-2-CARBOXYLIC ACID
HGNC:18994,BRSK1
chembl:CHEMBL828,PHENOTHIAZINE
NCBIGene:281125,DRD1
chembl:CHEMBL459825,NODAKENIN
chembl:CHEMBL818,IOBENGUANE
HGNC:24065,ARMCX3
HP:0002169,Clonus
UPHENO:0079845,abnormal social behavior
MONDO:0018760,DeSanto-Shinawi syndrome
HGNC:9305,PPP2R2B
chembl:CHEMBL1201248,CISATRACURIUM
chembl:CHEMBL1322218,PROCATEROL HYDROCHLORIDE
chembl:CHEMBL45068,PHLORETIN
chembl:CHEMBL27403,CHEMBL27403
chembl:CHEMBL1601846,CHEMBL1601846
chembl:CHEMBL180570,MEDRONIC ACID
HGNC:16435,HM13
chembl:CHEMBL2207339,CHEMBL2207339
chembl:CHEMBL555017,GAMBOGIC ACID
chembl:CHEMBL528373,CHEMBL528373
HP:0010533,Spasmus nutans
HP:0000496,Abnormality of eye movement
HGNC:26070,TRMT61B
HGNC:869,ATP7A
chembl:CHEMBL588859,CHEMBL588859
MONDO:0850282,chronic asthma
chembl:CHEMBL370753,OPIPRAMOL
chembl:CHEMBL1200828,CYCRIMINE HYDROCHLORIDE
FB:FBgn0038063,OctÎ²2R
CHEBI:59905,dopaminium(1+)
HGNC:395,ALAD
chembl:CHEMBL1201063,PROPAFENONE HYDROCHLORIDE
HGNC:8784,PDE5A
chembl:CHEMBL1215923,BIMOSIAMOSE
MONDO:0019436,psoriasis-related juvenile idiopathic arthritis
chembl:CHEMBL602150,CHEMBL602150
chembl:CHEMBL1172911,CHEMBL1172911
GO:0006302,double-strand break repair
chembl:CHEMBL450786,PHA-665752
HP:0007086,Social and occupational deterioration
chembl:CHEMBL817,TOLAZAMIDE
HGNC:1736,CDC42
MONDO:0002251,hepatitis
chembl:CHEMBL1200411,ROPINIROLE HYDROCHLORIDE
chembl:CHEMBL2171795,CHEMBL2171795
HGNC:9605,PTGS2
chembl:CHEMBL1006,AMIFOSTINE
chembl:CHEMBL495,ALPROSTADIL
chembl:CHEMBL1235482,GLUTARAL
HP:0011713,Left bundle branch block
chembl:CHEMBL98350,LY-294002
chembl:CHEMBL4216467,RIPRETINIB
CHEBI:27732,caffeine
chembl:CHEMBL1743067,SAMALIZUMAB
HP:0002282,Gray matter heterotopia
chembl:CHEMBL38827,LUMEFANTRINE
CHEBI:46920,N-methylpiperazine
chembl:CHEMBL1653,PHENIRAMINE MALEATE
chembl:CHEMBL1348974,(4-CHLOROPHENYL)(MORPHOLINO)METHANETHIONE
chembl:CHEMBL50894,ALSTERPAULLONE
MONDO:0018925,familial or sporadic hemiplegic migraine
MONDO:0005499,brain glioma
chembl:CHEMBL602413,CHEMBL602413
chembl:CHEMBL2108285,CAPROMAB
chembl:CHEMBL18028,5-OXO-ETE
MONDO:0013584,hereditary sensory neuropathy-deafness-dementia syndrome
chembl:CHEMBL604311,CHEMBL604311
chembl:CHEMBL284121,ILX23-7553
MONDO:0016809,spinocerebellar ataxia with epilepsy
chembl:CHEMBL4297682,ABBV-257
CHEBI:30616,ATP(4-)
HGNC:11272,SPTA1
HP:0012671,Abulia
chembl:CHEMBL3545036,RASEGLURANT
chembl:CHEMBL1667969,SAR-407899
MONDO:0030503,"cholestasis, progressive familial intrahepatic, 7, with or without hearing loss"
MONDO:0002923,uterine corpus endometrial stromal sarcoma
chembl:CHEMBL257119,CHEMBL257119
chembl:CHEMBL281350,SB-224289
HGNC:9376,PRKAA1
chembl:CHEMBL599088,CHEMBL599088
HGNC:10980,SLC25A10
HP:0010862,Delayed fine motor development
HGNC:27407,SMCO1
HP:0010543,Opsoclonus
chembl:CHEMBL1256667,CHEMBL1256667
chembl:CHEMBL153505,CHEMBL153505
chembl:CHEMBL596082,CHEMBL596082
chembl:CHEMBL783,NATEGLINIDE
chembl:CHEMBL1489812,CHEMBL1489812
HGNC:18305,ATP6AP2
MONDO:0008961,Charcot-Marie-Tooth disease type 4A
HGNC:6886,MAPK9
CHEBI:58092,N-phosphocreatinate(2-)
HP:0002104,Apnea
chembl:CHEMBL373872,BEAUVERICIN
chembl:CHEMBL86754,IODOQUINOL
chembl:CHEMBL3544974,ASENAPINE MALEATE
chembl:CHEMBL522983,CHEMBL522983
UPHENO:0077942,decreased reflex in patella
MONDO:0013625,Parkinson disease 17
HP:0031947,Tongue tremor
MONDO:0002058,breast adenoma
HP:0007549,Desquamation of skin soon after birth
chembl:CHEMBL1801219,CHEMBL1801219
NCBIGene:474572,LRPPRC
HP:0002500,Abnormal cerebral white matter morphology
MGI:97602,Prkcz
HP:0010885,Avascular necrosis
chembl:CHEMBL535307,CHEMBL535307
HGNC:2753,DECR1
MONDO:0006915,polyradiculoneuropathy
MONDO:0000315,commensal bacterial infectious disease
chembl:CHEMBL1880739,GW305074X
chembl:CHEMBL452861,(-)-PROPANOLOL 
HGNC:2021,CLCN3
chembl:CHEMBL1801250,NANATINOSTAT
HGNC:800,ATP1A2
CHEBI:16414,L-valine
chembl:CHEMBL94631,CHEMBL94631
chembl:CHEMBL1743004,CRENEZUMAB
MONDO:0005095,spondyloarthropathy
chembl:CHEMBL553025,VINORELBINE
HGNC:2433,CSF1R
HGNC:9159,PNMA2
chembl:CHEMBL84,TOPOTECAN
chembl:CHEMBL597452,CHEMBL597452
MONDO:0015159,multiple congenital anomalies/dysmorphic syndrome-intellectual disability
chembl:CHEMBL3128043,PF-03758309
chembl:CHEMBL47875,CHEMBL47875
chembl:CHEMBL1742987,ATINUMAB
MONDO:0023249,polyarticular juvenile rheumatoid arthritis
chembl:CHEMBL590919,CHEMBL590919
CHEBI:47622,acetate ester
HGNC:7114,MKRN3
HGNC:8976,PIK3CB
MONDO:0003827,transient hypogammaglobulinemia
MONDO:0005401,colonic neoplasm
chembl:CHEMBL2063052,CHEMBL2063052
chembl:CHEMBL1201199,LEUPROLIDE
chembl:CHEMBL407874,6-O-BENZYLGUANINE
chembl:CHEMBL2252949,(-)-CAMPHOR
chembl:CHEMBL2146124,CEFUROXIME SODIUM
chembl:CHEMBL1428564,PEFLOXACIN MESYLATE
HGNC:9721,PYCR1
HP:0009027,Foot dorsiflexor weakness
HP:0002064,Spastic gait
chembl:CHEMBL1983317,CHEMBL1983317
CHEBI:77932,tetracycline zwitterion
chembl:CHEMBL3545334,AVE8134
MONDO:0006637,acute kidney tubular necrosis
chembl:CHEMBL59030,CHEMBL59030
chembl:CHEMBL1363,ARFORMOTEROL
chembl:CHEMBL443462,DEMETHYLENCECALIN
PATO:0001673,cystic
chembl:CHEMBL448114,DOLASTATIN 12
HGNC:4432,GOT1
HGNC:5286,HTR1A
HP:0001133,Constriction of peripheral visual field
HGNC:11849,TLR3
chembl:CHEMBL1201741,OLANZAPINE PAMOATE
chembl:CHEMBL375781,NEOCUPROINE
chembl:CHEMBL321691,ETHYLISOTHIOUREA
HGNC:18171,CD244
HGNC:13875,FOXP2
HGNC:2383,CRX
chembl:CHEMBL761,NAPHAZOLINE
chembl:CHEMBL7010,FENCAMFAMIN
MONDO:0010726,Rett syndrome
chembl:CHEMBL177880,PAMOIC ACID
chembl:CHEMBL23,DILTIAZEM
chembl:CHEMBL73822,APAZIQUONE
chembl:CHEMBL280065,OLEOYLETHANOLAMIDE
HP:0030891,Periventricular white matter hyperintensities
chembl:CHEMBL1601,CEFONICID
chembl:CHEMBL1200934,NORGESTIMATE
chembl:CHEMBL2110725,VINFLUNINE
chembl:CHEMBL254328,ABIRATERONE
chembl:CHEMBL7257,5-MEO-DMT
chembl:CHEMBL297302,BENPERIDOL
GO:0043204,perikaryon
chembl:CHEMBL2109412,L19SIP 131I
MONDO:0031071,Diamond-Blackfan anemia 21
chembl:CHEMBL581044,CHEMBL581044
HP:0003712,Skeletal muscle hypertrophy
chembl:CHEMBL1565133,SANGUINARINE SULFATE
WB:WBGene00016449,tost-1
chembl:CHEMBL282686,TESAGLITAZAR
HP:0032398,Dysgyria
chembl:CHEMBL578944,CHEMBL578944
chembl:CHEMBL511667,TRIBUTYLTIN-OXIDE
MONDO:0011327,neuronal intranuclear inclusion disease
chembl:CHEMBL1201461,DEXTROMETHORPHAN POLISTIREX
chembl:CHEMBL403183,CHEMBL403183
FB:FBgn0005626,ple
HGNC:11779,TGM3
chembl:CHEMBL34431,CILOSTAMIDE
MONDO:0002766,larynx verrucous carcinoma
HGNC:24887,PNPLA4
chembl:CHEMBL91638,CHEMBL91638
HP:0025134,Increased serum estradiol
HGNC:89,ACADM
MONDO:0002810,pancreatic serous cystic neoplasm
HGNC:21498,ATG16L1
chembl:CHEMBL1256655,AMSACRINE HYDROCHLORIDE
CHEBI:24373,glycine derivative
chembl:CHEMBL3545026,FAMITINIB
chembl:CHEMBL29197,CHEMBL29197
chembl:CHEMBL2107333,DIMETHYL FUMARATE
CHEBI:17347,testosterone
CHEBI:17781,lumichrome
GO:0006805,xenobiotic metabolic process
chembl:CHEMBL2311030,ERGOLOID MESYLATES
HGNC:6561,LGALS1
HGNC:630,SHROOM2
chembl:CHEMBL1152,PREDNISOLONE ACETATE
chembl:CHEMBL1551666,PROPYLENE GLYCOL MONOSTEARATE
chembl:CHEMBL688,FENTANYL CITRATE
chembl:CHEMBL13852,CIRAZOLINE
chembl:CHEMBL2109268,NARATUXIMAB EMTANSINE
chembl:CHEMBL1908365,MALTOSE
HGNC:16803,UBE3C
HGNC:11580,TBCC
MONDO:0014392,"developmental and epileptic encephalopathy, 25"
chembl:CHEMBL2159122,ELUXADOLINE
chembl:CHEMBL1015,EVANS BLUE
chembl:CHEMBL186311,VALPROPYLHYDROXAMIC ACID
HGNC:18551,DGCR6L
MONDO:0016563,progressive supranuclear palsy-corticobasal syndrome
HGNC:25035,YOD1
chembl:CHEMBL931,HALOTHANE
chembl:CHEMBL3707366,ALANYL GLUTAMINE
HP:0002583,Colitis
chembl:CHEMBL599255,CHEMBL599255
HGNC:9678,PTPRO
HP:0007361,Abnormal pons morphology
MONDO:0018780,congenital generalized hypercontractile muscle stiffness syndrome
CHEBI:53665,oxazinoquinoline
chembl:CHEMBL1173141,CHEMBL1173141
chembl:CHEMBL187460,CRYPTOTANSHINONE
HGNC:4669,GTPBP1
chembl:CHEMBL1446650,MEBEVERINE HYDROCHLORIDE
chembl:CHEMBL4297774,JNJ-61186372
chembl:CHEMBL1256735,CHEMBL1256735
chembl:CHEMBL449782,CEPHARANTHINE
chembl:CHEMBL1313005,PHENAMIPHOS
chembl:CHEMBL480356,CHEMBL480356
chembl:CHEMBL1237135,MAPROTILINE HYDROCHLORIDE
MONDO:0009133,"cerebellar ataxia, intellectual disability, and dysequilibrium"
MONDO:0010252,"intellectual disability, X-linked, with panhypopituitarism"
chembl:CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE
chembl:CHEMBL611,TERAZOSIN
chembl:CHEMBL4085457,PF-06651600
MONDO:0019079,proximal spinal muscular atrophy
chembl:CHEMBL1200379,APRACLONIDINE HYDROCHLORIDE
CHEBI:17026,progesterone
CHEBI:16452,oxaloacetate(2-)
chembl:CHEMBL716,QUETIAPINE
MONDO:0002271,colon adenocarcinoma
HP:0100546,Carotid artery stenosis
chembl:CHEMBL97485,6-DIAZO-5-OXO-L-NORLEUCINE
chembl:CHEMBL389471,COUMERMYCIN A1
chembl:CHEMBL677,LEVONORDEFRIN
GO:0006865,amino acid transport
HGNC:5048,HNRNPU
chembl:CHEMBL46286,OMACETAXINE MEPESUCCINATE
chembl:CHEMBL364713,NOSCAPINE
MONDO:0000621,immune system cancer
chembl:CHEMBL123325,RAUWOLFIA SERPENTINA
HGNC:2750,DHX9
HGNC:20,AARS1
HP:0000743,Frontal release signs
chembl:CHEMBL594695,CHEMBL594695
chembl:CHEMBL3545277,OMS405
HP:0002102,Pleuritis
chembl:CHEMBL601952,CHEMBL601952
chembl:CHEMBL532452,CHEMBL532452
HP:0033203,Brachioradialis hyperreflexia
wikidata:Q21044462,DEL-22379
HP:0007370,Aplasia/Hypoplasia of the corpus callosum
HGNC:7064,MGST3
CHEBI:36063,oxytocic
GO:0097306,cellular response to alcohol
GO:0014070,response to organic cyclic compound
chembl:CHEMBL1548739,CHEMBL1548739
HGNC:23619,NIPSNAP3A
chembl:CHEMBL1885899,BENZODODECINIUM CHLORIDE
HGNC:7230,MRE11
RGD:620217,Slc5a2
HP:0007266,Cerebral dysmyelination
MONDO:0012391,neuronal ceroid lipofuscinosis 8 northern epilepsy variant
HGNC:5235,HSPA2
chembl:CHEMBL3545394,DRF-10945
HGNC:4206,OPN1MW
chembl:CHEMBL1200930,RABEPRAZOLE SODIUM
chembl:CHEMBL2088731,CHEMBL2088731
MONDO:0002648,mammary Paget disease
Reactome:R-HSA-2467813,Separation of Sister Chromatids
chembl:CHEMBL524376,CHEMBL524376
Xenbase:XB-GENE-490883,actb
HP:0000286,Epicanthus
chembl:CHEMBL519243,HOLACANTHONE
HGNC:3582,FANCA
CHEBI:87114,antibiotic fungicide
chembl:CHEMBL263376,PHENYLTHIOUREA
HGNC:367,AKAP1
chembl:CHEMBL578211,COTININE
MONDO:0005373,meningococcal infection
chembl:CHEMBL1200751,MERCAPTOPURINE
chembl:CHEMBL218166,BIFEPRUNOX
chembl:CHEMBL315021,FORASARTAN
HP:0002619,Varicose veins
HP:0003298,Spina bifida occulta
HP:0007429,Few cafe-au-lait spots
CHEBI:132157,"hydroxy-1,4-naphthoquinone"
HGNC:5474,IGFBP5
chembl:CHEMBL1095777,INDACATEROL
CHEBI:25235,monomethoxybenzene
HGNC:28817,LRRC59
GO:0098797,plasma membrane protein complex
MONDO:0033480,spinocerebellar ataxia 45
chembl:CHEMBL3301610,ABEMACICLIB
HGNC:9802,RAC2
HGNC:4901,HHEX
chembl:CHEMBL4297270,BMS-986020
MONDO:0003517,mature teratoma
MONDO:0005536,pancolitis
ZFIN:ZDB-GENE-040912-168,etfdh
HP:0002578,Gastroparesis
chembl:CHEMBL290914,EMODIC ACID
HGNC:23663,VKORC1
HGNC:24275,SCCPDH
chembl:CHEMBL2326966,SF-1126
chembl:CHEMBL279564,PYRENE
chembl:CHEMBL444,BARBITAL
HGNC:804,ATP1B1
chembl:CHEMBL1898523,PHENDIMETRAZINE TARTRATE
MONDO:0010342,"autism, susceptibility to, X-linked 3"
HP:0009113,Diaphragmatic weakness
chembl:CHEMBL486819,CHLORHEXIDINE DIACETATE
CHEBI:15727,carnosine
HGNC:4883,CFH
MONDO:0013217,Diamond-Blackfan anemia 10
HGNC:11701,CRIPTO
HP:0031759,Basic constant esotropia
MONDO:0013185,"leprosy, susceptibility to, 5"
chembl:CHEMBL1200681,MONTELUKAST SODIUM
chembl:CHEMBL1200418,DOBUTAMINE HYDROCHLORIDE
MONDO:0100244,paroxysmal nocturnal hemoglobinuria
CHEBI:66924,creatinate
HGNC:14902,RAB6B
HGNC:2595,CYP1A1
HGNC:59,ABCC8
chembl:CHEMBL1605700,TETRAHYDROGAMBOGIC ACID
HGNC:4079,GABRA5
HGNC:17008,TOPBP1
HGNC:9642,PTPN1
chembl:CHEMBL1496,ROSUVASTATIN
HP:0033252,Palmar hyperlinearity
chembl:CHEMBL770,TOLAZOLINE
chembl:CHEMBL64239,CHEMBL64239
chembl:CHEMBL1961795,GSK-4112
HP:0031767,Consecutive esotropia
chembl:CHEMBL42,CLOZAPINE
chembl:CHEMBL1448793,CHEMBL1448793
chembl:CHEMBL1370446,METIZOLINE
MONDO:0008567,"thyroid cancer, nonmedullary, 1"
chembl:CHEMBL581240,CHEMBL581240
HGNC:20247,MEPCE
chembl:CHEMBL2109467,AMG-714
HGNC:8646,PCBD1
chembl:CHEMBL2103810,EZATIOSTAT HYDROCHLORIDE
MGI:96756,Lck
chembl:CHEMBL502489,GARCINOL
HGNC:19344,DENND5A
chembl:CHEMBL30707,COUMESTROL
chembl:CHEMBL74913,CHEMBL74913
HGNC:17888,CRCP
HP:0001152,Saccadic smooth pursuit
HP:0001442,Typified by somatic mosaicism
HP:0012157,Subcortical cerebral atrophy
MGI:103293,Ptpn13
chembl:CHEMBL55934,NAPHTHOQUINONE
HGNC:3578,FAF1
HGNC:19985,SUB1
HGNC:16412,NLRC4
HGNC:7553,MYC
chembl:CHEMBL508583,TRODUSQUEMINE
HGNC:11007,SLC2A3
chembl:CHEMBL484662,CHEMBL484662
HGNC:18395,SCGB1D1
chembl:CHEMBL602213,CHEMBL602213
HP:0002442,Dyscalculia
chembl:CHEMBL253553,LYCOBETAINE
chembl:CHEMBL1200988,METHANTHELINE BROMIDE
chembl:CHEMBL428354,BACCHARIN
UPHENO:0081710,paralysed diaphragm
HGNC:17676,RABGEF1
chembl:CHEMBL1594640,CHEMBL1594640
HGNC:18996,VRK3
HGNC:4867,HERC1
HP:0025132,Abnormal circulating estrogen level
HGNC:29345,KIAA1671
chembl:CHEMBL52387,(RS)-ROSCOVITINE
chembl:CHEMBL201761,SALINAZID
MONDO:0015069,neuroendocrine tumor of the anal canal
HGNC:7226,MPZL1
chembl:CHEMBL592675,SILYBIN B
MONDO:0033549,optic atrophy 12
Reactome:R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
chembl:CHEMBL2333546,MADOLIN U
chembl:CHEMBL2109389,IMGATUZUMAB
HGNC:3691,FGFR4
chembl:CHEMBL4101487,GALICAFTOR
chembl:CHEMBL1902519,METRIBUZIN
chembl:CHEMBL1200822,FLECAINIDE ACETATE
HP:0010531,Spinal myoclonus
chembl:CHEMBL427216,GLICLAZIDE
HP:0000347,Micrognathia
HGNC:7456,MT-ND2
CHEBI:24532,organic heterocyclic compound
chembl:CHEMBL1503190,CHEMBL1503190
chembl:CHEMBL1401,NITAZOXANIDE
HP:0000725,Psychotic episodes
chembl:CHEMBL2111101,PIMAVANSERIN
chembl:CHEMBL1797708,CHEMBL1797708
HGNC:3594,FASN
MONDO:0011299,Huntington disease-like 1
HGNC:18337,PADI3
MONDO:0022742,occupational asthma
HP:0000835,Adrenal hypoplasia
HGNC:14524,SPAG9
chembl:CHEMBL124006,CHEMBL124006
chembl:CHEMBL1200490,CETRORELIX
chembl:CHEMBL224318,CHEMBL224318
chembl:CHEMBL1277315,CHEMBL1277315
HGNC:6949,MCM6
chembl:CHEMBL499609,NAKIJIQUINONE I
chembl:CHEMBL1095097,EPLERENONE
chembl:CHEMBL1201111,ONDANSETRON HYDROCHLORIDE
chembl:CHEMBL13828,OXATOMIDE
chembl:CHEMBL682,AMODIAQUINE
chembl:CHEMBL284104,DIPICOLINIC ACID
chembl:CHEMBL1201052,MESORIDAZINE BESYLATE
HGNC:6387,KLC1
chembl:CHEMBL1200707,BENZQUINAMIDE HYDROCHLORIDE
HGNC:29419,EARS2
chembl:CHEMBL2104054,ACEPROMETAZINE
MONDO:0003406,sleep-wake disorder
chembl:CHEMBL273891,CHEMBL273891
chembl:CHEMBL1256698,CHEMBL1256698
CHEBI:38514,quinoline alkaloid fundamental parent
chembl:CHEMBL605077,CHEMBL605077
chembl:CHEMBL1487115,BINOSPIRONE
chembl:CHEMBL82293,PALMITIC ACID
chembl:CHEMBL287045,CHEMBL287045
chembl:CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE
chembl:CHEMBL969,PRAZEPAM
RGD:3979,Ywhaq
MONDO:0024537,Brown-Vialetto-van Laere syndrome 1
MONDO:0043510,brain injury
MONDO:0033043,"spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy"
HP:0000164,Abnormality of the dentition
HGNC:17947,THEM4
HP:0003764,Nevus
HP:0002492,Morphological abnormality of the corticospinal tract
chembl:CHEMBL322970,CHEMBL322970
chembl:CHEMBL3989908,ENASIDENIB
chembl:CHEMBL1402376,CHEMBL1402376
chembl:CHEMBL1724,MEPENZOLATE BROMIDE
chembl:CHEMBL1765371,CHEMBL1765371
chembl:CHEMBL2111110,TEDISAMIL
chembl:CHEMBL1200920,ISOETHARINE HYDROCHLORIDE
chembl:CHEMBL1200569,"CAFFEINE, CITRATED"
HGNC:3380,EPB41L3
chembl:CHEMBL3545374,TREVOGRUMAB
chembl:CHEMBL466426,DIFENOCONAZOLE
chembl:CHEMBL412142,CHIR-99021
chembl:CHEMBL1751,DIGOXIN
HGNC:28106,TMEM97
HGNC:30184,PTPDC1
HP:0031434,Abnormal prosody
chembl:CHEMBL548629,CHEMBL548629
HP:0032794,Myoclonic seizure
chembl:CHEMBL1339015,CHEMBL1339015
chembl:CHEMBL62136,T091317
MONDO:0010774,"striatonigral degeneration, infantile, mitochondrial"
GO:0034486,vacuolar transmembrane transport
HP:0030953,Conjunctival hyperemia
chembl:CHEMBL3545297,PEXMETINIB
chembl:CHEMBL52030,CHEMBL52030
chembl:CHEMBL396000,METHYLISOTHIOCYANATE
chembl:CHEMBL1436,CEFUROXIME
HP:0100852,Abnormal fear/anxiety-related behavior
HP:0034251,Abnormal corneal reflex
chembl:CHEMBL45,MELATONIN
chembl:CHEMBL1095026,AESCULIOSIDE IIIF
MONDO:0011576,familial hyperaldosteronism type II
MONDO:0011826,glucocorticoid deficiency 2
chembl:CHEMBL93655,CHEMBL93655
chembl:CHEMBL1330022,AMINACRINE HYDROCHLORIDE
chembl:CHEMBL1201754,RUFINAMIDE
chembl:CHEMBL2109427,ZOLBETUXIMAB
HGNC:8778,PDE3A
chembl:CHEMBL1611308,CHEMBL1611308
chembl:CHEMBL464707,WISTIN
HP:0003236,Elevated circulating creatine kinase concentration
chembl:CHEMBL584442,CHEMBL584442
chembl:CHEMBL469036,ENNIATIN B
chembl:CHEMBL3301588,TAREXTUMAB
chembl:CHEMBL1388703,CHEMBL1388703
chembl:CHEMBL363332,CHEMBL363332
chembl:CHEMBL146525,CHEMBL146525
HGNC:1151,BUB3
chembl:CHEMBL2028661,AZILSARTAN MEDOXOMIL
HP:0009891,Underdeveloped supraorbital ridges
chembl:CHEMBL61133,SULOCHRIN
chembl:CHEMBL3545188,PASIREOTIDE PAMOATE
chembl:CHEMBL1513686,12A-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE
MONDO:0012264,preeclampsia/eclampsia 2
chembl:CHEMBL103735,ATIPRIMOD
chembl:CHEMBL15967,PYRAZOLE
chembl:CHEMBL559,DEXTROTHYROXINE
chembl:CHEMBL2095222,OCRIPLASMIN
chembl:CHEMBL2107759,MILATAXEL
chembl:CHEMBL62350,8-PHENYL THEOPHYLLINE
HP:0001337,Tremor
chembl:CHEMBL433,VALPROATE SODIUM
chembl:CHEMBL2332131,CARINATIN G
chembl:CHEMBL515,CHLORAMBUCIL
chembl:CHEMBL307346,CETRIMONIUM BROMIDE
chembl:CHEMBL1016,CANDESARTAN
HGNC:756,ASPA
HGNC:7670,NCOA3
HGNC:12679,VDR
chembl:CHEMBL4297466,GO-203-2C
chembl:CHEMBL1306524,CHEMBL1306524
HGNC:613,APOE
chembl:CHEMBL1201828,ECULIZUMAB
MONDO:0007256,hepatocellular carcinoma
HP:0007663,Reduced visual acuity
chembl:CHEMBL1614,DESLANOSIDE
GO:0022855,protein-N(PI)-phosphohistidine-glucose phosphotransferase system transporter activity
chembl:CHEMBL1867091,RIMSULFURON
HGNC:20739,IPMK
HGNC:16978,EDDM3A
HGNC:1785,CDKN1B
HGNC:7783,NFE2L3
HGNC:10549,ATXN10
chembl:CHEMBL168815,CEVIMELINE
chembl:CHEMBL1358,FULVESTRANT
HP:0001212,Prominent fingertip pads
chembl:CHEMBL1545737,CHEMBL1545737
chembl:CHEMBL309760,CHEMBL309760
HGNC:1479,CAPN2
chembl:CHEMBL408513,BELINOSTAT
HGNC:24834,GPRASP1
CHEBI:41774,tamoxifen
HGNC:7132,KMT2A
HGNC:29590,CTU1
HGNC:2211,COL6A1
chembl:CHEMBL417016,"LACTOSE, ANHYDROUS"
MONDO:0018161,non-hereditary retinoblastoma
chembl:CHEMBL2364619,METHYLSAMIDORPHAN
chembl:CHEMBL1082607,SALMETEROL XINAFOATE
chembl:CHEMBL3924151,TAK-448
MONDO:0002960,polyradiculopathy
chembl:CHEMBL1314044,HYDRASTININE
chembl:CHEMBL2108720,OXELUMAB
HGNC:438,ALPL
chembl:CHEMBL157101,KETOCONAZOLE
chembl:CHEMBL356066,DACINOSTAT
MONDO:0042980,Westphal disease
HGNC:4650,GTF2E1
chembl:CHEMBL39541,DOLASTATIN-10
RGD:3704,Slc2a1
RGD:1309504,Actbl2
MONDO:0012629,paroxysmal nonkinesigenic dyskinesia 2
UPHENO:0084118,abnormally dilated third ventricle
chembl:CHEMBL2105394,PROMESTRIENE
MONDO:0005096,squamous cell carcinoma
Xenbase:XB-GENE-921721,slc2a3
chembl:CHEMBL1585,PIPOBROMAN
HGNC:2637,CYP3A4
chembl:CHEMBL1743024,GANITUMAB
chembl:CHEMBL512164,ISOPIMARIC ACID
chembl:CHEMBL134342,THIOCTIC ACID
HGNC:2153,CNGB3
HGNC:914,B2M
MGI:2140940,Acacb
CHEBI:473992,nystatin A1
chembl:CHEMBL3559672,RAUWOLFIA SERPENTINA
chembl:CHEMBL520095,CHEMBL520095
HP:0012531,Pain
chembl:CHEMBL16901,HONOKIOL
HGNC:12840,YARS1
MONDO:0003731,adult central nervous system teratoma
HP:0002505,Loss of ambulation
chembl:CHEMBL269521,MK-212
chembl:CHEMBL487417,VITEXIN
chembl:CHEMBL478754,CHEMBL478754
CHEBI:28915,fosfomycin
chembl:CHEMBL1256717,ITRIGLUMIDE
chembl:CHEMBL514,LOMUSTINE
chembl:CHEMBL582055,CHEMBL582055
chembl:CHEMBL161,CEFTRIAXONE
HGNC:4624,GSS
chembl:CHEMBL535051,CHEMBL535051
HGNC:3155,ECT2
MONDO:0032930,intellectual developmental disorder with poor growth and with or without seizures or ataxia
HGNC:12373,TSHR
chembl:CHEMBL2178586,CHEMBL2178586
MONDO:0000980,aortic atherosclerosis
ZFIN:ZDB-GENE-030131-5400,zgc:162592
chembl:CHEMBL74644,CHEMBL74644
HGNC:10680,SDHA
WB:WBGene00012699,Y39B6A.41
MONDO:0011819,spinocerebellar ataxia type 19/22
chembl:CHEMBL2110659,APLINDORE
chembl:CHEMBL1200382,BEPRIDIL HYDROCHLORIDE
chembl:CHEMBL1570199,CHEMBL1570199
HGNC:23526,MCU
chembl:CHEMBL545,ALCOHOL
chembl:CHEMBL2107858,MYELOPEROXIDASE
chembl:CHEMBL584829,CHEMBL584829
chembl:CHEMBL3137310,BENZHYDROCODONE HYDROCHLORIDE
chembl:CHEMBL1596,CARBENICILLIN INDANYL
chembl:CHEMBL41286,DIACEREIN
chembl:CHEMBL1201361,ALCLOMETASONE
chembl:CHEMBL1712,ZIPRASIDONE HYDROCHLORIDE
chembl:CHEMBL30400,OXILOFRINE
chembl:CHEMBL1021,NEPAFENAC
HGNC:9023,PKP1
Reactome:R-DDI-71403,Citric acid cycle (TCA cycle)
HP:0032524,Long thumb
HGNC:3999,FTL
MONDO:0037872,bordetellosis
PR:000007494,fibroblast growth factor 3
GO:0061436,establishment of skin barrier
HP:0007286,Horizontal jerk nystagmus
UBERON:0002245,cerebellar hemisphere
GO:0030659,cytoplasmic vesicle membrane
chembl:CHEMBL3545088,PUQUITINIB
chembl:CHEMBL38943,GW501516
chembl:CHEMBL2172394,(-)-OLEOCANTHAL
chembl:CHEMBL603370,CHEMBL603370
chembl:CHEMBL3545054,INCB-40093
chembl:CHEMBL1237099,DOXACURIUM CHLORIDE
HGNC:11277,SPTLC1
CHEBI:5280,gatifloxacin
HGNC:4118,GALK1
chembl:CHEMBL497,CLIOQUINOL
chembl:CHEMBL222460,BMS-223131
HGNC:28883,PPA2
GO:0019897,extrinsic component of plasma membrane
HGNC:20069,USP40
chembl:CHEMBL3544983,TESEVATINIB
HGNC:582,APBB2
chembl:CHEMBL70927,DEFERIPRONE
Reactome:R-RNO-549127,Organic cation transport
HGNC:11273,SPTAN1
chembl:CHEMBL1594935,CYSTAMINE DIHYDROCHLORIDE
HGNC:26190,MTMR14
HP:0100008,Schwannoma
HP:0002490,Increased CSF lactate
chembl:CHEMBL1275761,CHEMBL1275761
chembl:CHEMBL2107829,EMIXUSTAT HYDROCHLORIDE
HGNC:14273,BOLL
HGNC:17089,SYNE1
MGI:3646373,Cyp3a57
chembl:CHEMBL164585,CHEMBL164585
chembl:CHEMBL2364651,TOVETUMAB
chembl:CHEMBL2332783,CHEMBL2332783
chembl:CHEMBL355200,ENILURACIL
MONDO:0016418,"multiple system atrophy, cerebellar type"
chembl:CHEMBL465251,DEMETHYLZEYLASTERONE
chembl:CHEMBL1083993,AMIODARONE HYDROCHLORIDE
MONDO:0020841,neurodevelopmental disorder with cerebellar atrophy and with or without seizures
CHEBI:3962,curcumin
chembl:CHEMBL1201383,"2',2'-DIFLUORODEOXYCYTIDINE 5'-TRIPHOSPHATE"
CHEBI:68489,"alkyl,acyl-sn-glycero-3-phosphocholine"
chembl:CHEMBL4298020,LODAPOLIMAB
MONDO:0043544,nosocomial infection
chembl:CHEMBL1324108,6-AMINONICOTINAMIDE
HGNC:20717,KLC3
HGNC:3386,EPHA2
HGNC:4510,KISS1R
chembl:CHEMBL1256738,CHEMBL1256738
chembl:CHEMBL318191,TONABERSAT
chembl:CHEMBL570176,CHEMBL570176
chembl:CHEMBL1230122,R-1487
chembl:CHEMBL1159650,CLOBETASOL PROPIONATE
chembl:CHEMBL281622,CP-339818
HGNC:6317,KIF1C
chembl:CHEMBL1742994,BRENTUXIMAB VEDOTIN
CHEBI:16349,L-citrulline
HGNC:7723,NEDD1
chembl:CHEMBL88612,CHEMBL88612
HGNC:14685,F11R
chembl:CHEMBL5,NALIDIXIC ACID
chembl:CHEMBL305195,CHEMBL305195
HGNC:2198,COL1A2
MONDO:0016171,polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies
HGNC:25018,TMEM216
HGNC:2577,CYBA
HGNC:9788,RAB7A
MONDO:0002758,vulva verrucous carcinoma
chembl:CHEMBL2108110,THROMBIN
GO:0005737,cytoplasm
chembl:CHEMBL3950712,DA-6886
HGNC:1094,BPHL
chembl:CHEMBL142703,VILDAGLIPTIN
chembl:CHEMBL282731,CICHORIC ACID
chembl:CHEMBL49080,CLENBUTEROL
chembl:CHEMBL93645,ACECLOFENAC
HGNC:2285,COX6C
GO:0031624,ubiquitin conjugating enzyme binding
HGNC:6250,KCNH1
MONDO:0005134,experimental autoimmune encephalomyelitis
chembl:CHEMBL2107677,UMESPIRONE
chembl:CHEMBL1687,TUBOCURARINE CHLORIDE
chembl:CHEMBL9514,NOCODAZOLE
chembl:CHEMBL1614710,OSI-930
chembl:CHEMBL531296,CHEMBL531296
MONDO:0004187,nodular fasciitis
chembl:CHEMBL7660,PHENIDONE
chembl:CHEMBL2107349,LECOZOTAN HYDROCHLORIDE
chembl:CHEMBL4297625,LICOGLIFLOZIN
HGNC:14620,TES
CHEBI:44185,methotrexate
HGNC:25221,MMADHC
HGNC:840,ATP5PB
chembl:CHEMBL14060,PHENOL
HGNC:4021,KDSR
HGNC:9163,PNOC
MONDO:0000703,collagenous colitis
MONDO:0010334,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome
chembl:CHEMBL154580,CHEMBL154580
HGNC:1727,CDC25C
chembl:CHEMBL13662,CI-218872
MONDO:0010543,Barth syndrome
chembl:CHEMBL258818,LITHOGLYCOCHOLATE
MONDO:0002867,pancreatic cystadenocarcinoma
chembl:CHEMBL1200990,FLURBIPROFEN SODIUM
Reactome:R-HSA-5626467,RHO GTPases activate IQGAPs
MONDO:0010788,Leber hereditary optic neuropathy
WB:WBGene00008730,F13B12.2
chembl:CHEMBL1834951,CHEMBL1834951
chembl:CHEMBL459014,CASEARINONE B
chembl:CHEMBL25,ASPIRIN
chembl:CHEMBL2106098,DABELOTINE
HGNC:30866,UEVLD
chembl:CHEMBL1201153,ISOETHARINE MESYLATE
MONDO:0012084,aromatic L-amino acid decarboxylase deficiency
chembl:CHEMBL1256813,CHEMBL1256813
chembl:CHEMBL1075,MORICIZINE
MONDO:0011445,hereditary spastic paraplegia 11
chembl:CHEMBL547483,CHEMBL547483
HGNC:26775,TMEM192
MONDO:0002741,uterine ligament adenocarcinoma
RGD:708502,Slc45a1
HGNC:24537,CHMP2B
HGNC:1237,UBQLN4
chembl:CHEMBL601353,CHEMBL601353
CHEBI:9168,sirolimus
chembl:CHEMBL1517542,CHEMBL1517542
HGNC:12363,TSC2
UPHENO:0080591,abnormal irritability behavior
chembl:CHEMBL1189432,OLOPATADINE
chembl:CHEMBL3184679,AZD-4547
HGNC:549,AOC2
HGNC:24596,DYNLL2
chembl:CHEMBL773,GLYCINE
HGNC:4616,GSK3A
chembl:CHEMBL469912,PUROMYCIN
HGNC:4691,GUCY2F
NCBIGene:508566,NQO2
NCBIGene:489110,DRD1
chembl:CHEMBL511995,LIQUIRITIN
chembl:CHEMBL180966,CHEMBL180966
chembl:CHEMBL1504,TRIAMCINOLONE ACETONIDE
MONDO:0024557,ataxia-telangiectasia-like disorder 1
HGNC:29038,OTUD3
chembl:CHEMBL26915,SC-560
HGNC:12687,VHL
HGNC:32487,ALKBH2
chembl:CHEMBL182,GANCICLOVIR
chembl:CHEMBL1014,CANDESARTAN CILEXETIL
HGNC:9388,PRKAR1A
HP:0000010,Recurrent urinary tract infections
GO:0005308,creatine transmembrane transporter activity
chembl:CHEMBL602807,CHEMBL602807
chembl:CHEMBL1213553,CHLORPROGUANIL
HP:0006866,Midline central nervous system lipomas
chembl:CHEMBL1950651,EVODENOSON
HGNC:2592,CYP11B2
HGNC:18667,PMPCA
chembl:CHEMBL637,VENLAFAXINE
CHEBI:6078,ivermectin
HP:0100725,Lichenification
MONDO:0009567,Marinesco-Sjogren syndrome
HP:0002028,Chronic diarrhea
HGNC:3383,STOM
chembl:CHEMBL427683,ORGANON
HP:0100832,Vitreous floaters
chembl:CHEMBL2108742,SIPLIZUMAB
HGNC:94,ACAT2
MONDO:0001235,appendix cancer
chembl:CHEMBL2219422,AFURESERTIB
chembl:CHEMBL2397733,SILYDIANIN
HP:0002444,Hypothalamic hamartoma
chembl:CHEMBL944,CHLOROPROCAINE HYDROCHLORIDE
chembl:CHEMBL312163,RHAMNETIN
chembl:CHEMBL521,IBUPROFEN
chembl:CHEMBL1272,REPAGLINIDE
chembl:CHEMBL1201151,MESTRANOL
HP:0000709,Psychosis
HGNC:848,ATP5MF
chembl:CHEMBL4298021,ZAGOTENEMAB
chembl:CHEMBL3545344,PF-05212377
chembl:CHEMBL1615374,VILAZODONE HYDROCHLORIDE
wikidata:Q47522095,RISPERDAL
GO:0005739,mitochondrion
chembl:CHEMBL1351761,DINALINE
HGNC:4023,FXR1
chembl:CHEMBL3039513,DECERNOTINIB
MONDO:0005126,tuberculoid leprosy
chembl:CHEMBL591118,CARMEGLIPTIN
chembl:CHEMBL797,PHENSUXIMIDE
HGNC:4087,GABRG2
chembl:CHEMBL56564,TROPISETRON
HP:0000411,Protruding ear
chembl:CHEMBL1779710,EVOGLIPTIN
chembl:CHEMBL1446254,CHEMBL1446254
HGNC:6816,MAK
FB:FBgn0000042,Act5C
HP:0002511,Alzheimer disease
chembl:CHEMBL404422,BUTETHAL
HGNC:397,ALAS2
chembl:CHEMBL1200760,BALSALAZIDE DISODIUM
chembl:CHEMBL3990026,ELAPEGADEMASE
chembl:CHEMBL16410,PNU-99194A
chembl:CHEMBL592435,DERENOFYLLINE
chembl:CHEMBL1256646,FENOLDOPAM BROMIDE
chembl:CHEMBL591641,CHEMBL591641
HGNC:12713,VPS41
HP:0000013,Hypoplasia of the uterus
chembl:CHEMBL406834,CHEMBL406834
HP:0001250,Seizure
HGNC:3261,EIF2B5
chembl:CHEMBL187734,TETRADECYLTHIOACETIC ACID
MONDO:0011330,spinocerebellar ataxia type 10
chembl:CHEMBL462018,TRICIRIBINE PHOSPHATE
chembl:CHEMBL116,AMPRENAVIR
chembl:CHEMBL518924,MAVORIXAFOR
HGNC:14928,UBXN6
HGNC:15483,CDKL3
chembl:CHEMBL99,TRICHOSTATIN
chembl:CHEMBL1631107,CEFQUINOME
HGNC:8878,PFKP
HGNC:7688,NDUFA5
HGNC:11283,SRC
chembl:CHEMBL2103836,IMAGABALIN
chembl:CHEMBL1472891,CHEMBL1472891
MONDO:0008948,cerebrotendinous xanthomatosis
MGI:2137706,Actn1
chembl:CHEMBL15870,INDOPROFEN
MONDO:0021022,hereditary hyperekplexia
HGNC:7126,MLF2
chembl:CHEMBL553,ERLOTINIB
chembl:CHEMBL2107841,ALBIGLUTIDE
MONDO:0008458,spinocerebellar ataxia type 2
HGNC:359,AIPL1
chembl:CHEMBL3039508,NALDEMEDINE TOSYLATE
chembl:CHEMBL579315,CHEMBL579315
HGNC:10802,SFTPC
HGNC:6697,LRP5
HGNC:21701,BRAT1
chembl:CHEMBL1742999,CARLUMAB
chembl:CHEMBL1079175,MK-2206
HP:0000822,Hypertension
HGNC:28611,RICTOR
chembl:CHEMBL151649,PHENETHYLISOTHIOCYANATE
HGNC:7499,MT-TT
chembl:CHEMBL66953,PURPUROGALLIN
chembl:CHEMBL111545,CHEMBL111545
chembl:CHEMBL435734,ARCTIGENIN
ZFIN:ZDB-GENE-040718-199,uqcrq
HGNC:13945,GPSM3
chembl:CHEMBL298734,LONAFARNIB
chembl:CHEMBL222993,CHEMBL222993
chembl:CHEMBL597449,CHEMBL597449
HGNC:1874,CFL1
HGNC:10067,RNF4
chembl:CHEMBL471005,CHEMBL471005
HGNC:20415,SUMF2
HGNC:30626,YTHDC1
chembl:CHEMBL2106615,BAZEDOXIFENE ACETATE
HGNC:2584,CYLD
chembl:CHEMBL481160,CHEMBL481160
HGNC:3278,EIF3D
RGD:1566036,Spidr
HP:0000842,Hyperinsulinemia
HGNC:27302,IBA57
chembl:CHEMBL1760,TERBUTALINE
HGNC:48813,HNRNPCL2
MONDO:0044638,hypopharynx squamous cell carcinoma
MONDO:0010808,fatal familial insomnia
chembl:CHEMBL215303,GARENOXACIN
MONDO:0013200,hypertrophic cardiomyopathy 15
MONDO:0006745,endometrioid stromal sarcoma
HGNC:15522,KCNIP2
CHEBI:63611,moxifloxacin
chembl:CHEMBL4297563,CX-072
chembl:CHEMBL487192,FUKINOLIC ACID
HGNC:11728,TERF1
MONDO:0015905,syndromic dyslipidemia
Reactome:R-CEL-71403,Citric acid cycle (TCA cycle)
HGNC:4208,GCSH
HP:0001138,Optic neuropathy
chembl:CHEMBL462880,ISOBOLDINE
MONDO:0012721,progressive myoclonic epilepsy type 3
chembl:CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL243664,ACACETIN
GO:0016608,growth hormone-releasing hormone activity
chembl:CHEMBL4298027,PRX-321
chembl:CHEMBL1940084,CHEMBL1940084
NCBIGene:492299,SLC5A1
chembl:CHEMBL2109248,APOMAB
HP:0410020,Fish odor
chembl:CHEMBL159226,MOXISYLYTE
chembl:CHEMBL1212972,NANAOMYCIN
UBERON:0001184,renal artery
chembl:CHEMBL59821,CHEMBL59821
chembl:CHEMBL546493,CHEMBL546493
chembl:CHEMBL1534035,CHEMBL1534035
MONDO:0002601,teratoma
chembl:CHEMBL2107881,REGRAMOSTIM
chembl:CHEMBL2105721,NIVOCASAN
chembl:CHEMBL455078,CHEMBL455078
HGNC:6600,LIG3
MONDO:0001763,ethmoid sinus cancer
FB:FBgn0000043,Act42A
chembl:CHEMBL284609,CHEMBL284609
chembl:CHEMBL33845,DICHLOROPHEN
chembl:CHEMBL2107846,DULANERMIN
chembl:CHEMBL59532,CHEMBL59532
NCBIGene:616871,UQCRB
chembl:CHEMBL606805,NAMITECAN
HP:0034674,Abnormal ankle physiology
HP:0001268,Mental deterioration
chembl:CHEMBL58,MITOXANTRONE
chembl:CHEMBL1555736,ETHAVERINE
chembl:CHEMBL4298178,TRASTUZUMAB DUOCARMAZINE
chembl:CHEMBL548469,CHEMBL548469
chembl:CHEMBL3681419,BASMISANIL
HGNC:25818,BRD9
HGNC:16831,TSPOAP1
chembl:CHEMBL403989,TG100-801
chembl:CHEMBL576175,CHEMBL576175
HGNC:1395,CACNA1H
chembl:CHEMBL1200732,AMCINONIDE
chembl:CHEMBL1493528,CHEMBL1493528
HGNC:28999,FAM168A
chembl:CHEMBL26,SULPIRIDE
chembl:CHEMBL4205422,MK-0752
HGNC:9412,PRKCZ
HGNC:18265,ATP6V1G3
HGNC:10604,SCO2
chembl:CHEMBL1597273,PERSEITOL
HGNC:7671,NCOA4
chembl:CHEMBL480626,CHEMBL480626
HP:0002716,Lymphadenopathy
chembl:CHEMBL639,AZELASTINE
MONDO:0003554,adenosquamous colon carcinoma
HGNC:7865,NODAL
MONDO:0004150,breast giant fibroadenoma
WB:WBGene00000247,bec-1
HP:0001629,Ventricular septal defect
HP:0410153,Increased level of methylsuccinic acid in urine
GO:0030280,structural constituent of skin epidermis
chembl:CHEMBL275809,FR-122047
HGNC:3788,FOLH1
chembl:CHEMBL581880,CHEMBL581880
HGNC:4170,GATA1
chembl:CHEMBL27508,CHEMBL27508
HGNC:2961,DYNC1H1
MONDO:0800044,congenital disorder of deglycosylation 1
wikidata:Q47521337,CENESTIN
Reactome:R-BTA-611105,Respiratory electron transport
MONDO:0017824,familial isolated pituitary adenoma
HP:0200101,Decreased/absent ankle reflexes
chembl:CHEMBL501867,VINCRISTINE SULFATE
chembl:CHEMBL1323355,DEXTROMEPROMAZINE
chembl:CHEMBL237500,LINAGLIPTIN
HP:0000113,Polycystic kidney dysplasia
chembl:CHEMBL1544,LIOTHYRONINE
chembl:CHEMBL1200434,OXTRIPHYLLINE
HGNC:169,ACTR2
HGNC:15864,RBCK1
chembl:CHEMBL1477383,CHEMBL1477383
Reactome:R-DRE-500753,Pyrimidine biosynthesis
HP:0004305,Involuntary movements
chembl:CHEMBL2109587,AZ9773
chembl:CHEMBL2109381,BHQ-880
chembl:CHEMBL2108359,NIMOTUZUMAB
chembl:CHEMBL1200866,PERFLUBRON
HP:0000297,Facial hypotonia
chembl:CHEMBL666,FOSCARNET
chembl:CHEMBL547833,CHEMBL547833
chembl:CHEMBL3301622,GILTERITINIB
chembl:CHEMBL1201646,INULIN
HP:0012473,Tongue atrophy
chembl:CHEMBL7890,L-NAME
MONDO:0016490,hemoglobin C-beta-thalassemia syndrome
HGNC:1058,BLM
chembl:CHEMBL1076839,CYANOPEPTOLIN SS
HP:0007018,Attention deficit hyperactivity disorder
FB:FBgn0038980,OctÎ²1R
MONDO:0010830,neuronal ceroid lipofuscinosis 8
chembl:CHEMBL474260,CARUBICIN
chembl:CHEMBL1256388,CYSTAMINE HYDROCHLORIDE
chembl:CHEMBL3545058,DEXTROTHYROXINE SODIUM
chembl:CHEMBL2107765,OXEGLITAZAR
HP:0025062,Geophagia
HGNC:28912,WDR45
chembl:CHEMBL166486,CHEMBL166486
chembl:CHEMBL1288652,5-BENZYLOXYTRYPTAMINE
chembl:CHEMBL277525,CHEMBL277525
HGNC:6834,MAOB
CHEBI:5118,fluoxetine
HGNC:6416,KRT14
HGNC:4056,G6PC1
chembl:CHEMBL1200471,PYRITHIONE ZINC
chembl:CHEMBL186526,CHEMBL186526
dictyBase:DDB_G0274993,bzpJ
chembl:CHEMBL3989954,ROSIPTOR
chembl:CHEMBL4297190,SURUFATINIB
CHEBI:57538,orotidine 5'-phosphate(3-)
chembl:CHEMBL77387,CHEMBL77387
HGNC:4711,GZMK
HP:0002870,Obstructive sleep apnea
chembl:CHEMBL4298023,M-1095
MONDO:0010820,autosomal recessive juvenile Parkinson disease 2
UPHENO:0088155,abnormal platysma morphology
chembl:CHEMBL1346025,CHEMBL1346025
chembl:CHEMBL286615,LUZINDOLE
chembl:CHEMBL565,CLOFIBRATE
chembl:CHEMBL593,DELAVIRDINE
chembl:CHEMBL1200343,PERINDOPRIL ERBUMINE
Reactome:R-BTA-549127,Organic cation transport
HP:0025116,Fetal distress
CHEBI:23697,dichlorobenzene
chembl:CHEMBL3544991,DOMAGROZUMAB
chembl:CHEMBL1606295,HYDROCOTARNINE
HGNC:6181,ITPR2
chembl:CHEMBL317115,CHEMBL317115
MONDO:0005185,chronic childhood arthritis
HGNC:4494,GPR37
chembl:CHEMBL2095211,LORCASERIN HYDROCHLORIDE
HP:0002457,Abnormal head movements
UPHENO:0078579,abnormal visual pursuit
HGNC:7050,SCGB2A2
MONDO:0016158,narcolepsy-cataplexy syndrome
chembl:CHEMBL191,LOSARTAN
HGNC:10430,RPS6KA1
chembl:CHEMBL1201064,FLUOROMETHOLONE ACETATE
HGNC:1603,CCR2
MONDO:0003820,mature ovarian teratoma
GO:0005488,binding
chembl:CHEMBL286136,CHEMBL286136
chembl:CHEMBL111077,MYRISTIC ACID
HP:0030148,Heart murmur
MONDO:0011836,thyroid Hurthle cell carcinoma
HP:0000054,Micropenis
CHEBI:26195,polyphenol
HGNC:13797,PRX
HGNC:10989,SLC25A3
HGNC:9319,PPP4C
chembl:CHEMBL402063,E-GUGGULSTERONE
chembl:CHEMBL2105762,OMARIGLIPTIN
chembl:CHEMBL527620,CHEMBL527620
chembl:CHEMBL1095337,AESCULIOSIDE IIE
chembl:CHEMBL2103802,DAPAGLIFLOZIN PROPYLENE GLYCOL
chembl:CHEMBL75124,NONIVAMIDE
CHEBI:8707,quetiapine
HGNC:11209,SP4
HP:0001376,Limitation of joint mobility
CHEBI:7660,nystatin
chembl:CHEMBL1200472,QUAZEPAM
chembl:CHEMBL124706,PHTHALAZINONE
HGNC:17117,SLC35C2
chembl:CHEMBL3989862,PEFCALCITOL
chembl:CHEMBL453066,BETA-CCM
HGNC:24634,EPS15L1
chembl:CHEMBL2104466,XAMOTEROL FUMARATE
chembl:CHEMBL398435,TICAGRELOR
CHEBI:17620,ferulic acid
chembl:CHEMBL275224,NORHARMANE
chembl:CHEMBL363535,TANSHINONE I
HGNC:11936,FASLG
chembl:CHEMBL84158,TIAPRIDE
chembl:CHEMBL1201115,ESMOLOL HYDROCHLORIDE
HP:0008619,Bilateral sensorineural hearing impairment
chembl:CHEMBL1797707,CHEMBL1797707
UBERON:0002240,spinal cord
HGNC:9362,PRG2
HGNC:6366,KLK5
chembl:CHEMBL1200769,TRIPELENNAMINE CITRATE
chembl:CHEMBL85826,CHEMBL85826
chembl:CHEMBL3833330,CINPANEMAB
HGNC:851,ATP6V1A
chembl:CHEMBL481161,CHEMBL481161
chembl:CHEMBL596631,CHEMBL596631
chembl:CHEMBL2064455,FLUOROCYCLOPENTENYLCYTOSINE
chembl:CHEMBL590636,GANCAONIN L
chembl:CHEMBL2043437,GLASDEGIB
MONDO:0800486,metabolic bone disorder
chembl:CHEMBL607400,BRIVARACETAM
chembl:CHEMBL591772,KANZONOL W
HGNC:3483,ETFDH
wikidata:Q798309,BCG VACCINE
chembl:CHEMBL998,LORATADINE
chembl:CHEMBL592316,CHEMBL592316
chembl:CHEMBL453905,BROMOXYNIL
chembl:CHEMBL2218885,VERTEPORFIN
HGNC:14295,SHANK2
HGNC:24999,ARMC8
chembl:CHEMBL374146,CYNAROPICRIN
HGNC:8827,PELI1
HGNC:15971,TSG101
HGNC:697,ARL6IP1
HGNC:9583,PTBP1
HP:0002076,Migraine
chembl:CHEMBL363506,CORALYNE
chembl:CHEMBL602954,CHEMBL602954
chembl:CHEMBL572878,TOZASERTIB
chembl:CHEMBL1000,CETIRIZINE
chembl:CHEMBL449214,GRACILIN A
chembl:CHEMBL452847,CHEMBL452847
CHEBI:36416,mancude organic heterotricyclic parent
chembl:CHEMBL547488,CHEMBL547488
chembl:CHEMBL1655,TOREMIFENE
HGNC:3690,FGFR3
CHEBI:25409,monoterpenoid
chembl:CHEMBL3301587,DURVALUMAB
chembl:CHEMBL1862887,IPRODIONE
MONDO:0012529,Diamond-Blackfan anemia 3
chembl:CHEMBL2171206,EUCALYPTIN A
HGNC:12491,UBE2M
HGNC:11150,SNRNP70
chembl:CHEMBL1201396,FLUTICASONE
CHEBI:17579,beta-carotene
GO:0015911,long-chain fatty acid import across plasma membrane
chembl:CHEMBL3334567,SAVOLITINIB
MONDO:0010997,"supranuclear palsy, progressive, 1"
HGNC:7096,MID2
HGNC:6836,MAP1B
HGNC:13886,ABCG5
chembl:CHEMBL534084,CHEMBL534084
chembl:CHEMBL839,CARTEOLOL
chembl:CHEMBL1337960,CHEMBL1337960
CHEBI:132142,"1,4-naphthoquinones"
chembl:CHEMBL447664,VIPADENANT
HP:0001999,Abnormal facial shape
MONDO:0005258,autism spectrum disorder
chembl:CHEMBL2333548,CHEMBL2333548
chembl:CHEMBL594153,CHEMBL594153
chembl:CHEMBL265686,CHEMBL265686
FB:FBgn0286222,Fum1
Reactome:R-HSA-8874211,CREB3 factors activate genes
chembl:CHEMBL207433,SB-705498
HP:0002519,Hypnagogic hallucinations
MONDO:0006209,fibroblastic neoplasm
HP:0410067,Increased level of L-fucose in urine
MONDO:0000694,seasonal affective disorder
chembl:CHEMBL150372,3-HYDROXYCOUMARIN
MONDO:0014339,autosomal recessive spinocerebellar ataxia 16
HGNC:19102,RIGI
chembl:CHEMBL1469,PHENYLBUTANOIC ACID
chembl:CHEMBL1200330,PILOCARPINE HYDROCHLORIDE
CHEBI:66884,N-alkylglycine zwitterion
MONDO:0011835,"sensory ataxic neuropathy, dysarthria, and ophthalmoparesis"
HGNC:25556,DNAJC17
HP:0034734,Elevated CSF argininosuccinic acid concentration
HGNC:292,ADSS2
chembl:CHEMBL1332616,ERYTHROSINE
HP:0000135,Hypogonadism
MONDO:0005081,preeclampsia
CHEBI:2676,amoxicillin
HGNC:327,AGPS
chembl:CHEMBL211670,CHEMBL211670
chembl:CHEMBL8488,CHEMBL8488
chembl:CHEMBL1320139,HELIOMYCIN
chembl:CHEMBL1743018,FICLATUZUMAB
CHEBI:16436,CDP-choline
HGNC:29641,PWWP3A
HP:0011848,Abdominal colic
CHEBI:58189,GDP(3-)
HGNC:1404,CACNB4
chembl:CHEMBL578061,CHEMBL578061
chembl:CHEMBL557555,CIPROFIBRATE
Reactome:R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC
NCBIGene:480511,AOC3
HGNC:20856,THAP1
chembl:CHEMBL1255778,BENSERAZIDE HYDROCHLORIDE
HGNC:2899,DLEC1
chembl:CHEMBL1490495,MECYSTEINE HYDROCHLORIDE
HGNC:4458,GPI
chembl:CHEMBL4297801,PEGUNIGALSIDASE ALFA
Reactome:R-DRE-390651,Dopamine receptors
HGNC:23703,ERMP1
MGI:1354695,Fbxw7
chembl:CHEMBL1231107,CYROMAZINE
chembl:CHEMBL547,ISOTRETINOIN
HGNC:57,ABCC6
HGNC:16384,TRIM28
chembl:CHEMBL1989853,CHEMBL1989853
chembl:CHEMBL250270,LERCANIDIPINE
chembl:CHEMBL50,QUERCETIN
chembl:CHEMBL73451,MEQUITAZINE
chembl:CHEMBL178707,CHEMBL178707
chembl:CHEMBL554041,ALEXIDINE DIHYDROCHLORIDE
Reactome:R-GGA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HGNC:3073,DUSP7
HP:0003198,Myopathy
HGNC:7907,NPHP3
MONDO:0005301,multiple sclerosis
HGNC:24821,RFFL
Reactome:R-DME-500753,Pyrimidine biosynthesis
chembl:CHEMBL672,FENOFIBRATE
MGI:105100,Ctnnd1
chembl:CHEMBL591628,CHEMBL591628
HGNC:9414,PRKG1
HGNC:10472,RUNX2
chembl:CHEMBL331372,CGS-21680
Reactome:R-HSA-390650,Histamine receptors
chembl:CHEMBL1201313,CHLOPHEDIANOL
HGNC:9942,PRPH2
MONDO:0009672,"spinal muscular atrophy, type III"
chembl:CHEMBL601534,CHEMBL601534
chembl:CHEMBL608,PROBUCOL
CHEBI:50694,minocycline
HGNC:399,ALB
chembl:CHEMBL2105659,VARESPLADIB METHYL
HGNC:8090,OASL
HP:0025169,Left ventricular systolic dysfunction
HGNC:1044,BGN
HGNC:2911,DLST
chembl:CHEMBL7724,AG1295
HP:0012705,Abnormal metabolic brain imaging by MRS
MONDO:0000914,"cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1"
HGNC:10303,RPL13
chembl:CHEMBL1201583,BEVACIZUMAB
chembl:CHEMBL156378,BROMOETHANE
HP:0004372,Reduced consciousness/confusion
chembl:CHEMBL1200810,DOXERCALCIFEROL
MONDO:0004994,cardiomyopathy
chembl:CHEMBL1237174,HYDRAZINE
CHEBI:3745,clindamycin
HGNC:1421,SLC25A20
UBERON:0004502,skeletal muscle tissue of biceps brachii
CHEBI:29687,teicoplanin
MONDO:0018823,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
chembl:CHEMBL546865,CHEMBL546865
chembl:CHEMBL1956070,CHEMBL1956070
chembl:CHEMBL1358137,CHEMBL1358137
chembl:CHEMBL1743038,LUCATUMUMAB
HGNC:5213,HSD17B4
chembl:CHEMBL2028066,CHEMBL2028066
chembl:CHEMBL1396177,PENICILLIN V BENZATHINE
HGNC:4180,GBE1
UPHENO:0084155,abnormally dilated fourth ventricle
MONDO:0014104,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4"
chembl:CHEMBL1835919,PF-04620110
MONDO:0006135,cervical clear cell adenocarcinoma
UBERON:0000992,ovary
chembl:CHEMBL1201242,INDECAINIDE
chembl:CHEMBL472212,CHEMBL472212
FB:FBgn0262872,milt
HP:0000713,Agitation
chembl:CHEMBL185073,PANCURONIUM
NCBIGene:475214,NDUFA5
NCBIGene:416391,NDUFB6
HGNC:1497,CASK
chembl:CHEMBL1360594,CHAULMOSULFONE
chembl:CHEMBL1326944,"7,3'-DIMETHOXYFLAVONE"
HGNC:27301,CRTC2
HGNC:22948,NLRP2
HGNC:11584,TBK1
chembl:CHEMBL592445,GEDATOLISIB
chembl:CHEMBL575448,BMS-754807
chembl:CHEMBL1200363,PENBUTOLOL SULFATE
chembl:CHEMBL578675,CHEMBL578675
chembl:CHEMBL473417,VISMODEGIB
chembl:CHEMBL731,4-HYDROXYCYCLOPHOSPHAMIDE
chembl:CHEMBL12,DIAZEPAM
HGNC:10586,SCN1B
chembl:CHEMBL239439,CHEMBL239439
CHEBI:15956,biotin
chembl:CHEMBL86464,CHEMBL86464
CHEBI:48339,"1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine"
HGNC:19195,ABLIM2
HGNC:28973,MLEC
chembl:CHEMBL186179,MURAGLITAZAR
chembl:CHEMBL1705373,THIOCOLCHICOSIDE
chembl:CHEMBL40919,KAEMPFERIDE
chembl:CHEMBL477052,CHEMBL477052
chembl:CHEMBL163,RITONAVIR
chembl:CHEMBL1682202,CHEMBL1682202
MONDO:0018770,Jeune syndrome
UPHENO:0077991,decreased reflex in calcaneal tendon
HP:0000504,Abnormality of vision
UBERON:0001234,left adrenal gland
HP:0034206,Abnormal fetal central nervous system morphology
chembl:CHEMBL85685,CHRYSENE
chembl:CHEMBL4297482,AZD-5991
MONDO:0002748,rectum mucinous adenocarcinoma
MONDO:0015548,Huntington disease-like syndrome
chembl:CHEMBL2010872,CEP-11981
chembl:CHEMBL2062266,DIHYDROCODEINE BITARTRATE
chembl:CHEMBL495873,MAHANIMBINE
CHEBI:46847,N-iminopiperazine
HP:0008936,Axial hypotonia
chembl:CHEMBL4297576,EFINOPEGDUTIDE
HGNC:7491,MT-TL2
HGNC:8790,PDE6H
chembl:CHEMBL1200450,TRIPROLIDINE HYDROCHLORIDE
chembl:CHEMBL601773,DIHYDROERGOCRISTINE
chembl:CHEMBL580076,CHEMBL580076
wikidata:Q47521541,ELMIRON
chembl:CHEMBL267744,TICRYNAFEN
chembl:CHEMBL487,DROLOXIFENE
chembl:CHEMBL4297971,PEPTIDE YY HUMAN (3-36)
HGNC:663,ARG1
chembl:CHEMBL578890,CHEMBL578890
MONDO:0003243,hepatocellular clear cell carcinoma
HGNC:11205,SP1
MONDO:0016305,atypical pantothenate kinase-associated neurodegeneration
chembl:CHEMBL57242,AZILSARTAN
HGNC:4189,GCDH
HGNC:26099,ARHGAP10
chembl:CHEMBL300982,LICOFELONE
CHEBI:26512,quinolinemonocarboxylic acid
chembl:CHEMBL3989843,TRANYLCYPROMINE
HGNC:19383,SOCS1
chembl:CHEMBL1417951,MECARBAM
chembl:CHEMBL581865,CHEMBL581865
MONDO:0009064,ocular cystinosis
chembl:CHEMBL3545298,AZD-6918
HGNC:12461,UBAP1
HGNC:24997,WDR91
chembl:CHEMBL1593906,LEVOPROPOXYPHENE NAPSYLATE
UBERON:0002119,left ovary
chembl:CHEMBL1526167,CHEMBL1526167
chembl:CHEMBL31410,CORYNANTHEINE
HGNC:7067,CIITA
chembl:CHEMBL240954,CHEMBL240954
HGNC:6427,KRT17
HGNC:9354,PRDX3
MONDO:0012756,proximal 16p11.2 microdeletion syndrome
CL:0000576,monocyte
chembl:CHEMBL846,CALCITRIOL
HP:0003484,Upper limb muscle weakness
HGNC:20952,TMEM14C
HGNC:27638,SYPL2
chembl:CHEMBL290352,CEP-1347
HP:0011463,Childhood onset
chembl:CHEMBL590927,CHEMBL590927
chembl:CHEMBL219568,GUANINE
chembl:CHEMBL1088751,PH-797804
chembl:CHEMBL1201274,LEVOBETAXOLOL
HGNC:32949,SMPD4
chembl:CHEMBL361362,SYRINGARESINOL
chembl:CHEMBL1475693,FAMPROFAZONE
chembl:CHEMBL1551165,IOPHENOXIC ACID
MONDO:0006235,granular cell tumor
UPHENO:0075942,abnormal vestibular nerve
chembl:CHEMBL1834675,SPHAEROPSIDIN A
HP:0006817,Aplasia/Hypoplasia of the cerebellar vermis
chembl:CHEMBL1206690,PARECOXIB
CHEBI:35610,antineoplastic agent
chembl:CHEMBL261118,CHEMBL261118
chembl:CHEMBL493636,SULFANITRAN
chembl:CHEMBL388979,CHEMBL388979
chembl:CHEMBL2109367,LMB-2
chembl:CHEMBL260560,CHEMBL260560
chembl:CHEMBL255300,CHEMBL255300
MONDO:0010790,MERRF syndrome
chembl:CHEMBL2140408,AMG-900
chembl:CHEMBL544428,MIANSERIN HYDROCHLORIDE
chembl:CHEMBL1517738,KOLAVENIC ACID
chembl:CHEMBL310871,CHEMBL310871
HGNC:6143,ITGA7
GO:0005765,lysosomal membrane
chembl:CHEMBL451158,CHEMBL451158
chembl:CHEMBL75228,1-PHENETHYLPIPERIDINE
HP:0000721,Lack of spontaneous play
HP:0000303,Mandibular prognathia
chembl:CHEMBL1201833,GOLIMUMAB
chembl:CHEMBL1201891,DEFLAZACORT
chembl:CHEMBL460026,ICOSAPENT
HGNC:3555,FABP1
HGNC:15606,LAMTOR3
CHEBI:30816,vanillic acid
chembl:CHEMBL1451633,ETOFENAMATE
chembl:CHEMBL4297432,SLV-334
chembl:CHEMBL1200589,CEFOTIAM HYDROCHLORIDE
wikidata:Q20817118,HISTAMINE PHOSPHATE
HP:0010546,Muscle fibrillation
chembl:CHEMBL601110,CHEMBL601110
chembl:CHEMBL285323,METHYL ISOBUTYL KETONE
chembl:CHEMBL1256689,CHEMBL1256689
chembl:CHEMBL460,MOLINDONE
HGNC:346,AHRR
GO:0014012,peripheral nervous system axon regeneration
MONDO:0019171,familial long QT syndrome
HGNC:4379,GNA11
HP:0003581,Adult onset
chembl:CHEMBL1201141,IBUPROFEN LYSINE
chembl:CHEMBL1743082,TRASTUZUMAB EMTANSINE
chembl:CHEMBL313737,CHEMBL313737
HP:0002367,Visual hallucinations
GO:0002080,acrosomal membrane
chembl:CHEMBL255027,(S)-MIDODRINE
HGNC:16059,PAK4
HGNC:975,BCAS2
chembl:CHEMBL581872,CHEMBL581872
chembl:CHEMBL65794,CEFPIROME
chembl:CHEMBL585408,CHEMBL585408
HGNC:3602,FBLN5
chembl:CHEMBL1200347,ISOPROPAMIDE IODIDE
HGNC:25766,CCDC14
MONDO:0014742,"Parkinson disease 22, autosomal dominant"
chembl:CHEMBL186784,XANTHONE
chembl:CHEMBL2313446,4-TRIETHYLGERMYLPHENOL
chembl:CHEMBL274070,9-AMINOCAMPTOTHECIN
HGNC:10294,RPE65
MONDO:0003245,aflatoxin-related hepatocellular carcinoma
chembl:CHEMBL2108081,TRAFERMIN
Reactome:R-HSA-500753,Pyrimidine biosynthesis
chembl:CHEMBL208484,KARANJIN
chembl:CHEMBL2105728,CRENOLANIB
UBERON:0002107,liver
MONDO:0011584,Fanconi anemia complementation group D1
chembl:CHEMBL602070,BMS-394136
chembl:CHEMBL1289926,AXITINIB
chembl:CHEMBL1213351,PROPOXYPHENE
chembl:CHEMBL22,TRIMETHOPRIM
chembl:CHEMBL3707319,GRC-15300
chembl:CHEMBL520275,TRIADIMENOL
chembl:CHEMBL43,AMSACRINE
chembl:CHEMBL1394328,CHEMBL1394328
chembl:CHEMBL3545243,AS-703988
chembl:CHEMBL6318,IDOXIFENE
MONDO:0020774,Menke-Hennekam syndrome
HP:0007859,Congenital horizontal nystagmus
chembl:CHEMBL3545398,PG-760564
HGNC:11587,TBL3
chembl:CHEMBL605525,DP001
chembl:CHEMBL3989972,BALIPODECT
chembl:CHEMBL2107761,NEMIFITIDE
chembl:CHEMBL583912,(-)-EPICATECHIN
chembl:CHEMBL1712842,MEPAZINE ACETATE
chembl:CHEMBL421088,CHEMBL421088
chembl:CHEMBL212579,BENZAMIL
chembl:CHEMBL1395579,CAPTAMINE
HGNC:649,ARCN1
chembl:CHEMBL1200545,DIFLORASONE DIACETATE
chembl:CHEMBL124660,TANDUTINIB
chembl:CHEMBL1304363,CHEMBL1304363
MONDO:0018608,pure autonomic failure
HP:0001596,Alopecia
HP:0032677,Generalized-onset motor seizure
chembl:CHEMBL101892,SANGIVAMYCIN
HGNC:13444,SLC2A10
chembl:CHEMBL1201264,METHANTHELINE
chembl:CHEMBL1521156,CHEMBL1521156
chembl:CHEMBL2216870,IDELALISIB
chembl:CHEMBL1201227,CYCRIMINE
chembl:CHEMBL1201130,BETAINE HYDROCHLORIDE
chembl:CHEMBL260046,EVOFOSFAMIDE
chembl:CHEMBL33884,CHEMBL33884
chembl:CHEMBL1200715,HEXYLCAINE HYDROCHLORIDE
chembl:CHEMBL3833346,TOFERSEN
chembl:CHEMBL4297408,NGX-267
chembl:CHEMBL2234294,[19F]-HALOPERIDOL
HGNC:14896,SPTBN4
chembl:CHEMBL703,SUXAMETHONIUM
MONDO:0018945,McLeod neuroacanthocytosis syndrome
chembl:CHEMBL4297775,KAI-1678
HGNC:9060,PLCD1
HP:0002829,Arthralgia
chembl:CHEMBL1288830,SPINASAPONIN A METHYL ESTER
chembl:CHEMBL667,ACETYLCHOLINE
chembl:CHEMBL337702,OXIDOPAMINE
MONDO:0002184,drug-induced hepatitis
CHEBI:52289,wortmannin
chembl:CHEMBL1200550,ANTAZOLINE PHOSPHATE
HGNC:16833,SOCS6
MONDO:0005574,tauopathy
NCBIGene:427897,NDUFA6
chembl:CHEMBL1738,DEXRAZOXANE
chembl:CHEMBL85139,RUTAECARPINE
HGNC:19083,CKS1B
chembl:CHEMBL2063869,GDC-0152
MONDO:0013392,autosomal recessive spinocerebellar ataxia 10
HP:0007928,Abnormal flash visual evoked potentials
HGNC:18170,CMPK1
chembl:CHEMBL1256660,CHEMBL1256660
HGNC:12496,UBE3A
chembl:CHEMBL585417,CHEMBL585417
CHEBI:9215,spectinomycin
chembl:CHEMBL2107911,ONERCEPT
chembl:CHEMBL681,ETOMIDATE
CHEBI:29623,manumycin A
HGNC:9664,PTPRA
chembl:CHEMBL343448,ROMIDEPSIN
chembl:CHEMBL1890813,METHABENZTHIAZURON
HP:0100035,Phonic tics
chembl:CHEMBL305666,LURTOTECAN
HP:0002863,Myelodysplasia
chembl:CHEMBL1220,TINIDAZOLE
CHEBI:50401,cholestanoid
chembl:CHEMBL1789842,INDACATEROL MALEATE
HP:0006956,Lateral ventricle dilatation
chembl:CHEMBL3545040,AZD7009
chembl:CHEMBL476351,GW775608X
UBERON:0002453,ethmoid sinus
HP:0031355,Maintenance insomnia
chembl:CHEMBL2107762,NERISPIRDINE
chembl:CHEMBL428496,WORTMANNIN
chembl:CHEMBL1213252,CLORAZEPIC ACID
chembl:CHEMBL104,CLOTRIMAZOLE
chembl:CHEMBL3990012,PEGAPAMODUTIDE
CHEBI:23778,dihydroxybenzoic acid
chembl:CHEMBL55659,ANTHRAQUINONE
MONDO:0016692,pilomyxoid astrocytoma
HP:0012187,Increased erythrocyte protoporphyrin concentration
HGNC:9081,PLOD1
chembl:CHEMBL530682,CHEMBL530682
chembl:CHEMBL421486,THUNBERGINOL E
MGI:1930638,Cyp3a25
MONDO:0008383,rheumatoid arthritis
HP:0031958,Spastic paraparetic gait
chembl:CHEMBL3545409,BVT.115959
chembl:CHEMBL2172378,CHEMBL2172378
CHEBI:27701,oxytetracycline
MGI:97175,Map2
HP:0011808,Decreased patellar reflex
chembl:CHEMBL1256180,5-(N-METHYL-N-ISOBUTYL)AMILORIDE
HGNC:7497,MT-TS1
HGNC:903,AXIN1
chembl:CHEMBL4297207,STANNSOPORFIN
chembl:CHEMBL16312,4'-METHOXYFLAVONE
MONDO:0009696,juvenile myoclonic epilepsy
HP:0003487,Babinski sign
HP:0001882,Leukopenia
chembl:CHEMBL1200443,MERETHOXYLLINE PROCAINE
chembl:CHEMBL597845,SALERMIDE
HGNC:7707,NDUFS1
chembl:CHEMBL559876,"2,6-DIDEHYDROPEPEROMIN B"
chembl:CHEMBL1460,DIDANOSINE
HP:0025236,Somnambulism
chembl:CHEMBL1201193,LEVOBUPIVACAINE
HGNC:10274,RP2
HP:0011397,Abnormality of the dorsal column of the spinal cord
chembl:CHEMBL2108767,RUPLIZUMAB
CHEBI:17196,L-asparagine
chembl:CHEMBL487356,CHEMBL487356
HGNC:10348,RPL37A
chembl:CHEMBL1489769,LASALOCID A SODIUM
chembl:CHEMBL435191,EDOTECARIN
chembl:CHEMBL27,PROPRANOLOL
chembl:CHEMBL551064,AEW-541
chembl:CHEMBL270299,BAY-11-7085
chembl:CHEMBL4298006,ENVAFOLIMAB
chembl:CHEMBL1909300,HEPARIN
UPHENO:0079840,abnormal sexual inhibition
HGNC:16948,MYDGF
chembl:CHEMBL404916,CHEMBL404916
Xenbase:XB-GENE-971750,cyp3a4.2
chembl:CHEMBL1200844,METHYLPREDNISOLONE ACETATE
chembl:CHEMBL1818099,SUVANINE'S SODIUM SALT
chembl:CHEMBL1800368,CHEMBL1800368
chembl:CHEMBL1200802,TALBUTAL
chembl:CHEMBL604664,CHEMBL604664
HGNC:6524,LCK
chembl:CHEMBL530361,CHEMBL530361
chembl:CHEMBL1200973,ESTRADIOL CYPIONATE
HGNC:13481,UNC93B1
HGNC:987,BCKDHB
HP:0000556,Retinal dystrophy
MONDO:0005661,babesiosis
chembl:CHEMBL1534878,IPRONIAZID SULFATE
HGNC:24912,LARP7
HP:0012379,Abnormal circulating enzyme concentration or activity
chembl:CHEMBL1493,FLAVOXATE
chembl:CHEMBL587615,CHEMBL587615
chembl:CHEMBL1516410,ECADOTRIL
chembl:CHEMBL251230,(S)-NITRENDIPINE
chembl:CHEMBL590691,CHEMBL590691
chembl:CHEMBL3990016,OLECLUMAB
MONDO:0009896,"polymyoclonus, infantile"
HGNC:18618,LRRK2
chembl:CHEMBL1477,CERIVASTATIN
chembl:CHEMBL42624,PHYSCION
chembl:CHEMBL441,THIOPENTAL
chembl:CHEMBL576349,IC261
chembl:CHEMBL6623,EPIBATIDINE
chembl:CHEMBL1481509,CHEMBL1481509
chembl:CHEMBL424278,O-CHLOROACETYLCARBAMOYLFUMAGILLOL
chembl:CHEMBL345124,PROPIDIUM
chembl:CHEMBL111659,ALTINICLINE
chembl:CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE
HP:0010505,Limitation of movement at ankles
HP:0007024,Pseudobulbar paralysis
chembl:CHEMBL374478,RIFAMPIN
chembl:CHEMBL1201148,MEPREDNISONE
chembl:CHEMBL1455,ALTRETAMINE
NCBIGene:540225,COX7A2L
chembl:CHEMBL599872,VANIPREVIR
chembl:CHEMBL606159,CHEMBL606159
HGNC:28596,B3GALNT2
CHEBI:29919,hydrosulfide
chembl:CHEMBL1554531,4-METHOXYDALBERGIONE
chembl:CHEMBL261693,CHEMBL261693
chembl:CHEMBL578915,CHEMBL578915
chembl:CHEMBL1908355,TENIDAP
chembl:CHEMBL454890,CHEMBL454890
chembl:CHEMBL1671,PROPRANOLOL HYDROCHLORIDE
UPHENO:0071137,absent reflex in pelvic complex
HP:0000007,Autosomal recessive inheritance
HP:0007064,Progressive language deterioration
chembl:CHEMBL3545254,OLESOXIME
chembl:CHEMBL656,OXYCODONE
chembl:CHEMBL282575,ESTRADIOL BENZOATE
HGNC:7112,MKRN1
chembl:CHEMBL280998,CATECHOL
MONDO:0000605,hypersensitivity reaction disease
chembl:CHEMBL1377940,GIPARMEN
HGNC:6950,MCM7
chembl:CHEMBL236150,CLIOXANIDE
HGNC:16951,IVNS1ABP
chembl:CHEMBL3707277,DEPATUXIZUMAB MAFODOTIN
chembl:CHEMBL1696,DESIPRAMINE HYDROCHLORIDE
HGNC:8140,OPA1
CHEBI:132130,hydroxyquinone
HP:0001320,Cerebellar vermis hypoplasia
chembl:CHEMBL29741,IRAMPANEL
chembl:CHEMBL329592,CHEMBL329592
chembl:CHEMBL529640,CHEMBL529640
UBERON:0005343,cortical plate
HGNC:18241,PRMT6
chembl:CHEMBL325441,TIPLASININ
CHEBI:28859,5alpha-androstane
chembl:CHEMBL1566,ACARBOSE
chembl:CHEMBL2108566,NERELIMOMAB
HP:0002549,Deficit in phonologic short-term memory
chembl:CHEMBL1668775,2'-EPI-TUBERATOLIDE B
CHEBI:87113,antibiotic antifungal drug
CHEBI:43968,meropenem
chembl:CHEMBL1201032,RIZATRIPTAN BENZOATE
chembl:CHEMBL623,NEFAZODONE
HP:0001903,Anemia
MONDO:0021605,benign eyelid neoplasm
chembl:CHEMBL163316,3-O-METHYLQUERCETIN
chembl:CHEMBL172350,EUPAFOLIN
HP:0025234,Parasomnia
chembl:CHEMBL283196,ALPHA-NAPHTHOFLAVONE
chembl:CHEMBL285913,TREQUINSIN
HP:0000734,Disinhibition
MONDO:0002911,brain stem glioma
chembl:CHEMBL590949,CHEMBL590949
HGNC:25186,TMEM240
chembl:CHEMBL69863,PICEATANNOL
chembl:CHEMBL1789844,IPILIMUMAB
HGNC:14348,HTRA2
HP:0040148,Cortical myoclonus
CHEBI:59770,cyclic acetal
HP:0033725,Thin corpus callosum
CHEBI:17015,riboflavin
chembl:CHEMBL3545071,SERIBANTUMAB
chembl:CHEMBL204543,CHEMBL204543
chembl:CHEMBL834,PAMIDRONIC ACID
chembl:CHEMBL1200880,DIPHEMANIL METHYLSULFATE
HGNC:2973,DNM1L
chembl:CHEMBL7413,METHOHEXITAL
chembl:CHEMBL419564,DINITRO CRESOL
HP:0001017,Anemic pallor
HGNC:2652,CYP7B1
chembl:CHEMBL90852,N-OXALYLGLYCINE 
MONDO:0002120,neuroendocrine carcinoma
Reactome:R-RNO-71288,Creatine metabolism
chembl:CHEMBL260311,CHEMBL260311
wikidata:Q58526200,HUMAN GROWTH HORMONE
chembl:CHEMBL307893,CHEMBL307893
chembl:CHEMBL316446,ENDOMORPHIN-1
CHEBI:76359,butylated hydroxyanisole
CHEBI:149836,tigecycline
HP:0007792,Microsaccadic pursuit
chembl:CHEMBL370252,FLUMEQUINE
MONDO:0014096,microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome
chembl:CHEMBL2105763,QUISINOSTAT
HP:0002621,Atherosclerosis
chembl:CHEMBL258405,ICILLIN
HGNC:3573,FADD
MONDO:0018996,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2"
CHEBI:36005,docosahexaenoic acid
chembl:CHEMBL3039502,DUVELISIB
HP:0200147,Neuronal loss in basal ganglia
MONDO:0010341,"autism, susceptibility to, X-linked 2"
HGNC:1965,CHRND
chembl:CHEMBL512832,CHEMBL512832
CHEBI:28794,coumarin
HP:0002936,Distal sensory impairment
chembl:CHEMBL54,HALOPERIDOL
HP:0000158,Macroglossia
chembl:CHEMBL1165,MOEXIPRIL
chembl:CHEMBL811,BROMPHENIRAMINE
HGNC:26827,MPV17L
HP:0003587,Insidious onset
chembl:CHEMBL1106,EPINASTINE
ZFIN:ZDB-GENE-031118-95,idh2
HP:0006938,Impaired vibration sensation at ankles
HGNC:25582,SLC38A7
HGNC:4384,GNAI1
GO:0033574,response to testosterone
chembl:CHEMBL541887,IRINOTECAN HYDROCHLORIDE
chembl:CHEMBL305686,CORDYCEPIN
HGNC:11134,SNAPC1
UPHENO:0080596,abnormal impulsive behavior
chembl:CHEMBL435295,CALOTHRIXIN A
chembl:CHEMBL1396626,DICHLOFENTHION
chembl:CHEMBL592,LEVORPHANOL
HP:0010982,Polygenic inheritance
chembl:CHEMBL916,TIROFIBAN
chembl:CHEMBL233302,2-(PHENOXYMETHYL)BENZOTHIAZOLE
HGNC:17363,YAF2
HGNC:18068,SLC15A3
MONDO:0005549,renal cell adenocarcinoma
chembl:CHEMBL2332580,CHEMBL2332580
HGNC:4778,H3-4
GO:0036126,sperm flagellum
GO:0016521,pituitary adenylate cyclase activating polypeptide activity
CHEBI:15891,taurine
MONDO:0019502,autosomal recessive non-syndromic intellectual disability
chembl:CHEMBL1077126,YESSOTOXIN
chembl:CHEMBL33864,"LIPOIC ACID, ALPHA"
chembl:CHEMBL585656,CHEMBL585656
HGNC:2859,DHCR24
chembl:CHEMBL3235279,CAPADENOSON
chembl:CHEMBL1287895,CHEMBL1287895
HGNC:6308,KEL
CHEBI:4781,emetine
chembl:CHEMBL538965,CHEMBL538965
CHEBI:26580,rifamycins
HGNC:11160,SNRPD3
HP:0000712,Emotional lability
chembl:CHEMBL499,TIMOLOL
HGNC:4329,GLRB
HGNC:33848,COA5
MONDO:0014627,dystonia 27
chembl:CHEMBL3989759,EXATECAN MESYLATE
WB:WBGene00012340,dct-15
MONDO:0010185,methylmalonic aciduria and homocystinuria type cblD
HGNC:11274,SPTB
chembl:CHEMBL376408,ABT 737
chembl:CHEMBL600353,CHEMBL600353
MONDO:0004285,pancreatic intraductal papillary-mucinous carcinoma
chembl:CHEMBL1076930,INARIGIVIR SOPROXIL
chembl:CHEMBL1938870,MK-8245
MONDO:0859147,Marbach-Rustad progeroid syndrome
HGNC:3951,FXN
HGNC:405,ALDH3A1
HP:0006889,"Intellectual disability, borderline"
chembl:CHEMBL411907,SONOLISIB
HGNC:10382,RPN2
chembl:CHEMBL2103880,CERLAPIRDINE
HGNC:9175,POLD1
HGNC:8547,P4HA2
chembl:CHEMBL18132,SR-2640
NCBIGene:489526,ALDH3A1
chembl:CHEMBL3545050,BMS-817378
chembl:CHEMBL259784,CHEMBL259784
chembl:CHEMBL1110,ALOSETRON
chembl:CHEMBL1076495,METHIOCARB
HP:0007199,Progressive spastic paraparesis
HGNC:25009,UBE2T
HGNC:5041,HNRNPH1
MONDO:0002418,ethmoid sinus adenocarcinoma
chembl:CHEMBL223575,CHEMBL223575
HGNC:237,ADCY6
MONDO:0014095,dilated cardiomyopathy 1JJ
chembl:CHEMBL1238,AZELAIC ACID
chembl:CHEMBL600572,CHEMBL600572
WB:WBGene00004860,sma-6
chembl:CHEMBL841,LOPERAMIDE
CHEBI:29007,ceftriaxone
chembl:CHEMBL284906,NICORANDIL
HGNC:17996,NAGS
chembl:CHEMBL82242,QUERCITRIN
chembl:CHEMBL590665,CHEMBL590665
chembl:CHEMBL2103830,FOSTAMATINIB
chembl:CHEMBL27577,SALICYLAMIDE
HGNC:29239,INTU
chembl:CHEMBL94394,BUFEXAMAC
GO:0046872,metal ion binding
chembl:CHEMBL2062277,CHEMBL2062277
chembl:CHEMBL527585,CHEMBL527585
chembl:CHEMBL70,MORPHINE
MGI:1347061,Abcg2
MONDO:0014862,"cerebral palsy, spastic quadriplegic, 3"
HGNC:5294,HTR2B
chembl:CHEMBL1200425,PARGYLINE HYDROCHLORIDE
HGNC:6187,IVL
HGNC:20584,SLC35B4
MONDO:0012812,"developmental and epileptic encephalopathy, 4"
chembl:CHEMBL528045,CHEMBL528045
HP:0030784,Anomic aphasia
chembl:CHEMBL2071180,CHEMBL2071180
chembl:CHEMBL454138,TUROFEXORATE ISOPROPYL
HGNC:4388,GNAL
HP:0007307,Rapid neurologic deterioration
HP:0003474,Somatic sensory dysfunction
chembl:CHEMBL2109406,PATRITUMAB
chembl:CHEMBL1084643,PROSTAGLANDIN A2
chembl:CHEMBL468439,CYCLOPROPARADICICOL
chembl:CHEMBL81977,3-AMINOBENZAMIDE
HGNC:407,ALDH1B1
HGNC:11535,TAF1
chembl:CHEMBL2108051,STAMULUMAB
chembl:CHEMBL3707313,TRIFAROTENE
HGNC:9561,PSMD4
HP:0002075,Dysdiadochokinesis
chembl:CHEMBL1430,PENICILLAMINE
CHEBI:17549,5-aminolevulinic acid
chembl:CHEMBL506069,GERANIIN
chembl:CHEMBL296419,ASTEMIZOLE
chembl:CHEMBL2096643,HALOPERIDOL LACTATE
MONDO:0010404,X-linked non progressive cerebellar ataxia
chembl:CHEMBL2107834,RIOCIGUAT
HGNC:2349,ATF6B
chembl:CHEMBL139935,CHEMBL139935
chembl:CHEMBL1200600,FLUOROMETHOLONE
chembl:CHEMBL528181,CHEMBL528181
CHEBI:17824,propan-2-ol
HP:0100578,Lipoatrophy
GO:0042910,xenobiotic transmembrane transporter activity
chembl:CHEMBL1084172,VILANTEROL TRIFENATATE
chembl:CHEMBL1221984,PURMORPHAMINE
chembl:CHEMBL73820,CHEMBL73820
chembl:CHEMBL1200440,MEPIVACAINE HYDROCHLORIDE
chembl:CHEMBL573111,CHEMBL573111
MONDO:0008119,spinocerebellar ataxia type 1
chembl:CHEMBL1406487,THIOPROPERAZINE MESYLATE
chembl:CHEMBL455185,CHEMBL455185
chembl:CHEMBL180022,NERATINIB
HP:0007817,Horizontal supranuclear gaze palsy
chembl:CHEMBL458094,CHEMBL458094
chembl:CHEMBL1201346,BALSALAZIDE
HGNC:240,ADCY9
HGNC:817,ATP2B4
chembl:CHEMBL1100,PARAMETHADIONE
wikidata:Q27075960,CHIDAMIDE
chembl:CHEMBL548017,CHEMBL548017
chembl:CHEMBL2108309,CUSTIRSEN
chembl:CHEMBL4204794,AVAPRITINIB
chembl:CHEMBL1201832,ROMIPLOSTIM
chembl:CHEMBL1256183,FIDUXOSIN
HGNC:6088,INSL5
HGNC:10555,ATXN2
HP:0009590,Unilateral vestibular schwannoma
chembl:CHEMBL2108338,OBINEPITIDE
MONDO:0700217,neonatal sepsis
chembl:CHEMBL1256678,CHEMBL1256678
MONDO:0005580,esophageal squamous cell carcinoma
chembl:CHEMBL356388,ETAZOLATE
HP:0006961,Jerky head movements
chembl:CHEMBL2358147,CARPHENAZINE MALEATE
HGNC:18237,CD99L2
chembl:CHEMBL601554,CHEMBL601554
NCBIGene:615979,COX16
chembl:CHEMBL1721885,SU-014813
HGNC:7788,NFIX
HGNC:3260,EIF2B4
HGNC:24374,CYB5B
HGNC:21155,MYLIP
HGNC:12877,ZMPSTE24
HGNC:403,ALDH3A2
HP:0025336,Delayed ability to sit
chembl:CHEMBL336961,AZAKENPAULLONE
MONDO:0000837,bone resorption disease
HGNC:30033,PHPT1
chembl:CHEMBL1873440,MESOTRIONE
HP:0002090,Pneumonia
chembl:CHEMBL4297965,GSK-1614235
chembl:CHEMBL226034,TAMARIXETIN
CHEBI:26895,tetracyclines
HP:0002198,Dilated fourth ventricle
chembl:CHEMBL486196,ANGUSTIBALIN
HGNC:13352,MAP1LC3B
chembl:CHEMBL1351,CARBOPLATIN
chembl:CHEMBL3989413,TAFLUPOSIDE
chembl:CHEMBL3545307,MERESTINIB
MONDO:0008590,"tremor, hereditary essential, 1"
chembl:CHEMBL130835,PIPERTRAMINE AMIDE
HP:0007082,Dilated third ventricle
chembl:CHEMBL1235969,SIMOCYCLINONE D8
chembl:CHEMBL1200574,SODIUM CHLORIDE
chembl:CHEMBL542257,PRAMIPEXOLE DIHYDROCHLORIDE
chembl:CHEMBL1201011,QUINAPRIL HYDROCHLORIDE
GO:0030667,secretory granule membrane
FB:FBgn0037873,SdhC
chembl:CHEMBL412603,CHEMBL412603
chembl:CHEMBL20734,NEMONAPRIDE
HP:0011977,Elevated urinary homovanillic acid
chembl:CHEMBL930,GLUTAMINE
chembl:CHEMBL1160544,TERBUTALINE SULFATE
chembl:CHEMBL1562,HOMOVANILLIC ACID
MONDO:0005010,coronary artery disorder
chembl:CHEMBL4297934,DIAPEP-277
chembl:CHEMBL2105648,PALOVAROTENE
chembl:CHEMBL2216904,DARUISOLINE
MONDO:0013665,"epilepsy, juvenile myoclonic, susceptibility to, 9"
chembl:CHEMBL1201728,DESVENLAFAXINE SUCCINATE
HGNC:9226,PPA1
HGNC:11105,SMARCC2
chembl:CHEMBL75133,IRX-4204
chembl:CHEMBL889,PALIFOSFAMIDE
WB:WBGene00018964,F56D2.2
HGNC:10327,RPL26
MONDO:0700005,idiopathic
chembl:CHEMBL1200875,FLAVOXATE HYDROCHLORIDE
chembl:CHEMBL1090173,SD-0006
chembl:CHEMBL1232972,GABACULINE
HGNC:25613,CWF19L1
HGNC:1125,BTF3
chembl:CHEMBL227298,CHEMBL227298
chembl:CHEMBL592106,CHEMBL592106
chembl:CHEMBL1437,NOREPINEPHRINE
HGNC:688,RHOJ
HGNC:7692,NDUFA8
chembl:CHEMBL266510,FLINDOKALNER
chembl:CHEMBL1095015,AESCULIOSIDE IIB
HGNC:32225,WIPI2
chembl:CHEMBL1743019,FIGITUMUMAB
GO:0022871,protein-N(PI)-phosphohistidine-sorbose phosphotransferase system transporter activity
HGNC:5297,HTR3A
chembl:CHEMBL1201556,BECAPLERMIN
chembl:CHEMBL4297376,E-7820
chembl:CHEMBL2109328,IMC-EB10
chembl:CHEMBL2108209,LENTINAN
chembl:CHEMBL1743062,RAMUCIRUMAB
chembl:CHEMBL986,RETINOL
chembl:CHEMBL2108709,COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
MONDO:0043267,rheumatoid vasculitis
HP:0002461,Dense calcifications in the cerebellar dentate nucleus
CHEBI:51569,N-acyl-amino acid
chembl:CHEMBL1201729,DRONEDARONE HYDROCHLORIDE
MP:0001405,impaired coordination
chembl:CHEMBL471225,CHEMBL471225
chembl:CHEMBL2094484,CHEMBL2094484
chembl:CHEMBL1079787,TODRALAZINE
MGI:1915710,Dhrs7c
chembl:CHEMBL3833353,PRAMLINTIDE ACETATE
chembl:CHEMBL176599,CHEMBL176599
HGNC:668,RHOB
chembl:CHEMBL1588679,CHEMBL1588679
chembl:CHEMBL964,DISULFIRAM
Xenbase:XB-GENE-5806705,cyp2a6.8
CHEBI:29985,L-glutamate(1-)
chembl:CHEMBL581225,CHEMBL581225
HP:0025372,Loud snoring
HGNC:16768,GRIN3B
chembl:CHEMBL606111,ANTIBIOTIC
MONDO:0018023,hemoglobin M disease
Reactome:R-GGA-611105,Respiratory electron transport
GO:0030674,protein-macromolecule adaptor activity
HGNC:8858,PEX3
chembl:CHEMBL454746,CLADRIN
HGNC:26068,LAMTOR1
chembl:CHEMBL3545389,LY2245461
chembl:CHEMBL1201320,ESOMEPRAZOLE
chembl:CHEMBL1900522,FLUSILAZOLE
HP:0004808,Acute myeloid leukemia
chembl:CHEMBL544,MEQUINOL
chembl:CHEMBL1650,CORTISONE ACETATE
chembl:CHEMBL1201038,ACRISORCIN
HGNC:6896,MARK1
HP:0007430,Generalized edema
HGNC:21304,ADPRS
HGNC:9634,PTP4A1
chembl:CHEMBL251904,(S)-PROMETHAZINE
MONDO:0011663,juvenile primary lateral sclerosis
chembl:CHEMBL3183740,TRELANSERIN
MONDO:0006268,liver diffuse large B-cell lymphoma
HGNC:20858,SLC39A14
HP:0008994,Proximal muscle weakness in lower limbs
chembl:CHEMBL77552,CENTAUREIDIN
chembl:CHEMBL1362503,CHEMBL1362503
chembl:CHEMBL279260,RAFABEGRON
HP:0001274,Agenesis of corpus callosum
HGNC:18801,POGZ
HGNC:16882,HCN4
chembl:CHEMBL311489,CHEMBL311489
MONDO:0002746,fallopian tube adenocarcinoma
HGNC:9829,RAF1
chembl:CHEMBL1275969,ALPHA-THUJAPLICIN
HP:0011968,Feeding difficulties
chembl:CHEMBL406819,IMIDACLOPRID
chembl:CHEMBL233248,ALLYL ISOTHIOCYANATE
HGNC:470,AMPD3
chembl:CHEMBL1294,QUINIDINE
chembl:CHEMBL444161,CHEMBL444161
CL:0002576,perineurial cell
HGNC:12648,VAPA
MONDO:0002651,anal Paget disease
HP:0011392,Abnormality of the vestibular nerve
chembl:CHEMBL641,ATOMOXETINE
HGNC:32017,ACSM2A
chembl:CHEMBL2074871,PHENETHYL ISOCYANATE
chembl:CHEMBL2107830,EMPAGLIFLOZIN
MGI:1350922,Cadps
MONDO:0018767,severe primary trimethylaminuria
NCBIGene:478880,NDUFS1
chembl:CHEMBL4297556,MM-111
MONDO:0010354,Allan-Herndon-Dudley syndrome
CHEBI:131609,pneumocandin B0
HGNC:9781,RAB4A
chembl:CHEMBL1743025,GANTENERUMAB
chembl:CHEMBL1231,OXYBUTYNIN
chembl:CHEMBL560579,PROPICONAZOLE
chembl:CHEMBL1738797,ALECTINIB
chembl:CHEMBL429,LABETALOL
GO:0008645,hexose transmembrane transport
chembl:CHEMBL504369,NICOXAMAT
HP:0032104,Saccadic oscillation
MONDO:0012671,"tremor, hereditary essential, 3"
chembl:CHEMBL588038,CHEMBL588038
CHEBI:45951,trifluoperazine
HP:0008945,Loss of ability to walk in early childhood
HP:0011443,Abnormality of coordination
HGNC:9786,RAB6A
RGD:3705,Slc2a2
HGNC:7329,MSH6
NCBITaxon:2039,Tropheryma whipplei
chembl:CHEMBL1520282,CHEMBL1520282
HGNC:8893,PGF
CHEBI:26979,organic heterotricyclic compound
chembl:CHEMBL4297813,PRI-724
chembl:CHEMBL70501,THUNBERGINOL B
HGNC:26401,MARVELD2
chembl:CHEMBL1256695,NISOXETINE HYDROCHLORIDE
chembl:CHEMBL476968,CHEMBL476968
chembl:CHEMBL477772,PAZOPANIB
chembl:CHEMBL1411693,EPIRIZOLE
chembl:CHEMBL20,ACETAZOLAMIDE
HGNC:4226,GDI1
HGNC:4404,GNG2
MONDO:0021085,gastric neoplasm
GO:0005774,vacuolar membrane
chembl:CHEMBL1201167,CARVEDILOL PHOSPHATE
chembl:CHEMBL1200909,PREDNISOLONE TEBUTATE
chembl:CHEMBL108851,CHEMBL108851
GO:0140930,fructose:sodium symporter activity
HGNC:9236,PPARG
chembl:CHEMBL3989912,IBERDOMIDE HYDROCHLORIDE
HP:0006915,Inability to walk by childhood/adolescence
chembl:CHEMBL601994,CHEMBL601994
MONDO:0018784,pediatric multiple sclerosis
HGNC:1527,CAV1
HP:0002883,Hyperventilation
chembl:CHEMBL4078100,AZD-5153
HGNC:32952,SNORD118
dictyBase:DDB_G0269902,act26
chembl:CHEMBL2105631,BUDIODARONE
HP:0006808,Cerebral hypomyelination
chembl:CHEMBL1200948,TRIMIPRAMINE MALEATE
MONDO:0004765,intrinsic asthma
chembl:CHEMBL1256697,CHEMBL1256697
chembl:CHEMBL450940,PRINABEREL
MONDO:0002851,mediastinum rhabdomyosarcoma
chembl:CHEMBL322862,CHEMBL322862
chembl:CHEMBL3545287,LY2624803
HGNC:5229,DNAJA1
MONDO:0850287,aspirin-induced respiratory disease
MONDO:0018604,familial colorectal cancer type X
chembl:CHEMBL584841,CHEMBL584841
MONDO:0012266,preeclampsia/eclampsia 4
chembl:CHEMBL1377,CHLOROGUANIDE
HP:0000016,Urinary retention
HP:0002267,Exaggerated startle response
chembl:CHEMBL244948,DAPHNETIN
chembl:CHEMBL3545201,TA-5493
chembl:CHEMBL1834096,CHEMBL1834096
WB:WBGene00004259,pyr-1
HP:0040201,Simultanapraxia
MONDO:0018686,acquired Creutzfeldt-Jakob disease
HGNC:7737,NEFH
chembl:CHEMBL598279,CHEMBL598279
HP:0001283,Bulbar palsy
MONDO:0007298,spinocerebellar ataxia type 29
chembl:CHEMBL432162,TASOSARTAN
chembl:CHEMBL1089318,OPICAPONE
chembl:CHEMBL3989680,AXOMADOL
chembl:CHEMBL3989407,QUARFLOXIN
chembl:CHEMBL1558,PRAZOSIN HYDROCHLORIDE
HGNC:12155,TRB
chembl:CHEMBL196814,CHEMBL196814
UBERON:0001468,intervertebral joint
chembl:CHEMBL1256647,CHEMBL1256647
HGNC:179,ACYP1
HGNC:6657,LNX1
chembl:CHEMBL1201759,BEPOTASTINE BESYLATE
chembl:CHEMBL360861,NIFEKALANT
MONDO:0010826,childhood absence epilepsy
CHEBI:86411,"cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine"
Reactome:R-HSA-389977,Post-chaperonin tubulin folding pathway
chembl:CHEMBL589715,CHEMBL589715
Reactome:R-GGA-390650,Histamine receptors
chembl:CHEMBL1367746,CLOFENOXYDE
chembl:CHEMBL3545063,OSIMERTINIB MESYLATE
CHEBI:30772,butyric acid
CHEBI:47909,3-oxo-Delta(4) steroid
chembl:CHEMBL320361,CHEMBL320361
chembl:CHEMBL2104745,PAGOCLONE
chembl:CHEMBL1517651,HYDRASTININE HYDROCHLORIDE
HGNC:4599,GRM7
HGNC:14479,MRPL21
MONDO:0013352,intellectual disability-severe speech delay-mild dysmorphism syndrome
HP:0011947,Respiratory tract infection
CHEBI:61355,3-hydroxy carboxylic acid
HP:0003445,EMG: neuropathic changes
chembl:CHEMBL36148,(S)-VERAPAMIL
chembl:CHEMBL24828,VANDETANIB
chembl:CHEMBL328540,CHEMBL328540
HP:0100957,Abnormal renal medulla morphology
chembl:CHEMBL441738,AFAMELANOTIDE
CHEBI:7528,netilmycin
MONDO:0012081,15q11q13 microduplication syndrome
chembl:CHEMBL547101,CHEMBL547101
chembl:CHEMBL1201658,ALKAVERVIR
MGI:95771,Gnai1
HP:0034863,Reduced leukocyte arylsulfatase A activity
MONDO:0011638,neuroferritinopathy
chembl:CHEMBL586026,CHEMBL586026
chembl:CHEMBL189584,PD-173074
MONDO:0012214,glucocorticoid deficiency 3
chembl:CHEMBL234338,CHEMBL234338
chembl:CHEMBL104028,CHEMBL104028
HP:0001260,Dysarthria
chembl:CHEMBL372764,PERIFOSINE
HGNC:6122,IRF7
UBERON:0000002,uterine cervix
chembl:CHEMBL443683,TELOMESTATIN
chembl:CHEMBL2105107,INECALCITOL
GO:0007416,synapse assembly
HGNC:35164,C12orf75
HGNC:8014,YBX1
HGNC:17677,RABEP1
chembl:CHEMBL521851,PICTILISIB
chembl:CHEMBL3989983,COFETUZUMAB PELIDOTIN
UBERON:0002030,nipple
UBERON:0002298,brainstem
chembl:CHEMBL2108357,EPRATUZUMAB 90Y
MGI:1929699,Arl3
HP:0011394,Hypoplasia of the vestibular nerve
WB:WBGene00018603,F48E3.2
chembl:CHEMBL531,PERGOLIDE
HP:0012075,Personality disorder
HGNC:21099,ARMC12
MONDO:0044336,colorectal signet ring cell carcinoma
chembl:CHEMBL1153,DIGOXIGENIN
HGNC:12932,TRIM25
chembl:CHEMBL1773,CAPECITABINE
chembl:CHEMBL1451921,CHEMBL1451921
HGNC:13312,GSTO1
HGNC:3091,DYRK1A
HP:0008736,Hypoplasia of penis
chembl:CHEMBL1529609,CHEMBL1529609
chembl:CHEMBL2303630,SPARSOMYCIN
chembl:CHEMBL537669,YOHIMBINE HYDROCHLORIDE
chembl:CHEMBL26138,CHEMBL26138
chembl:CHEMBL2027925,CAPESEROD
HGNC:1837,CEBPG
chembl:CHEMBL27769,STANOLONE
HGNC:3527,EZH2
chembl:CHEMBL1201329,TRIMETHAPHAN
WB:WBGene00014097,ZK829.9
HGNC:2500,CCN2
MONDO:0040502,glucocorticoid deficiency 5
chembl:CHEMBL460100,FERBAM
chembl:CHEMBL227875,PRETOMANID
HP:0010950,Abnormal fourth ventricle morphology
chembl:CHEMBL497613,FLUDEOXYGLUCOSE-F18
HP:0001399,Hepatic failure
HGNC:11773,TGFBR2
MONDO:0002301,frontal sinus squamous cell carcinoma
chembl:CHEMBL527271,CHEMBL527271
chembl:CHEMBL79,LIDOCAINE
HGNC:6256,KCNJ10
MONDO:0003612,uterine ligament cancer
MONDO:0003847,hereditary disease
HGNC:12632,USP9X
UBERON:0001150,body of pancreas
HGNC:7464,MTNR1B
chembl:CHEMBL61872,TALAMPANEL
chembl:CHEMBL311226,CASTANOSPERMINE
HGNC:16962,CGREF1
MONDO:0018710,megalencephaly-severe kyphoscoliosis-overgrowth syndrome
chembl:CHEMBL1767164,GSK-1004723
chembl:CHEMBL1852688,INFIGRATINIB
MONDO:0000704,lymphocytic colitis
HGNC:9039,PLA2G6
HGNC:18955,SYNJ2BP
chembl:CHEMBL600908,CHEMBL600908
HGNC:24460,EIF3M
chembl:CHEMBL1076347,TRICLOCARBAN
chembl:CHEMBL544665,FINGOLIMOD HYDROCHLORIDE
HP:0002079,Hypoplasia of the corpus callosum
chembl:CHEMBL1683,HYDROCORTISONE BUTYRATE
HGNC:811,ATP2A1
HGNC:11167,SNTA1
MONDO:0006647,anterior cerebral artery infarction
HGNC:719,ARSL
MGI:1347062,Creb3l1
chembl:CHEMBL1200403,BUCLIZINE HYDROCHLORIDE
HP:0002063,Rigidity
chembl:CHEMBL329673,CHEMBL329673
HGNC:6637,LMNB1
MONDO:0013763,Joubert syndrome 15
HP:0001618,Dysphonia
CL:0000023,oocyte
HGNC:7133,KMT2D
MONDO:0010100,Tay-Sachs disease
chembl:CHEMBL4297454,ABBV-744
chembl:CHEMBL506929,LICOFLAVANONE A
chembl:CHEMBL4297702,BMS-936559
HGNC:2292,COX7C
chembl:CHEMBL3545413,FLUMATINIB
chembl:CHEMBL860,E-DOXEPIN
chembl:CHEMBL591613,CHEMBL591613
HP:0031468,Separation insecurity
Reactome:R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs
HGNC:6876,MAPK14
HP:0025267,Snoring
HP:0009053,Distal lower limb muscle weakness
chembl:CHEMBL491550,CHEMBL491550
chembl:CHEMBL4296717,RESMINOSTAT
chembl:CHEMBL249190,CHEMBL249190
MGI:1891917,Ywhab
chembl:CHEMBL313971,ZUCAPSAICIN
HP:0012044,Seesaw nystagmus
HP:0002136,Broad-based gait
chembl:CHEMBL1200883,THONZONIUM BROMIDE
MONDO:0014200,aldosterone-producing adenoma with seizures and neurological abnormalities
chembl:CHEMBL449388,LIPIDYL PSEUDOPTERANE D
chembl:CHEMBL1054,TRICHLORMETHIAZIDE
chembl:CHEMBL6291,BISINDOLYLMALEIMIDE IX
chembl:CHEMBL375673,CHEMBL375673
chembl:CHEMBL2108167,VEPALIMOMAB
MONDO:0020488,atypical progressive supranuclear palsy syndrome
chembl:CHEMBL1201043,CEPHAPIRIN SODIUM
chembl:CHEMBL597857,CHEMBL597857
HGNC:9928,RBX1
chembl:CHEMBL1516890,GW441756X
MONDO:0000589,autoimmune disorder of musculoskeletal system
CHEBI:16151,"3,4-dihydrocoumarin"
chembl:CHEMBL48880,ASULACRINE
HGNC:30551,TXNL4A
chembl:CHEMBL590184,CHEMBL590184
chembl:CHEMBL1200322,ESCITALOPRAM OXALATE
chembl:CHEMBL225164,CLOXYQUIN
chembl:CHEMBL2105711,TOFOGLIFLOZIN
chembl:CHEMBL4298004,VOPRATELIMAB
chembl:CHEMBL3545010,ORDOPIDINE
HGNC:18656,RIOK1
chembl:CHEMBL281764,TABIMORELIN
chembl:CHEMBL376180,AMINOPTERIN
chembl:CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE
MONDO:0012700,"renal tubular acidosis, distal, 4, with hemolytic anemia"
HGNC:20473,BRIP1
HP:0040082,Happy demeanor
chembl:CHEMBL1200597,ETIDOCAINE HYDROCHLORIDE
HGNC:6898,MARS1
chembl:CHEMBL3301604,RALINEPAG
HGNC:9688,CAVIN1
chembl:CHEMBL446991,PHOMOPSIN A
chembl:CHEMBL1200586,PRILOCAINE HYDROCHLORIDE
chembl:CHEMBL1290,PENBUTOLOL
HGNC:2602,CYP24A1
MONDO:0000402,small cell carcinoma
chembl:CHEMBL2109633,IMGN-388
HGNC:19988,ANAPC1
chembl:CHEMBL1148,TORSEMIDE
HGNC:30167,PDIA4
chembl:CHEMBL107131,DIMETHYLPINOCEMBRIN
chembl:CHEMBL1269022,CHEMBL1269022
MONDO:0011716,acute hemorrhagic leukoencephalitis
MONDO:0005311,atherosclerosis
chembl:CHEMBL2028019,CARIPRAZINE
HGNC:11178,SOAT2
chembl:CHEMBL226267,ARZOXIFENE
chembl:CHEMBL71893,ABIETIC ACID
chembl:CHEMBL7634,OXOTREMORINE
chembl:CHEMBL1089501,CHEMBL1089501
chembl:CHEMBL221137,EMBELIN
NCBIGene:504261,CAD
HGNC:10810,SGK1
HGNC:15894,PANK2
MONDO:0008729,congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
chembl:CHEMBL87223,AMINOQUINURIDE
chembl:CHEMBL2103739,EMEDASTINE DIFUMARATE
chembl:CHEMBL1420370,CHEMBL1420370
CHEBI:26789,streptothricin
chembl:CHEMBL4297559,HILTONOL
HP:0010923,Anterior subcapsular cataract
NCBIGene:397639,EPHX1
chembl:CHEMBL1200532,METHDILAZINE HYDROCHLORIDE
HP:0005946,Ventilator dependence with inability to wean
wikidata:Q29005818,ERBITUX
HGNC:801,ATP1A3
chembl:CHEMBL1129,TRIFLURIDINE
chembl:CHEMBL45029,MEPHOBARBITAL
RGD:1306952,Cmbl
GO:0030426,growth cone
UPHENO:0074374,abnormally decreased rate of limb coordination
chembl:CHEMBL3120215,OSI-027
HGNC:4181,GBF1
chembl:CHEMBL3137336,UPROSERTIB
chembl:CHEMBL1569487,LORNOXICAM
MONDO:0005299,brain ischemia
chembl:CHEMBL1708,PAROXETINE HYDROCHLORIDE
chembl:CHEMBL152408,PIMETHIXENE
HP:0031825,Freezing of gait
MONDO:0002424,rectosigmoid carcinoma
HGNC:449,ALX3
chembl:CHEMBL539216,UK-240455
HP:0001272,Cerebellar atrophy
chembl:CHEMBL2002487,CHEMBL2002487
chembl:CHEMBL3989514,IRINOTECAN HYDROCHLORIDE
chembl:CHEMBL14092,BIPHENYL
chembl:CHEMBL2360628,EUFLAVINE
chembl:CHEMBL509999,AROMOLINE
MONDO:0022687,cerebellar degeneration
MONDO:0014041,"autism, susceptibility to, 19"
HP:0002599,Head titubation
chembl:CHEMBL184450,CHEMBL184450
HGNC:11291,SRF
chembl:CHEMBL178,DAUNORUBICIN
MONDO:0850285,environmental induced asthma
chembl:CHEMBL3544994,VOLANESORSEN
CHEBI:134361,allylic alcohol
HP:0001304,Torsion dystonia
chembl:CHEMBL1270168,CHEMBL1270168
chembl:CHEMBL519504,ALEGLITAZAR
chembl:CHEMBL1473252,TANSHINONE IIA SULFONATE
chembl:CHEMBL1190,DECAMETHONIUM
dictyBase:DDB_G0274917,vps13B
chembl:CHEMBL3707395,ELAFIBRANOR
HGNC:1618,CCT5
chembl:CHEMBL1951050,LANPERISONE
MONDO:0005621,vascular brain injury
chembl:CHEMBL1823681,ETILEVODOPA
chembl:CHEMBL2219425,ARIPIPRAZOLE LAUROXIL
chembl:CHEMBL13291,FLUDIAZEPAM
HGNC:17059,SACM1L
HGNC:14550,CDHR1
chembl:CHEMBL71263,VADIMEZAN
GO:0001666,response to hypoxia
chembl:CHEMBL3622533,FIMEPINOSTAT
chembl:CHEMBL2103878,ODELEPRAN
chembl:CHEMBL220190,ASCORBYL PALMITATE
CHEBI:58359,L-glutamine zwitterion
CHEBI:3638,chloroquine
HGNC:26202,MRM1
MONDO:0017999,fatty acid hydroxylase-associated neurodegeneration
chembl:CHEMBL4297438,T-817 MALEATE
chembl:CHEMBL555196,SILVESTROL
chembl:CHEMBL294199,CAPSAICIN
CHEBI:41879,dexamethasone
chembl:CHEMBL278489,DCMU
chembl:CHEMBL1322879,"2,3,4-TRIHYDROXY-4'-ETHOXYBENZOPHENONE"
ZFIN:ZDB-GENE-050522-542,uqcrb
chembl:CHEMBL1813518,CHEMBL1813518
chembl:CHEMBL38934,DIPHENYLETHER
chembl:CHEMBL103552,LAVENDUSTIN A
HGNC:14681,SPATA2
MONDO:0850048,classic eosinophilic pustular folliculitis
HGNC:115,ACLY
HGNC:8621,PAX7
HGNC:6943,MCL1
chembl:CHEMBL772,RESERPINE
chembl:CHEMBL169046,CHEMBL169046
chembl:CHEMBL600554,CHEMBL600554
chembl:CHEMBL404954,CHEMBL404954
HP:0430015,Abnormal morphology of musculature of pharynx
chembl:CHEMBL44884,ETHAMBUTOL
chembl:CHEMBL900,ORPHENADRINE
HGNC:29608,MTDH
chembl:CHEMBL7728,HEXOBARBITAL
HGNC:1722,CDK1
HGNC:20225,DPF1
chembl:CHEMBL110458,MIGALASTAT
HGNC:18301,SLC2A14
chembl:CHEMBL151475,ABAPERIDONE
HGNC:7800,NFKBIL1
chembl:CHEMBL1475252,TENATOPRAZOLE
HP:0003805,Rimmed vacuoles
HGNC:11157,SNRPC
chembl:CHEMBL1729579,LISINOPRIL HYDRATE
chembl:CHEMBL406393,DEOXYCHOLIC ACID
chembl:CHEMBL1200396,BUPIVACAINE HYDROCHLORIDE
HGNC:6990,MECP2
MGI:95755,Slc2a1
chembl:CHEMBL60796,DESMETHEYLASTEMIZOLE
chembl:CHEMBL312032,CHEMBL312032
chembl:CHEMBL3545407,TRABODENOSON
HGNC:21151,RNF126
chembl:CHEMBL1200567,DOXYCYCLINE HYCLATE
chembl:CHEMBL105310,"2',4'-DIHYDROXYCHALCONE"
chembl:CHEMBL2107387,VORTIOXETINE HYDROBROMIDE
chembl:CHEMBL463665,MOROLIC ACID
chembl:CHEMBL4297282,GDC-0917
chembl:CHEMBL2338397,CRENIGACESTAT
chembl:CHEMBL277522,FENBUFEN
chembl:CHEMBL3545051,CEP-37440
chembl:CHEMBL2108349,TIPRELESTAT
HGNC:29823,MYL6B
HGNC:28913,HSCB
HGNC:1514,CASR
HGNC:27110,ANKRD29
MONDO:0003819,childhood teratoma of the ovary
HGNC:3151,ECHS1
chembl:CHEMBL4297395,MANNOSE 6-PHOSPHATE
WB:WBGene00015381,C03B1.13
chembl:CHEMBL1743008,DROZITUMAB
chembl:CHEMBL486598,EVODIAMINE
HP:0011342,Mild global developmental delay
HP:0003749,Pelvic girdle muscle weakness
chembl:CHEMBL600360,CHEMBL600360
chembl:CHEMBL1320453,CHEMBL1320453
HGNC:6025,CXCL8
chembl:CHEMBL68096,CHEMBL68096
chembl:CHEMBL1873045,CHEMBL1873045
HGNC:1260,CFAP410
HGNC:11013,SLC30A2
chembl:CHEMBL1477760,GRINIMIBINE
chembl:CHEMBL1449187,"3,7-DIMETHOXYFLAVONE"
HGNC:600,APOA1
chembl:CHEMBL235934,CLAUSINE E
HP:0033505,Livedo reticularis
chembl:CHEMBL240597,CHENODIOL
GO:0007049,cell cycle
MONDO:0002517,tenosynovitis of foot and ankle
HGNC:12640,UVRAG
HGNC:6210,CD82
HGNC:239,ADCY8
GO:0004088,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity
chembl:CHEMBL254550,POLYGODIAL
HGNC:4010,FUS
MONDO:0008029,Bethlem myopathy
HGNC:8543,P2RY6
MONDO:0100096,COVID-19
ZFIN:ZDB-GENE-040808-73,ndufv1
chembl:CHEMBL4297920,TIMOLUMAB
HGNC:11261,SPRR2A
NCBIGene:479805,NDUFAB1
HP:0040200,Motor impersistence
chembl:CHEMBL333826,DEQUALINIUM
chembl:CHEMBL506247,TANNIC ACID
chembl:CHEMBL1201173,MEDRYSONE
WB:WBGene00000199,arx-1
chembl:CHEMBL4297522,PEMIGATINIB
NCBIGene:526682,CYP3A76
CHEBI:16240,hydrogen peroxide
MONDO:0009764,"ocular motor apraxia, Cogan type"
HGNC:32060,H3-7
NCBITaxon:2,Bacteria
chembl:CHEMBL1200878,TRIAMCINOLONE HEXACETONIDE
chembl:CHEMBL1164954,CHEMBL1164954
GO:0010035,response to inorganic substance
chembl:CHEMBL3545166,DRINABANT
chembl:CHEMBL1090479,GSK-1070916
HP:0002983,Micromelia
chembl:CHEMBL54661,FLUPENTIXOL
GO:0016027,inaD signaling complex
chembl:CHEMBL268868,DAPH
chembl:CHEMBL6466,COUMARIN
MONDO:0018892,Wyburn-Mason syndrome
HGNC:544,ANXA6
chembl:CHEMBL541230,CHEMBL541230
HGNC:14000,PRDM16
chembl:CHEMBL252417,CHEMBL252417
MONDO:0000603,autoimmune disorder of cardiovascular system
HGNC:23238,HSD17B14
HP:0002378,Hand tremor
chembl:CHEMBL2109224,ROVELIZUMAB
chembl:CHEMBL1566650,ACACETIN DIACETATE
chembl:CHEMBL591361,CHEMBL591361
CHEBI:15611,sarcosine
chembl:CHEMBL1256709,KETANSERIN TARTRATE
chembl:CHEMBL3545247,CAL-263
HGNC:28139,SPX
chembl:CHEMBL2103847,TOSEDOSTAT
chembl:CHEMBL1797711,CHEMBL1797711
HP:0007295,Chaotic rapid conjugate ocular movements
chembl:CHEMBL4283683,DOMATINOSTAT
HGNC:18803,ATPAF1
HGNC:9689,PTS
chembl:CHEMBL494668,CHEMBL494668
HGNC:7460,MT-ND4L
chembl:CHEMBL374632,CHEMBL374632
chembl:CHEMBL1743003,CONATUMUMAB
chembl:CHEMBL1200725,SERTACONAZOLE NITRATE
CHEBI:139588,alpha-hydroxy ketone
chembl:CHEMBL117287,PRUCALOPRIDE
chembl:CHEMBL135561,CHEMBL135561
chembl:CHEMBL3414621,TAZEMETOSTAT
chembl:CHEMBL328710,CHEMBL328710
chembl:CHEMBL1193948,AMIBEGRON
chembl:CHEMBL3039511,BEVENOPRAN
chembl:CHEMBL1287867,CHEMBL1287867
HGNC:553,AOX1
MONDO:0008136,isolated optic nerve hypoplasia
CHEBI:43474,hydrogenphosphate
chembl:CHEMBL193482,ESTRIOL
HGNC:13583,FBXO4
chembl:CHEMBL2338329,ROXADUSTAT
chembl:CHEMBL13817,IBUTAMOREN
HGNC:5238,HSPA5
HP:0010871,Sensory ataxia
chembl:CHEMBL577887,CHEMBL577887
chembl:CHEMBL1096009,ALLOXAN
MONDO:0002278,benign colon neoplasm
chembl:CHEMBL127810,MEPRYLCAINE
MONDO:0044325,"Fanconi anemia, complementation group W"
CHEBI:478164,cefepime
Reactome:R-BTA-71288,Creatine metabolism
chembl:CHEMBL3544932,TAK-901
chembl:CHEMBL1497,BETAMETHASONE VALERATE
HP:0002027,Abdominal pain
HGNC:18451,MCFD2
chembl:CHEMBL1438439,IRIGENOL
MONDO:0956971,intermittent asthma
chembl:CHEMBL1623992,PIPERIDOLATE
chembl:CHEMBL376359,ALOGLIPTIN
FB:FBgn0261929,5-HT2B
chembl:CHEMBL214321,CHRYSOERIOL
chembl:CHEMBL222519,NBQX
GO:0030427,site of polarized growth
UBERON:0000989,penis
chembl:CHEMBL4297422,RG-4733
HGNC:15559,CHCHD10
HGNC:6901,MASP1
chembl:CHEMBL529939,CHEMBL529939
HGNC:8587,PAICS
HGNC:10560,ATXN7
chembl:CHEMBL457246,CHEMBL457246
chembl:CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE
HGNC:11896,TNFAIP3
chembl:CHEMBL2336071,SIPONIMOD
HGNC:28449,ZFTA
chembl:CHEMBL1603949,BITHIONOLOXIDE
chembl:CHEMBL590675,CHEMBL590675
MONDO:0007435,dentatorubral-pallidoluysian atrophy
HGNC:7973,NR2E1
HP:0011441,Abnormal medulla oblongata morphology
HGNC:23360,CCAR2
HGNC:29945,TENM4
chembl:CHEMBL1068,OXCARBAZEPINE
chembl:CHEMBL483531,ALTENUSIN
chembl:CHEMBL275177,CHEMBL275177
chembl:CHEMBL899,LANSOPRAZOLE SULFIDE
HP:0010442,Polydactyly
chembl:CHEMBL1743001,CIXUTUMUMAB
chembl:CHEMBL590985,TALOTREXIN
HGNC:26909,HTRA4
chembl:CHEMBL524981,NEOCYCLOCITRINOL C
UBERON:0001697,orbit of skull
MONDO:0012100,major depressive disorder 2
chembl:CHEMBL1200493,NAFTIFINE HYDROCHLORIDE
MGI:2449818,Cyp3a44
MONDO:0002562,demyelinating disease
Reactome:R-DME-390651,Dopamine receptors
HGNC:32016,ACSM4
HGNC:16369,PARK7
HGNC:16389,HSPBAP1
HGNC:5044,HNRNPK
HGNC:145,ACTG2
chembl:CHEMBL1401508,SILIBININ
chembl:CHEMBL1200470,ESOMEPRAZOLE SODIUM
HGNC:16935,ATG7
WB:WBGene00000491,che-12
chembl:CHEMBL2109513,PD-360324
chembl:CHEMBL81379,RETINAL
chembl:CHEMBL39878,CHEMBL39878
UPHENO:0080280,decreased limb coordination
chembl:CHEMBL1307453,CHEMBL1307453
HGNC:714,ARSB
chembl:CHEMBL459192,CASEARINOL B
MONDO:0003246,sclerosing hepatic carcinoma
chembl:CHEMBL1256665,TERAZOSIN HYDROCHLORIDE
chembl:CHEMBL384903,CHEMBL384903
HGNC:7693,NDUFA9
chembl:CHEMBL1280,VERAPAMIL HYDROCHLORIDE
chembl:CHEMBL1201006,PYRILAMINE MALEATE
CHEBI:184376,streptidine(2+)
HP:0002624,Abnormal venous morphology
chembl:CHEMBL327980,CHEMBL327980
HGNC:30605,SEPSECS
HP:0012169,Self-biting
chembl:CHEMBL599896,CHEMBL599896
chembl:CHEMBL1201362,CLOBETASOL
chembl:CHEMBL1091971,CHEMBL1091971
chembl:CHEMBL1200961,BROMPHENIRAMINE MALEATE
chembl:CHEMBL602740,CHEMBL602740
MONDO:0017283,DeSanto-Shinawi Syndrome due to 10p11.21p12.31 microdeletion
UPHENO:0079838,abnormal impulsive behavior
UBERON:0004811,endometrium epithelium
CHEBI:36709,aminoquinoline
chembl:CHEMBL303124,CHEMBL303124
chembl:CHEMBL507001,DIOSCIN
chembl:CHEMBL3707330,ROLAPITANT HYDROCHLORIDE
chembl:CHEMBL464982,GAMOLENIC ACID
chembl:CHEMBL1218,RAMELTEON
GO:0001091,RNA polymerase II general transcription initiation factor binding
chembl:CHEMBL1200901,HALOFANTRINE HYDROCHLORIDE
chembl:CHEMBL786,TAMOXIFEN CITRATE
chembl:CHEMBL1201047,ANILERIDINE HYDROCHLORIDE
chembl:CHEMBL1782581,THEONELLASTEROL F
chembl:CHEMBL333177,CHEMBL333177
chembl:CHEMBL7939,CGP-53353
MONDO:0013060,autosomal recessive Parkinson disease 14
chembl:CHEMBL160519,PROCATEROL
MONDO:0005091,severe acute respiratory syndrome
HGNC:4082,GABRB2
CHEBI:6801,metformin
HP:0003560,Muscular dystrophy
HGNC:9171,PODXL
chembl:CHEMBL259805,CHEMBL259805
HGNC:19703,ULK3
HP:0007057,Poor hand-eye coordination
chembl:CHEMBL513197,SANDARACOPIMARIC ACID
UPHENO:0003586,abnormal vestibulocochlear nerve
chembl:CHEMBL1396170,AVOCADYNE ACETATE
chembl:CHEMBL63440,ALOXISTATIN
HP:0031469,Low self esteem
chembl:CHEMBL2107457,ITOPRIDE
HGNC:30882,USE1
chembl:CHEMBL220998,"FUCHSIN, BASIC"
HP:0003390,Sensory axonal neuropathy
chembl:CHEMBL1613209,CEAROIN
chembl:CHEMBL2402904,TAK-954
chembl:CHEMBL191534,CHEMBL191534
HGNC:9652,PTPN22
HGNC:18594,L3MBTL2
chembl:CHEMBL17127,SCH-58261
MONDO:0009497,Kifafa seizure disorder
chembl:CHEMBL507122,CHEMBL507122
chembl:CHEMBL411066,KINETIN RIBOSIDE
GO:0035623,renal glucose absorption
MONDO:0007959,medulloblastoma
chembl:CHEMBL1555,GALANTAMINE HYDROBROMIDE
chembl:CHEMBL2103790,ADERBASIB
chembl:CHEMBL1201251,ARBUTAMINE
chembl:CHEMBL1200845,HALCINONIDE
HGNC:23746,NECAB2
HGNC:24535,DCAF13
HGNC:7614,MYOM2
chembl:CHEMBL95692,SB-242235
HGNC:8785,PDE6A
HGNC:19833,FBXO33
chembl:CHEMBL1329443,CHEMBL1329443
chembl:CHEMBL2097081,NITROPRUSSIDE
chembl:CHEMBL2109527,MEDI-578
chembl:CHEMBL1350036,LEAD DIACETATE TRIHYDRATE
chembl:CHEMBL166863,POLMACOXIB
MONDO:0014199,"developmental and epileptic encephalopathy, 17"
chembl:CHEMBL241858,ONONETIN
CHEBI:31941,oxaliplatin
ZFIN:ZDB-GENE-040426-2592,nnt
HGNC:10469,RTN3
HGNC:21268,ANKRD13A
HGNC:9204,PON1
HGNC:8979,PIK3R1
MONDO:0033481,spinocerebellar ataxia 46
chembl:CHEMBL449081,AGROCLAVINE
HP:0002616,Aortic root aneurysm
MGI:2653235,Slc45a1
MONDO:0012449,spinocerebellar ataxia type 23
chembl:CHEMBL276618,4-METHYLDAPHNETIN
chembl:CHEMBL3545144,TAS-115
CHEBI:26338,prostaglandins E
HP:0001824,Weight loss
HGNC:30417,SH2B1
HGNC:17964,RDH11
chembl:CHEMBL48310,HINOKITIOL
chembl:CHEMBL2103794,ANAMORELIN HYDROCHLORIDE
chembl:CHEMBL64391,ITRACONAZOLE
chembl:CHEMBL15770,SULINDAC
HP:0001249,Intellectual disability
HP:0011960,Substantia nigra gliosis
HGNC:14214,CIC
HGNC:7883,NOTCH3
HGNC:20297,SLITRK1
HGNC:13315,HDAC8
MONDO:0017825,silent pituitary adenoma
MONDO:0009539,"lymphoblastic leukemia, acute, with lymphomatous features"
chembl:CHEMBL1373,MODAFINIL
HP:0003715,Myofibrillar myopathy
chembl:CHEMBL1094408,NMS-1286937
chembl:CHEMBL671,THIOTEPA
chembl:CHEMBL3306803,LUMATEPERONE
CHEBI:17234,glucose
chembl:CHEMBL1201735,BUPROPION HYDROBROMIDE
HP:0000726,Dementia
chembl:CHEMBL3039588,PASIREOTIDE DIASPARTATE
HGNC:7415,MT-ATP8
chembl:CHEMBL1174,EPTIFIBATIDE
chembl:CHEMBL169,URSOLIC ACID
CHEBI:3393,carbenicillin
FB:FBgn0053517,Dop2R
RGD:2625,Fnta
HGNC:3061,DTYMK
chembl:CHEMBL1357517,DEXEFAROXAN
HGNC:4191,GCG
MONDO:0011381,dominant beta-thalassemia
HGNC:26189,MTARC1
MONDO:0012173,long chain 3-hydroxyacyl-CoA dehydrogenase deficiency
chembl:CHEMBL1611,PHENYTOIN SODIUM
chembl:CHEMBL486816,HARMALOL HYDROCHLORIDE
MONDO:0003664,hemolytic anemia
CHEBI:134396,secondary allylic alcohol
chembl:CHEMBL340807,HARMALINE
HGNC:23366,ARPC5L
chembl:CHEMBL584269,CHEMBL584269
chembl:CHEMBL2088303,CHEMBL2088303
chembl:CHEMBL1637,GEMCITABINE HYDROCHLORIDE
MONDO:0021661,coronary atherosclerosis
HGNC:9976,TRIM13
chembl:CHEMBL1288253,CHEMBL1288253
chembl:CHEMBL1576310,CHEMBL1576310
chembl:CHEMBL2110900,DAPOXETINE
HGNC:9872,RASA2
MONDO:0004975,Alzheimer disease
HGNC:26600,WDR81
chembl:CHEMBL2108475,PRILIXIMAB
HP:0030858,Addictive behavior
chembl:CHEMBL46740,BAZEDOXIFENE
GO:0005543,phospholipid binding
HGNC:4336,GLUD2
chembl:CHEMBL2107341,FISPEMIFENE
CHEBI:50733,nutraceutical
chembl:CHEMBL1365576,TETRASUL
MONDO:0043218,neurovascular disorder
chembl:CHEMBL506678,SITOGLUSIDE
chembl:CHEMBL588749,CHEMBL588749
HGNC:251,ADH1C
HGNC:3401,EPHX1
chembl:CHEMBL177126,CHEMBL177126
HGNC:3282,EIF4A1
chembl:CHEMBL428676,AMONAFIDE
chembl:CHEMBL1201505,"FIBRINOLYSIN, HUMAN"
chembl:CHEMBL157844,PUUPEHENONE
HGNC:4162,GARS1
CHEBI:2038,5-azacytidine
HP:0000012,Urinary urgency
chembl:CHEMBL194399,ENDOSULFAN
HGNC:16063,MLLT10
HGNC:11796,THRA
HGNC:16205,MGME1
HGNC:30546,FDX2
chembl:CHEMBL584,NELFINAVIR
GO:0005886,plasma membrane
chembl:CHEMBL842,CHLOROTHIAZIDE
chembl:CHEMBL538798,CHEMBL538798
HGNC:19744,SRGAP3
chembl:CHEMBL16024,DESMEDIPHAM
chembl:CHEMBL191044,BENZOXATHIAN
HGNC:3020,DRD1
chembl:CHEMBL1743014,ETARACIZUMAB
CHEBI:34999,teicoplanin A3-1
chembl:CHEMBL1367478,LEVDOBUTAMINE
chembl:CHEMBL691,ETHINYL ESTRADIOL
chembl:CHEMBL614,PYRAZINAMIDE
UBERON:0009853,body of uterus
chembl:CHEMBL1921976,ORTERONEL
chembl:CHEMBL323533,EQUILIN
chembl:CHEMBL3137304,DAGROCORAT
HGNC:4617,GSK3B
HGNC:245,ADD3
HGNC:25576,NAXD
MONDO:0006704,CNS demyelinating autoimmune disease
chembl:CHEMBL362558,LY-2090314
FB:FBgn0261439,SdhA
chembl:CHEMBL14830,ADENOSINE DIPHOSPHATE
HGNC:2514,CTNNB1
MONDO:0013972,Perrault syndrome 2
chembl:CHEMBL989,FLUOCINOLONE ACETONIDE
chembl:CHEMBL2348314,TYROSOL SINAPATE
chembl:CHEMBL334533,DEXANABINOL
chembl:CHEMBL33,LEVOFLOXACIN
chembl:CHEMBL1606022,SAPPANONE A TRIMETHYL ETHER
chembl:CHEMBL405,AMPHETAMINE
chembl:CHEMBL285674,ESTAZOLAM
chembl:CHEMBL3544939,LY2979165
HGNC:24979,HS1BP3
HGNC:7773,NF2
chembl:CHEMBL19476,L-765314
chembl:CHEMBL1684099,CHEMBL1684099
chembl:CHEMBL79834,SPIRAMIDE
HP:0002311,Incoordination
HGNC:16832,ATP6V1F
chembl:CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE
chembl:CHEMBL580140,CHEMBL580140
chembl:CHEMBL514138,CGS-27023A
chembl:CHEMBL701,BACLOFEN
HP:0031247,Whooping cough
HGNC:11027,SLC4A1
CHEBI:51026,macrocycle
chembl:CHEMBL129482,(+)-EPICATECHIN
HGNC:8874,PFKFB3
chembl:CHEMBL225072,PEMETREXED
chembl:CHEMBL4297552,AMV-564
chembl:CHEMBL3545282,KC-706
HGNC:4912,HINT1
Reactome:R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism"
HP:0006970,Periventricular leukomalacia
MONDO:0005011,Crohn disease
CHEBI:57540,NAD(1-)
HGNC:20233,COQ6
chembl:CHEMBL3989984,NAVICIXIZUMAB
chembl:CHEMBL3707354,ABT-560
chembl:CHEMBL558459,HYDRAZOBENZENE
chembl:CHEMBL1408862,BRONOPOL
MONDO:0009875,achromatopsia 3
chembl:CHEMBL359164,TROXACITABINE
HP:0003621,Juvenile onset
chembl:CHEMBL597874,CHEMBL597874
chembl:CHEMBL1077773,CHEMBL1077773
chembl:CHEMBL1201752,IXABEPILONE
chembl:CHEMBL455056,CUCURBITACIN E
HGNC:31399,SLC6A17
MONDO:0012186,Fanconi anemia complementation group I
MONDO:0008199,late-onset Parkinson disease
chembl:CHEMBL715,OLANZAPINE
chembl:CHEMBL897,PROBENECID
chembl:CHEMBL1042,CHOLECALCIFEROL
chembl:CHEMBL1092508,CHEMBL1092508
chembl:CHEMBL939,GEFITINIB
HGNC:23781,POLDIP2
chembl:CHEMBL1327821,ENPIROLINE
MONDO:0003384,uterine ligament clear cell adenocarcinoma
chembl:CHEMBL277535,BIFONAZOLE
chembl:CHEMBL101510,CHEMBL101510
chembl:CHEMBL345768,THIOURACIL
CL:0000842,mononuclear cell
chembl:CHEMBL57394,CHEMBL57394
chembl:CHEMBL1467,ALLOPURINOL
chembl:CHEMBL1915763,GANODERMANONTRIOL
chembl:CHEMBL855,TRIPROLIDINE
chembl:CHEMBL3707293,XEN-D0501
HGNC:20505,H3C15
chembl:CHEMBL255231,LADOSTIGIL
chembl:CHEMBL77456,TYRPHOSTIN 1
HP:0011345,Moderate expressive language delay
chembl:CHEMBL2146063,CHLORTETRACYCLINE HYDROCHLORIDE
chembl:CHEMBL3545049,BAY-1125976
chembl:CHEMBL222021,PROTOCATECHUALDEHYDE
chembl:CHEMBL1200344,NAFCILLIN SODIUM
chembl:CHEMBL1449007,2-(2'-METHOXYPHENYL)-1H-INDOLE
chembl:CHEMBL434063,CHEMBL434063
chembl:CHEMBL1201286,OXYPHENONIUM
chembl:CHEMBL2109267,M195
chembl:CHEMBL1200622,PARICALCITOL
HGNC:7452,MTMR4
MONDO:0007566,multiple self-healing squamous epithelioma
chembl:CHEMBL582983,CHEMBL582983
chembl:CHEMBL279556,CHEMBL279556
HGNC:4067,GABARAP
chembl:CHEMBL41541,METHAPHIT
HGNC:5960,IKBKB
chembl:CHEMBL3137314,ESUBERAPROST
chembl:CHEMBL1604848,CHEMBL1604848
chembl:CHEMBL14,CARBACHOL
chembl:CHEMBL1560680,PROTHIOFOS
chembl:CHEMBL306764,CHEMBL306764
HGNC:4851,HTT
chembl:CHEMBL3544936,XL-844
chembl:CHEMBL1256028,FIDUXOSIN HYDROCHLORIDE
HGNC:7436,MTHFR
chembl:CHEMBL1201506,GEMTUZUMAB OZOGAMICIN
chembl:CHEMBL2105325,RILOPIROX
UBERON:0036262,uterine ligament
MGI:2181411,Slc5a2
chembl:CHEMBL2181046,CHEMBL2181046
HGNC:3671,FGF14
MONDO:0002665,extrahepatic bile duct adenocarcinoma
chembl:CHEMBL579045,CHEMBL579045
MONDO:0016987,neuroacanthocytosis
HGNC:5045,HNRNPL
chembl:CHEMBL582439,ZAMPANOLIDE
MONDO:0011178,infantile convulsions and choreoathetosis
chembl:CHEMBL289277,EMODIN
chembl:CHEMBL418068,RHEIN
chembl:CHEMBL351231,CHEMBL351231
HP:0002463,Language impairment
HGNC:8872,PFKFB1
chembl:CHEMBL586701,ZSTK-474
chembl:CHEMBL1557,DOPAMINE HYDROCHLORIDE
CHEBI:25830,p-quinones
GO:0006225,UDP biosynthetic process
chembl:CHEMBL4113131,ENSARTINIB
chembl:CHEMBL1099167,CHEMBL1099167
HP:0001114,Xanthelasma
HGNC:11498,SYNGR1
chembl:CHEMBL496634,DOCOSAPENTAENOIC ACID
MONDO:0002419,transient tic disorder
chembl:CHEMBL435,HYDROCHLOROTHIAZIDE
chembl:CHEMBL1208903,ISOGINKGETIN
chembl:CHEMBL306226,BENZIMIDAZOLE
HP:0002506,Diffuse cerebral atrophy
HP:0000823,Delayed puberty
chembl:CHEMBL541388,FASUDIL HYDROCHLORIDE
HGNC:3586,FANCE
chembl:CHEMBL1214124,PERAMPANEL
chembl:CHEMBL378104,CARDAMOMIN
chembl:CHEMBL1374504,"DALBERGIONE, 4-METHOXY-4'-HYDROXY-"
chembl:CHEMBL4297540,4-ISOTHIOUREIDOBUTYRONITRILE
chembl:CHEMBL453388,AMPICILLIN TRIHYDRATE
HP:0011006,Abnormal morphology of the musculature of the neck
chembl:CHEMBL4297362,CBP-501
MONDO:0019296,subcutaneous tissue disorder
chembl:CHEMBL3545121,EPITINIB
chembl:CHEMBL379064,ISORHAMNETIN
HGNC:23112,FAT3
HP:0002396,Cogwheel rigidity
HP:0025405,Visual fixation instability
HGNC:5465,IGF1R
HGNC:10526,SALL2
HGNC:838,ATP5F1E
chembl:CHEMBL1505471,LOMOFUNGIN
MONDO:0005890,osteitis fibrosa
chembl:CHEMBL2333547,ARISTOLACTONE
HGNC:14938,PIGT
HP:0000486,Strabismus
chembl:CHEMBL64894,GENTIAN VIOLET
chembl:CHEMBL513024,GLYCITEIN
CHEBI:132155,hydroxynaphthoquinone
chembl:CHEMBL506569,LANATOSIDE C
MGI:96245,Hspa9
chembl:CHEMBL27810,CELIPROLOL
GO:0120025,plasma membrane bounded cell projection
MONDO:0020352,"multiple system atrophy, parkinsonian type"
HP:0002240,Hepatomegaly
HGNC:18449,LAP3
chembl:CHEMBL622,ETODOLAC
chembl:CHEMBL497011,LINAPRAZAN
HGNC:12799,WWOX
chembl:CHEMBL1445,FLUOXYMESTERONE
chembl:CHEMBL2336325,VISTUSERTIB
chembl:CHEMBL579742,CHEMBL579742
MONDO:0018189,autosomal recessive cerebellar ataxia - pyramidal signs - nystagmus - oculomotor apraxia syndrome
chembl:CHEMBL1078244,CHEMBL1078244
MONDO:0002204,transient arthritis
chembl:CHEMBL8,CIPROFLOXACIN
chembl:CHEMBL2181039,CHEMBL2181039
HGNC:7565,MYF5
chembl:CHEMBL464859,NECA
HGNC:3066,DUSP11
HGNC:20758,ZFYVE19
MONDO:0008723,very long chain acyl-CoA dehydrogenase deficiency
HGNC:12672,VDAC2
HGNC:7660,NCF1
chembl:CHEMBL528724,CHEMBL528724
HGNC:386,AKR1C3
chembl:CHEMBL287631,PROGABIDE
CHEBI:32807,o-orsellinic acid
HGNC:9052,PLAU
chembl:CHEMBL590201,CHEMBL590201
HP:0002522,Areflexia of lower limbs
chembl:CHEMBL528734,CHEMBL528734
HGNC:14581,PINK1
GO:1901563,response to camptothecin
chembl:CHEMBL2104992,VESTIPITANT MESYLATE
chembl:CHEMBL1096979,BENSERAZIDE
chembl:CHEMBL3039518,BATEFENTEROL
chembl:CHEMBL598797,CUDC-101
MONDO:0024479,epithelial tumor of colon
chembl:CHEMBL146032,LONAPRISAN
HP:0000338,Hypomimic face
HGNC:6597,LIFR
chembl:CHEMBL2103839,RIDAFOROLIMUS
chembl:CHEMBL1257092,CHEMBL1257092
MONDO:0017706,disorder of carbohydrate transmembrane transport and absorption
HP:0011153,Focal motor seizure
GO:0004639,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity
chembl:CHEMBL464251,ISOXANTHOPTERIN
chembl:CHEMBL3833307,SATRALIZUMAB
MONDO:0024650,drug-induced osteoporosis
HGNC:18040,ARID1B
chembl:CHEMBL3707320,ALECTINIB HYDROCHLORIDE
chembl:CHEMBL74189,CHEMBL74189
HP:0011499,Mydriasis
CHEBI:25000,lactone
MONDO:0004648,vascular dementia
chembl:CHEMBL1200531,ALFENTANIL HYDROCHLORIDE
MONDO:0015770,congenital hypogonadotropic hypogonadism
chembl:CHEMBL580816,CHEMBL580816
chembl:CHEMBL2108738,NIVOLUMAB
GO:0007420,brain development
chembl:CHEMBL256967,CHEMBL256967
chembl:CHEMBL291481,HEXAMETHYLENEBISACETAMIDE
chembl:CHEMBL86931,CHEMBL86931
chembl:CHEMBL1483796,SPICLOMAZINE
HP:0010820,Focal emotional seizure with crying
chembl:CHEMBL3545137,PF-00477736
HGNC:6119,IRF4
chembl:CHEMBL517341,CINOBUFOTALIN
HGNC:328,AGR2
HGNC:2379,CRTAP
MONDO:0018513,squamous cell carcinoma of colon
GO:0042589,zymogen granule membrane
HGNC:11817,TIMM8A
HGNC:18806,CAMTA1
chembl:CHEMBL1938400,PF-03715455
dictyBase:DDB_G0286545,vps13D
HGNC:13291,GABARAPL2
chembl:CHEMBL1950289,TANZISERTIB
chembl:CHEMBL30219,METHOHEXITAL SODIUM
UBERON:0002728,entorhinal cortex
chembl:CHEMBL764,NORDEFRIN
chembl:CHEMBL1200955,MYCOPHENOLATE MOFETIL HYDROCHLORIDE
HGNC:3033,ATN1
chembl:CHEMBL1682200,CHEMBL1682200
chembl:CHEMBL1253830,ISOBONDUCELLIN
HP:0008872,Feeding difficulties in infancy
HGNC:11438,STX3
chembl:CHEMBL545437,AMIBEGRON HYDROCHLORIDE
MONDO:0005498,botulism
MONDO:0100426,iatrogenic
chembl:CHEMBL526,PROPOFOL
HGNC:12774,WNT1
HGNC:19960,KIAA0586
chembl:CHEMBL1614713,CC-401
chembl:CHEMBL78150,TYRPHOSTIN A9
chembl:CHEMBL219916,DOMPERIDONE
chembl:CHEMBL461101,ELTROMBOPAG
chembl:CHEMBL2103884,OPROZOMIB
chembl:CHEMBL2094833,CHEMBL2094833
chembl:CHEMBL605003,CHEMBL605003
HGNC:545,ANXA7
GO:0016084,myostimulatory hormone activity
chembl:CHEMBL228792,KINETIN
chembl:CHEMBL515387,GOSOGLIPTIN
chembl:CHEMBL138921,ARACHIDONOYL DOPAMINE
chembl:CHEMBL1369632,CHEMBL1369632
chembl:CHEMBL2103846,ULIPRISTAL
HP:0032507,Labiomental fasciculations
HGNC:18261,NPLOC4
chembl:CHEMBL1407943,CLEMIZOLE
chembl:CHEMBL24983,CHEMBL24983
chembl:CHEMBL547407,CHEMBL547407
chembl:CHEMBL4297884,PEPINEMAB
chembl:CHEMBL504256,FANGCHINOLINE
chembl:CHEMBL1200522,AVOBENZONE
chembl:CHEMBL3301593,DECOGLURANT
HP:0006794,Loss of ability to walk in first decade
chembl:CHEMBL227075,DIHYDROTANSHINONE I
chembl:CHEMBL2108086,SULODEXIDE
MONDO:0000702,microscopic colitis
HGNC:21059,MAD2L1BP
UPHENO:0079844,abnormal physical aggression behavior
chembl:CHEMBL2364605,CEBRANOPADOL
HGNC:8873,PFKFB2
HGNC:8533,P2RX1
chembl:CHEMBL416755,OXOLINIC ACID
chembl:CHEMBL1354007,ETOCARLIDE
chembl:CHEMBL210868,AURIN
chembl:CHEMBL2059073,SULISOBENZONE
chembl:CHEMBL3039539,OTLERTUZUMAB
HP:0100021,Cerebral palsy
HGNC:28688,CCDC24
chembl:CHEMBL975,MESNA
MGI:108482,Hrh2
HGNC:7582,MYL1
MONDO:0012334,hereditary spastic paraplegia 29
HGNC:14336,PLEKHA2
chembl:CHEMBL546597,CHEMBL546597
chembl:CHEMBL1245,TRIMETHAPHAN CAMSYLATE
HGNC:10705,SEC24C
HGNC:9355,PRDX5
chembl:CHEMBL2104682,NEBRACETAM
chembl:CHEMBL164449,CHEMBL164449
HP:0002094,Dyspnea
chembl:CHEMBL274826,ANDROSTENEDIONE
chembl:CHEMBL1200812,METAPROTERENOL SULFATE
HGNC:25402,OTUD5
SO:1000008,
chembl:CHEMBL1714,KETAMINE HYDROCHLORIDE
chembl:CHEMBL1327172,CHEMBL1327172
chembl:CHEMBL1902591,FLUOXASTROBIN
HGNC:1424,CAD
chembl:CHEMBL299155,TRANSTORINE
CHEBI:53212,isocyanates
chembl:CHEMBL446452,ARUNDINE
HGNC:8548,P4HB
MONDO:0014165,multiple congenital anomalies-hypotonia-seizures syndrome 3
chembl:CHEMBL386492,CLOCINNAMOX
chembl:CHEMBL1070,NABUMETONE
CHEBI:16857,L-threonine
NCBIGene:327680,NDUFS4
MONDO:0040500,glycosylphosphatidylinositol biosynthesis defect 16
HP:0012174,Glioblastoma multiforme
chembl:CHEMBL254760,MGCD-265
chembl:CHEMBL2110954,NERAMEXANE
chembl:CHEMBL46765,BEMORADAN
MGI:1926089,Slc5a10
chembl:CHEMBL504535,IMRECOXIB
MONDO:0014693,Noonan syndrome 10
chembl:CHEMBL602209,CHEMBL602209
CHEBI:15378,hydron
MONDO:0000705,Clostridium difficile colitis
chembl:CHEMBL307341,AURAPTENE
chembl:CHEMBL1922282,LIRIMILAST
chembl:CHEMBL14173,ANTHRANILIC ACID
MONDO:0054791,"leukodystrophy, hypomyelinating, 16"
HGNC:2254,CORO1C
HGNC:16628,SLC49A4
chembl:CHEMBL589915,CHEMBL589915
HP:0003722,Neck flexor weakness
MONDO:0007089,Alzheimer disease 2
HGNC:238,ADCY7
MONDO:0007766,Morgagni-Stewart-Morel syndrome
chembl:CHEMBL1315166,CHEMBL1315166
chembl:CHEMBL425027,CHEMBL425027
chembl:CHEMBL1408927,AMARANTH
WB:WBGene00004780,ser-7
chembl:CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE
HGNC:8101,OCA2
chembl:CHEMBL526952,CHEMBL526952
chembl:CHEMBL260213,CHEMBL260213
chembl:CHEMBL2164552,CHEMBL2164552
HP:0011151,Atypical absence status epilepticus
HGNC:2269,COX5B
chembl:CHEMBL3137349,BOCOCIZUMAB
HGNC:9964,DPF2
chembl:CHEMBL197194,VIDOFLUDIMUS
chembl:CHEMBL92870,LIDOFLAZINE
chembl:CHEMBL2347631,CHEMBL2347631
HGNC:22965,PEX26
chembl:CHEMBL1213646,CALCDPWW
chembl:CHEMBL1208155,ELAGOLIX
HGNC:30092,NAMPT
HGNC:7224,MPV17
chembl:CHEMBL3544909,CALCIFEDIOL
HGNC:7803,NFX1
HGNC:30766,TRAF3IP3
HGNC:17805,DIRC3
HGNC:16074,OCIAD1
chembl:CHEMBL52609,THYMIDINE
MONDO:0005072,neuroblastoma
chembl:CHEMBL1908376,SEOCALCITOL
HGNC:8967,PIGN
chembl:CHEMBL2103758,PRAMLINTIDE
HP:0033230,Biceps areflexia
chembl:CHEMBL574737,UCN-01
chembl:CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL603,ZAFIRLUKAST
chembl:CHEMBL257158,CHEMBL257158
chembl:CHEMBL33986,BUTORPHANOL
chembl:CHEMBL1201219,VECURONIUM
HGNC:29639,MAGEF1
CHEBI:138141,17alpha-hydroxy-C21-steroid
MONDO:0006140,"cervical mucinous adenocarcinoma, minimal deviation variant"
HGNC:9325,PPT1
HGNC:11825,NKX2-1
chembl:CHEMBL475908,CHEMBL475908
HP:0012043,Pendular nystagmus
chembl:CHEMBL1200,BENOXINATE
HGNC:12843,YME1L1
HGNC:164,ACTN2
chembl:CHEMBL1200584,AMINOSALICYLATE POTASSIUM
chembl:CHEMBL1743056,PATECLIZUMAB
HP:0001574,Abnormality of the integument
HGNC:24987,NMRAL1
chembl:CHEMBL1231124,AZD-1480
chembl:CHEMBL321582,BUCINDOLOL
chembl:CHEMBL1457,HYDROCODONE
chembl:CHEMBL313842,ZARDAVERINE
HP:0030391,Spoken word recognition deficit
chembl:CHEMBL4,OFLOXACIN
NCBITaxon:2697049,Severe acute respiratory syndrome coronavirus 2
chembl:CHEMBL3544989,VOLANESORSEN SODIUM
CHEBI:144644,a tetracycline zwitterion
NCBIGene:510509,COX11
HP:0002415,Leukodystrophy
HP:0007367,Atrophy/Degeneration affecting the central nervous system
MONDO:0016387,mitochondrial oxidative phosphorylation disorder
chembl:CHEMBL582593,CHEMBL582593
chembl:CHEMBL590695,CHEMBL590695
chembl:CHEMBL44746,KHELLIN
MONDO:0005371,mood disorder
HGNC:20229,DCAF4
MONDO:0010464,X-linked cerebral-cerebellar-coloboma syndrome syndrome
chembl:CHEMBL15928,GR-127935
MONDO:0004496,myocarditis
MONDO:0002158,fallopian tube cancer
HP:0002342,"Intellectual disability, moderate"
chembl:CHEMBL2062261,LEVORPHANOL TARTRATE
chembl:CHEMBL483158,ALISERTIB
chembl:CHEMBL1910970,CHEMBL1910970
chembl:CHEMBL698,TETRACAINE
chembl:CHEMBL3545383,RG-7167
chembl:CHEMBL118722,TRIBUTYRIN
HGNC:30628,SPSB1
HGNC:25564,ARL8B
CHEBI:50854,hydrocortamate hydrochloride
chembl:CHEMBL548338,CHEMBL548338
MONDO:0014748,progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome
chembl:CHEMBL1591258,"3,4-DIMETHOXYDALBERGIONE"
chembl:CHEMBL490,PAROXETINE
HGNC:9258,PPIE
MONDO:0009340,non-spherocytic hemolytic anemia due to hexokinase deficiency
chembl:CHEMBL1360,ATRACURIUM
chembl:CHEMBL1201237,LEVOBUNOLOL
HP:0002439,Frontolimbic dementia
chembl:CHEMBL587449,CHEMBL587449
chembl:CHEMBL1619,CLADRIBINE
CHEBI:46245,coenzyme Q10
chembl:CHEMBL580071,CHEMBL580071
HGNC:1076,BMPR1A
chembl:CHEMBL139835,CYPROTERONE ACETATE
chembl:CHEMBL1355821,TEMEFOS
NCBIGene:423016,DRD4
MONDO:0011401,Alzheimer disease without neurofibrillary tangles
chembl:CHEMBL3545320,ME-344
chembl:CHEMBL2012520,LY377604
MONDO:0005172,skeletal system disorder
chembl:CHEMBL571948,Y-39983
HGNC:2518,CTNS
GO:0022877,protein-N(PI)-phosphohistidine-fructose phosphotransferase system transporter activity
HP:0033228,Triceps areflexia
chembl:CHEMBL1201024,METHSCOPOLAMINE BROMIDE
HP:0007054,Proximal hyperreflexia
HP:0002544,Retrocollis
GO:0043025,neuronal cell body
chembl:CHEMBL1201355,CERULETIDE
chembl:CHEMBL1200877,FLUMETHASONE PIVALATE
HGNC:28526,EOGT
GO:0017151,DEAD/H-box RNA helicase binding
chembl:CHEMBL3989992,PEGILODECAKIN
chembl:CHEMBL1553566,CHEMBL1553566
HP:0007704,Paroxysmal involuntary eye movements
MONDO:0033638,"mitochondrial complex 4 deficiency, nuclear type 8"
HP:0008046,Abnormal retinal vascular morphology
HGNC:408,ALDH5A1
chembl:CHEMBL445813,AT-7519
chembl:CHEMBL3707401,MK-8777
MONDO:0000507,inclusion body myopathy with Paget disease of bone and frontotemporal dementia
chembl:CHEMBL2105464,SAFIRONIL
chembl:CHEMBL240963,LAWSONE
chembl:CHEMBL813,EPROSARTAN
chembl:CHEMBL2146121,CALCIUM
HGNC:4466,GPR12
chembl:CHEMBL189963,PALBOCICLIB
chembl:CHEMBL768,ESMOLOL
UPHENO:0084109,abnormally dilated telencephalic ventricle
HP:0007263,Spinocerebellar atrophy
chembl:CHEMBL3707357,BROLUCIZUMAB
chembl:CHEMBL3545403,BMS-833923
Reactome:R-HSA-2132295,MHC class II antigen presentation
chembl:CHEMBL354349,ACRIFLAVINE
HP:0033204,Triceps hyperreflexia
chembl:CHEMBL406557,CHEMBL406557
HGNC:18344,HINT2
HGNC:21062,FARS2
WB:WBGene00019800,mtss-1
chembl:CHEMBL2347633,CHEMBL2347633
chembl:CHEMBL89598,VIGABATRIN
chembl:CHEMBL605747,CHEMBL605747
MGI:1916824,Cmbl
HGNC:27035,UBXN2B
chembl:CHEMBL1200469,PROMAZINE HYDROCHLORIDE
chembl:CHEMBL242341,FORMONONETIN
HGNC:6840,MAP2K1
NCBIGene:415129,CYP3A12
HGNC:4177,GBA1
chembl:CHEMBL1288013,CHEMBL1288013
CHEBI:72596,papulacandin
HGNC:25941,TET2
HGNC:11578,TBC1D1
chembl:CHEMBL3137317,SONIDEGIB PHOSPHATE
HGNC:4761,H2BC11
chembl:CHEMBL1881783,PYROXAMINE MALEATE
HP:0002312,Clumsiness
CHEBI:7852,oxycodone
chembl:CHEMBL4297321,PR-104
HGNC:10947,SLC20A2
NCBIGene:476794,NDUFC2
chembl:CHEMBL3545148,PHE377
UBERON:0001017,central nervous system
chembl:CHEMBL1902074,CHEMBL1902074
MONDO:0043224,multi-infarct dementia
chembl:CHEMBL1094679,AESCULIOSIDE IVC
chembl:CHEMBL3137318,TALAZOPARIB TOSYLATE
HGNC:30384,NENF
GO:0017085,response to insecticide
GO:1902334,fructose export from vacuole to cytoplasm
MONDO:0006684,brain edema
wikidata:Q47521310,CAMPTOSAR
NCBIGene:415876,DHODH
HP:0008947,Infantile muscular hypotonia
HP:0003596,Middle age onset
MONDO:0002718,central nervous system teratoma
HGNC:7106,ATXN3
MGI:2152844,Slc2a9
MONDO:0018027,duplication/inversion 15q11
HP:0002474,Expressive language delay
chembl:CHEMBL4297485,CFG-920
chembl:CHEMBL1332922,ETHYL ANTHRANILATE
MONDO:0012235,autosomal recessive spinocerebellar ataxia 7
chembl:CHEMBL555260,CHEMBL555260
MONDO:0005098,stroke disorder
chembl:CHEMBL1201420,UROKINASE
chembl:CHEMBL1524273,PHTHALYLSULFATHIAZOLE
chembl:CHEMBL816,ETHYLENEDIAMINE
CHEBI:25461,myxothiazol
chembl:CHEMBL3039521,VINTAFOLIDE
HP:0003736,Autophagic vacuoles
HGNC:735,ASAH1
GO:0005777,peroxisome
HGNC:29330,METTL14
HGNC:11405,BRSK2
HP:0010536,Central sleep apnea
GO:0009743,response to carbohydrate
HGNC:11168,SNTB1
chembl:CHEMBL3678076,EVENAMIDE
HGNC:3381,EPB42
chembl:CHEMBL1240772,GLP-1
chembl:CHEMBL582764,CHEMBL582764
UPHENO:0055092,increased reflex
MONDO:0009268,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
MONDO:0001023,prolymphocytic leukemia
chembl:CHEMBL323197,MANGOSTIN
chembl:CHEMBL1201821,PALIFERMIN
chembl:CHEMBL86473,VANADATE
HP:0009830,Peripheral neuropathy
HP:0008026,Horizontal opticokinetic nystagmus
HP:0007193,Bilateral tonic-clonic seizure on awakening
chembl:CHEMBL2108615,LAPULEUCEL-T
chembl:CHEMBL1742996,BRODALUMAB
chembl:CHEMBL3545162,PBF-680
MONDO:0016318,progressive multifocal leukoencephalopathy
HGNC:3025,DRD4
chembl:CHEMBL1256876,CHEMBL1256876
chembl:CHEMBL51149,GALLOPAMIL
HP:0003438,Absent Achilles reflex
chembl:CHEMBL195953,ALDRIN
chembl:CHEMBL1200776,CINACALCET HYDROCHLORIDE
HGNC:5292,HTR1F
HP:0003115,Abnormal EKG
GO:0005654,nucleoplasm
chembl:CHEMBL428768,(S)-FELODIPINE
HGNC:6842,MAP2K2
MONDO:0010482,X-linked parkinsonism-spasticity syndrome
chembl:CHEMBL1194,PRILOCAINE
MONDO:0008731,familial adrenal hypoplasia with absent pituitary luteinizing hormone
chembl:CHEMBL1200766,SILVER SULFADIAZINE
HP:0002352,Leukoencephalopathy
HGNC:3296,EIF4G1
chembl:CHEMBL3707227,ATEZOLIZUMAB
RGD:621261,Pla1a
chembl:CHEMBL131,PREDNISOLONE
chembl:CHEMBL1865517,CHEMBL1865517
chembl:CHEMBL3989682,BECAMPANEL
chembl:CHEMBL2109449,MEDI-570
HP:0002487,Hyperkinetic movements
HP:0025312,Esophoria
chembl:CHEMBL154111,SALSALATE
chembl:CHEMBL1984884,CHEMBL1984884
MONDO:0014612,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4"
chembl:CHEMBL502,DONEPEZIL
FB:FBgn0036565,CG5235
GO:0005402,carbohydrate:monoatomic cation symporter activity
chembl:CHEMBL2094549,CHEMBL2094549
chembl:CHEMBL488,AMINOGLUTETHIMIDE
HGNC:6021,IL6ST
chembl:CHEMBL459265,HEXAMETHYL PARAROSANILINE
HGNC:5344,ICAM1
HGNC:11137,SNAPC4
MONDO:0003504,anal canal neuroendocrine neoplasm
chembl:CHEMBL606167,CHEMBL606167
chembl:CHEMBL2109544,CDP-860
chembl:CHEMBL142130,CYPROTERONE
chembl:CHEMBL1165268,IODIPAMIDE
chembl:CHEMBL1164729,FEBUXOSTAT
HP:0002521,Hypsarrhythmia
HGNC:83,ACAA2
chembl:CHEMBL973,TERIFLUNOMIDE
HP:0007269,Spinal muscular atrophy
HP:0002494,Abnormal rapid eye movement sleep
chembl:CHEMBL1230314,ESTETROL
HGNC:10852,SHMT2
chembl:CHEMBL3545032,PF-04634817
HP:0025331,Upgaze palsy
HGNC:3811,FOXG1
chembl:CHEMBL331627,GLIOTOXIN
MGI:106388,Abhd17a
HGNC:12718,VRK1
HGNC:1100,BRCA1
HGNC:10808,SGCE
HGNC:9762,RAB13
chembl:CHEMBL478,CHLOROPHENYLPIPERAZINE
MONDO:0003650,mixed hepatoblastoma
HGNC:55,ABCC4
chembl:CHEMBL902,FAMOTIDINE
CHEBI:29105,zinc(2+)
chembl:CHEMBL252556,IDEBENONE
chembl:CHEMBL1256390,CHEMBL1256390
HP:0002446,Astrocytosis
chembl:CHEMBL300555,SPIROXATRINE
MONDO:0013725,"colorectal cancer, hereditary nonpolyposis, type 7"
HGNC:6872,MAPK10
HGNC:9281,PPP1CA
CHEBI:134251,guaiacols
HP:0004453,Overfolding of the superior helices
chembl:CHEMBL3544966,GSK-1059615
chembl:CHEMBL3545125,MIROGABALIN
HGNC:16031,RNF31
HGNC:21689,FIS1
GO:0015149,hexose transmembrane transporter activity
chembl:CHEMBL538542,CHEMBL538542
chembl:CHEMBL2107773,RITOBEGRON
chembl:CHEMBL751,BROMFENAC SODIUM
CHEBI:315019,cilofungin
HGNC:290,GRK3
chembl:CHEMBL2109635,SAR-566658
CHEBI:59780,cyclic hemiketal
HGNC:16526,ACSL5
HP:0100025,Overfriendliness
HGNC:20486,UBAC2
MONDO:0009855,d-bifunctional protein deficiency
HGNC:349,AHSG
chembl:CHEMBL78871,GANTOFIBAN
chembl:CHEMBL183,"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]"
chembl:CHEMBL1488,URACIL MUSTARD
chembl:CHEMBL546170,CHEMBL546170
MONDO:0019260,adult neuronal ceroid lipofuscinosis
HP:0007867,Restrictive partial external ophthalmoplegia
chembl:CHEMBL88153,CDC-801
chembl:CHEMBL4297699,BALIXAFORTIDE
chembl:CHEMBL56542,CHEMBL56542
chembl:CHEMBL1437888,CHEMBL1437888
MONDO:0017809,parkinsonism due to ATP13A2 deficiency
chembl:CHEMBL1256818,DEXTROMETHORPHAN HYDROBROMIDE
chembl:CHEMBL267936,MECAMYLAMINE
HP:0002633,Vasculitis
GO:0015757,galactose transmembrane transport
MONDO:0018204,20q11.2 microduplication syndrome
HP:0025423,Abnormal larynx morphology
UBERON:0002129,cerebellar cortex
chembl:CHEMBL1628233,FLUORESCEIN SODIUM
HP:0001986,Hypertonic dehydration
dictyBase:DDB_G0283755,arpC
HP:0003758,Reduced subcutaneous adipose tissue
chembl:CHEMBL1201187,MARAVIROC
chembl:CHEMBL1221911,LACTIMIDOMYCIN
chembl:CHEMBL1740701,CHEMBL1740701
Reactome:R-CFA-71288,Creatine metabolism
chembl:CHEMBL227959,CHEMBL227959
chembl:CHEMBL581677,CHEMBL581677
chembl:CHEMBL1182833,MIVACURIUM
chembl:CHEMBL590427,CHEMBL590427
chembl:CHEMBL584619,CHEMBL584619
GO:0006914,autophagy
chembl:CHEMBL1200989,ALCLOMETASONE DIPROPIONATE
HGNC:253,ADH5
chembl:CHEMBL592598,CHEMBL592598
HGNC:28273,TENT5B
HGNC:31859,TRIM67
HGNC:348,AHR
chembl:CHEMBL1200637,DEXAMETHASONE SODIUM PHOSPHATE
chembl:CHEMBL537445,FENOTEROL HBR
HGNC:5248,HSPB3
chembl:CHEMBL1380480,VANITIOLIDE
chembl:CHEMBL363160,PHA-680632
chembl:CHEMBL422942,CHEMBL422942
chembl:CHEMBL76904,TYRPHOSTIN 23
HGNC:4175,GATM
chembl:CHEMBL2103838,DILMAPIMOD
chembl:CHEMBL1315701,IMIDOCARB DIPROPIONATE
chembl:CHEMBL1287866,CHEMBL1287866
HGNC:9066,PLCG2
UBERON:0001876,amygdala
chembl:CHEMBL353846,ADIPHENINE
chembl:CHEMBL155625,INDOLE-3-CARBINOL
chembl:CHEMBL590674,CHEMBL590674
MONDO:0000114,cerebelloparenchymal disorder
chembl:CHEMBL265502,SURAMIN
chembl:CHEMBL4297398,LY-2300559
HGNC:16695,BCAP31
HGNC:10839,SHBG
HP:0000511,Vertical supranuclear gaze palsy
chembl:CHEMBL41,FLUOXETINE
chembl:CHEMBL2110922,AMEZINIUM
chembl:CHEMBL1286,LEVETIRACETAM
chembl:CHEMBL1444,LETROZOLE
chembl:CHEMBL3039528,ZICRONAPINE
chembl:CHEMBL77622,DOPEXAMINE
HGNC:20778,TUBB
chembl:CHEMBL51085,EBSELEN
chembl:CHEMBL551288,APOGOSSYPOL
chembl:CHEMBL1077391,CHEMBL1077391
chembl:CHEMBL1788402,CHINIOFON
chembl:CHEMBL15023,TRIFLUPERIDOL
HGNC:9387,PRKAG3
HP:0006931,Pericallosal lipoma
HP:0001262,Excessive daytime somnolence
chembl:CHEMBL252518,ARTENIMOL
HGNC:5183,HRH2
MONDO:0010422,Alzheimer disease 16
chembl:CHEMBL654,MIRTAZAPINE
HGNC:20066,USP34
chembl:CHEMBL863,CYSTEINE
chembl:CHEMBL435381,CIMICOXIB
HGNC:4389,GNAO1
chembl:CHEMBL121556,CHEMBL121556
WB:WBGene00012929,rsks-1
chembl:CHEMBL388342,BOLDINE
chembl:CHEMBL1085,ACETOPHENAZINE
chembl:CHEMBL1005,REMIFENTANIL
chembl:CHEMBL3319236,GLPG-0187
chembl:CHEMBL90593,PRASTERONE
chembl:CHEMBL278623,MACIMORELIN
chembl:CHEMBL61593,CYCLOTHIAZIDE
HP:0000641,Dysmetric saccades
HGNC:12619,USP20
HGNC:4816,HARS1
HGNC:25629,OTULINL
chembl:CHEMBL465,DRONABINOL
chembl:CHEMBL576208,CHEMBL576208
chembl:CHEMBL218394,BOCEPREVIR
chembl:CHEMBL1186894,AMRUBICIN
HP:0007333,Hypoplasia of the frontal lobes
chembl:CHEMBL3545322,PANULISIB
chembl:CHEMBL1079,TIZANIDINE
chembl:CHEMBL56367,NIMESULIDE
chembl:CHEMBL287689,CHEMBL287689
chembl:CHEMBL657,DIPHENHYDRAMINE
HGNC:1840,CECR2
HGNC:9118,PMP22
MGI:1923831,Wipi2
HP:0000243,Trigonocephaly
chembl:CHEMBL2146140,ESOMEPRAZOLE STRONTIUM
chembl:CHEMBL2107818,ALDOXORUBICIN
chembl:CHEMBL1201485,SOYBEAN OIL
chembl:CHEMBL39560,ACEPROMAZINE
HP:0006803,Vivid hallucinations
WB:WBGene00017981,figl-1
chembl:CHEMBL941,IMATINIB
GO:0048870,cell motility
chembl:CHEMBL10,SB-203580
chembl:CHEMBL399121,HESPERETIN
chembl:CHEMBL1201146,NORETHINDRONE ACETATE
chembl:CHEMBL190474,CHEMBL190474
chembl:CHEMBL3544907,PICOPLATIN
chembl:CHEMBL44,GENISTEIN
CHEBI:35469,antidepressant
chembl:CHEMBL3707446,RIVIPANSEL
chembl:CHEMBL167911,DICHLORVOS
chembl:CHEMBL45816,MIBEFRADIL
chembl:CHEMBL1712057,OXYCARBOXIN
chembl:CHEMBL14227,BUTANOIC ACID
MONDO:0004988,breast adenocarcinoma
CHEBI:17823,calcitriol
NCBIGene:480204,NDUFV2
chembl:CHEMBL515966,EZLOPITANT
MONDO:0002291,cutaneous granular cell tumor
chembl:CHEMBL464176,CHEMBL464176
MONDO:0016102,subacute inflammatory demyelinating polyneuropathy
chembl:CHEMBL1255840,NEBOGLAMINE
chembl:CHEMBL1018,DIENESTROL
HGNC:7225,MPZ
MONDO:0002547,nerve sheath neoplasm
chembl:CHEMBL54918,CHEMBL54918
CHEBI:133131,spiro-epoxide
MONDO:0005077,pertussis
chembl:CHEMBL1224789,VOLVALERENAL D
MONDO:0859365,"neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures"
HP:0007103,Hypointensity of cerebral white matter on MRI
chembl:CHEMBL149463,3-ACETYLCOUMARIN
chembl:CHEMBL3545180,THELIATINIB
chembl:CHEMBL448290,THIOINOSINE
CHEBI:87632,statin (naturally occurring)
HGNC:15927,ERGIC3
chembl:CHEMBL1476605,CLOFOCTOL
chembl:CHEMBL256997,ATALUREN
chembl:CHEMBL1201263,HYDROCORTAMATE
HGNC:1502,CASP14
MONDO:0002412,disorder of glycogen metabolism
GO:0005359,low-affinity glucose:proton symporter activity
chembl:CHEMBL126077,INDIRUBIN-3-MONOXIME
chembl:CHEMBL480,LANSOPRAZOLE
HGNC:17429,CGN
chembl:CHEMBL1272307,SB-649868
chembl:CHEMBL12610,BENZYDAMINE
chembl:CHEMBL1608067,CHEMBL1608067
chembl:CHEMBL4298113,BAMOSIRAN
chembl:CHEMBL1535,HYDROXYCHLOROQUINE
chembl:CHEMBL407,FLUMAZENIL
chembl:CHEMBL166415,CHEMBL166415
chembl:CHEMBL3545145,WX-554
chembl:CHEMBL668,PROTRIPTYLINE
UBERON:0001873,caudate nucleus
chembl:CHEMBL1835207,APRICOXIB
HGNC:12618,USP2
HGNC:404,ALDH2
HGNC:19681,DUSP13B
HGNC:24284,TRAPPC12
CHEBI:28364,"all-cis-5,8,11,14,17-icosapentaenoic acid"
HGNC:2933,DMPK
wikidata:Q47521966,PARNATE
chembl:CHEMBL2313444,CHEMBL2313444
MONDO:0013588,Perrault syndrome 3
chembl:CHEMBL14690,CLOBENPROPIT
GO:0004359,glutaminase activity
HGNC:17142,OPTN
chembl:CHEMBL191482,AR-42
HGNC:6218,KCNA1
chembl:CHEMBL601146,CHEMBL601146
chembl:CHEMBL1237123,DOXACURIUM
chembl:CHEMBL3544949,CTCE-9908
chembl:CHEMBL529918,CHEMBL529918
CHEBI:32682,L-argininium(1+)
HGNC:33846,ARHGEF35
chembl:CHEMBL225513,CHEMBL225513
chembl:CHEMBL1289601,LENVATINIB
chembl:CHEMBL1408276,CHEMBL1408276
chembl:CHEMBL1802135,PROTUBOXEPIN A
CHEBI:13601,3-oxo-5alpha-steroid
UBERON:0008338,plantar part of pes
HP:0001105,Retinal atrophy
chembl:CHEMBL3707253,BEVACIZUMAB 111IN
GO:0005354,galactose transmembrane transporter activity
chembl:CHEMBL957,BOSENTAN
chembl:CHEMBL3544953,SAF312
chembl:CHEMBL8809,RACLOPRIDE
HGNC:12754,WDR1
HGNC:461,AMELX
chembl:CHEMBL42485,DUP-697
HP:0011008,Temporal pattern
chembl:CHEMBL2448348,CARBOXYMETHYL-TRIMETHYL-ARSONIUM
CHEBI:142676,ribozinoindole-1
MONDO:0016788,obsolete genetic hyperferritinemia without iron overload
MONDO:0014756,"tremor, hereditary essential, 5"
chembl:CHEMBL1680,OCTREOTIDE
HGNC:1273,GATD3
HP:0012444,Brain atrophy
Reactome:R-HSA-8986944,Transcriptional Regulation by MECP2
chembl:CHEMBL406845,CHEMBL406845
MONDO:0014604,Parkinson disease 21
HGNC:2213,COL6A3
MONDO:0045016,cholesterol catabolic process disease
HP:0032005,Hemidystonia
chembl:CHEMBL445268,SENNOSIDE B
chembl:CHEMBL2023193,[18F]FLUORORASAGILINE
chembl:CHEMBL286020,SULMAZOLE
HGNC:1391,CACNA1D
chembl:CHEMBL876,MECLOFENAMATE SODIUM
Reactome:R-SPO-71288,Creatine metabolism
HP:0410219,Hypoplasia of mandible relative to maxilla
chembl:CHEMBL268609,(R)-NITRENDIPINE
chembl:CHEMBL1200761,CHLOROTRIANISENE
HGNC:9635,PTP4A2
chembl:CHEMBL350221,OXITRIPTAN
chembl:CHEMBL305544,SAPRISARTAN
chembl:CHEMBL442,ERGOTAMINE
UPHENO:0075900,abnormal cochlear nerve
chembl:CHEMBL3545249,GLPG-0555
MONDO:0014795,"exercise intolerance, riboflavin-responsive"
chembl:CHEMBL54909,FRAXETIN
HGNC:12816,XPC
chembl:CHEMBL1684984,PA-799
ZFIN:ZDB-GENE-050522-133,cox5aa
chembl:CHEMBL1606248,IRETOL
chembl:CHEMBL419792,SUMANIROLE
HGNC:1157,BYSL
chembl:CHEMBL1184904,RETASPIMYCIN
chembl:CHEMBL1346468,CHEMBL1346468
HGNC:23513,USP54
HGNC:4741,H2AZ1
CHEBI:15365,acetylsalicylic acid
HP:0006852,Episodic generalized hypotonia
HGNC:9390,PRKAR1B
HGNC:9177,POLE
chembl:CHEMBL1782598,THEONELLASTEROL B
chembl:CHEMBL506538,TRIPHENYLSTANNANOL
chembl:CHEMBL1405447,VITAMIN K3H2
chembl:CHEMBL550,PILOCARPINE
chembl:CHEMBL4297538,MK-0812
WB:WBGene00019641,cank-26
CHEBI:59769,acetal
UPHENO:0005625,decreased reflex
chembl:CHEMBL1520837,CHEMBL1520837
chembl:CHEMBL3545009,PBF-509
chembl:CHEMBL1743087,VEDOLIZUMAB
ZFIN:ZDB-GENE-040625-38,cycsb
HGNC:30950,ZNF639
chembl:CHEMBL421431,CHEMBL421431
HGNC:10703,SEC24A
HGNC:18119,AFG2A
HGNC:1868,CETN3
HP:0001271,Polyneuropathy
chembl:CHEMBL1095699,AZASERINE
HP:0001287,Meningitis
HGNC:14111,GLOD4
GO:0032836,glomerular basement membrane development
HGNC:26267,POMK
chembl:CHEMBL1200511,GONADORELIN ACETATE
chembl:CHEMBL281211,ARACHIDONYL TRIFLUOROMETHYLKETONE
chembl:CHEMBL1621597,IPRATROPIUM
MONDO:0010789,MELAS syndrome
WB:WBGene00006459,tag-89
MONDO:0010765,"46,XY complete gonadal dysgenesis"
HP:5200044,Reduced attention regulation
chembl:CHEMBL29166,CHEMBL29166
HGNC:318,AGA
chembl:CHEMBL122,ROFECOXIB
chembl:CHEMBL483633,CHEMBL483633
HGNC:3756,FLNC
MONDO:0002368,papillary serous cystadenocarcinoma
MONDO:0024609,vulvar squamous cell carcinoma
chembl:CHEMBL1200907,TRILOSTANE
chembl:CHEMBL4292264,MILADEMETAN
chembl:CHEMBL443014,CARBOQUONE
MGI:1858451,Cyp3a41a
chembl:CHEMBL481611,ODANACATIB
chembl:CHEMBL451321,METAGLIDASEN
MONDO:0800112,non-atopic asthma
chembl:CHEMBL2105708,PONATINIB HYDROCHLORIDE
MONDO:0016295,neuronal ceroid lipofuscinosis
HGNC:13919,BAG6
HGNC:20885,AGPAT4
chembl:CHEMBL2108717,ALGENPANTUCEL-L
chembl:CHEMBL1467200,CHEMBL1467200
chembl:CHEMBL3544947,BURAPITANT
chembl:CHEMBL590186,CHEMBL590186
HP:0001520,Large for gestational age
HP:0100299,Muscle fiber inclusion bodies
chembl:CHEMBL494255,AROMATICIN
HGNC:16394,CARD6
chembl:CHEMBL3545300,CP-459632
chembl:CHEMBL59356,ATRELEUTON
HP:0003226,Rectilinear intracellular accumulation of autofluorescent lipopigment storage material
chembl:CHEMBL482767,SNS-314
MONDO:0002416,ethmoid sinus squamous cell carcinoma
HGNC:2768,DEK
HGNC:708,ARPC5
chembl:CHEMBL582722,CHEMBL582722
chembl:CHEMBL2171778,CHEMBL2171778
HGNC:12515,UCHL3
chembl:CHEMBL2107658,TOSAGESTIN
chembl:CHEMBL1329326,CHEMBL1329326
chembl:CHEMBL2105395,OSPEMIFENE
chembl:CHEMBL160,CYCLOSPORINE
HGNC:16354,ADHFE1
HGNC:12013,TPM4
Reactome:R-CEL-390650,Histamine receptors
HP:0005184,Prolonged QTc interval
HGNC:1788,CDKN2B
HP:0007377,Abnormality of somatosensory evoked potentials
UBERON:0001264,pancreas
chembl:CHEMBL311158,DIHYDROCAPSAICIN
GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules
MONDO:0024542,"cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1"
chembl:CHEMBL77305,RUBITECAN
chembl:CHEMBL3833321,BAN2401
HGNC:7699,NDUFB4
HGNC:4584,GRIN1
HGNC:18037,ARID2
HGNC:25716,COA7
chembl:CHEMBL478960,MACLURAXANTHONE
chembl:CHEMBL3545250,GSK-2269557
chembl:CHEMBL140130,CHEMBL140130
MONDO:0001651,scrotum squamous cell carcinoma
MONDO:0011513,"Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology"
HGNC:13585,FBXO6
chembl:CHEMBL1187833,UMECLIDINIUM
WB:WBGene00043980,F11D5.7
chembl:CHEMBL2146126,LITHIUM
HGNC:2703,ECI1
chembl:CHEMBL343803,ICOFUNGIPEN
chembl:CHEMBL2165224,ANISODAMINE
HGNC:8831,PENK
chembl:CHEMBL415049,BARASERTIB
UPHENO:0063698,absent social behavior
MONDO:0005192,exocrine pancreatic carcinoma
chembl:CHEMBL602776,CHEMBL602776
chembl:CHEMBL8739,LINOLENIC ACID
chembl:CHEMBL2103920,ULARITIDE
chembl:CHEMBL465980,ONONIN
HGNC:823,ATP5F1A
chembl:CHEMBL1886341,AZINPHOS-ETHYL
HP:0031008,Lingual dystonia
chembl:CHEMBL1200475,DAUNORUBICIN CITRATE
GO:0019902,phosphatase binding
CHEBI:26051,phosphoamino acid
HGNC:6839,MAP2
HGNC:10371,RPLP0
chembl:CHEMBL19224,PAPAVERINE
chembl:CHEMBL1201717,MECASERMIN RINFABATE
chembl:CHEMBL84446,FIDARESTAT
HP:0011172,Complex febrile seizure
chembl:CHEMBL1201152,NALMEFENE HYDROCHLORIDE
HP:0002074,Increased neuronal autofluorescent lipopigment
chembl:CHEMBL48361,DABIGATRAN
chembl:CHEMBL3544927,L-21649
HGNC:1172,VPS51
chembl:CHEMBL1201119,LIOTHYRONINE SODIUM
MONDO:0009902,cutaneous porphyria
HGNC:842,ATP5MC2
chembl:CHEMBL301742,ARBACLOFEN
chembl:CHEMBL10878,AGOMELATINE
HP:0003128,Lactic acidosis
chembl:CHEMBL585827,CHEMBL585827
Reactome:R-CFA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HP:0002465,Poor speech
UBERON:0009835,anterior cingulate cortex
HGNC:2077,CLN6
HGNC:23508,STOX1
CHEBI:36027,stilbenol
HGNC:4983,HMGB1
chembl:CHEMBL1479103,HAEMATOXYLIN
CHEBI:10106,zearalenone
chembl:CHEMBL1730601,GIMERACIL
chembl:CHEMBL3545200,S-222611
chembl:CHEMBL2106618,GLISOXEPIDE
chembl:CHEMBL42161,MISONIDAZOLE
chembl:CHEMBL1887067,NALED
HP:0002362,Shuffling gait
CHEBI:16733,D-alpha-amino acid
HP:0001394,Cirrhosis
MONDO:0003300,appendix leiomyoma
chembl:CHEMBL365795,TIAPROFENIC ACID
chembl:CHEMBL2108611,INOTUZUMAB OZOGAMICIN
MONDO:0016333,familial dilated cardiomyopathy
HGNC:28395,SGMS2
MONDO:0016486,beta-thalassemia major
UPHENO:0080597,abnormal physical aggression behavior
chembl:CHEMBL10835,CHEMBL10835
FB:FBgn0004396,CrebA
HGNC:1778,CDK7
GO:0004817,cysteine-tRNA ligase activity
chembl:CHEMBL1742428,DONITRIPTAN
MONDO:0012549,"autosomal recessive ataxia, Beauce type"
chembl:CHEMBL127273,PIPERTRAMINE
HGNC:2001,GREM1
CHEBI:25105,macrolide antibiotic
chembl:CHEMBL1201565,EPOETIN ALFA
chembl:CHEMBL344469,"0-HEXYL-1,3-DIAMINE-PLATINUM 2,2-DICHLORIDE"
chembl:CHEMBL3545082,RG-7376
chembl:CHEMBL28517,E927A
HP:0032006,Lip tremor
HGNC:29587,RFESD
HGNC:15663,UGGT1
chembl:CHEMBL1614766,RO-4987655
MONDO:0007614,congenital fibrosis of extraocular muscles
chembl:CHEMBL1055,CHLORTHALIDONE
RGD:1561555,Fancb
MONDO:0010085,Schilder disease
chembl:CHEMBL87992,ESLICARBAZEPINE ACETATE
GO:0017098,sulfonylurea receptor binding
chembl:CHEMBL1200893,PROTOKYLOL HYDROCHLORIDE
chembl:CHEMBL893,DICLOXACILLIN
chembl:CHEMBL1518159,3-METHOXYCATECHOL
chembl:CHEMBL338604,C-1311
HP:0007272,Progressive psychomotor deterioration
chembl:CHEMBL1763,HYDROFLUMETHIAZIDE
HGNC:8001,NRIP1
chembl:CHEMBL995,LOSARTAN POTASSIUM
Reactome:R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins
chembl:CHEMBL1438389,CHEMBL1438389
chembl:CHEMBL3039520,LASMIDITAN
chembl:CHEMBL4298043,ROLUPERIDONE HYDROCHLORIDE
chembl:CHEMBL1173445,LARGAZOLE
MP:0001516,abnormal motor coordination/balance
HGNC:3482,ETFB
MONDO:0019500,extragonadal teratoma
MONDO:0004979,asthma
HGNC:5385,IDH3B
chembl:CHEMBL1193,PHENIRAMINE
chembl:CHEMBL1043,DAPSONE
HGNC:18578,TXLNG
MONDO:0005086,renal cell carcinoma
CHEBI:34848,mevastatin
chembl:CHEMBL1326499,CHEMBL1326499
chembl:CHEMBL1379243,CHEMBL1379243
chembl:CHEMBL400514,BERKELEYDIONE
HGNC:28957,EMC1
HGNC:1974,CHUK
MONDO:0014033,dystonia 25
HP:0002092,Pulmonary arterial hypertension
chembl:CHEMBL186141,ANDROGRAPHOLIDE
HGNC:2555,CUL4B
chembl:CHEMBL1425995,DIFLUFENICAN
MONDO:0030634,"leukoencephalopathy, hereditary diffuse, with spheroids 2"
HGNC:13557,ACE2
chembl:CHEMBL408194,OBATOCLAX
MONDO:0030455,dystonia 31
HGNC:1307,CBY1
HGNC:28396,TMEM67
chembl:CHEMBL20684,ABT-751
HP:0002518,Abnormal periventricular white matter morphology
chembl:CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE
HP:0012179,Craniofacial dystonia
chembl:CHEMBL604710,Z160
MONDO:0003352,colon sarcoma
MONDO:0014108,Fanconi anemia complementation group Q
chembl:CHEMBL1201567,FILGRASTIM
chembl:CHEMBL351769,ARSANILIC ACID
chembl:CHEMBL3833357,BEGELOMAB
GO:0044877,protein-containing complex binding
GO:0008092,cytoskeletal protein binding
MONDO:0044704,oropharynx squamous cell carcinoma
chembl:CHEMBL3544960,AT-13148
chembl:CHEMBL389685,CHEMBL389685
HGNC:8571,PACSIN2
HGNC:2234,COPE
HGNC:8867,PFDN2
HP:0008873,Disproportionate short-limb short stature
chembl:CHEMBL2104993,VORTIOXETINE
chembl:CHEMBL268229,CHEMBL268229
chembl:CHEMBL118378,CHEMBL118378
HP:0007328,Impaired pain sensation
HP:0010975,Abnormal B cell count
chembl:CHEMBL275638,FLAVONE
chembl:CHEMBL172064,E324
chembl:CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE
chembl:CHEMBL242740,TECTORIGENIN
chembl:CHEMBL49,BUSPIRONE
chembl:CHEMBL2171803,CHEMBL2171803
chembl:CHEMBL481049,CITROPTEN
chembl:CHEMBL494669,CHEMBL494669
chembl:CHEMBL2182009,CHEMBL2182009
chembl:CHEMBL3545005,PLX-8394
HGNC:28240,HVCN1
HGNC:30002,DCAF6
chembl:CHEMBL348107,ACRYLAMIDE
HP:0002060,Abnormal cerebral morphology
HGNC:21156,PCGF6
NCBIGene:396086,RAD51
chembl:CHEMBL1215661,PRUVANSERIN
HGNC:8172,OR10H1
HP:0031764,Fully accomodative esotropia
HGNC:14211,BLNK
HP:0001953,Diabetic ketoacidosis
chembl:CHEMBL534319,CHEMBL534319
HP:0025404,Abnormal visual fixation
HGNC:8905,PGM1
chembl:CHEMBL347036,PROADIFEN HYDROCHLORIDE
chembl:CHEMBL3545094,ELOCALCITOL
chembl:CHEMBL1201866,LIRAGLUTIDE
NCBIGene:478639,NDUFB5
NCBIGene:488824,DRD5
MONDO:0011017,Naxos disease
chembl:CHEMBL233930,ASTRAGALIN
chembl:CHEMBL253786,CHEMBL253786
CHEBI:50427,platelet aggregation inhibitor
chembl:CHEMBL539947,TYRPHOSTIN AG 879
chembl:CHEMBL1645462,AC-480
HGNC:1958,CHRNA4
HP:0007141,Sensorimotor neuropathy
chembl:CHEMBL582715,CHEMBL582715
HGNC:496,RIPK4
chembl:CHEMBL1079959,KHRINONE E
chembl:CHEMBL8618,NAN-190
chembl:CHEMBL2057662,CHEMBL2057662
chembl:CHEMBL14563,SB-242084
chembl:CHEMBL1200338,PINACIDIL
HGNC:535,ANXA11
chembl:CHEMBL1208858,CALMIDAZOLIUM CHLORIDE
HGNC:3226,EFNB1
chembl:CHEMBL119405,BENZENETHIOL
chembl:CHEMBL1200485,SORAFENIB TOSYLATE
HGNC:5,A1BG
HGNC:25732,KLHL25
chembl:CHEMBL140220,CHEMBL140220
HGNC:7572,MYH2
HP:0000966,Hypohidrosis
MONDO:0013817,preeclampsia/eclampsia 5
HGNC:12524,UGCG
HP:0033202,Brachioradialis hyporeflexia
chembl:CHEMBL2107359,PAFURAMIDINE MALEATE
CHEBI:16180,N-acylglycine
MONDO:0013056,"developmental and epileptic encephalopathy, 39"
MONDO:0020590,mycobacterial infectious disease
chembl:CHEMBL598679,CHEMBL598679
MONDO:0003008,hereditary renal cell carcinoma
chembl:CHEMBL1200329,TIZANIDINE HYDROCHLORIDE
chembl:CHEMBL689,MANNITOL
FB:FBgn0262716,Arp3
HP:0032491,Increased circulating argininosuccinic acid
MONDO:0008768,"ceroid lipofuscinosis, neuronal, 6B (Kufs type)"
chembl:CHEMBL80830,BUCILLAMINE
CHEBI:21766,N-methylglycines
chembl:CHEMBL250711,OLEOYL DOPAMINE
HGNC:20766,TUBA1A
MGI:1351646,Abca7
HGNC:17757,TNMD
HGNC:9021,PKM
chembl:CHEMBL324842,ROSMARINIC ACID
HP:0033054,Myoclonic tremor
chembl:CHEMBL3286830,LORLATINIB
chembl:CHEMBL1201733,PAZOPANIB HYDROCHLORIDE
chembl:CHEMBL197,DEXVERAPAMIL
CHEBI:49302,2-hydroxy monocarboxylic acid
chembl:CHEMBL1213492,GIVINOSTAT
GO:0005102,signaling receptor binding
HGNC:9293,PPP1R3C
MONDO:0054764,neurodegeneration with brain iron accumulation 8
GO:0042789,mRNA transcription by RNA polymerase II
chembl:CHEMBL609030,CHEMBL609030
HGNC:12716,TRPV1
HGNC:1774,CDK5
chembl:CHEMBL32800,FENOTEROL
HGNC:27310,FLCN
chembl:CHEMBL2104991,VABICASERIN HYDROCHLORIDE
HGNC:28486,MFSD8
chembl:CHEMBL588525,CHEMBL588525
chembl:CHEMBL258316,CHEMBL258316
chembl:CHEMBL2270444,DESACETYL SALANNIN
chembl:CHEMBL2103778,CILANSETRON
HGNC:13397,CYB5R1
HP:0000758,Abnormal nonverbal communicative behavior
MONDO:0002495,colon signet ring cell adenocarcinoma
chembl:CHEMBL1395,METHYLTESTOSTERONE
HP:0100896,Rectal polyposis
MONDO:0005559,neurodegenerative disease
CHEBI:46915,sarcosinate
HGNC:12757,WDR5
chembl:CHEMBL169901,DEBRISOQUIN
chembl:CHEMBL714,ALBUTEROL
chembl:CHEMBL472,GLYBURIDE
HGNC:68,ABCD4
HGNC:12680,VEGFA
HGNC:25782,MCMBP
chembl:CHEMBL249973,LINTITRIPT
chembl:CHEMBL12713,SERTINDOLE
HGNC:16657,BCL2L14
MONDO:0008695,chorea-acanthocytosis
HP:0000005,Mode of inheritance
chembl:CHEMBL3545432,IXAZOMIB CITRATE
HGNC:4084,GABRD
chembl:CHEMBL607707,PELITINIB
chembl:CHEMBL3545278,ATX08-001
HGNC:2158,CNP
chembl:CHEMBL1200530,CEFOXITIN SODIUM
HGNC:12468,UBC
MONDO:0018585,pediatric arterial ischemic stroke
chembl:CHEMBL1485809,CHEMBL1485809
HGNC:8032,NTRK2
wikidata:Q20801763,ALDESLEUKIN
chembl:CHEMBL837,7-ETHYL-10-HYDROXYCAMPTOTHECIN
chembl:CHEMBL1200722,PIPECURONIUM BROMIDE
chembl:CHEMBL182120,VOACANGINE
chembl:CHEMBL697,METHSUXIMIDE
chembl:CHEMBL296522,RENZAPRIDE
HGNC:14277,MRPL9
chembl:CHEMBL70971,CARBENDAZIM
HGNC:1956,CHRNA2
HGNC:4687,GUCY1B1
HGNC:21063,MOXD1
chembl:CHEMBL18,ETHOXZOLAMIDE
HGNC:30098,CPSF7
chembl:CHEMBL67535,CHEMBL67535
HGNC:7673,NCOR2
MONDO:0012358,"leprosy, susceptibility to, 1"
Reactome:R-HSA-9837999,Mitochondrial protein degradation
HP:0000073,Ureteral duplication
chembl:CHEMBL231616,TRIAPINE
MONDO:0003663,uterine ligament endometrioid adenocarcinoma
chembl:CHEMBL1214827,ONALESPIB
chembl:CHEMBL3544908,AZATADINE MALEATE
HGNC:6883,MAPK8IP2
chembl:CHEMBL3545177,AZD-0424
chembl:CHEMBL20562,ZAPA
MONDO:0003689,familial hemolytic anemia
MONDO:0011175,Friedreich ataxia 2
GO:0005509,calcium ion binding
chembl:CHEMBL504,DIMETHYL SULFOXIDE
HGNC:4716,H1-2
GO:0009410,response to xenobiotic stimulus
chembl:CHEMBL3601398,CGM-097
HGNC:14090,RAB9B
HGNC:7490,MT-TL1
HGNC:28948,TMEM41B
HP:0000729,Autistic behavior
chembl:CHEMBL276832,HYDRALAZINE
chembl:CHEMBL3545003,MSC-2363318A
chembl:CHEMBL308954,ETRAVIRINE
chembl:CHEMBL1256719,CHEMBL1256719
chembl:CHEMBL2103860,USISTAPIDE
chembl:CHEMBL1172241,NERVIANO
chembl:CHEMBL2109390,MAB-425
MONDO:0030360,"cholestasis, progressive familial intrahepatic, 6"
HGNC:17761,TREM2
MONDO:0000167,Huntington disease and related disorders
UBERON:0001007,digestive system
chembl:CHEMBL3989686,IFERANSERIN
HGNC:6183,ITSN1
MONDO:0002883,intestinal neuroendocrine neoplasm
HGNC:9462,PRPS1
chembl:CHEMBL1483,ALBENDAZOLE
HP:0007240,Progressive gait ataxia
chembl:CHEMBL1668776,YEZOQUINOLIDE
HGNC:13371,MS4A4A
HP:0000580,Pigmentary retinopathy
HGNC:19918,MYORG
HGNC:18001,TOMM40
chembl:CHEMBL52606,COLFORSIN
chembl:CHEMBL1398126,AMILORIDE HYDROCHLORIDE
HGNC:18475,ZDHHC9
HP:0032308,Increased circulating procalcitonin concentration
HP:0020181,Reduced haptoglobin level
HGNC:1585,CCND3
chembl:CHEMBL472172,CHEMBL472172
MONDO:0002444,melancholia
HP:0001919,Acute kidney injury
HGNC:15464,SPINK5
CHEBI:47518,"(2S,4R)-ketoconazole"
chembl:CHEMBL1703,METFORMIN HYDROCHLORIDE
chembl:CHEMBL1897483,TRIFLOXYSTROBIN
HP:0020045,Esodeviation
HP:0000194,Open mouth
chembl:CHEMBL1200708,BISOPROLOL FUMARATE
HGNC:2551,CUL1
chembl:CHEMBL1230095,N-PROPYL BROMIDE
chembl:CHEMBL1514735,CEFDITORIN PIVOXIL
UPHENO:0080033,increased reflex in pelvic complex
HGNC:20675,CNDP1
HP:0002445,Tetraplegia
MONDO:0000646,ovarian benign neoplasm
chembl:CHEMBL1808388,BEXAGLIFLOZIN
chembl:CHEMBL407501,CHEMBL407501
chembl:CHEMBL1274,NILUTAMIDE
chembl:CHEMBL300138,ENZASTAURIN
chembl:CHEMBL1701915,CHEMBL1701915
HGNC:5017,HMX1
GO:0045944,positive regulation of transcription by RNA polymerase II
MONDO:0024614,neurotic depression
HGNC:3382,DMTN
chembl:CHEMBL707,DOXAZOSIN
HGNC:15492,ANKH
chembl:CHEMBL3989914,GLESATINIB
chembl:CHEMBL252909,CHELIDAMIC ACID
chembl:CHEMBL1255865,IOFETAMINE HYDROCHLORIDE
chembl:CHEMBL1458880,CADMIUM DICHLORIDE
chembl:CHEMBL431525,BETUNOLIC ACID
HGNC:2494,CTBP1
chembl:CHEMBL1091644,LINSITINIB
GO:0017022,myosin binding
chembl:CHEMBL1253688,R-RUGULACTONE
chembl:CHEMBL464443,GONIOTHALAMIN
chembl:CHEMBL209821,NALUZOTAN
HGNC:3700,FH
HP:0002120,Cerebral cortical atrophy
chembl:CHEMBL27006,CHEMBL27006
chembl:CHEMBL586024,CHEMBL586024
chembl:CHEMBL266349,MELAGATRAN
chembl:CHEMBL1088,MESORIDAZINE
HGNC:20820,TPCN2
HGNC:11119,SMO
chembl:CHEMBL563251,PF-03463275
chembl:CHEMBL217354,CHEMBL217354
chembl:CHEMBL88478,CHEMBL88478
chembl:CHEMBL260374,THIOPERAMIDE
HGNC:794,ATIC
chembl:CHEMBL2146133,ESOMEPRAZOLE MAGNESIUM
HGNC:3595,FAT1
MONDO:0017325,early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
chembl:CHEMBL1442890,PROSULTIAMINE
wikidata:Q5134843,CLOCORTOLONE
chembl:CHEMBL440115,FK453
HGNC:2060,CLGN
MONDO:0018666,hepatoblastoma
HP:0032792,Tonic seizure
UPHENO:0071321,abnormally formed posterior cranial fossa
chembl:CHEMBL1201060,LOXAPINE HYDROCHLORIDE
HGNC:11509,SYT1
chembl:CHEMBL1207366,GW468816
HGNC:676,ARHGAP6
chembl:CHEMBL582503,CHEMBL582503
HGNC:3057,DTNA
NCBIGene:403568,RAD51
chembl:CHEMBL4205783,JNJ-18038683
chembl:CHEMBL307697,SIVIFENE
MONDO:0016489,delta-beta-thalassemia
MONDO:0011487,Huntington disease-like 3
chembl:CHEMBL3989934,AVADOMIDE
CHEBI:168396,mycophenolic acid
HGNC:6735,LYN
chembl:CHEMBL1738757,REBASTINIB
HGNC:24624,SIL1
HGNC:1382,CA8
CHEBI:36141,quinone
HGNC:19012,CORIN
GO:0045202,synapse
chembl:CHEMBL2108063,ZANOLIMUMAB
HP:0001188,Hand clenching
UBERON:0001965,substantia nigra pars compacta
chembl:CHEMBL1201206,PIPECURONIUM
HGNC:16228,TRIB3
chembl:CHEMBL586078,CHEMBL586078
chembl:CHEMBL278172,BENZOCAINE
chembl:CHEMBL2096631,CLORAZEPATE DIPOTASSIUM
chembl:CHEMBL216462,INDOTECAN
chembl:CHEMBL779,TADALAFIL
Reactome:R-CFA-390651,Dopamine receptors
chembl:CHEMBL532510,CHEMBL532510
chembl:CHEMBL1551453,FURATHIOCARB
chembl:CHEMBL1922094,APITOLISIB
MONDO:0012994,dopa-responsive dystonia due to sepiapterin reductase deficiency
chembl:CHEMBL4298094,ARCHEXIN
chembl:CHEMBL2103737,HYDROXOCOBALAMIN
HP:0007100,Progressive ventriculomegaly
CHEBI:26177,polyene antibiotic
chembl:CHEMBL396609,MACROCARPAL A
chembl:CHEMBL1213583,GESTODENE
chembl:CHEMBL266497,SORBINIL
HGNC:18291,DMAP1
CHEBI:138029,14alpha-methyl steroid
chembl:CHEMBL2218896,NABILONE
Reactome:R-SCE-71288,Creatine metabolism
CHEBI:16389,ubiquinones
HGNC:7173,MMP3
chembl:CHEMBL181954,NAVEGLITAZAR
chembl:CHEMBL41355,EZOGABINE
chembl:CHEMBL1076184,CIMIRACEMATE A
chembl:CHEMBL2111086,CANFOSFAMIDE
chembl:CHEMBL2135460,TERLIPRESSIN
chembl:CHEMBL1201201,METHAMPHETAMINE
chembl:CHEMBL2105712,AFATINIB DIMALEATE
MONDO:0009747,mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
CHEBI:3992,cyclic ketone
HGNC:3518,EXTL3
HP:0012690,T2 hypointense thalamus
HP:0100710,Impulsivity
chembl:CHEMBL2107371,SELODENOSON
chembl:CHEMBL2151197,PF-03654746
chembl:CHEMBL79513,CHEMBL79513
chembl:CHEMBL1090089,PAMAPIMOD
chembl:CHEMBL2104984,SODELGLITAZAR
chembl:CHEMBL1096882,FLUDARABINE PHOSPHATE
chembl:CHEMBL359744,DOXORUBICIN HYDROCHLORIDE
MONDO:0007100,familial amyloid neuropathy
UBERON:0002116,ileum
chembl:CHEMBL145725,CHEMBL145725
UBERON:0000945,stomach
chembl:CHEMBL598883,CHEMBL598883
chembl:CHEMBL523200,CHEMBL523200
chembl:CHEMBL2028063,CHEMBL2028063
HP:0000657,Oculomotor apraxia
HGNC:2570,CYB5A
chembl:CHEMBL1370,BUDESONIDE
chembl:CHEMBL392394,GS-39783
HGNC:7879,CNOT3
HGNC:10420,RPS3
HGNC:19071,ALYREF
chembl:CHEMBL1743032,INTETUMUMAB
chembl:CHEMBL1237119,TREPROSTINIL
chembl:CHEMBL520733,SEMAGACESTAT
chembl:CHEMBL45244,"PD-168,077"
HP:0001159,Syndactyly
chembl:CHEMBL2219536,MIPOMERSEN
chembl:CHEMBL1201303,PYRVINIUM
GO:0005198,structural molecule activity
MONDO:0013521,"dyskeratosis congenita, autosomal dominant 2"
chembl:CHEMBL579105,CHEMBL579105
chembl:CHEMBL1414353,LOMATIN
chembl:CHEMBL8706,CLORGILINE
MONDO:0007496,dystonia 12
MGI:2181202,Pfkfb3
HGNC:10886,SIRT2
chembl:CHEMBL589270,CHEMBL589270
chembl:CHEMBL599469,CHEMBL599469
HGNC:21182,NUP43
chembl:CHEMBL550011,CHLORPYRAMIN HYDROCHLORIDE
MONDO:0014381,"cholestasis, progressive familial intrahepatic, 4"
chembl:CHEMBL592566,CHEMBL592566
chembl:CHEMBL501562,DICARBONODITHIOIMIDIC DIAMIDE
HGNC:753,ASNS
HP:0033349,Seizure cluster
Reactome:R-HSA-375276,Peptide ligand-binding receptors
HGNC:6944,MCM2
MONDO:0003007,childhood kidney cell carcinoma
HGNC:12758,WDR6
FB:FBgn0250910,OctÎ²3R
NCBITaxon:694009,Severe acute respiratory syndrome-related coronavirus
chembl:CHEMBL2152009,COSMOMYCIN C
FB:FBgn0000447,Dhod
MONDO:0018982,Niemann-Pick disease type C
HGNC:21034,NDUFAF4
chembl:CHEMBL599957,CHEMBL599957
HGNC:17890,HPGDS
chembl:CHEMBL43064,CINNARIZINE
HGNC:6971,MDH2
GO:0055054,fructose:proton symporter activity
chembl:CHEMBL2109357,AVE-1642
chembl:CHEMBL470648,GYROPHORIC ACID
chembl:CHEMBL84281,CHEMBL84281
HGNC:26120,RBFA
MONDO:0001092,colon leiomyoma
chembl:CHEMBL3545111,HEMAY-022
chembl:CHEMBL1256875,SPIPERONE HYDROCHLORIDE
chembl:CHEMBL36327,EPICATECHIN GALLATE
chembl:CHEMBL1556914,METHYL 7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE
HGNC:16804,WWP2
HGNC:655,ARF4
chembl:CHEMBL570408,"1,4-DIMETHOXYANTHRAQUINONE"
HGNC:2591,CYP11B1
MONDO:0004323,muscular atrophy
HGNC:11305,SRPK1
chembl:CHEMBL1201,THIOTHIXENE
wikidata:Q47521625,LESCOL
CHEBI:142548,ent-tamsulosin
chembl:CHEMBL1684098,CHEMBL1684098
HGNC:12735,WASL
HGNC:177,ACY1
UBERON:0000473,testis
UBERON:0001535,vertebral artery
chembl:CHEMBL3707249,ASM-024
chembl:CHEMBL308106,CHEMBL308106
chembl:CHEMBL1552997,RHODOMYRTOXIN B
HGNC:132,ACTB
chembl:CHEMBL4297847,VGX-100
chembl:CHEMBL1200503,BROMOCRIPTINE MESYLATE
HGNC:10074,RNH1
MONDO:0005026,endometrioid adenocarcinoma
chembl:CHEMBL4297917,BPN-14770
chembl:CHEMBL14377,"2,2',4,4',5,5'-HEXACHLOROBIPHENYL"
UBERON:0001507,biceps brachii
chembl:CHEMBL473841,AGG-523
MONDO:0044745,nervous system injury
HP:0025382,Hypodipsia
HGNC:14677,DEAF1
chembl:CHEMBL2364626,RALIMETINIB
HP:0000122,Unilateral renal agenesis
chembl:CHEMBL1343568,CHEMBL1343568
chembl:CHEMBL1073,GLIPIZIDE
MONDO:0011866,pontocerebellar hypoplasia type 1A
chembl:CHEMBL178862,ANETHOLTRITHION
HGNC:30661,UBA2
HGNC:2671,DAO
chembl:CHEMBL741,LAMOTRIGINE
WB:WBGene00016162,crh-2
chembl:CHEMBL202243,CHEMBL202243
chembl:CHEMBL564009,CHEMBL564009
chembl:CHEMBL1473,FLUTICASONE PROPIONATE
chembl:CHEMBL1219,RABEPRAZOLE
HGNC:29559,VMP1
HP:0011351,Moderate receptive language delay
chembl:CHEMBL83954,CHEMBL83954
chembl:CHEMBL2107801,RESEQUINIL
chembl:CHEMBL1257002,ZIMELIDINE DIHYDROCHLORIDE
chembl:CHEMBL595,PIOGLITAZONE
chembl:CHEMBL2364618,MAVATREP
chembl:CHEMBL2104753,RIVOGLITAZONE
chembl:CHEMBL68117,VOSAROXIN
chembl:CHEMBL3707400,INDANTADOL
HP:0010549,Weakness due to upper motor neuron dysfunction
chembl:CHEMBL582099,CHEMBL582099
HP:0007002,Motor axonal neuropathy
chembl:CHEMBL1098658,YANGONIN
chembl:CHEMBL580130,CHEMBL580130
chembl:CHEMBL485980,BUCLADESINE
MGI:2675603,Trpm6
chembl:CHEMBL11,IMIPRAMINE
HGNC:2452,CSNK1D
chembl:CHEMBL365739,DIPHENYLENEIODONIUM
MONDO:0007329,"cirrhosis, familial"
chembl:CHEMBL590,MENADIONE
MONDO:0007200,blepharonasofacial malformation syndrome
chembl:CHEMBL1255739,METHAPYRILENE HYDROCHLORIDE
chembl:CHEMBL1771,CLOPIDOGREL
chembl:CHEMBL1929396,ANAGLIPTIN
chembl:CHEMBL4297611,VENGLUSTAT
HGNC:30793,EIF5B
chembl:CHEMBL1232111,OMIGAPIL
CHEBI:39867,valproic acid
chembl:CHEMBL599712,CHEMBL599712
HP:0030500,Yellow/white lesions of the macula
chembl:CHEMBL1553726,TRIAZOPHOS
chembl:CHEMBL122355,CHEMBL122355
chembl:CHEMBL2107860,TASPOGLUTIDE
UBERON:0002581,postcentral gyrus
MONDO:0044350,"hyperparathyroidism, primary, caused by water clear cell hyperplasia"
HGNC:82,ACAA1
chembl:CHEMBL1092023,EOSIN_Y
HP:0006323,Premature loss of primary teeth
MONDO:0010150,head and neck squamous cell carcinoma
chembl:CHEMBL1328968,MELENGESTROL ACETATE
MONDO:0800029,interstitial lung disease 2
chembl:CHEMBL1200467,HYDROXYZINE PAMOATE
HGNC:9093,PLTP
HP:0034360,Action myoclonus
HGNC:11934,TNFSF4
WB:WBGene00000423,ced-9
chembl:CHEMBL463210,CHLORPYRIFOS
CHEBI:26878,tertiary alcohol
HP:0003623,Neonatal onset
UPHENO:0081315,muscle of neck hypoplasia
HGNC:3750,FLII
CHEBI:9588,ticlopidine
HGNC:27561,TSEN54
chembl:CHEMBL1255944,CHEMBL1255944
chembl:CHEMBL1720,PALONOSETRON HYDROCHLORIDE
chembl:CHEMBL1366408,CARMINE
chembl:CHEMBL299853,CHEMBL299853
chembl:CHEMBL1201051,CIMETIDINE HYDROCHLORIDE
chembl:CHEMBL1360024,CEFAMANDOLE SODIUM
chembl:CHEMBL1089641,TRYPAN BLUE
HGNC:15939,WFDC2
chembl:CHEMBL1723343,ZOLPIDEM TARTRATE
chembl:CHEMBL531048,PHANQUONE
chembl:CHEMBL448343,LESOGABERAN
CHEBI:70979,N-isobutyrylglycine
chembl:CHEMBL400875,(S)-ISRADIPINE
MONDO:0013270,"Rett syndrome, congenital variant"
chembl:CHEMBL1256775,PHENAMIL METHANESULFONATE
CHEBI:17688,(S)-nicotine
HGNC:21528,DIABLO
HGNC:9437,EIF2AK2
MONDO:0003789,hereditary papillary renal cell carcinoma
MONDO:0006917,posterior cerebral artery infarction
chembl:CHEMBL242172,CHEMBL242172
chembl:CHEMBL1337502,BENZO[B]FLUORANTHENE
HGNC:16983,OLIG1
chembl:CHEMBL532160,CHEMBL532160
chembl:CHEMBL199592,CHEMBL199592
Reactome:R-HSA-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL587579,CHEMBL587579
HGNC:6973,MDM2
MONDO:0011694,spinocerebellar ataxia type 15/16
MONDO:0017091,bilateral polymicrogyria
CHEBI:30527,flavin
chembl:CHEMBL528791,CHEMBL528791
chembl:CHEMBL3545424,AZD-8186
MONDO:0019026,autosomal recessive osteopetrosis
HGNC:3221,EFNA1
HGNC:20303,SLC30A8
HGNC:6512,LARS1
chembl:CHEMBL1235157,PENTABROMOPHENOL
GO:0004594,pantothenate kinase activity
chembl:CHEMBL3545395,BI-811283
chembl:CHEMBL1200598,DIETHYLSTILBESTROL DIPHOSPHATE
chembl:CHEMBL24171,BERGAPTEN
MONDO:0004855,tenosynovitis
HGNC:11199,SOX3
chembl:CHEMBL585502,CHEMBL585502
chembl:CHEMBL602466,CHEMBL602466
HGNC:10683,SDHD
chembl:CHEMBL1614701,SELUMETINIB
chembl:CHEMBL3989926,SITRAVATINIB
chembl:CHEMBL1215869,PHYTANIC ACID
HGNC:2676,DAPK3
HGNC:30100,PSENEN
chembl:CHEMBL79993,Z-PRO-PROLINAL
HP:0003218,Oroticaciduria
HGNC:34383,PCARE
UPHENO:0078006,decreased reflex in cornea
chembl:CHEMBL138649,6-HYDROXYFLAVONE
HGNC:2495,CTBP2
chembl:CHEMBL1236682,REFAMETINIB
chembl:CHEMBL114,SAQUINAVIR
chembl:CHEMBL3545265,MLN-0415
HGNC:3530,F12
chembl:CHEMBL88972,"PYRIDINE-2,5-DICARBOXYLIC ACID"
chembl:CHEMBL1197091,HALOFUGINONE
HP:0031763,Cyclic esotropia
chembl:CHEMBL581869,CHEMBL581869
chembl:CHEMBL112816,CHEMBL112816
CHEBI:28940,calciol
chembl:CHEMBL1364,PYRIDOXINE
Reactome:R-HSA-390666,Serotonin receptors
HGNC:2180,COCH
HP:0003334,Elevated circulating catecholamine level
HGNC:555,AP1G1
chembl:CHEMBL433461,CHEMBL433461
chembl:CHEMBL1241855,RIGOSERTIB
chembl:CHEMBL2103869,DASOLAMPANEL
chembl:CHEMBL3353410,OSIMERTINIB
chembl:CHEMBL1504869,TALIPEXOLE HYDROCHLORIDE
chembl:CHEMBL462721,GLABROL
HGNC:8854,PEX12
chembl:CHEMBL2103791,ADIPIPLON
chembl:CHEMBL221877,CHEMBL221877
HGNC:6263,KCNJ2
Reactome:R-HSA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL1386,TRANSPLATIN
chembl:CHEMBL2368547,SENNOSIDE A
chembl:CHEMBL418134,BUNITROLOL
HGNC:21202,KIF6
MONDO:0003335,chronic polyneuropathy
HGNC:10442,RPS9
HGNC:15886,AAR2
chembl:CHEMBL101253,VATALANIB
chembl:CHEMBL2110562,CHLORMERODRIN
chembl:CHEMBL55895,PHENYLBUTYRYLHYDROXAMIC ACID
chembl:CHEMBL85799,ETIOCHOLANOLONE
chembl:CHEMBL16264,ETHER
HGNC:18178,VPS28
HGNC:170,ACTR3
HGNC:26486,CNST
CHEBI:194499,oripavine(1+)
GO:0048839,inner ear development
HGNC:32925,ATXN8
chembl:CHEMBL133342,(S)-ROSCOVITINE
HP:0002277,Horner syndrome
chembl:CHEMBL19019,NALTREXONE
chembl:CHEMBL3244648,METHOTREXATE SODIUM
chembl:CHEMBL601528,CHEMBL601528
chembl:CHEMBL59,DOPAMINE
HGNC:1232,EGLN1
HGNC:6182,ITPR3
MONDO:0006130,central nervous system neoplasm
wikidata:Q27088419,PLX8394
chembl:CHEMBL1416586,BENZPIPERYLON
chembl:CHEMBL1201234,MEPHENTERMINE
HP:0011442,Abnormal central motor function
chembl:CHEMBL4297181,SAMOTOLISIB
HGNC:24188,SDF4
chembl:CHEMBL186113,GW-328267
chembl:CHEMBL539934,TT-232
chembl:CHEMBL593211,CHEMBL593211
HGNC:11630,HNF1B
MONDO:0002882,colon neuroendocrine neoplasm
CHEBI:57287,coenzyme A(4-)
chembl:CHEMBL459729,CHEMBL459729
MONDO:0002865,anus sarcoma
HGNC:752,GET3
UPHENO:0014097,cerebellar cortex atrophy
chembl:CHEMBL1581,PERINDOPRIL
HGNC:7863,NNT
chembl:CHEMBL374508,E-64
chembl:CHEMBL1160028,TETRAIDOFLUORESCEIN
HGNC:23160,SAT2
chembl:CHEMBL203266,TRIMETAZIDINE
HGNC:11026,SLC3A2
chembl:CHEMBL4112930,PAMIPARIB
chembl:CHEMBL509860,CHEMBL509860
HGNC:18644,KLHL8
HP:0001969,Abnormal tubulointerstitial morphology
HGNC:2529,CTSD
chembl:CHEMBL3707317,LOREDIPLON
chembl:CHEMBL448,PENTOBARBITAL
chembl:CHEMBL47986,ERBSTATIN
HP:0000821,Hypothyroidism
HP:0001760,Abnormal foot morphology
chembl:CHEMBL1201168,ISOCARBOXAZID
CHEBI:15705,L-alpha-amino acid
MONDO:0003110,skin hemangioma
chembl:CHEMBL3989941,TINOSTAMUSTINE
HGNC:4597,GRM5
MONDO:0003351,colon leiomyosarcoma
HP:0000072,Hydroureter
HP:0025387,Pill-rolling tremor
HGNC:11425,STS
Reactome:R-HSA-196783,Coenzyme A biosynthesis
chembl:CHEMBL476323,MK-0249
CHEBI:606564,prostaglandin E2(1-)
MONDO:0001241,transient neonatal neutropenia
HP:0007221,Progressive truncal ataxia
chembl:CHEMBL1200327,PENTAZOCINE LACTATE
HP:0011477,Upbeat nystagmus
chembl:CHEMBL44072,ENDRIN
HGNC:28116,CPTP
chembl:CHEMBL166112,CHEMBL166112
HGNC:4399,RACK1
chembl:CHEMBL216973,CHEMBL216973
chembl:CHEMBL2108038,MATUZUMAB
MONDO:0017394,ketamine-induced biliary dilatation
chembl:CHEMBL601364,CHEMBL601364
MGI:107813,Tubb3
HGNC:8528,OXT
MONDO:0012004,parathyroid gland carcinoma
chembl:CHEMBL17594,QUINIZARIN
HGNC:8977,PIK3CD
chembl:CHEMBL2103829,FAXELADOL
HGNC:11730,TERT
HGNC:18608,LRRK1
chembl:CHEMBL3545226,ACUMAPIMOD
HP:0020219,Motor seizure
HGNC:30887,TRAPPC2L
chembl:CHEMBL1089636,ANG1005
Reactome:R-HSA-380320,Recruitment of NuMA to mitotic centrosomes
HGNC:2265,COX4I1
MONDO:0012103,spinocerebellar ataxia type 25
MONDO:0010772,Leber optic atrophy and dystonia
HP:0005528,Bone marrow hypocellularity
chembl:CHEMBL4297684,ABICIPAR PEGOL
MONDO:0011913,Alzheimer disease 3
HP:0010984,Digenic inheritance
chembl:CHEMBL985,UREA
chembl:CHEMBL1095027,AESCULIOSIDE IIIE
MONDO:0002546,schwannoma
chembl:CHEMBL597744,TRIACETYLRESVERATROL
chembl:CHEMBL8165,5-METHOXYTRYPTAMINE
UPHENO:0082827,increased hallucination
chembl:CHEMBL2028050,CHEMBL2028050
HGNC:20772,TUBB3
HGNC:2860,DHCR7
HP:0001511,Intrauterine growth retardation
chembl:CHEMBL543557,CHEMBL543557
chembl:CHEMBL354663,CHEMBL354663
chembl:CHEMBL23588,FLUFENAMIC ACID
chembl:CHEMBL1200765,SIBUTRAMINE HYDROCHLORIDE
HP:0031004,Hemiareflexia
chembl:CHEMBL4297326,SLX-4090
HGNC:234,ADCY3
chembl:CHEMBL1631540,GSK163090
chembl:CHEMBL3545353,TC-6499
chembl:CHEMBL3545092,CR 1447
MONDO:0004976,amyotrophic lateral sclerosis
HGNC:2348,CREBBP
chembl:CHEMBL4298195,NARSOPLIMAB
HP:0031629,Impaired tandem gait
chembl:CHEMBL2041933,AZD-7762
chembl:CHEMBL578512,CHEMBL578512
HGNC:4699,GYG1
HGNC:2649,CYP51A1
HP:0030215,Inappropriate crying
HP:0012893,Neck muscle hypertrophy
chembl:CHEMBL1200386,PREDNICARBATE
HGNC:11364,STAT3
chembl:CHEMBL1201262,DIPIVEFRIN
MONDO:0014163,left ventricular noncompaction 10
chembl:CHEMBL117,CHRYSIN
chembl:CHEMBL1072,BUMETANIDE
HP:0007010,Poor fine motor coordination
CHEBI:15422,ATP
MONDO:0014019,dystonia 24
HGNC:692,ARL1
chembl:CHEMBL1210769,CHEMBL1210769
chembl:CHEMBL448515,"2,6-DIMETHOXYQUINONE"
HGNC:6080,INPPL1
HP:0007325,Generalized dystonia
HP:0003398,Abnormal synaptic transmission at the neuromuscular junction
Reactome:R-RNO-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
chembl:CHEMBL223448,BROXYQUINOLINE
HGNC:4249,GGPS1
chembl:CHEMBL14762,SELICICLIB
chembl:CHEMBL450802,CHEMBL450802
HP:0007158,Progressive extrapyramidal muscular rigidity
chembl:CHEMBL365617,CHEMBL365617
HGNC:12509,UBQLN2
chembl:CHEMBL195350,CHEMBL195350
chembl:CHEMBL59990,MAFOSFAMIDE
chembl:CHEMBL2048028,LIFITEGRAST
chembl:CHEMBL597670,CHEMBL597670
chembl:CHEMBL1346,DARIFENACIN
chembl:CHEMBL2108747,TORALIZUMAB
chembl:CHEMBL260538,ULIPRISTAL ACETATE
HGNC:17019,PRICKLE1
HP:0002345,Action tremor
chembl:CHEMBL1366,AURANOFIN
chembl:CHEMBL3039583,PASIREOTIDE
chembl:CHEMBL92281,FLUACIZINE
chembl:CHEMBL535650,MEFLOQUINE HYDROCHLORIDE
chembl:CHEMBL2364652,VANTICTUMAB
chembl:CHEMBL1448187,FLUPHENAZINE HYDROCHLORIDE
HGNC:25321,SHARPIN
chembl:CHEMBL74656,REL-CISAPRIDE
chembl:CHEMBL1743049,OLARATUMAB
NCBIGene:476722,NDUFA7
HGNC:9722,ALDH18A1
HGNC:1386,CABP4
chembl:CHEMBL954,ENCLOMIPHENE
HGNC:7082,CD99
chembl:CHEMBL1520346,CHEMBL1520346
CHEBI:142708,tigecycline(1+)
MONDO:0002909,hyperglycemia
MONDO:0020800,demyelinating disease of central nervous system
chembl:CHEMBL3215298,ABAMECTIN
FB:FBgn0010329,Tbh
chembl:CHEMBL553204,ICARIIN
Xenbase:XB-GENE-1016087,cyb5b
CHEBI:27690,acetazolamide
chembl:CHEMBL470881,OXOGLAUCINE
MONDO:0004830,fasciitis
chembl:CHEMBL238465,SOFINICLINE
FB:FBgn0039112,SdhD
HGNC:1925,CHEK1
HGNC:3686,FGF8
chembl:CHEMBL459,METHYLDOPA
chembl:CHEMBL532,ERYTHROMYCIN
chembl:CHEMBL1094677,AESCULIOSIDE IVA
chembl:CHEMBL1093458,ENDOXIFEN
chembl:CHEMBL1201322,THONZONIUM
HGNC:18683,EIF4A3
chembl:CHEMBL581251,CHEMBL581251
chembl:CHEMBL602946,CHEMBL602946
HGNC:29118,TMEM63A
chembl:CHEMBL587564,CHEMBL587564
HGNC:6877,MAPK3
chembl:CHEMBL2107826,VIBEGRON
HGNC:622,APPBP2
MONDO:0019409,idiopathic juvenile osteoporosis
chembl:CHEMBL444236,CHEMBL444236
HGNC:4646,GTF2A1
HGNC:19360,KLHL12
chembl:CHEMBL3544981,TAVILERMIDE
HP:0000529,Progressive visual loss
chembl:CHEMBL235668,TIPIRACIL
HP:0000574,Thick eyebrow
HGNC:6112,IRAK1
HGNC:15968,GDAP1
MONDO:0012764,RIDDLE syndrome
chembl:CHEMBL77921,MEDETOMIDINE
chembl:CHEMBL3545391,ORG-34517
chembl:CHEMBL3545325,SAR-125844
chembl:CHEMBL1237082,MECAMYLAMINE HYDROCHLORIDE
chembl:CHEMBL461308,MANASSANTIN B
MONDO:0016304,classic pantothenate kinase-associated neurodegeneration
chembl:CHEMBL282567,PROADIFEN
chembl:CHEMBL2103824,ARHALOFENATE
chembl:CHEMBL269366,RO-194603
chembl:CHEMBL3545308,ROCILETINIB
chembl:CHEMBL2107804,BEMESETRON
HGNC:2898,DLD
HP:0007209,Facial paralysis
chembl:CHEMBL1201347,ANILERIDINE
chembl:CHEMBL602990,CHEMBL602990
chembl:CHEMBL57,NEVIRAPINE
chembl:CHEMBL146624,MITOGLITAZONE
HGNC:746,ASL
chembl:CHEMBL319620,LAVENDUSTIN C
GO:0090482,vitamin transmembrane transporter activity
chembl:CHEMBL278164,NAPHTHYLAMINE
MONDO:0004478,pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma
GO:0046332,SMAD binding
chembl:CHEMBL546475,CHEMBL546475
chembl:CHEMBL2106798,NERAMEXANE MESYLATE
HGNC:24281,OTUD6B
HGNC:12833,XRCC5
HP:0000649,Abnormality of visual evoked potentials
HGNC:5284,HTN3
chembl:CHEMBL12014,HARMAN
MONDO:0020067,infectious encephalitis
chembl:CHEMBL1200980,ESTROPIPATE
chembl:CHEMBL1580,PENTOSTATIN
chembl:CHEMBL569864,CHEMBL569864
chembl:CHEMBL1607273,CETIRIZINE HYDROCHLORIDE
chembl:CHEMBL2104704,NOBERASTINE
HGNC:5414,IFITM3
HGNC:29091,ATG13
MONDO:0056797,neurodevelopmental disorder with midbrain and hindbrain malformations
chembl:CHEMBL447955,SERLOPITANT
MONDO:0042964,Machado-Joseph disease type 4
chembl:CHEMBL1567,SUNITINIB MALATE
chembl:CHEMBL524603,CHEMBL524603
chembl:CHEMBL1330596,RACEMETYROSINE
HGNC:12930,ZBTB16
CHEBI:5613,haloperidol
chembl:CHEMBL3545335,AG-13958
chembl:CHEMBL338404,CHEMBL338404
chembl:CHEMBL388978,STAUROSPORINE
HP:0002460,Distal muscle weakness
chembl:CHEMBL429844,ORE-1001
chembl:CHEMBL553503,CHEMBL553503
MONDO:0016369,Rothmund-Thomson syndrome type 2
chembl:CHEMBL582486,CHEMBL582486
chembl:CHEMBL2364614,LIAFENSINE
HP:0002406,Limb dysmetria
chembl:CHEMBL1448437,REMACEMIDE HYDROCHLORIDE
chembl:CHEMBL316966,CYCLIC ADENOSINE MONOPHOSPHATE
MGI:1913362,Mtarc1
HGNC:986,BCKDHA
chembl:CHEMBL602922,CHEMBL602922
HGNC:2964,DYNC1I2
HP:0005988,Congenital muscular torticollis
chembl:CHEMBL1682201,CHEMBL1682201
CHEBI:34997,teicoplanin A2-4
GO:0031514,motile cilium
HGNC:11556,TAL1
MONDO:0010449,"autism, susceptibility to, X-linked 5"
chembl:CHEMBL483321,CP-724714
HP:0030188,Tremor by anatomical site
chembl:CHEMBL1911631,YUANHUADINE
chembl:CHEMBL3545110,RIBOCICLIB
chembl:CHEMBL976,PRAZIQUANTEL
MONDO:0000706,chemical colitis
HGNC:19962,ATG14
FB:FBgn0004888,ScsÎ±1
CHEBI:17495,cholesteryl beta-D-glucoside
HP:0001450,Y-linked inheritance
HGNC:7695,NDUFB1
chembl:CHEMBL2108619,LONTUCIREV (REPLICATING ADENOVIRUS)
CHEBI:28971,ampicillin
HGNC:15833,PHACTR3
chembl:CHEMBL546,OXPRENOLOL
CHEBI:16643,L-methionine
chembl:CHEMBL1462710,CHEMBL1462710
chembl:CHEMBL2109481,ICM3
chembl:CHEMBL301735,HOECHST 33258
chembl:CHEMBL1478334,BUTANAL
chembl:CHEMBL601400,CHEMBL601400
MONDO:0002425,rectosigmoid junction cancer
chembl:CHEMBL36994,ANIRACETAM
MONDO:0007403,inherited Creutzfeldt-Jakob disease
HGNC:10402,RPS19
chembl:CHEMBL1399702,NEBULARINE
MONDO:0003734,adult central nervous system immature teratoma
HGNC:19139,POMGNT1
MONDO:0100467,preeclampsia/eclampsia 1
MONDO:0014884,"cholestasis, progressive familial intrahepatic, 5"
chembl:CHEMBL945,AMILORIDE
chembl:CHEMBL599890,CHEMBL599890
HP:0001100,Heterochromia iridis
chembl:CHEMBL3545245,BAY-1082439
chembl:CHEMBL853,ZALCITABINE
chembl:CHEMBL584883,CHEMBL584883
HP:0002315,Headache
chembl:CHEMBL655,MIDAZOLAM
HGNC:10799,SFTPA2
chembl:CHEMBL591887,CHEMBL591887
chembl:CHEMBL43612,JUGLONE
MONDO:0008938,early-onset cerebellar ataxia with retained tendon reflexes
chembl:CHEMBL1520512,DEHYDROVARIABILIN
chembl:CHEMBL582081,CHEMBL582081
HGNC:1815,CEACAM3
chembl:CHEMBL2108253,ARCITUMOMAB
chembl:CHEMBL251766,KAEMPFERITRIN
HGNC:21100,QKI
GO:0071312,cellular response to alkaloid
GO:0015407,ABC-type monosaccharide transporter activity
chembl:CHEMBL594259,CHEMBL594259
HP:0000458,Anosmia
PATO:0002097,"neoplastic, malignant"
HP:0007015,Poor gross motor coordination
GO:0015631,tubulin binding
HP:0001324,Muscle weakness
chembl:CHEMBL496,HEXACHLOROPHENE
chembl:CHEMBL472566,ZOXAZOLAMINE
chembl:CHEMBL3833393,EMICIZUMAB
HGNC:4566,GRB2
HP:0000218,High palate
chembl:CHEMBL1404865,CHEMBL1404865
chembl:CHEMBL563777,CHEMBL563777
HGNC:2747,DDX6
CHEBI:6887,methylphenidate
chembl:CHEMBL2108208,LENERCEPT
HGNC:12828,XRCC1
chembl:CHEMBL2107815,TREPROSTINIL DIOLAMINE
HGNC:16783,CDC73
MONDO:0012801,"autism, susceptibility to, 15"
chembl:CHEMBL1725730,LEVOMEPROMAZINE MALEATE
chembl:CHEMBL1389794,CHEMBL1389794
chembl:CHEMBL1209491,DAPHNORIN
chembl:CHEMBL129857,AS-602868
chembl:CHEMBL1482931,THYMOL IODIDE
HGNC:9657,PTPN5
chembl:CHEMBL585769,CHEMBL585769
HGNC:11985,TOMM70
chembl:CHEMBL600336,CHEMBL600336
MONDO:0009419,Woodhouse-Sakati syndrome
MGI:2448558,Fancb
HGNC:9993,RGS11
HP:0007256,Abnormal pyramidal sign
chembl:CHEMBL116438,CURCUMIN
HGNC:27344,TMEM218
chembl:CHEMBL542581,PHENCYCLIDINE HYDROCHLORIDE
chembl:CHEMBL1449575,HARMOL HYDROCHLORIDE
chembl:CHEMBL1577,METHYCLOTHIAZIDE
HGNC:11411,CDKL5
HP:0010695,Sutural cataract
HP:0002376,Developmental regression
HP:0001482,Subcutaneous nodule
chembl:CHEMBL242080,E319
chembl:CHEMBL388823,CHEMBL388823
chembl:CHEMBL474579,CEFOTETAN
chembl:CHEMBL486422,DAIDZIN
chembl:CHEMBL1086,DIBUCAINE
HGNC:17909,DUSP16
HGNC:3976,FTH1
HGNC:25118,OTULIN
chembl:CHEMBL557670,CHEMBL557670
HGNC:25890,TMEM25
PomBase:SPBC16C6.02c,vps1302
HGNC:17589,LTO1
UBERON:0001950,neocortex
MONDO:0017175,Machado-Joseph disease type 2
HGNC:2039,CLDN18
MONDO:0030679,Noonan syndrome 14
HGNC:8049,NUDT2
HP:0006357,Premature loss of permanent teeth
chembl:CHEMBL1593,ALDOPHOSPHAMIDE
HP:0007159,Fluctuations in consciousness
chembl:CHEMBL122270,LOBELINE
HGNC:428,ALMS1
chembl:CHEMBL71271,CHEMBL71271
HGNC:9036,PLA2G4B
chembl:CHEMBL443,SULFAMETHOXAZOLE
MONDO:0012704,dilated cardiomyopathy 1X
HP:0000738,Hallucinations
chembl:CHEMBL30327,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN"
MONDO:0044319,"intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies"
chembl:CHEMBL4297400,MB-07803
chembl:CHEMBL63354,AMENTOFLAVONE
chembl:CHEMBL1201470,HYDROCODONE POLISTIREX
CHEBI:16919,creatine
chembl:CHEMBL192627,CHLORANIL
chembl:CHEMBL80155,CHEMBL80155
chembl:CHEMBL521589,BAMBUTEROL
chembl:CHEMBL190083,TARENFLURBIL
chembl:CHEMBL1722838,XANTHOANGELOL F
chembl:CHEMBL337309,TAXIFOLIN
CHEBI:17359,sulfite
HGNC:18448,NEIL1
chembl:CHEMBL277465,DENBUFYLLINE
chembl:CHEMBL12658,CHEMBL12658
HGNC:20151,SLC17A8
chembl:CHEMBL1200792,FLUPHENAZINE HYDROCHLORIDE
HP:0002123,Generalized myoclonic seizure
CHEBI:77315,spectinomycin(2+)
chembl:CHEMBL1410398,PIMARIC ACID
CHEBI:16469,17beta-estradiol
chembl:CHEMBL3544911,PREXASERTIB
HP:0100706,Abnormal oligodendroglia morphology
chembl:CHEMBL405317,CHEMBL405317
chembl:CHEMBL1580175,CHEMBL1580175
chembl:CHEMBL1610591,AMCINAFIDE
HGNC:4315,GLE1
chembl:CHEMBL157138,LISURIDE
WB:WBGene00000554,cnb-1
chembl:CHEMBL1095025,AESCULIOSIDE IIID
chembl:CHEMBL580421,CHEMBL580421
chembl:CHEMBL104943,MONOETHANOLAMINE
HP:0001293,Cranial nerve compression
HP:0000605,Supranuclear gaze palsy
chembl:CHEMBL18772,QUIPAZINE
chembl:CHEMBL1200728,GUANIDINE HYDROCHLORIDE
HP:0001264,Spastic diplegia
HGNC:1591,CCNF
chembl:CHEMBL1134,DECAMETHONIUM BROMIDE
chembl:CHEMBL577419,CHEMBL577419
chembl:CHEMBL597244,CHEMBL597244
FB:FBgn0038922,Idh3b
chembl:CHEMBL20883,TEGAFUR
HGNC:11306,SRPK2
ZFIN:ZDB-GENE-030131-1058,cs
GO:0005412,glucose:sodium symporter activity
GO:0098827,endoplasmic reticulum subcompartment
MONDO:0010542,dilated cardiomyopathy 3B
chembl:CHEMBL1436035,BISANHYDRORUTILANTINONE
HP:0002168,Scanning speech
chembl:CHEMBL2109556,MLN-2704
chembl:CHEMBL243712,AMISULPRIDE
chembl:CHEMBL1441961,SOFALCONE
MONDO:0014114,cardiofaciocutaneous syndrome 4
HGNC:1743,CDC5L
HGNC:13221,BCL11A
UPHENO:0082557,decreased muscle organ tone
RGD:621618,Icmt
HGNC:24526,ATL3
chembl:CHEMBL4298105,VALZIFLOCEPT
chembl:CHEMBL1256761,CHEMBL1256761
chembl:CHEMBL42403,BORIC ACID
HGNC:4006,FUCA1
HGNC:9178,POLE2
chembl:CHEMBL3707398,PAC-14028
HGNC:7856,NQO2
chembl:CHEMBL1201609,CORTICOTROPIN ZINC HYDROXIDE
HGNC:4319,GLI3
HP:0003259,Elevated circulating creatinine concentration
HGNC:11442,STX7
HGNC:4886,HFE
HGNC:174,ACVR2B
chembl:CHEMBL1330729,CLENBUTEROL HYDROCHLORIDE
chembl:CHEMBL582675,CHEMBL582675
chembl:CHEMBL546168,CHEMBL546168
chembl:CHEMBL605,PROCAINAMIDE HYDROCHLORIDE
chembl:CHEMBL1738758,ONVANSERTIB
chembl:CHEMBL820,BUSULFAN
chembl:CHEMBL9249,(+)-EPITAXIFOLIN
chembl:CHEMBL1200831,SPIRAPRIL HYDROCHLORIDE
HP:0020206,Simple ear
MONDO:0019771,oromandibular dystonia
chembl:CHEMBL269732,TACROLIMUS
chembl:CHEMBL1333386,CHEMBL1333386
HGNC:9969,RFC1
chembl:CHEMBL1370561,AMINOPHYLLINE
chembl:CHEMBL787,MONTELUKAST
HP:0010472,Abnormal circulating porphyrin concentration
chembl:CHEMBL73234,CARBETAPENTANE
chembl:CHEMBL1200599,DIFENOXIN HYDROCHLORIDE
chembl:CHEMBL46874,PINAFIDE
chembl:CHEMBL1448140,CHEMBL1448140
MONDO:0017593,juvenile amyotrophic lateral sclerosis
chembl:CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II
HGNC:16277,TRIM6
GO:0006383,transcription by RNA polymerase III
HP:0004302,Functional motor deficit
chembl:CHEMBL1200670,SARALASIN ACETATE
chembl:CHEMBL1481873,PHOSMET
NCBIGene:488165,SLC2A2
chembl:CHEMBL582473,CHEMBL582473
chembl:CHEMBL2179529,AZD1446
HGNC:10050,RNASEL
HGNC:129,ACTA1
chembl:CHEMBL2108546,PEGASPARGASE
chembl:CHEMBL9967,PIRENZEPINE
chembl:CHEMBL3545376,ERDAFITINIB
chembl:CHEMBL388676,CAPTAN
HGNC:8768,AIFM1
chembl:CHEMBL68534,CHEMBL68534
HP:0100952,Enlarged sylvian cistern
MONDO:0009319,pantothenate kinase-associated neurodegeneration
HGNC:4588,GRIN2D
HGNC:12851,YWHAE
chembl:CHEMBL1091502,CHEMBL1091502
CHEBI:29108,calcium(2+)
chembl:CHEMBL8085,LYSINE
chembl:CHEMBL602763,CHEMBL602763
chembl:CHEMBL189753,CHEMBL189753
chembl:CHEMBL1564747,DROMETRIZOLE
chembl:CHEMBL83628,CHROMOCARB
HP:0001386,Joint swelling
HP:0030214,Hypersexuality
chembl:CHEMBL529,AZITHROMYCIN
HGNC:2740,DDX17
MONDO:0003665,cervical endometrioid adenocarcinoma
HGNC:12703,BEST1
chembl:CHEMBL301722,PALMITOYL-CARNITINE
HGNC:12631,USP8
MGI:97890,Rad51
HGNC:9323,PPP6C
GO:0005353,fructose transmembrane transporter activity
MONDO:0020074,progressive myoclonus epilepsy
MONDO:0014938,aniridia 3
HGNC:14082,ANLN
MONDO:0005292,colitis
chembl:CHEMBL46,ONDANSETRON
CHEBI:4885,ethionamide
chembl:CHEMBL2103870,LUMACAFTOR
chembl:CHEMBL601719,CRIZOTINIB
CHEBI:22315,alkaloid
chembl:CHEMBL2108313,CONBERCEPT
chembl:CHEMBL589694,CHEMBL589694
HGNC:4124,GALNT2
Reactome:R-HSA-549127,Organic cation transport
chembl:CHEMBL3545218,VORUCICLIB
chembl:CHEMBL3544956,PYROTINIB
chembl:CHEMBL2048484,CANAGLIFLOZIN
wikidata:Q29004870,AVASTIN
chembl:CHEMBL1463,FLUCYTOSINE
MONDO:0004884,eye degenerative disorder
HGNC:3468,ESR2
CHEBI:30879,alcohol
chembl:CHEMBL454246,REDIOCIDE A
chembl:CHEMBL287556,KOJIC ACID
chembl:CHEMBL580955,CHEMBL580955
chembl:CHEMBL307429,DUVOGLUSTAT
GO:0044381,glucose import in response to insulin stimulus
chembl:CHEMBL507237,CUCURBITACIN B
chembl:CHEMBL1258006,BRADANICLINE
chembl:CHEMBL1201294,DIPHENOXYLATE
HGNC:5164,HPSE
chembl:CHEMBL433680,ANGUIDIN
chembl:CHEMBL1622802,CHEMBL1622802
HGNC:5253,HSP90AA1
HP:0000953,Hyperpigmentation of the skin
MONDO:0003193,bile duct adenocarcinoma
HGNC:3023,DRD2
HP:0002900,Hypokalemia
GO:0098858,actin-based cell projection
chembl:CHEMBL1598608,AZASETRON
HGNC:3236,EGFR
MONDO:0024476,epithelial neoplasm of rectum
chembl:CHEMBL1822982,TRICITRINOL B
MGI:1891497,Jph3
HGNC:9386,PRKAG2
Reactome:R-GGA-390651,Dopamine receptors
chembl:CHEMBL578063,ALAZANINE
chembl:CHEMBL831,LOXAPINE
HGNC:23068,TRAPPC2
HGNC:8647,PCBP1
chembl:CHEMBL2104449,SARAKALIM
HP:0002392,EEG with polyspike wave complexes
chembl:CHEMBL259103,CHEMBL259103
chembl:CHEMBL2109198,METHYLCELLULOSE
HGNC:941,BAG5
HGNC:28746,FUNDC1
chembl:CHEMBL1201835,USTEKINUMAB
HGNC:6857,MAP3K5
chembl:CHEMBL3545203,RG7342
GO:0004707,MAP kinase activity
chembl:CHEMBL496102,AMG-208
HGNC:28572,FRMPD2
HGNC:6518,LBR
chembl:CHEMBL12998,L-755507
MONDO:0004152,chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation
chembl:CHEMBL178459,OLTIPRAZ
HGNC:2095,CLU
chembl:CHEMBL469309,CHEMBL469309
HGNC:12472,UBE2A
chembl:CHEMBL1201027,GLYCOPYRROLATE
MONDO:0011647,Alzheimer disease 7
CHEBI:37948,oxaspiro compound
chembl:CHEMBL274064,SB-220025
chembl:CHEMBL411085,CHEMBL411085
chembl:CHEMBL267548,PROTOPORPHYRIN
CHEBI:18012,fumaric acid
HGNC:33,ABCA3
HGNC:7966,NR1H3
chembl:CHEMBL482967,CYC-116
chembl:CHEMBL1093059,BARDOXOLONE
chembl:CHEMBL337612,DIMIRACETAM
chembl:CHEMBL286738,IROSUSTAT
chembl:CHEMBL1232461,MOLIBRESIB
chembl:CHEMBL844,BRIMONIDINE
chembl:CHEMBL609628,CHEMBL609628
chembl:CHEMBL1599728,"2,3,4'-TRIHYDROXY-4-METHOXYBENZOPHENONE"
HGNC:7719,NDUFV3
HGNC:6293,KCNN4
chembl:CHEMBL15594,ARACHIDONIC ACID
GO:0005778,peroxisomal membrane
chembl:CHEMBL2094422,CHEMBL2094422
CHEBI:16581,pregnenolone
HGNC:711,ARRB1
chembl:CHEMBL488436,AZD-5438
chembl:CHEMBL599924,CHEMBL599924
WB:WBGene00001053,dop-2
chembl:CHEMBL1927048,CHEMBL1927048
MONDO:0100030,adolescent/adult-onset epilepsy syndrome
CHEBI:8058,phencyclidine
chembl:CHEMBL9352,NARINGENIN
HP:0001276,Hypertonia
HGNC:3585,FANCD2
chembl:CHEMBL628,PENTOXIFYLLINE
chembl:CHEMBL1200993,GALLAMINE TRIETHIODIDE
HGNC:16100,FAM209A
chembl:CHEMBL578878,CHEMBL578878
HGNC:15476,DYNLL1
HP:0000037,Male pseudohermaphroditism
chembl:CHEMBL608533,MIDOSTAURIN
HP:0002078,Truncal ataxia
MGI:107619,Hrh1
chembl:CHEMBL3707381,OFRANERGENE OBADENOVEC
HP:0004887,Respiratory failure requiring assisted ventilation
HP:0000128,Renal potassium wasting
HGNC:12005,TPD52
chembl:CHEMBL449362,DIBROMOACETIC ACID
chembl:CHEMBL1762593,CHEMBL1762593
chembl:CHEMBL33171,NB-ACETYLTRYPTAMINE
HP:0002365,Hypoplasia of the brainstem
GO:0007268,chemical synaptic transmission
HP:0031252,Dilated left subclavian artery
WB:WBGene00000065,act-3
HGNC:4396,GNB1
PomBase:SPBC56F2.03,arp10
chembl:CHEMBL1402420,PIFEXOLE
MONDO:0024495,"tumor grade 1 or 2, general grading system"
chembl:CHEMBL2109616,ABX-IL8
UBERON:0013554,Brodmann (1909) area 23
HGNC:7981,NR4A2
chembl:CHEMBL491820,AMORFRUTIN A
chembl:CHEMBL528694,CHEMBL528694
chembl:CHEMBL1915761,GANODERIOL F
chembl:CHEMBL1422704,CHEMBL1422704
chembl:CHEMBL4297888,APX-005M
MONDO:0002009,major depressive disorder
chembl:CHEMBL1414316,2-ETHOXYCARBONYL-2-ETHOXYOXALOYLOXYDIHYDROCHRYSIN DIMETHYL ETHER
HGNC:14499,MRPS7
HP:0000514,Slow saccadic eye movements
HGNC:4400,GNB3
MONDO:0021152,inherited
HGNC:26278,ISOC2
chembl:CHEMBL2110588,ELIGLUSTAT
chembl:CHEMBL464135,DYRENE
HGNC:18809,TUBA1B
chembl:CHEMBL126804,CHEMBL126804
HGNC:5258,HSP90AB1
HGNC:11571,TARDBP
HGNC:19263,LMAN2L
CHEBI:15765,L-dopa
chembl:CHEMBL282622,FAGARONINE
chembl:CHEMBL414157,TONAPOFYLLINE
HP:0002366,Abnormal lower motor neuron morphology
GO:0140425,galactose import across plasma membrane
chembl:CHEMBL1240967,PF-00610355
HGNC:9099,PLXNA1
chembl:CHEMBL103583,CHEMBL103583
chembl:CHEMBL494,ILOPROST
chembl:CHEMBL506871,VELIPARIB
HGNC:15910,NFS1
chembl:CHEMBL1568,FLUDARABINE
chembl:CHEMBL514409,HESPERADIN
HP:0002515,Waddling gait
chembl:CHEMBL1237044,TRAMADOL
HGNC:16468,LACTB
chembl:CHEMBL287542,RAFOXANIDE
HGNC:2074,CLN3
chembl:CHEMBL452,CLONAZEPAM
chembl:CHEMBL584905,CHEMBL584905
HGNC:936,BAD
GO:0120041,positive regulation of macrophage proliferation
chembl:CHEMBL96051,SCRIPTAID
UBERON:0003053,ventricular zone
MONDO:0008892,progressive familial intrahepatic cholestasis type 1
chembl:CHEMBL461193,CHEMBL461193
chembl:CHEMBL2133806,JNJ-38877605
chembl:CHEMBL2108679,OZANEZUMAB
chembl:CHEMBL3219124,AZD-1656
chembl:CHEMBL3545212,AMG-337
MONDO:0004542,"cervical adenosquamous carcinoma, glassy cell variant"
HGNC:4193,GCH1
HGNC:7603,MYO5B
chembl:CHEMBL2074725,ACETYLDIGOXIN
MONDO:0017176,Machado-Joseph disease type 3
chembl:CHEMBL347698,FENITROTHION
MONDO:0000314,primary bacterial infectious disease
HGNC:894,AVP
chembl:CHEMBL546975,CHEMBL546975
chembl:CHEMBL493241,CHEMBL493241
HGNC:7568,MYH10
chembl:CHEMBL501174,LYCOPENE
MP:0001524,impaired limb coordination
HGNC:11359,STAR
chembl:CHEMBL22077,HYCANTHONE
chembl:CHEMBL1201533,THYROTROPIN ALFA
chembl:CHEMBL525519,CHEMBL525519
chembl:CHEMBL1200590,MECLIZINE HYDROCHLORIDE
HP:0000962,Hyperkeratosis
chembl:CHEMBL586000,CHEMBL586000
chembl:CHEMBL610622,CHEMBL610622
HGNC:28881,PATJ
chembl:CHEMBL43078,CHEMBL43078
MONDO:0011451,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1"
MONDO:0016019,Rasmussen subacute encephalitis
chembl:CHEMBL185885,AES-103
MONDO:0012187,Fanconi anemia complementation group J
HGNC:21474,INPP5E
HGNC:412,ALDH9A1
HP:0003307,Hyperlordosis
chembl:CHEMBL449,BUTABARBITAL
chembl:CHEMBL1025,ISOFLUROPHATE
chembl:CHEMBL282199,CHEMBL282199
HGNC:644,AR
chembl:CHEMBL252151,CHEMBL252151
chembl:CHEMBL1963681,AVANAFIL
HGNC:24591,CLEC4G
HGNC:9477,PRSS12
CHEBI:32158,streptomycin sulfate
HP:0000613,Photophobia
HGNC:236,ADCY5
chembl:CHEMBL3545385,WX-037
chembl:CHEMBL1627202,CHEMBL1627202
chembl:CHEMBL465226,GEDUNIN
chembl:CHEMBL2107870,PEGNIVACOGIN
HGNC:13487,VPS35
chembl:CHEMBL514800,APREMILAST
chembl:CHEMBL487611,PINORESINOL
chembl:CHEMBL460124,BENZYL SALICYLATE
HP:0009072,Decreased Achilles reflex
MONDO:0016814,maternally-inherited Leigh syndrome
chembl:CHEMBL778,DEXMEDETOMIDINE
chembl:CHEMBL1200817,LEVOMETHADYL ACETATE HYDROCHLORIDE
HP:0006824,Cranial nerve paralysis
HP:0032273,Increased circulating N-acetylaspartic acid concentration
chembl:CHEMBL1200748,CARBIDOPA
CHEBI:16027,adenosine 5'-monophosphate
MONDO:0024651,corticosteroid-induced osteoporosis
MONDO:0012450,spinocerebellar ataxia type 28
chembl:CHEMBL1200798,TRAZODONE HYDROCHLORIDE
HP:0002637,Cerebral ischemia
chembl:CHEMBL67654,CAREBASTINE
chembl:CHEMBL509895,BRUCEANTIN
chembl:CHEMBL1256,ISOFLURANE
chembl:CHEMBL178803,BLONANSERIN
FB:FBgn0026761,Trap1
chembl:CHEMBL112060,CHEMBL112060
HP:0000716,Depression
RGD:3706,Slc2a3
Reactome:R-HSA-5610787,Hedgehog 'off' state
MONDO:0004967,acute lymphoblastic leukemia
chembl:CHEMBL422,TRIFLUOPERAZINE
chembl:CHEMBL161343,ARACHIDONOYL GLYCINE
HP:0030665,Rubral tremor
HGNC:411,ALDH3B2
chembl:CHEMBL680,CEFACLOR
chembl:CHEMBL484853,CARNOSIC ACID
chembl:CHEMBL606241,KANZONOL X
CHEBI:16444,2-acetyllactic acid
MONDO:0002734,anal mucinous adenocarcinoma
chembl:CHEMBL594,EMEDASTINE
HP:0000028,Cryptorchidism
MONDO:0004877,transient neonatal thrombocytopenia
HGNC:12030,TRADD
MONDO:0013803,leukoencephalopathy with calcifications and cysts
HGNC:8907,PGM3
HP:0001055,Erysipelas
HP:0002419,Molar tooth sign on MRI
chembl:CHEMBL1454910,NITROXOLINE
chembl:CHEMBL1241153,IBUPROFEN SODIUM
chembl:CHEMBL1201649,"ESTROGENS, CONJUGATED"
CHEBI:16162,o-orsellinate
HGNC:92,ACADVL
HGNC:17091,NCSTN
HP:0007334,Bilateral tonic-clonic seizure with focal onset
chembl:CHEMBL70582,CHEMBL70582
HGNC:30579,SSH1
WB:WBGene00000064,act-2
chembl:CHEMBL462861,CHEMBL462861
HGNC:8010,NRXN3
HP:0002730,Chronic noninfectious lymphadenopathy
Reactome:R-HSA-9022534,Loss of MECP2 binding ability to 5hmC-DNA
HP:0008997,Proximal muscle weakness in upper limbs
HGNC:3574,FADS1
chembl:CHEMBL4297361,1.ALPHA.-HYDROXYVITAMIN D5
HGNC:8772,PDE10A
FB:FBgn0001223,Hsp22
chembl:CHEMBL56393,CHEMBL56393
WB:WBGene00017382,F11D5.5
chembl:CHEMBL1191361,HYDROXYAMINE
chembl:CHEMBL1257030,LONIDAMINE
chembl:CHEMBL6622,ISOSORBIDE DINITRATE
chembl:CHEMBL1368696,CHEMBL1368696
chembl:CHEMBL400716,BERKELEYACETAL C
HGNC:23472,SLC25A28
chembl:CHEMBL123,ELLIPTECINE
HGNC:14085,RTN4
Reactome:R-SSC-71288,Creatine metabolism
HP:0002013,Vomiting
HGNC:10519,SACS
NCBIGene:477762,HTR7
chembl:CHEMBL2103803,DAROTROPIUM BROMIDE
HGNC:17062,HABP4
HGNC:2675,DAPK2
chembl:CHEMBL1160008,IODOPHTHALEIN
chembl:CHEMBL2108702,IMETELSTAT SODIUM
chembl:CHEMBL1565335,DIMETHENAMID
chembl:CHEMBL3545263,LGX-806
chembl:CHEMBL1256364,CHEMBL1256364
HP:0006989,Dysplastic corpus callosum
CHEBI:8081,phentolamine
chembl:CHEMBL1200774,FLUPREDNISOLONE
chembl:CHEMBL251941,(S)-ALAPROCLATE
Reactome:R-HSA-9022692,Regulation of MECP2 expression and activity
chembl:CHEMBL1413199,DIPHENADIONE
chembl:CHEMBL2022567,AMAUROMINE
chembl:CHEMBL3545311,BRIGATINIB
HGNC:9760,RAB11A
chembl:CHEMBL530499,CHEMBL530499
HGNC:24519,TCTN3
HP:0002322,Resting tremor
chembl:CHEMBL154,NAPROXEN
chembl:CHEMBL564201,6-AZAURIDINE
chembl:CHEMBL292702,MAYTANSINE
chembl:CHEMBL296035,BUFURALOL
chembl:CHEMBL64,ISONIAZID
chembl:CHEMBL52884,CHEMBL52884
HGNC:18150,MYO18B
HGNC:9119,PMPCB
chembl:CHEMBL1201758,BEPOTASTINE
chembl:CHEMBL1316,CARPROFEN
HGNC:23297,KCTD15
HGNC:1681,CD44
HGNC:20731,GNB4
chembl:CHEMBL4297695,AQ-13
HP:0012477,Vocal tremor
chembl:CHEMBL3545221,AZD2423
chembl:CHEMBL1639,ALISKIREN
HGNC:10440,RPS7
HGNC:6284,KCNMA1
chembl:CHEMBL514057,GERONTOXANTHONE H
HP:0000767,Pectus excavatum
chembl:CHEMBL292439,NORLEUCINE
chembl:CHEMBL301523,PHENYLALANINE
HGNC:1084,BNIP3
chembl:CHEMBL1183717,ALMITRINE
chembl:CHEMBL1650443,TRELAGLIPTIN
chembl:CHEMBL541400,CHEMBL541400
MONDO:0006685,brain hypoxia - ischemia
HGNC:620,APP
chembl:CHEMBL3545378,MK-6592
chembl:CHEMBL978,METHACHOLINE
chembl:CHEMBL533954,CHEMBL533954
chembl:CHEMBL460433,CALPHOSTIN C
chembl:CHEMBL2364607,COBIMETINIB FUMARATE
chembl:CHEMBL1627429,CHEMBL1627429
chembl:CHEMBL1200405,BITOLTEROL MESYLATE
HGNC:10569,SERPINB3
ZFIN:ZDB-GENE-030131-8005,sdhb
HGNC:16974,SRCAP
HGNC:9701,PURA
HGNC:11036,SLC5A1
HGNC:11522,TACC1
chembl:CHEMBL3544968,GSK-610677
chembl:CHEMBL4297728,CIRMTUZUMAB
chembl:CHEMBL468403,QUINOCIDE
chembl:CHEMBL477,ADENOSINE
chembl:CHEMBL233632,PHENYLGLYOXAL
chembl:CHEMBL1371696,CHEMBL1371696
chembl:CHEMBL3889654,LAROTRECTINIB
chembl:CHEMBL411317,RICCARDI C
HGNC:6853,MAP3K14
CHEBI:37324,"7,8-dimethylbenzo[g]pteridine-2,4-dione"
chembl:CHEMBL3622821,UPADACITINIB
chembl:CHEMBL1888176,TROSPIUM
MONDO:0023258,glycogen storage disease type 1 due to SLC37A4 mutation
chembl:CHEMBL1697744,ERDOSTEINE
chembl:CHEMBL1456697,(Z)-PIPLARTINE
chembl:CHEMBL1434513,NOREPINEPHRINE BITARTRATE
HP:0031959,Leg dystonia
chembl:CHEMBL279229,URAPIDIL
HGNC:6235,KCNC3
MONDO:0014787,severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome
MONDO:0011719,gastrointestinal stromal tumor
HGNC:20064,USP44
chembl:CHEMBL528119,CHEMBL528119
HP:0007787,Posterior subcapsular cataract
chembl:CHEMBL2107313,BECATECARIN
HGNC:11569,TARBP2
HP:0002451,Limb dystonia
NCBIGene:481907,HTR1E
chembl:CHEMBL456295,OXOPURPUREINE
chembl:CHEMBL533226,CHEMBL533226
CHEBI:45863,paclitaxel
Reactome:R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs
chembl:CHEMBL1094691,AESCULIOSIDE IIA
chembl:CHEMBL1200478,DYCLONINE HYDROCHLORIDE
chembl:CHEMBL521373,SERGEOLIDE
chembl:CHEMBL165790,IPRIFLAVONE
chembl:CHEMBL2109271,MDX-210
chembl:CHEMBL2108184,CROFELEMER
HGNC:29079,KDM1A
HGNC:13581,FBXO2
chembl:CHEMBL1256842,NOMIFENSINE MALEATE
chembl:CHEMBL463526,LICARIN A
chembl:CHEMBL592611,CHEMBL592611
HP:0002356,Writer's cramp
chembl:CHEMBL1537417,CHEMBL1537417
HGNC:9784,RAB5B
chembl:CHEMBL429335,CHEMBL429335
MONDO:0007763,nonpapillary renal cell carcinoma
chembl:CHEMBL434200,TERTATOLOL
chembl:CHEMBL1901818,BROMETHALIN
chembl:CHEMBL1200953,HYDROCORTISONE PROBUTATE
chembl:CHEMBL1256291,CHEMBL1256291
chembl:CHEMBL2145077,IVABRADINE HYDROCHLORIDE
MONDO:0010041,Charlevoix-Saguenay spastic ataxia
MONDO:0013456,constitutional megaloblastic anemia with severe neurologic disease
chembl:CHEMBL4297618,GRANOTAPIDE
chembl:CHEMBL4298045,INDUSATUMAB VEDOTIN
GO:0004346,glucose-6-phosphatase activity
HGNC:30697,ITFG1
HP:0002464,Spastic dysarthria
HGNC:3819,FOXO1
MONDO:0021921,Arnold stickler bourne syndrome
MONDO:0003333,benign struma ovarii
chembl:CHEMBL6437,MIANSERIN
chembl:CHEMBL904,DEXMETHYLPHENIDATE HYDROCHLORIDE
HGNC:6341,KISS1
chembl:CHEMBL1093490,CHEMBL1093490
chembl:CHEMBL255044,FLUPIRTINE
chembl:CHEMBL2443262,OLICERIDINE
chembl:CHEMBL1079947,LORNEIC ACID A
HP:0040322,Purple urine
chembl:CHEMBL542541,HYDRALAZINE HYDROCHLORIDE
chembl:CHEMBL554054,APTIGANEL HYDROCHLORIDE
chembl:CHEMBL581194,CHEMBL581194
MONDO:0008566,"thyroid cancer, nonmedullary, 2"
HP:0002080,Intention tremor
chembl:CHEMBL85,RISPERIDONE
chembl:CHEMBL1082552,CHEMBL1082552
chembl:CHEMBL2323775,MK-8033
chembl:CHEMBL1560,CAPTOPRIL
chembl:CHEMBL532849,CHEMBL532849
MONDO:0005554,rheumatic disorder
HGNC:9759,RAB10
chembl:CHEMBL275311,CHEMBL275311
MONDO:0004985,bipolar disorder
NCBIGene:281126,DRD2
chembl:CHEMBL2105738,GALETERONE
HGNC:11355,STAG2
HGNC:6643,LMO3
chembl:CHEMBL444109,GAMBOGIC AMIDE
chembl:CHEMBL4298025,ZENOCUTUZUMAB
chembl:CHEMBL1790006,TOLONIUM CHLORIDE
chembl:CHEMBL1490851,BENZYLACETONE
MONDO:0007164,spastic ataxia 1
HP:0001382,Joint hypermobility
chembl:CHEMBL1814509,CHEMBL1814509
chembl:CHEMBL36,PYRIMETHAMINE
ZFIN:ZDB-GENE-040426-2143,mdh2
chembl:CHEMBL1200837,LEVOBETAXOLOL HYDROCHLORIDE
WB:WBGene00001519,gar-3
HGNC:29878,NIT2
HGNC:13815,BCO1
chembl:CHEMBL1201035,BIPERIDEN HYDROCHLORIDE
chembl:CHEMBL1542,AZATHIOPRINE
chembl:CHEMBL2105695,TELOTRISTAT ETHYL
chembl:CHEMBL39,SEROTONIN
MONDO:0001876,renal artery atheroma
chembl:CHEMBL270995,BRIVANIB ALANINATE
HGNC:20712,ZDHHC18
MGI:97360,Nos1
HGNC:16994,OS9
CHEBI:75954,vancomycin aglycone zwitterion
HP:0040096,Neoplasm of the inner ear
MONDO:0001641,severe pre-eclampsia
chembl:CHEMBL513800,PENICILLIOL B
HGNC:837,ATP5F1D
HGNC:12629,USP6
MONDO:0018055,pediatric hepatocellular carcinoma
MONDO:0020752,"myoclonic epilepsy, juvenile, susceptibility to, 1"
chembl:CHEMBL41092,CHRYSOPHANOL
HP:0004756,Ventricular tachycardia
chembl:CHEMBL1256752,FLUPIRTINE MALEATE
CHEBI:15940,nicotinic acid
HGNC:5175,AGFG1
chembl:CHEMBL1534034,CHEMBL1534034
chembl:CHEMBL479,THIORIDAZINE
HP:0031956,Elevated circulating aspartate aminotransferase concentration
chembl:CHEMBL202721,CHEMBL202721
MONDO:0044937,rectal carcinoma
HGNC:3622,FKTN
HP:0000735,Impaired social interactions
chembl:CHEMBL1200419,MOLINDONE HYDROCHLORIDE
HGNC:6297,KCNQ3
chembl:CHEMBL49055,CHEMBL49055
CHEBI:22720,benzodiazepine
CHEBI:15372,"5,6,7,8-tetrahydrobiopterin"
HP:0010951,Abnormal third ventricle morphology
CHEBI:204928,cefotaxime
MONDO:0023076,eosinophilic pustular folliculitis
chembl:CHEMBL1404,RANOLAZINE
chembl:CHEMBL14935,TEZAMPANEL
HGNC:8820,PDYN
chembl:CHEMBL461579,CHEMBL461579
chembl:CHEMBL2108029,ERTUMAXOMAB
HGNC:25773,WDR76
HP:0000531,Corneal crystals
MONDO:0011671,Huntington disease-like 2
chembl:CHEMBL1471,APREPITANT
HP:0011711,Left anterior fascicular block
HGNC:6563,LGALS3
chembl:CHEMBL1215,PHENYLEPHRINE
Xenbase:XB-GENE-987974,jph3
chembl:CHEMBL1271059,CHEMBL1271059
chembl:CHEMBL447,SECOBARBITAL
NCBIGene:100858928,HRH1
HGNC:6700,LRP8
GO:0010961,intracellular magnesium ion homeostasis
chembl:CHEMBL3545295,AVE0847
chembl:CHEMBL3545155,JI-101
chembl:CHEMBL265945,IRISOLIDONE
HGNC:4326,GLRA1
NCBIGene:423179,NDUFS3
WB:WBGene00008799,fdgt-2
CHEBI:28077,rifampicin
chembl:CHEMBL1201154,PROCHLORPERAZINE EDISYLATE
chembl:CHEMBL405821,SENICAPOC
ZFIN:ZDB-GENE-040822-17,sdhdb
HGNC:2600,CYP21A2
chembl:CHEMBL41632,TIRATRICOL
MGI:104913,Abi1
MONDO:0013594,spinocerebellar ataxia type 36
chembl:CHEMBL279678,S-ETOMIDATE
chembl:CHEMBL3544986,PERINDOPRIL ARGININE
HGNC:4390,GNAQ
chembl:CHEMBL601492,CHEMBL601492
HP:0007166,Paroxysmal dyskinesia
HGNC:1171,ELP4
chembl:CHEMBL527584,CHEMBL527584
HGNC:6541,LDHB
chembl:CHEMBL485750,PLUKENETIONE A
chembl:CHEMBL2108703,LIPROTAMASE
chembl:CHEMBL99408,CHEMBL99408
CHEBI:27902,tetracycline
HGNC:4279,GJA5
chembl:CHEMBL1503729,CHEMBL1503729
chembl:CHEMBL1256995,CHEMBL1256995
chembl:CHEMBL4298210,ISCALIMAB
chembl:CHEMBL1549,HYDROCORTISONE CYPIONATE
chembl:CHEMBL1084546,PF-00562271
chembl:CHEMBL1388,MONOBENZONE
chembl:CHEMBL979,MEPROBAMATE
HGNC:17052,SEC31A
chembl:CHEMBL486004,KLUGINE
chembl:CHEMBL441282,PROPYLPYRAZOLETRIOL
chembl:CHEMBL1179743,CHEMBL1179743
HGNC:11177,SOAT1
chembl:CHEMBL3833344,GANCOTAMAB
HGNC:11022,SLC35A2
chembl:CHEMBL592558,CHEMBL592558
HGNC:3584,FANCC
HP:0003388,Easy fatigability
MONDO:0006499,hamartoma
HGNC:1388,CACNA1A
HP:0030917,Low APGAR score
HGNC:20156,JPH4
chembl:CHEMBL1980297,ILORASERTIB
MONDO:0003651,macrotrabecular hepatoblastoma
HGNC:9091,PLS3
HP:0002650,Scoliosis
CHEBI:25481,naphthoquinone
CHEBI:142348,hexahydronaphthalenes
chembl:CHEMBL457504,CHEMBL457504
HGNC:8974,PIK3C3
WB:WBGene00016328,pde-5
chembl:CHEMBL404431,OZ277
chembl:CHEMBL29919,ELPETRIGINE
HGNC:12613,USP15
chembl:CHEMBL2203686,ARUNCIN B
MONDO:0005595,laryngeal squamous cell carcinoma
chembl:CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE
chembl:CHEMBL4297755,FP-1039
chembl:CHEMBL1863429,CYAZOFAMID
MONDO:0006669,bacterial endocarditis
chembl:CHEMBL1200690,LYPRESSIN
chembl:CHEMBL30,CIMETIDINE
chembl:CHEMBL3545020,MBX-2044
MONDO:0005284,chronic progressive multiple sclerosis
chembl:CHEMBL9419,METACETAMOL
chembl:CHEMBL1546228,CHEMBL1546228
chembl:CHEMBL1242196,DEHYDROMUTACTIN
HP:0100315,Lewy bodies
chembl:CHEMBL189676,SURINABANT
chembl:CHEMBL283078,THIOGUANOSINE
HGNC:225,ADAR
HGNC:30788,TLE6
chembl:CHEMBL95704,CHEMBL95704
chembl:CHEMBL148831,CHEMBL148831
chembl:CHEMBL28721,CHEMBL28721
chembl:CHEMBL1192517,BIFEMELANE
MONDO:0007108,anal canal carcinoma
chembl:CHEMBL4298088,CETUXIMAB SAROTALOCAN
chembl:CHEMBL62,SCH-23390
CHEBI:7025,mupirocin
chembl:CHEMBL156897,CANTHIN-6-ONE
MONDO:0011886,torsion dystonia 13
HGNC:12393,TTC3
chembl:CHEMBL589258,CHEMBL589258
CHEBI:2468,secondary alpha-hydroxy ketone
chembl:CHEMBL3360203,PILARALISIB
HP:0004906,Hypernatremic dehydration
HP:0031206,Striatal T2 hyperintensity
chembl:CHEMBL521171,CHEMBL521171
HGNC:33237,DUSP28
chembl:CHEMBL448382,RESINIFERATOXIN
chembl:CHEMBL603154,CHEMBL603154
chembl:CHEMBL3235620,ANTROQUINONOL
HGNC:33882,INPP5K
HGNC:1734,CDC34
HP:0000035,Abnormal testis morphology
chembl:CHEMBL85398,THIAZOLIDINEDIONE
NCBIGene:327669,IDH2
CHEBI:58297,glutathione disulfide(2-)
HGNC:16952,TXNIP
CHEBI:35344,21-hydroxy steroid
chembl:CHEMBL2103842,VARLITINIB
chembl:CHEMBL153062,4-NONYLPHENOL
HP:0001508,Failure to thrive
chembl:CHEMBL2108404,EPRATUZUMAB
chembl:CHEMBL1588237,CHEMBL1588237
HP:0007738,Uncontrolled eye movements
HP:0011425,Fetal ultrasound soft marker
chembl:CHEMBL1495,OXYPHENCYCLIMINE
chembl:CHEMBL580819,CHEMBL580819
HP:0003470,Paralysis
CHEBI:37323,"7,8-dimethylisoalloxazine"
HGNC:3629,FDFT1
HP:0007270,Atypical absence seizure
HGNC:11541,TAF7
chembl:CHEMBL449158,BRYOSTATIN
chembl:CHEMBL554190,QUINACRINE DIHYDROCHLORIDE
chembl:CHEMBL400598,(R)-PROCYCLIDINE
chembl:CHEMBL1201404,MOMETASONE
chembl:CHEMBL1335833,CHEMBL1335833
ZFIN:ZDB-GENE-040428-2,actr3
HGNC:25550,RMDN3
HGNC:693,ARL2
HGNC:25491,FRMD4A
MONDO:0015452,Coffin-Siris syndrome
chembl:CHEMBL4297284,HE3286
MGI:1347343,Usp5
HGNC:11226,SPG11
chembl:CHEMBL4297407,ALTROPANE I-123
chembl:CHEMBL845,N-DESMETHYLCLOZAPINE
HP:0002069,Bilateral tonic-clonic seizure
HGNC:1739,CDC45
RGD:621358,Kcnc3
HP:0007772,Impaired smooth pursuit
HGNC:21699,CERKL
chembl:CHEMBL468640,BERKELEYAMIDE B
MONDO:0014681,"thyroid cancer, nonmedullary, 4"
chembl:CHEMBL1511,ESTRADIOL VALERATE
HP:0005506,Chronic myelogenous leukemia
HP:0020046,Accommodative esotropia
HGNC:1962,CHRNB2
MONDO:0012278,"supranuclear palsy, progressive, 2"
HP:0001317,Abnormal cerebellum morphology
chembl:CHEMBL1200733,DESFLURANE
chembl:CHEMBL3545122,DOLCANATIDE
CHEBI:4139,D-galactopyranose
HP:0003731,Quadriceps muscle weakness
chembl:CHEMBL936,DIPHENIDOL
chembl:CHEMBL1255835,DIAMIDE
HGNC:9187,POLR2A
MONDO:0000701,ischemic colitis
HP:0025143,Chills
chembl:CHEMBL4228124,ORG-25935
NCBIGene:768048,COX14
chembl:CHEMBL251647,(S)-PINACIDIL
NCBITaxon:227984,SARS coronavirus Tor2
MONDO:0015518,infantile bilateral striatal necrosis
chembl:CHEMBL405110,METHYLTHIONINIUM CHLORIDE
chembl:CHEMBL170988,PHENFORMIN
chembl:CHEMBL28218,BROMPERIDOL
MONDO:0007661,Tourette syndrome
chembl:CHEMBL661,ALPRAZOLAM
chembl:CHEMBL1899565,GEOPYXIN A
chembl:CHEMBL3137305,DEFACTINIB HYDROCHLORIDE
HP:0000651,Diplopia
chembl:CHEMBL530609,CHEMBL530609
FB:FBgn0037153,olf413
HP:0002167,Abnormality of speech or vocalization
chembl:CHEMBL3039522,BIRINAPANT
chembl:CHEMBL397420,ACENOCOUMAROL
CHEBI:8116,phorbol
chembl:CHEMBL413376,SURAMIN HEXASODIUM
chembl:CHEMBL1358709,AZOCYCLOTIN
chembl:CHEMBL1108,DROPERIDOL
HGNC:11916,TNFRSF1A
chembl:CHEMBL517,DISOPYRAMIDE
HP:0012076,Borderline personality disorder
chembl:CHEMBL1144,PRAVASTATIN
HGNC:14310,BRD7
CHEBI:32681,L-argininate
chembl:CHEMBL515914,AZARIBINE
chembl:CHEMBL3545047,BMS-852927
ZFIN:ZDB-GENE-040801-26,sdhc
chembl:CHEMBL106124,SENKTIDE
chembl:CHEMBL1201245,BROMODIPHENHYDRAMINE
chembl:CHEMBL1200978,ARSENIC TRIOXIDE
chembl:CHEMBL3545042,SELURAMPANEL
CHEBI:23367,molecular entity
HGNC:87,ACAD8
HGNC:17893,PGAP2
chembl:CHEMBL598903,CHEMBL598903
HP:0011147,Typical absence seizure
MONDO:0003441,dystonic disorder
CHEBI:32688,D-argininate
CHEBI:85251,teicoplanin A2-2
chembl:CHEMBL848,LENALIDOMIDE
chembl:CHEMBL1873475,IBRUTINIB
chembl:CHEMBL545880,CHEMBL545880
chembl:CHEMBL331743,DIXANTHOGEN
HGNC:3227,EFNB2
CHEBI:4027,cyclophosphamide
chembl:CHEMBL222280,BROXURIDINE
chembl:CHEMBL137,METRONIDAZOLE
chembl:CHEMBL84440,CHEMBL84440
HP:0002350,Cerebellar cyst
chembl:CHEMBL119,TRIMETREXATE
chembl:CHEMBL588143,CHEMBL588143
chembl:CHEMBL252925,GAMMA-FAGARINE
MONDO:0005144,familial amyotrophic lateral sclerosis
chembl:CHEMBL51931,"9,10-PHENANTHRENEQUINONE"
chembl:CHEMBL2028852,ICATIBANT ACETATE
chembl:CHEMBL17860,LOFEXIDINE
GO:0006541,glutamine metabolic process
chembl:CHEMBL2062276,LEVALLORPHAN TARTRATE
chembl:CHEMBL3337527,JNJ-40411813
chembl:CHEMBL4297844,TRASTUZUMAB DERUXTECAN
Reactome:R-SSC-211945,Phase I - Functionalization of compounds
HGNC:1349,SAMD9L
HP:0002974,Radioulnar synostosis
UBERON:0002165,endocardium
chembl:CHEMBL3545401,X-82
HGNC:2197,COL1A1
chembl:CHEMBL541,BENZOIC ACID
HP:0002370,Poor coordination
HP:0002630,Fat malabsorption
chembl:CHEMBL1201570,ANAKINRA
HGNC:4235,GFAP
HGNC:13890,ITCH
HGNC:11344,ST14
chembl:CHEMBL211501,ANTIMYCIN A
HP:0001195,Single umbilical artery
chembl:CHEMBL1214274,CHEMBL1214274
HGNC:7459,MT-ND4
MONDO:0018160,hereditary retinoblastoma
chembl:CHEMBL283800,CREATINE
chembl:CHEMBL2109500,LIRILUMAB
HGNC:9879,RASGRP2
chembl:CHEMBL76,CHLOROQUINE
chembl:CHEMBL1201155,LOXAPINE SUCCINATE
HGNC:9053,PLAUR
HGNC:10978,SLC24A4
CHEBI:100246,norfloxacin
CHEBI:57292,succinyl-CoA(5-)
chembl:CHEMBL179611,CHEMBL179611
chembl:CHEMBL1876799,CLANFENUR
HGNC:26244,CEP97
chembl:CHEMBL1201191,LEVOCETIRIZINE
chembl:CHEMBL64545,MECLOFENOXATE
chembl:CHEMBL1337,NITISINONE
HP:0012392,Jaw hyporeflexia
HGNC:7843,NMBR
MONDO:0016487,beta-thalassemia intermedia
MONDO:0042983,neurocutaneous syndrome
HP:0003217,Hyperglutaminemia
HP:0010788,Testicular neoplasm
chembl:CHEMBL3137343,PEMBROLIZUMAB
HGNC:10917,SLC13A2
HGNC:588,ATG12
chembl:CHEMBL2068504,STIBOGLUCONATE
HGNC:3024,DRD3
chembl:CHEMBL591864,CHEMBL591864
CHEBI:30031,succinate(2-)
chembl:CHEMBL1201593,ALTEPLASE
chembl:CHEMBL464812,HYDRAMETHYLNON
MONDO:0011562,autosomal dominant Parkinson disease 4
chembl:CHEMBL247920,CHEMBL247920
HGNC:560,AP1S2
HGNC:10681,SDHB
HP:0009886,Trichorrhexis nodosa
MONDO:0007863,Kleine-Levin syndrome
chembl:CHEMBL600956,CHEMBL600956
chembl:CHEMBL3545349,EVT-101
HGNC:745,ASIP
chembl:CHEMBL4094440,BMS-919373
HGNC:20716,KLC2
MONDO:0700007,idiopathic disease
chembl:CHEMBL310934,CHEMBL310934
chembl:CHEMBL600,ACETYLCYSTEINE
chembl:CHEMBL1222251,INOSITOL
chembl:CHEMBL45305,BEFIRADOL
chembl:CHEMBL2104864,APLINDORE FUMARATE
CHEBI:16856,glutathione
chembl:CHEMBL2108576,BAPINEUZUMAB
MONDO:0003233,essential tremor
chembl:CHEMBL22108,DIMETHINDENE
chembl:CHEMBL315838,ENCAINIDE
CHEBI:37532,phorbol ester
MONDO:0016564,progressive supranuclear palsy-progressive non-fluent aphasia syndrome
wikidata:Q1851701,DALTEPARIN
chembl:CHEMBL3545007,RG-7602
HP:0002134,Abnormal basal ganglia morphology
chembl:CHEMBL403741,CHEMBL403741
HP:0031847,Difficulty walking backward
chembl:CHEMBL1010,CEFOTAXIME SODIUM
HGNC:6679,LPP
chembl:CHEMBL35482,CHEMBL35482
HGNC:3776,AFF2
UPHENO:0074367,abnormally decreased rate of motor coordination
chembl:CHEMBL1200494,GUANFACINE HYDROCHLORIDE
chembl:CHEMBL151146,CHEMBL151146
HGNC:26489,TMEM154
MONDO:0006692,central pontine myelinolysis
chembl:CHEMBL89786,2-PHENYLQUINOLINE
chembl:CHEMBL53929,OCTOPAMINE
chembl:CHEMBL3137348,SENREBOTASE
CHEBI:16962,cortisone
HGNC:5951,CADM1
chembl:CHEMBL494213,HYMENOIC ACID
HGNC:3467,ESR1
MONDO:0010065,spinocerebellar degeneration with slow eye movements
HP:0007302,Bipolar affective disorder
MGI:2444304,Vps13a
chembl:CHEMBL1256726,CHEMBL1256726
CHEBI:10023,voriconazole
chembl:CHEMBL1517425,ACETOCHLOR
chembl:CHEMBL504652,TC-2216
chembl:CHEMBL269881,CHEMBL269881
HP:0011396,Abnormality of the cochlear nerve
chembl:CHEMBL2108336,LIXISENATIDE
chembl:CHEMBL2109355,DUSIGITUMAB
chembl:CHEMBL1447815,INDIUM CHLORIDE
chembl:CHEMBL1917739,LUCIDUMOL A
chembl:CHEMBL1201061,LEVALBUTEROL HYDROCHLORIDE
HGNC:1553,CBX3
chembl:CHEMBL3545274,MK-6913
wikidata:Q29005654,COMETRIQ
chembl:CHEMBL1383812,CHEMBL1383812
chembl:CHEMBL375611,LY404039
Reactome:R-HSA-390651,Dopamine receptors
chembl:CHEMBL1904600,"TRIS(2,3-DIBROMOPROPYL)PHOSPHATE"
chembl:CHEMBL47386,EPIGALLOCATECHIN
chembl:CHEMBL1071,OXAPROZIN
chembl:CHEMBL430060,APICIDIN
chembl:CHEMBL510801,HEMOPRESSIN
MONDO:8000015,"46,XY sex reversal 11"
HGNC:12814,XPA
chembl:CHEMBL601137,CHEMBL601137
HGNC:226,ADARB1
chembl:CHEMBL15245,YOHIMBINE
HGNC:19094,IL4I1
chembl:CHEMBL129177,HARMALOL
chembl:CHEMBL194014,PROPYLPARABEN
MONDO:0012134,"myoclonic epilepsy, juvenile, susceptibility to, 3"
chembl:CHEMBL2408045,SAPITINIB
chembl:CHEMBL19449,IBUDILAST
HGNC:28971,SPIDR
chembl:CHEMBL1161,MOMETASONE FUROATE
chembl:CHEMBL781,MAZINDOL
HP:0031982,Abnormal putamen morphology
HGNC:12485,UBE2I
chembl:CHEMBL1445650,CHEMBL1445650
chembl:CHEMBL3544942,RONICICLIB
GO:0005634,nucleus
chembl:CHEMBL1091250,INDIGOTINDISULFONATE
chembl:CHEMBL9470,SHIKONIN
chembl:CHEMBL2104954,BALAMAPIMOD
chembl:CHEMBL571700,BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE
HGNC:9675,PTPRM
chembl:CHEMBL1328913,DIMETACRINE
chembl:CHEMBL566,URACIL
chembl:CHEMBL109317,GITOXIN
chembl:CHEMBL127516,BUTAMBEN
HGNC:14234,NSD1
MONDO:0002938,metatypical basal cell carcinoma
chembl:CHEMBL515763,CHEMBL515763
chembl:CHEMBL592943,TINORIDINE
chembl:CHEMBL357047,ALDISIN
chembl:CHEMBL1712170,ETHYLMORPHINE
HP:0100754,Mania
MONDO:0700089,paroxysmal nonkinesigenic dyskinesia 1
chembl:CHEMBL507986,CHEMBL507986
HP:0001387,Joint stiffness
chembl:CHEMBL534423,CHEMBL534423
chembl:CHEMBL1200902,THIOTHIXENE HYDROCHLORIDE
HGNC:20760,ZFYVE21
chembl:CHEMBL459505,TALAROZOLE
chembl:CHEMBL292352,CHEMBL292352
HGNC:8021,NT5E
chembl:CHEMBL80,NALOXONE
CHEBI:474180,caspofungin
chembl:CHEMBL1201195,CEFMETAZOLE
chembl:CHEMBL242383,RESOKAEMPFEROL
HP:0030083,Salt craving
chembl:CHEMBL1682,SORBITOL
HGNC:12825,XPO1
chembl:CHEMBL317094,IMIDAPRIL
chembl:CHEMBL600968,CHEMBL600968
HP:0000646,Amblyopia
chembl:CHEMBL1201295,BITOLTEROL
HGNC:9792,RAB9A
HP:0001943,Hypoglycemia
chembl:CHEMBL1515,METHIMAZOLE
chembl:CHEMBL3545015,RAD1901
chembl:CHEMBL1234354,PF-04691502
chembl:CHEMBL2403108,CERITINIB
chembl:CHEMBL582496,CHEMBL582496
HGNC:11195,SOX2
chembl:CHEMBL1591,DEMECLOCYCLINE
HGNC:777,ZFHX3
chembl:CHEMBL429405,SARCOLYSIN
chembl:CHEMBL1411,LISOFYLLINE
chembl:CHEMBL452231,TENIPOSIDE
chembl:CHEMBL1532,QUINETHAZONE
chembl:CHEMBL1491099,GANGALEOIDIN
HGNC:22219,KIAA1549
chembl:CHEMBL258756,CHEMBL258756
chembl:CHEMBL600374,CHEMBL600374
chembl:CHEMBL1201212,MIDODRINE
chembl:CHEMBL1200648,ROCURONIUM BROMIDE
ZFIN:ZDB-GENE-050522-437,ndufs5
Xenbase:XB-GENE-955485,nqo1
chembl:CHEMBL3989990,ISTIRATUMAB
chembl:CHEMBL470375,HURATOXIN
MONDO:0020047,autosomal recessive syndromic cerebellar ataxia
HGNC:15905,L3MBTL1
MONDO:0011706,Kufor-Rakeb syndrome
HP:0000089,Renal hypoplasia
MONDO:0019032,X-linked intellectual disability with isolated growth hormone deficiency
HP:0001131,Corneal dystrophy
MONDO:0021568,renal tubule disorder
chembl:CHEMBL2110660,IGMESINE
HGNC:9208,POR
GO:0006357,regulation of transcription by RNA polymerase II
chembl:CHEMBL3663929,NAQUOTINIB
MONDO:0005087,respiratory system disorder
HP:0000026,Male hypogonadism
chembl:CHEMBL280563,CHEMBL280563
chembl:CHEMBL1328898,MELEVODOPA
chembl:CHEMBL2349065,PETROSIOL A
chembl:CHEMBL289351,FOSBRETABULIN DISODIUM
chembl:CHEMBL588804,CHEMBL588804
GO:0005743,mitochondrial inner membrane
chembl:CHEMBL285063,CHEMBL285063
HGNC:8783,PDE4D
HGNC:6757,MAB21L1
GO:0006886,intracellular protein transport
HGNC:5467,IGF2R
chembl:CHEMBL581574,CHEMBL581574
chembl:CHEMBL563919,CHEMBL563919
chembl:CHEMBL1201271,BUCLIZINE
wikidata:Q31686490,ANDROSTANOLONE
chembl:CHEMBL191003,JNJ-7706621
HGNC:20134,GLRX5
HGNC:29,ABCA1
HGNC:15888,RTEL1
chembl:CHEMBL266195,ALPRENOLOL
chembl:CHEMBL582278,CHEMBL582278
HGNC:26064,MTARC2
chembl:CHEMBL3545293,FGF401
HGNC:2018,CLCA4
HGNC:2690,DBI
UPHENO:0048015,increased thickness of the corpus callosum
HGNC:10289,RPA1
UBERON:0000310,breast
HGNC:19009,CLUAP1
chembl:CHEMBL996,CEFOXITIN
chembl:CHEMBL592118,CHEMBL592118
chembl:CHEMBL600347,CHEMBL600347
MONDO:0004139,normocytic anemia
chembl:CHEMBL265715,CHEMBL265715
chembl:CHEMBL2108401,ENLIMOMAB PEGOL
chembl:CHEMBL196537,CHLORDANE
GO:0005324,long-chain fatty acid transporter activity
UBERON:0002358,peritoneum
MONDO:0020512,precursor T-cell acute lymphoblastic leukemia
chembl:CHEMBL1226,AMINODIMETHOXYQUINAZOLINYLPIPERAZINE
chembl:CHEMBL1200895,PHENELZINE SULFATE
chembl:CHEMBL527,PIROXICAM
chembl:CHEMBL386630,TESTOSTERONE
chembl:CHEMBL75094,PRINOMASTAT
chembl:CHEMBL184,ACYCLOVIR
chembl:CHEMBL589207,CHEMBL589207
GO:0097333,response to olanzapine
CHEBI:34994,teicoplanin A2
chembl:CHEMBL494089,GSK-690693
chembl:CHEMBL1507526,CHEMBL1507526
chembl:CHEMBL30008,FLUNARIZINE
chembl:CHEMBL1231160,PEVONEDISTAT
HGNC:20452,INSIG2
MONDO:0015059,progressive non-fluent aphasia
chembl:CHEMBL3545112,ME-401
chembl:CHEMBL429095,CHEMBL429095
MONDO:0011194,Alzheimer disease 5
chembl:CHEMBL3545213,BENTAMAPIMOD
HGNC:10916,SLC13A1
CHEBI:38532,hydrazone
HGNC:728,ARVCF
MONDO:0023149,infection due to clostridium perfringens
GO:0015571,N-acetylgalactosamine transmembrane transporter activity
chembl:CHEMBL1200703,CHLORDIAZEPOXIDE HYDROCHLORIDE
chembl:CHEMBL97453,WEDELOLACTONE
chembl:CHEMBL530280,CHEMBL530280
HGNC:4556,GPX4
CHEBI:87101,triazole antifungal drug
chembl:CHEMBL113051,GIMATECAN
chembl:CHEMBL2088301,CHEMBL2088301
chembl:CHEMBL3137301,SACUBITRIL
chembl:CHEMBL389433,LIAROZOLE
GO:0048018,receptor ligand activity
chembl:CHEMBL244268,CHEMBL244268
CHEBI:16737,creatinine
HP:0001257,Spasticity
HGNC:26658,POC5
chembl:CHEMBL1324,TOLCAPONE
HGNC:5287,HTR1B
HGNC:20790,ATG4B
HGNC:31326,ATXN2L
HP:0003325,Limb-girdle muscle weakness
chembl:CHEMBL636,RIVASTIGMINE
chembl:CHEMBL2105729,DABRAFENIB MESYLATE
chembl:CHEMBL589390,LATREPIRDINE
chembl:CHEMBL567597,ARTEMISININ
chembl:CHEMBL354676,DIPHENYLUREA
CHEBI:35692,dicarboxylic acid
CHEBI:16467,L-arginine
CHEBI:58228,carbamoyl phosphate(2-)
CHEBI:50845,doxycycline
HGNC:18276,SEC61A1
chembl:CHEMBL1623897,CHEMBL1623897
chembl:CHEMBL1234231,CALCIPOTRIOL
chembl:CHEMBL38874,DAMGO
chembl:CHEMBL278398,PHENINDAMINE
chembl:CHEMBL1201863,DEXLANSOPRAZOLE
chembl:CHEMBL486504,CHEMBL486504
HGNC:2681,DAXX
chembl:CHEMBL2062267,HYDROCODONE BITARTRATE
MONDO:0100035,structural epilepsy
chembl:CHEMBL1709,SERTRALINE HYDROCHLORIDE
chembl:CHEMBL1762594,CHEMBL1762594
HGNC:18155,TXNRD2
chembl:CHEMBL1364172,CHEMBL1364172
chembl:CHEMBL119878,CHEMBL119878
chembl:CHEMBL1743072,SOLANEZUMAB
CHEBI:30087,guanidinium
MONDO:0008159,postmenopausal osteoporosis
HGNC:7989,NRAS
MONDO:0010940,inherited susceptibility to asthma
chembl:CHEMBL1465,PHENPROCOUMON
HGNC:25679,ATG101
chembl:CHEMBL1783734,PIRAGLIATIN
HGNC:14063,HDAC4
chembl:CHEMBL445102,CHEMBL445102
chembl:CHEMBL1884669,SULFENTRAZONE
chembl:CHEMBL592600,CHEMBL592600
HGNC:10934,SLC18A1
HP:0001302,Pachygyria
HGNC:14064,HDAC6
chembl:CHEMBL278315,GELDANAMYCIN
chembl:CHEMBL9387,L-365260
MONDO:0032673,"basal ganglia calcification, idiopathic, 7, autosomal recessive"
chembl:CHEMBL3545001,MK-8353
HGNC:4623,GSR
HGNC:30599,CHMP4C
HGNC:60,ABCC9
PR:000007497,fibroblast growth factor 6
chembl:CHEMBL253144,CORTODOXONE
chembl:CHEMBL269733,DEPHOSTATIN
chembl:CHEMBL1341830,CHEMBL1341830
CHEBI:17790,methanol
chembl:CHEMBL1700,SOTALOL HYDROCHLORIDE
chembl:CHEMBL1621,PALIPERIDONE
chembl:CHEMBL18840,CHEMBL18840
chembl:CHEMBL1956073,CHEMBL1956073
chembl:CHEMBL551842,LOBARIC ACID
chembl:CHEMBL1223743,7-O-METHYLCRYPTOCHINONE B
chembl:CHEMBL1088186,TRIBUTYLCHLOROSTANNANE
HP:0002073,Progressive cerebellar ataxia
UPHENO:0081343,vestibular nerve hypoplasia
MONDO:0020183,neurogenic palpebral tumor
chembl:CHEMBL1869551,CHLORFENAPYR
chembl:CHEMBL2436861,TRIMETHYL-[3-(TETRADECANE-1-SULFONYLAMINO)-PROPYL]-AMMONIUM IODIDE
HP:0002151,Increased serum lactate
chembl:CHEMBL2105160,NAMINIDIL
HGNC:26784,MTRFR
chembl:CHEMBL1232258,D-LEUCINE
HGNC:11998,TP53
CHEBI:33859,aromatic carboxylic acid
HGNC:12827,XPR1
chembl:CHEMBL991,STAVUDINE
chembl:CHEMBL592588,CHEMBL592588
UPHENO:0079820,abnormally increased rate of hallucination
chembl:CHEMBL435298,ESFLURBIPROFEN
HP:0002015,Dysphagia
chembl:CHEMBL42115,THYROXINE
chembl:CHEMBL1939691,CHEMBL1939691
HGNC:2719,DDC
chembl:CHEMBL1201132,NALBUPHINE HYDROCHLORIDE
chembl:CHEMBL1513,IRBESARTAN
chembl:CHEMBL28319,QUESTIOMYCIN B
HP:0004866,Impaired ADP-induced platelet aggregation
chembl:CHEMBL4297397,QUERCETIN-3'-O-PHOSPHATE
HGNC:11399,NEK4
HP:0002100,Recurrent aspiration pneumonia
chembl:CHEMBL3544930,SC-80036
MONDO:0006047,pancreatic adenocarcinoma
chembl:CHEMBL565540,CHEMBL565540
HGNC:11935,CD40LG
GO:0030141,secretory granule
chembl:CHEMBL25856,DIHYDREXIDINE
MGI:107825,Adam8
HGNC:5047,HNRNPR
chembl:CHEMBL2112314,CHEMBL2112314
chembl:CHEMBL1397270,CHEMBL1397270
HGNC:9937,RCVRN
chembl:CHEMBL32,MOXIFLOXACIN
chembl:CHEMBL1237054,PLICAMYCIN
chembl:CHEMBL531401,CHEMBL531401
chembl:CHEMBL1079593,VS-5584
chembl:CHEMBL598695,CHEMBL598695
chembl:CHEMBL2108396,DEFIBROTIDE
CHEBI:171664,antiamoebic agent
HGNC:2712,DCTN2
chembl:CHEMBL339427,TUBOCURARINE
HGNC:11503,SYNJ1
GO:0003909,DNA ligase activity
chembl:CHEMBL579919,CHEMBL579919
CHEBI:66933,N-alkylglycine
Reactome:R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
HP:0000662,Nyctalopia
HGNC:3228,EFNB3
chembl:CHEMBL1326877,DIOXYBENZONE
HGNC:2445,CSN1S1
MONDO:0003409,colonic disorder
HGNC:11103,SMARCB1
HGNC:8003,NRM
HGNC:2579,CYC1
GO:0019838,growth factor binding
HP:0000774,Narrow chest
HP:0000505,Visual impairment
wikidata:Q7842230,TRIMETHOPRIM/SULFADOXINE
chembl:CHEMBL696,ETHOSUXIMIDE
chembl:CHEMBL547924,CHEMBL547924
HGNC:18856,CREB3L1
chembl:CHEMBL258867,EUPALININ A
HGNC:819,ATP4A
chembl:CHEMBL442687,TIOXOLONE
HGNC:8728,PCMT1
chembl:CHEMBL4297463,CPI-1205
HGNC:6392,KIF23
chembl:CHEMBL461462,LISSOCLINIDINE B
HGNC:4223,MSTN
chembl:CHEMBL1519,TRANDOLAPRIL
HGNC:2714,DCX
HP:0001310,Dysmetria
MONDO:0003818,childhood mature teratoma of the ovary
chembl:CHEMBL32147,2'-HYDROXYCHALCONE
chembl:CHEMBL101,PHENYLBUTAZONE
chembl:CHEMBL946,AZATADINE
chembl:CHEMBL856,PRIMIDONE
MONDO:0004210,colonic L-cell glucagon-like peptide producing tumor
chembl:CHEMBL2103799,COBIPROSTONE
HGNC:11999,TP53BP1
chembl:CHEMBL1120,BISMUTH SUBSALICYLATE
UPHENO:0080275,decreased motor coordination
MONDO:0042972,meningococcemia
HGNC:3120,E2F6
chembl:CHEMBL2103867,PLECANATIDE
chembl:CHEMBL1094683,AESCULIOSIDE IIIB
chembl:CHEMBL1589978,METHYLEPHEDRINE
CHEBI:57670,N-acylglycinate
chembl:CHEMBL1743029,IBALIZUMAB
chembl:CHEMBL1908360,EVEROLIMUS
chembl:CHEMBL3707235,GEMIGLIPTIN
HGNC:24990,COA3
HGNC:23244,RBM25
HGNC:30024,PEX5L
chembl:CHEMBL510279,DIHYDROXANTHOHUMOL
chembl:CHEMBL268089,WR-159412
chembl:CHEMBL460508,CHEMBL460508
chembl:CHEMBL1691,BETAXOLOL HYDROCHLORIDE
MONDO:0014094,severe congenital hypochromic anemia with ringed sideroblasts
HP:0000121,Nephrocalcinosis
HP:0030185,Isometric tremor
chembl:CHEMBL52,NORDIHYDROGUAIARETIC ACID
chembl:CHEMBL3545264,LY-2874455
chembl:CHEMBL7162,NS-398
HGNC:28171,HDHD3
chembl:CHEMBL832,SULFINPYRAZONE
GO:0006468,protein phosphorylation
MONDO:0018632,11q22.2q22.3 microdeletion syndrome
HGNC:7794,NFKB1
chembl:CHEMBL1451216,CHEMBL1451216
chembl:CHEMBL3545348,BKT140
chembl:CHEMBL18442,PLERIXAFOR
chembl:CHEMBL463563,ISOTHYMONIN
chembl:CHEMBL1783282,AZD7325
chembl:CHEMBL90555,VINCRISTINE
chembl:CHEMBL94,PHYSOSTIGMINE
chembl:CHEMBL629,AMITRIPTYLINE
HGNC:11237,SPG7
chembl:CHEMBL206253,NETUPITANT
HP:0030050,Narcolepsy
chembl:CHEMBL1517,OXYTETRACYCLINE
HP:0000040,Long penis
chembl:CHEMBL3545102,SB-773812
chembl:CHEMBL2105667,ORVEPITANT
chembl:CHEMBL1079421,PHENMEDIPHAM
chembl:CHEMBL125,MILTEFOSINE
MGI:1929270,Dstn
GO:1903491,response to simvastatin
HP:0025425,Laryngospasm
HGNC:3801,FOXC2
chembl:CHEMBL602260,CHEMBL602260
chembl:CHEMBL472646,MORONIC ACID
chembl:CHEMBL74852,CHEMBL74852
chembl:CHEMBL307145,PYROGALLOL
CHEBI:55370,imidazolidinone
HGNC:11018,SLC32A1
WB:WBGene00011629,vps-13
chembl:CHEMBL18785,RU-24969
HGNC:12033,TRAF3
UPHENO:0025440,absent vestibular nerve in the independent continuant
chembl:CHEMBL1366933,ESMIRTAZAPINE
chembl:CHEMBL1076211,TOLPERISONE
HGNC:14353,DNALI1
HGNC:30722,TEX101
MONDO:0011823,developmental malformations-deafness-dystonia syndrome
chembl:CHEMBL590168,CHEMBL590168
chembl:CHEMBL2323582,BODILISANT
chembl:CHEMBL4297333,VB-201
chembl:CHEMBL1201477,POLYESTRADIOL PHOSPHATE
HP:0001338,Partial agenesis of the corpus callosum
HP:0000571,Hypometric saccades
HGNC:6513,LASP1
chembl:CHEMBL542157,SARAFLOXACIN HYDROCHLORIDE
chembl:CHEMBL1201247,GOSERELIN
chembl:CHEMBL490129,SANGUINARIUM CHLORIDE
chembl:CHEMBL151797,CHEMBL151797
chembl:CHEMBL211045,CHEMBL211045
CHEBI:71337,minocycline(1-)
HGNC:3070,DUSP4
chembl:CHEMBL2103812,GOLOTIMOD
MONDO:0019755,developmental defect during embryogenesis
chembl:CHEMBL50882,TIRAPAZAMINE
HP:0045007,Abnormal substantia nigra morphology
chembl:CHEMBL1256708,APOMORPHINE HYDROCHLORIDE HEMIHYDRATE
HP:0003614,Trimethylaminuria
chembl:CHEMBL2108187,CLENOLIXIMAB
HP:0000126,Hydronephrosis
chembl:CHEMBL282433,DITOLYLGUANIDINE
HGNC:26927,FOXRED1
chembl:CHEMBL375563,CHEMBL375563
chembl:CHEMBL3545117,AVE-9940
NCBIGene:403882,HTR2A
chembl:CHEMBL1571863,ISOCONAZOLE
MONDO:0000761,syndrome caused by partial chromosomal deletion
HGNC:15454,SHOC2
HGNC:6231,KCNB1
HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
MONDO:0012595,"leprosy, susceptibility to, 4"
CHEBI:17859,glutaric acid
HGNC:15842,ERBIN
HP:0003204,Intracellular accumulation of autofluorescent lipopigment storage material
chembl:CHEMBL2105747,TOZADENANT
chembl:CHEMBL224032,CHEMBL224032
MONDO:0021095,parkinsonian disorder
chembl:CHEMBL2109150,LINTUZUMAB
HGNC:7063,MGST2
chembl:CHEMBL3931971,RAZUPROTAFIB
chembl:CHEMBL586163,CHEMBL586163
chembl:CHEMBL402915,CHEMBL402915
CHEBI:16827,corticosterone
chembl:CHEMBL566315,OBETICHOLIC ACID
chembl:CHEMBL422872,AZD-4769
HGNC:700,ARNT
RGD:621321,Myo1d
chembl:CHEMBL516616,CHEMBL516616
chembl:CHEMBL252716,BERKELEYTRIONE
HGNC:16085,SFXN1
chembl:CHEMBL198877,AUS-131
HGNC:32207,LIN28B
Reactome:R-DRE-71288,Creatine metabolism
chembl:CHEMBL1349,VALACYCLOVIR
MGI:1916847,Afg3l2
chembl:CHEMBL1279,FROVATRIPTAN
chembl:CHEMBL3301572,NUSINERSEN
CHEBI:35627,beta-lactam
chembl:CHEMBL604538,CHEMBL604538
HGNC:19118,TNIP2
HP:0001548,Overgrowth
chembl:CHEMBL586135,CHEMBL586135
HGNC:6556,LETM1
HGNC:11118,SMN2
chembl:CHEMBL1201764,FESOTERODINE
HGNC:9201,POMC
chembl:CHEMBL464658,GITOXIGENIN
chembl:CHEMBL267930,SPIPERONE
chembl:CHEMBL316034,CHEMBL316034
chembl:CHEMBL1329032,ISOSPAGLUMIC ACID
MONDO:0014804,sideroblastic anemia 3
WB:WBGene00020506,dop-3
HGNC:6607,LILRB3
HGNC:12336,TRPC4
RGD:1309714,Cln6
chembl:CHEMBL3990567,ZALOSPIRONE
HP:0002793,Abnormal pattern of respiration
HGNC:877,ALDH7A1
HGNC:25532,MTPAP
chembl:CHEMBL1426508,CHEMBL1426508
RGD:68328,Slc2a5
chembl:CHEMBL2105760,BREXPIPRAZOLE
chembl:CHEMBL599165,CHEMBL599165
chembl:CHEMBL2108025,DEPELESTAT
MONDO:0032726,combined oxidative phosphorylation deficiency 39
HGNC:24731,NHLRC2
GO:0050896,response to stimulus
CHEBI:61049,tacrolimus (anhydrous)
chembl:CHEMBL560296,CHEMBL560296
HGNC:24229,CIDEC
chembl:CHEMBL1390650,CHEMBL1390650
HGNC:15450,TGOLN2
chembl:CHEMBL1466,DICUMAROL
CHEBI:31355,carboplatin
HGNC:16744,CIZ1
wikidata:Q47521055,ANTABUSE
chembl:CHEMBL1201468,"ESTROGENS, ESTERIFIED"
HGNC:11280,SQSTM1
chembl:CHEMBL220845,CHEMBL220845
chembl:CHEMBL4297630,COTADUTIDE
chembl:CHEMBL3137345,DULIGOTUZUMAB
MONDO:0008438,hereditary spastic paraplegia 4
chembl:CHEMBL548681,CHEMBL548681
chembl:CHEMBL4297782,MINNELIDE
HGNC:8774,PDE1A
HGNC:13887,ABCG8
chembl:CHEMBL509032,TAE-684
chembl:CHEMBL1062,HYDROXYPROGESTERONE
chembl:CHEMBL66114,CHEMBL66114
HGNC:9823,RAD51D
HGNC:4373,GMFB
MONDO:0032865,"pulmonary fibrosis and/or bone marrow failure, telomere-related, 5"
chembl:CHEMBL638,VORICONAZOLE
MONDO:0016681,gliosarcoma
NCBIGene:444878,COX5A
chembl:CHEMBL1206,ETHOPROPAZINE
chembl:CHEMBL549386,FOTEMUSTINE
MONDO:0009480,Joubert syndrome with oculorenal defect
chembl:CHEMBL460702,BMS-777607
chembl:CHEMBL1394829,PROPACHLOR
chembl:CHEMBL2107549,BINDARIT
HGNC:6535,LDHA
HGNC:6179,ITPKB
HGNC:3299,EIF5
HP:0030190,Oral motor hypotonia
HGNC:30528,DNAJC19
HGNC:11158,SNRPD1
HGNC:8583,SERPINE1
HGNC:11312,TRIM21
HGNC:16422,CARD10
chembl:CHEMBL258465,CHEMBL258465
chembl:CHEMBL617,CEPHALOTHIN
CHEBI:38925,benzopteridine
CHEBI:8386,pregnane
chembl:CHEMBL2109520,ONCOLYSIN M
chembl:CHEMBL468167,CHLOROTHALONIL
HGNC:20194,POLR1C
chembl:CHEMBL1095284,CEFATRIZINE
chembl:CHEMBL265439,CHEMBL265439
chembl:CHEMBL1702,ATOMOXETINE HYDROCHLORIDE
chembl:CHEMBL590635,SHINFLAVANONE
MGI:88543,Csnk2a1
chembl:CHEMBL378544,VINBLASTINE SULFATE
MONDO:0010237,X-linked intellectual disability-plagiocephaly syndrome
HGNC:587,APEX1
chembl:CHEMBL1197,HEXYLCAINE
MONDO:0006757,extrahepatic cholestasis
WB:WBGene00000063,act-1
HP:0031472,Risk taking
HP:0034342,Trapezius muscle aplasia
chembl:CHEMBL1550,PHYTONADIONE
MONDO:0009279,triple-A syndrome
CL:0000094,granulocyte
HGNC:7905,NPHP1
chembl:CHEMBL1351908,CHEMBL1351908
HP:0002671,Basal cell carcinoma
chembl:CHEMBL4297508,DORZAGLIATIN
chembl:CHEMBL1201334,TRIPTORELIN
HGNC:14289,NLGN3
HGNC:10910,SLC12A1
chembl:CHEMBL1797712,CHEMBL1797712
HP:0002231,Sparse body hair
chembl:CHEMBL375293,CHEMBL375293
chembl:CHEMBL591137,CHEMBL591137
HP:0003394,Muscle spasm
HP:0002664,Neoplasm
HP:0000722,Compulsive behaviors
HGNC:6229,KCNAB2
chembl:CHEMBL481422,CHEMBL481422
chembl:CHEMBL1237080,GRANISETRON HYDROCHLORIDE
HP:0009020,Exercise-induced muscle fatigue
chembl:CHEMBL1201149,NALTREXONE HYDROCHLORIDE
chembl:CHEMBL257748,CHEMBL257748
MONDO:0003876,eyelid carcinoma
chembl:CHEMBL3545080,RG-7256
chembl:CHEMBL195515,CHEMBL195515
wikidata:Q47522014,PREMARIN
chembl:CHEMBL276139,CHEMBL276139
chembl:CHEMBL392149,TECADENOSON
chembl:CHEMBL83668,TOLNAFTATE
chembl:CHEMBL1310138,CHEMBL1310138
chembl:CHEMBL1477036,DOCUSATE
chembl:CHEMBL35354,CHEMBL35354
chembl:CHEMBL473773,CHEMBL473773
chembl:CHEMBL2180604,TAK-593
HGNC:17366,AASS
chembl:CHEMBL3545004,PL-225B
chembl:CHEMBL3989865,MIPSAGARGIN
MONDO:0009518,"leprosy, susceptibility to, 3"
HGNC:16806,UBR5
chembl:CHEMBL3301576,PEGPLERANIB SODIUM
MONDO:0016216,adult hepatocellular carcinoma
HGNC:11370,STAU1
chembl:CHEMBL1933349,MK-0893
HP:0012389,Appendicular hypotonia
HP:0002905,Hyperphosphatemia
chembl:CHEMBL295316,PLUMBAGIN
HGNC:6180,ITPR1
HGNC:6742,LZTR1
MONDO:0021100,breast neoplasm
HGNC:14333,BAALC
HGNC:4739,H2AX
chembl:CHEMBL3545027,XL-281
chembl:CHEMBL1743063,RILOTUMUMAB
chembl:CHEMBL445969,CAULIBUGULONE C
HGNC:1573,KRIT1
chembl:CHEMBL1088937,"3,4-DIMETHOXYBENZALDEHYDE"
HGNC:18855,CREB3L3
chembl:CHEMBL1200645,ETOPOSIDE PHOSPHATE
chembl:CHEMBL1464,WARFARIN
chembl:CHEMBL118218,IROFULVEN
chembl:CHEMBL3126832,OBP-801
HP:5200123,Abnormal response to social norms
HP:0001187,Hyperextensibility of the finger joints
chembl:CHEMBL1170,TESTOSTERONE PROPIONATE
CHEBI:192979,nystatin A2
HGNC:4083,GABRB3
chembl:CHEMBL549,CITALOPRAM
HGNC:8127,OGT
HGNC:13480,ULK2
UBERON:0035825,left adrenal gland cortex
chembl:CHEMBL1569494,CHEMBL1569494
chembl:CHEMBL4297608,ELDECALCITOL
MONDO:0013903,"nystagmus 7, congenital, autosomal dominant"
chembl:CHEMBL3545326,TAS-119
HGNC:21143,ZBTB24
MONDO:0017859,colchicine poisoning
chembl:CHEMBL356359,PIBOSEROD
chembl:CHEMBL132530,FORMESTANE
chembl:CHEMBL563,FLURBIPROFEN
chembl:CHEMBL284348,DALFAMPRIDINE
chembl:CHEMBL1201532,THYROTROPIN
chembl:CHEMBL75880,PERHEXILINE
chembl:CHEMBL1276446,CHEMBL1276446
HGNC:37,ABCA7
chembl:CHEMBL2109300,GSK933776
HGNC:11892,TNF
MONDO:0007739,Huntington disease
WB:WBGene00019547,K09C4.1
chembl:CHEMBL1213187,CHEMBL1213187
chembl:CHEMBL1175,DULOXETINE
Reactome:R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane
chembl:CHEMBL1518,PROPYLTHIOURACIL
chembl:CHEMBL2104967,FIRATEGRAST
chembl:CHEMBL177820,TETRABROMOBENZOTRIAZOLE
HGNC:6037,ILF2
MONDO:0005550,infectious disease
HGNC:9588,PTEN
HGNC:12513,UCHL1
chembl:CHEMBL1201287,DEXBROMPHENIRAMINE
chembl:CHEMBL2346738,DIPRAGLURANT
chembl:CHEMBL287327,CHEMBL287327
chembl:CHEMBL1201118,CEFMETAZOLE SODIUM
chembl:CHEMBL1684,BENDROFLUMETHIAZIDE
chembl:CHEMBL221907,CUDRAFLAVONE B
HGNC:9284,PPP1R10
HP:0009725,Bladder neoplasm
chembl:CHEMBL3545382,R-348
HGNC:16712,FBXW7
chembl:CHEMBL1118,DESVENLAFAXINE
chembl:CHEMBL494283,CHEMBL494283
MONDO:0014668,"cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4"
chembl:CHEMBL90017,ALPHA-TERTHIENYL
HGNC:11104,SMARCC1
HP:0002119,Ventriculomegaly
HGNC:2979,DNMT3B
MONDO:0003410,Wolffian duct adenocarcinoma
UBERON:0003701,calcaneal tendon
HGNC:21224,ZUP1
HGNC:1361,AOPEP
chembl:CHEMBL582286,CHEMBL582286
chembl:CHEMBL596,FENTANYL
HGNC:14525,CHORDC1
chembl:CHEMBL2448613,PIMAVANSERIN TARTRATE
HGNC:29506,SRCIN1
chembl:CHEMBL283820,SPIROGLUMIDE
chembl:CHEMBL1626,CLEMASTINE
chembl:CHEMBL599304,CHEMBL599304
chembl:CHEMBL1082508,LANDIPIRDINE
chembl:CHEMBL2107862,RINTATOLIMOD
chembl:CHEMBL55400,PROFLAVINE
HP:0000317,Facial myokymia
HGNC:10780,SRSF1
chembl:CHEMBL388529,GUTTIFERONE K
CHEBI:36683,organochlorine compound
GO:0098588,bounding membrane of organelle
HP:0006863,Severe expressive language delay
chembl:CHEMBL263116,DIMETHYL YELLOW
chembl:CHEMBL924,ZOLEDRONIC ACID
HGNC:17646,NGLY1
chembl:CHEMBL1393904,MIRIPIRIUM
chembl:CHEMBL471226,CHEMBL471226
ECTO:0001591,
chembl:CHEMBL24038,RAGAGLITAZAR
chembl:CHEMBL608855,CHEMBL608855
HGNC:16002,MPLKIP
chembl:CHEMBL1476646,CHEMBL1476646
chembl:CHEMBL1200446,TRIPELENNAMINE HYDROCHLORIDE
chembl:CHEMBL3916717,SELONSERTIB
chembl:CHEMBL1200558,BACITRACIN
HGNC:7850,NME2
MONDO:0011963,Joubert syndrome 2
chembl:CHEMBL578276,CHEMBL578276
HP:0008003,Jerky ocular pursuit movements
chembl:CHEMBL4297182,PEGCANTRATINIB
HP:0003737,Mitochondrial myopathy
chembl:CHEMBL1200749,LEVOBUPIVACAINE HYDROCHLORIDE
chembl:CHEMBL3989936,VILAPRISAN
chembl:CHEMBL529348,CHEMBL529348
HP:0003593,Infantile onset
HGNC:7422,MT-CO3
chembl:CHEMBL275835,DARBUFELONE
chembl:CHEMBL591412,CHEMBL591412
MONDO:0024189,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset"
chembl:CHEMBL485053,LEUCETTAMINE B
MONDO:0006640,adrenal gland hyperfunction
HGNC:16870,MELK
chembl:CHEMBL1079109,RALOXIFEN
HGNC:19832,CLEC14A
HGNC:10671,SDCCAG8
MONDO:0020300,autosomal dominant nocturnal frontal lobe epilepsy
chembl:CHEMBL3545224,BURIXAFOR
HGNC:1440,CALCR
chembl:CHEMBL120526,METHANANDAMIDE
chembl:CHEMBL490125,SCHISANHENOL
HGNC:7763,NEUROD2
chembl:CHEMBL491981,7-HYDROXY ISOFLAVONE
NCBIGene:415826,COX4I1
chembl:CHEMBL27768,CHEMBL27768
HP:0003739,Myoclonic spasms
HGNC:13584,FBXO5
chembl:CHEMBL414357,EXENATIDE
chembl:CHEMBL93240,METITEPINE
chembl:CHEMBL602418,CHEMBL602418
HGNC:11621,HNF1A
HGNC:10301,RPL11
chembl:CHEMBL286204,QUINOLINIC ACID
chembl:CHEMBL544713,BENOXATHIAN HYDROCHLORIDE
chembl:CHEMBL1200492,NEFAZODONE HYDROCHLORIDE
chembl:CHEMBL1200665,DIPHENOXYLATE HYDROCHLORIDE
HGNC:4281,GJA8
GO:0042092,type 2 immune response
MONDO:0020655,juvenile ankylosing spondylitis
chembl:CHEMBL609438,CHEMBL609438
HGNC:2460,CSNK2B
chembl:CHEMBL580159,CHEMBL580159
NCBIGene:535293,EPHX1
chembl:CHEMBL12636,HYMECROMONE METHYL ETHER
MONDO:0003010,multilocular clear cell renal cell carcinoma
chembl:CHEMBL2108278,ETEPLIRSEN
MONDO:0015753,cap myopathy
HGNC:2186,COL11A1
HP:0007351,Upper limb postural tremor
chembl:CHEMBL586670,CHEMBL586670
chembl:CHEMBL1677,TACRINE HYDROCHLORIDE
chembl:CHEMBL3545077,MK-1496
ZFIN:ZDB-GENE-010724-6,fh
chembl:CHEMBL454843,CANDIDIN
HGNC:26053,THG1L
GO:0004111,creatine kinase activity
HGNC:29186,ANKRD26
chembl:CHEMBL1271027,AMPKINONE
chembl:CHEMBL400912,CHEMBL400912
HGNC:678,ARHGDIA
GO:0022881,protein-N(PI)-phosphohistidine-N-acetylgalactosamine phosphotransferase system transporter activity
GO:0016922,nuclear receptor binding
Xenbase:XB-GENE-5915063,actr3
chembl:CHEMBL144472,NILE RED
MONDO:0006617,vesiculobullous skin disease
CHEBI:25106,macrolide
HP:0001182,Tapered finger
CHEBI:35474,anxiolytic drug
chembl:CHEMBL2178577,AZD-5363
HP:0025160,Abnormal temper tantrums
chembl:CHEMBL1278089,"CHOLESTAN-3BETA,5ALPHA,6BETA-TRIOL"
chembl:CHEMBL605959,CHEMBL605959
chembl:CHEMBL111861,CORTISONE
chembl:CHEMBL1370698,CHEMBL1370698
chembl:CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE
HGNC:3678,FGF21
CHEBI:6121,ketamine
MONDO:0002159,fallopian tube leiomyosarcoma
chembl:CHEMBL1442783,CHEMBL1442783
chembl:CHEMBL521027,CYPRODINIL
chembl:CHEMBL17289,CHS-828
HGNC:2726,DDIT3
chembl:CHEMBL2103826,DAVUNETIDE
chembl:CHEMBL589912,CHEMBL589912
HGNC:17383,HRH4
HP:0005301,Persistent left superior vena cava
HP:0001328,Specific learning disability
CHEBI:100241,ciprofloxacin
HGNC:30858,EFTUD2
chembl:CHEMBL3904602,LEROCICLIB
chembl:CHEMBL1354529,VIOLASTYRENE
NCBIGene:478853,COQ10B
HGNC:4172,GATA3
chembl:CHEMBL730,NITROGLYCERIN
MONDO:0006322,non-neoplastic bile duct disorder
HGNC:9394,PICK1
HP:0011152,Early onset absence seizures
chembl:CHEMBL532525,CHEMBL532525
HGNC:16807,SMURF1
HGNC:4376,GMPR
WB:WBGene00006865,slcf-2
MONDO:0005394,brain infarction
HGNC:1476,CAPN1
chembl:CHEMBL607253,CHEMBL607253
HGNC:11989,TOP2A
CHEBI:15394,(-)-borneol
HP:0007020,Progressive spastic paraplegia
chembl:CHEMBL255068,CHEMBL255068
chembl:CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE
MONDO:0016163,autosomal dominant cerebellar ataxia type II
Reactome:R-GGA-500753,Pyrimidine biosynthesis
MONDO:0014867,spinocerebellar ataxia 43
HGNC:6008,IL2RA
MONDO:0007110,Diamond-Blackfan anemia 1
MONDO:0002947,adamantinoid basal cell epithelioma
chembl:CHEMBL74355,VOLINANSERIN
chembl:CHEMBL2108721,CENDERITIDE
HGNC:2873,CYB5R3
chembl:CHEMBL571546,KX2-391
chembl:CHEMBL473535,FENTICLOR
chembl:CHEMBL3545139,PS-516895
MGI:1860103,Slc2a8
chembl:CHEMBL1200870,TIMOLOL MALEATE
chembl:CHEMBL215853,MONOCILLIN I
chembl:CHEMBL1256778,CHEMBL1256778
chembl:CHEMBL329123,ETALOCIB
chembl:CHEMBL126,LINEZOLID
MONDO:0016430,Balo concentric sclerosis
HP:0000728,Impaired ability to form peer relationships
HGNC:990,BCL2
chembl:CHEMBL2108893,ALFIMEPRASE
GO:0005185,neurohypophyseal hormone activity
HGNC:812,ATP2A2
chembl:CHEMBL17442,CHEMBL17442
HGNC:9646,PTPN13
chembl:CHEMBL2109325,AMG-191
chembl:CHEMBL262083,N6-PHENYLADENOSINE
chembl:CHEMBL223228,EFAVIRENZ
HGNC:10935,SLC18A2
chembl:CHEMBL311498,CIANIDANOL
chembl:CHEMBL3545169,AZD1305
chembl:CHEMBL452374,NEOCHAMAEJASMIN A
chembl:CHEMBL25202,TAMIBAROTENE
CHEBI:48132,tetracenomycin
CHEBI:16933,ergosterol
MONDO:0004110,refractory hairy cell leukemia
HP:0500001,Body odor
chembl:CHEMBL13470,SNC-80
chembl:CHEMBL2103796,BERUBICIN HYDROCHLORIDE
chembl:CHEMBL468154,SCYLLITOL
HGNC:16947,ERLIN1
chembl:CHEMBL1201184,LANREOTIDE ACETATE
chembl:CHEMBL3545069,PELAREOREP
HP:0001136,Retinal arteriolar tortuosity
HGNC:7797,NFKBIA
chembl:CHEMBL525106,CHEMBL525106
chembl:CHEMBL275040,KAINIC ACID
chembl:CHEMBL584458,CHEMBL584458
HGNC:7578,MYH8
chembl:CHEMBL1079935,AMPEROZIDE
chembl:CHEMBL2332352,ARGENTEOSIDE A
chembl:CHEMBL182310,CHEMBL182310
MONDO:0005613,mesonephric adenocarcinoma
HGNC:14628,CDCA7
CHEBI:32955,epoxide
UBERON:0001893,telencephalon
PATO:0002132,"neoplastic, non-invasive"
chembl:CHEMBL1200629,VECURONIUM BROMIDE
MONDO:0014487,congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome
CHEBI:33572,resorcinols
HP:0001252,Hypotonia
GO:0042875,D-galactonate transmembrane transport
HP:0000751,Personality changes
HP:0001102,Angioid streaks of the fundus
chembl:CHEMBL1201065,THIAMYLAL SODIUM
chembl:CHEMBL3707280,CG250 111IN
chembl:CHEMBL34234,IBROLIPIM
MONDO:0013878,"pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1"
CHEBI:36836,3beta-hydroxy steroid
MONDO:0043424,digestive system infectious disorder
chembl:CHEMBL586344,CHEMBL586344
chembl:CHEMBL1201208,PHENMETRAZINE
HGNC:9949,RECQL4
chembl:CHEMBL59150,CHEMBL59150
HP:0002148,Hypophosphatemia
HGNC:9508,PSEN1
chembl:CHEMBL577862,CHEMBL577862
chembl:CHEMBL1061,GLITAZONE
chembl:CHEMBL3408947,CFI-400945
chembl:CHEMBL79140,CHEMBL79140
HGNC:4274,GJA1
HP:3000046,Abnormal geniohyoid muscle morphology
HGNC:8522,OTX2
MONDO:0015244,autosomal recessive cerebellar ataxia
chembl:CHEMBL1502,PANTOPRAZOLE
MONDO:0009830,parkinsonian-pyramidal syndrome
HGNC:5724,RBPJ
MONDO:0006038,indeterminate colitis
chembl:CHEMBL1484,NICARDIPINE
chembl:CHEMBL257991,CHEMBL257991
chembl:CHEMBL1200587,PROCHLORPERAZINE MALEATE
chembl:CHEMBL1200487,ETHACRYNATE SODIUM
chembl:CHEMBL373204,ALPHA-CYPERMETHRIN
chembl:CHEMBL1180,O-DEMETHYLATED ADAPALENE
chembl:CHEMBL598172,NELOTANSERIN
MONDO:0012231,Charcot-Marie-Tooth disease type 2A2
chembl:CHEMBL3545081,RG-7304
HGNC:10991,SLC25A5
HP:0002313,Spastic paraparesis
chembl:CHEMBL600315,CHEMBL600315
HGNC:11128,SNAI1
chembl:CHEMBL85109,ORTHOTOLIDINE
MONDO:0005125,borderline leprosy
chembl:CHEMBL468641,BERKELEYAMIDE C
chembl:CHEMBL3545359,ARRY-300
MONDO:0012805,childhood onset GLUT1 deficiency syndrome 2
HGNC:48,ABCB7
HGNC:11741,TFAM
chembl:CHEMBL581868,CHEMBL581868
chembl:CHEMBL865,VALDECOXIB
chembl:CHEMBL589909,CHEMBL589909
chembl:CHEMBL113178,SELENOMETHIONINE
HGNC:23594,VPS13C
HGNC:10073,RNGTT
MONDO:0958233,Bethlem myopathy 1B
HGNC:7419,MT-CO1
HGNC:29290,LRFN1
MONDO:0002050,depressive disorder
chembl:CHEMBL1314,TIOPRONIN
MONDO:0030513,dystonia 33
HGNC:186,ADA
HGNC:1663,CD36
HGNC:10435,RPS6KA6
chembl:CHEMBL604321,CHEMBL604321
chembl:CHEMBL1743030,ICRUCUMAB
MONDO:0003626,uterine ligament serous adenocarcinoma
HP:0003510,Severe short stature
chembl:CHEMBL552659,FLUNARIZINE HYDROCHLORIDE
chembl:CHEMBL606532,CHEMBL606532
HGNC:3265,EIF2S1
chembl:CHEMBL584860,CHEMBL584860
HP:0100962,Shyness
HGNC:17997,FKRP
HGNC:19104,NPHP4
HGNC:20738,SYVN1
chembl:CHEMBL1605629,CHEMBL1605629
UPHENO:0075796,abnormal musculature of neck
HP:0003743,Genetic anticipation
HGNC:710,ARR3
HGNC:14579,VPS45
HGNC:14584,VPS16
chembl:CHEMBL259850,CHEMBL259850
chembl:CHEMBL1200383,BENZTROPINE MESYLATE
chembl:CHEMBL1179047,CHLOROPROCAINE
chembl:CHEMBL451887,CARFILZOMIB
chembl:CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE
chembl:CHEMBL2089002,DEMETHYLWEDELOLACTONE
chembl:CHEMBL363648,TAK-715
MONDO:0012655,"myoclonic epilepsy, juvenile, susceptibility to, 4"
chembl:CHEMBL1094681,AESCULIOSIDE IVB
MONDO:0015653,monogenic epilepsy
chembl:CHEMBL84567,TRACAZOLATE
chembl:CHEMBL2108567,TANEZUMAB
HGNC:17587,MTCH2
chembl:CHEMBL1549738,CHEMBL1549738
chembl:CHEMBL1668,RESCINNAMINE
chembl:CHEMBL631,PROPAFENONE
chembl:CHEMBL513909,BI-2536
MONDO:0005124,leprosy
HGNC:24953,HEXIM1
chembl:CHEMBL1059,PREGABALIN
HGNC:23177,KEAP1
chembl:CHEMBL385517,SAXAGLIPTIN
HGNC:18751,RIN3
HP:0030187,Titubation
GO:0042552,myelination
CHEBI:32696,argininium(1+)
HGNC:4586,GRIN2B
HGNC:3688,FGFR1
HGNC:17399,ARHGAP32
HGNC:795,ATM
chembl:CHEMBL1378,THIETHYLPERAZINE
CHEBI:41983,4'-epidoxorubicinium
MGI:1349414,Cops4
HGNC:757,ASPH
chembl:CHEMBL1710,TRIFLUOPERAZINE HYDROCHLORIDE
chembl:CHEMBL1242017,BIS(2-ETHYLHEXYL) PHTHALATE
chembl:CHEMBL477841,CHEMBL477841
HGNC:9086,PLP1
chembl:CHEMBL1200638,DEXBROMPHENIRAMINE MALEATE
HGNC:12811,XK
MONDO:0003937,spondylitis
chembl:CHEMBL1449651,"PYRROLIDINE DITHIOCARBAMIC ACID, AMMONIUM SALT"
ZFIN:ZDB-GENE-040718-467,cox20
MONDO:0011489,hereditary spastic paraplegia 12
chembl:CHEMBL4298212,RAVAGALIMAB
HGNC:607,APOC1
MONDO:0012177,posterior column ataxia-retinitis pigmentosa syndrome
FB:FBgn0263116,5-HT1B
MONDO:0003939,muscle tissue disorder
chembl:CHEMBL1441574,BENZO(K)FLUORANTHENE
CHEBI:134547,TOP-53
MONDO:0014377,"developmental and epileptic encephalopathy, 24"
HGNC:29529,TBL1XR1
chembl:CHEMBL1492044,FLUORESCEIN DIACETATE
chembl:CHEMBL401930,CHEMBL401930
CHEBI:38164,organic heteropentacyclic compound
chembl:CHEMBL4297762,GOLODIRSEN
HP:0000400,Macrotia
chembl:CHEMBL2104619,OCAPERIDONE
MONDO:0000414,childhood electroclinical syndrome
MGI:2139279,Hrh3
HGNC:24628,MED28
chembl:CHEMBL1565444,CHEMBL1565444
chembl:CHEMBL407391,DIMETHYLADENINE
chembl:CHEMBL1752,DYPHYLLINE
MONDO:0012116,spinocerebellar ataxia type 8
CHEBI:20106,vanillylmandelic acid
chembl:CHEMBL1488010,HAPLAMINE
chembl:CHEMBL1200865,LOTEPREDNOL ETABONATE
HGNC:25850,RMND5A
MONDO:0020683,acute disease
chembl:CHEMBL433041,EPTASTIGMINE
chembl:CHEMBL2109286,COLTUXIMAB RAVTANSINE
chembl:CHEMBL207824,CHEMBL207824
MONDO:0002558,melanotic neurilemmoma
HP:0001944,Dehydration
MONDO:0018342,Joubert syndrome with Jeune asphyxiating thoracic dystrophy
chembl:CHEMBL450,METHARBITAL
HP:0007374,Atrophy/Degeneration involving the caudate nucleus
chembl:CHEMBL1200950,CLIDINIUM BROMIDE
HGNC:29799,SGMS1
CHEBI:28600,farnesol
NCBIGene:507536,TACO1
HP:0002373,Febrile seizure (within the age range of 3 months to 6 years)
HGNC:13082,LTN1
chembl:CHEMBL269644,ACETANILIDE
chembl:CHEMBL1334465,CHEMBL1334465
chembl:CHEMBL2028850,ICATIBANT
MONDO:0002941,anal margin carcinoma
GO:0101003,ficolin-1-rich granule membrane
UBERON:0001300,scrotum
chembl:CHEMBL962,EPOPROSTENOL SODIUM
HGNC:29005,TRIM66
HGNC:4910,HIF1A
MONDO:0007603,Felty syndrome
HP:0003028,Abnormality of the ankle
HP:0000494,Downslanted palpebral fissures
chembl:CHEMBL1419,SIBUTRAMINE
HGNC:21750,LLCFC1
chembl:CHEMBL3188267,CAPMATINIB
HGNC:11544,TAF11
chembl:CHEMBL3545314,DUSQUETIDE
HP:0031936,Delayed ability to walk
MONDO:0004699,gastrointestinal lymphoma
HGNC:34410,NEURL4
HP:0000817,Reduced eye contact
chembl:CHEMBL1743358,CHEMBL1743358
chembl:CHEMBL177,AMIKACIN
chembl:CHEMBL21731,MAPROTILINE
chembl:CHEMBL69367,CHEMBL69367
MONDO:0016491,hemoglobin E-beta-thalassemia syndrome
Reactome:R-HSA-9022538,Loss of MECP2 binding ability to 5mC-DNA
chembl:CHEMBL236789,MONASTROL
chembl:CHEMBL272005,CHEMBL272005
chembl:CHEMBL2107312,ARBACLOFEN PLACARBIL
HP:0002121,Generalized non-motor (absence) seizure
chembl:CHEMBL3218578,BGT-226
HGNC:1578,CCNA2
HP:0000256,Macrocephaly
Xenbase:XB-GENE-5917368,rcn2
HGNC:11655,TCP1
chembl:CHEMBL2109477,SELICRELUMAB
HGNC:20771,TUBB4B
chembl:CHEMBL4297943,"ECHINACEA, UNSPECIFIED"
chembl:CHEMBL127592,OXETHAZAINE
chembl:CHEMBL53898,CHEMBL53898
HP:0012407,Scissor gait
HGNC:10968,SLC22A4
chembl:CHEMBL1494499,SAVIRIN
chembl:CHEMBL1201150,SUMATRIPTAN SUCCINATE
HGNC:25223,COQ2
CHEBI:28697,21-deoxycortisol
HP:0011999,Paranoia
chembl:CHEMBL1255837,DIHYDROERGOCRISTINE MESYLATE
HGNC:26075,PIH1D1
chembl:CHEMBL3545107,GRC-6211
HGNC:28032,EMC4
chembl:CHEMBL1196,PROPARACAINE
HP:0002514,Cerebral calcification
chembl:CHEMBL591135,CHEMBL591135
HGNC:19692,NRBF2
chembl:CHEMBL1200609,PAROXETINE MESYLATE
chembl:CHEMBL439849,VILAZODONE
CHEBI:28680,cytarabine
HGNC:4648,GTF2B
chembl:CHEMBL1398631,LAURYL ISOQUINOLINIUM
chembl:CHEMBL1224512,HISPIDIN
chembl:CHEMBL435224,LAPAQUISTAT ACETATE
MONDO:0017704,familial partial epilepsy
chembl:CHEMBL1201225,IODINE
MONDO:0000415,adolescence-adult electroclinical syndrome
MONDO:0004537,intestinal variant cervical mucinous adenocarcinoma
NCBIGene:100683938,HTR1F
chembl:CHEMBL154709,APOCIDEINE
chembl:CHEMBL3545323,PWT-33579
chembl:CHEMBL208427,SOLABEGRON
chembl:CHEMBL2062862,CHEMBL2062862
HGNC:4803,HADHB
chembl:CHEMBL267894,AMOBARBITAL
chembl:CHEMBL22242,REMOXIPRIDE
HGNC:7646,NAT2
HGNC:25662,AAGAB
chembl:CHEMBL401362,CHEMBL401362
chembl:CHEMBL226335,RUTIN
chembl:CHEMBL187266,TANSHINONE IIA
GO:0031175,neuron projection development
chembl:CHEMBL170365,ACETALDEHYDE
chembl:CHEMBL1374379,BENZONATATE
ZFIN:ZDB-GENE-121031-5,slc2a3b
HGNC:11546,TAF13
chembl:CHEMBL1516007,"8,2'-DIMETHOXYFLAVONE"
chembl:CHEMBL401844,CHEMBL401844
HP:0002176,Spinal cord compression
chembl:CHEMBL52229,OSTHOLE
HGNC:1701,CD81
MONDO:0002656,skin carcinoma
HP:0000819,Diabetes mellitus
HGNC:3333,EMP1
chembl:CHEMBL222102,KU-55933
chembl:CHEMBL425,OLSALAZINE
HGNC:15870,RAB5IF
HGNC:10704,SEC24B
chembl:CHEMBL1892987,DINOSEB
HP:0010965,Abnormal circulating phytanic acid concentration
chembl:CHEMBL1201177,LEVOBUNOLOL HYDROCHLORIDE
chembl:CHEMBL1200969,DUTASTERIDE
chembl:CHEMBL403233,MANZAMINE A
chembl:CHEMBL6,INDOMETHACIN
chembl:CHEMBL483838,CHEMBL483838
CHEBI:38101,organonitrogen heterocyclic compound
HGNC:25784,DCAF17
chembl:CHEMBL7463,GF-109203
HGNC:3068,DUSP2
CHEBI:23994,ethyl methanesulfonate
chembl:CHEMBL426084,SAMIDORPHAN
chembl:CHEMBL451930,PLITIDEPSIN
HGNC:13607,FBXW11
chembl:CHEMBL23327,PURVALANOLA
chembl:CHEMBL211456,EPHEDRINE
chembl:CHEMBL128748,DIMETHYLCURCUMIN
HGNC:20421,LNX2
HGNC:2674,DAPK1
HGNC:4313,GLDC
MGI:87977,Ak1
chembl:CHEMBL459324,DIACETYLMORPHINE
chembl:CHEMBL473,DOFETILIDE
NCBIGene:475258,CYCS
chembl:CHEMBL553939,CHEMBL553939
ZFIN:ZDB-GENE-040912-86,ndufs6
HGNC:21641,TSPAN12
HGNC:18258,VEZT
HGNC:12011,TPM2
chembl:CHEMBL107367,FARGLITAZAR
chembl:CHEMBL2095095,CHEMBL2095095
UBERON:0000458,endocervix
MGI:1929866,Rgs20
chembl:CHEMBL3039598,FOSINOPRIL
HGNC:865,ATP6V0A1
chembl:CHEMBL583824,CHEMBL583824
HGNC:25507,VAC14
HP:0010880,Increased nuchal translucency
HGNC:9768,RAB28
chembl:CHEMBL515617,CHEMBL515617
chembl:CHEMBL1297,FENOPROFEN
HP:0025235,Non-rapid eye movement parasomnia
chembl:CHEMBL1237,LISINOPRIL
HP:0000717,Autism
chembl:CHEMBL3644587,2X-121
chembl:CHEMBL1256686,CALCIMYCIN
chembl:CHEMBL1255663,RACEPINEPHRINE HYDROCHLORIDE
chembl:CHEMBL4297320,PL-3994
HP:0001278,Orthostatic hypotension
HP:0002020,Gastroesophageal reflux
HP:0002089,Pulmonary hypoplasia
HGNC:76,ABL1
chembl:CHEMBL3545360,ASP-3026
chembl:CHEMBL259389,QUINOXALINE1
chembl:CHEMBL51697,CHEMBL51697
chembl:CHEMBL2070241,BREMELANOTIDE
chembl:CHEMBL254857,FIPEXIDE
chembl:CHEMBL1742992,BLINATUMOMAB
HGNC:4296,GLA
MONDO:0020574,central nervous system nongerminomatous germ cell tumor
chembl:CHEMBL490029,MK-0533
HGNC:29090,SMCHD1
chembl:CHEMBL1200705,HYDROXYAMPHETAMINE HYDROBROMIDE
chembl:CHEMBL1318287,PENTOLINIUM TARTRATE
chembl:CHEMBL74635,PHENYLETHENYLSEMICARBAZONE
chembl:CHEMBL2164551,CHEMBL2164551
chembl:CHEMBL1201550,DENILEUKIN DIFTITOX
NCBIGene:477798,NDUFB8
HP:0001290,Generalized hypotonia
chembl:CHEMBL576353,CHEMBL576353
MONDO:0019793,autosomal dominant cerebellar ataxia type III
HGNC:17164,BCL2L13
chembl:CHEMBL3545324,RG-7666
HP:0001369,Arthritis
Reactome:R-MMU-425366,"Transport of bile salts and organic acids, metal ions and amine compounds"
chembl:CHEMBL596633,CHEMBL596633
chembl:CHEMBL2105662,LOMITAPIDE MESYLATE
chembl:CHEMBL3989481,FRAKEFAMIDE
chembl:CHEMBL2031465,AZD-6703
HP:0007703,Abnormality of retinal pigmentation
chembl:CHEMBL1963502,PKI-166
HGNC:25420,RNF208
HGNC:11506,SYP
HGNC:12518,UCP2
HGNC:457,AMD1
HGNC:14139,PRR35
chembl:CHEMBL14276,CHEMBL14276
chembl:CHEMBL43469,ASARININ
chembl:CHEMBL1893890,QUINALPHOS
chembl:CHEMBL479291,UNGEREMINE
chembl:CHEMBL3990032,TELISOTUZUMAB VEDOTIN
HGNC:28685,OCIAD2
HP:0000298,Mask-like facies
chembl:CHEMBL1200686,PIMECROLIMUS
HGNC:10471,RUNX1
chembl:CHEMBL45245,CHEMBL45245
HP:0007098,Paroxysmal choreoathetosis
HGNC:23181,RASA4
chembl:CHEMBL3545332,CEP-2563
chembl:CHEMBL527730,CHEMBL527730
chembl:CHEMBL1643880,PUMOSETRAG
chembl:CHEMBL1201179,LAPATINIB DITOSYLATE
HGNC:5033,HNRNPA2B1
chembl:CHEMBL1305393,CHEMBL1305393
HGNC:11579,TBCA
chembl:CHEMBL1201068,PROPIOMAZINE HYDROCHLORIDE
chembl:CHEMBL2177350,NEOPETROFORMYNE A
chembl:CHEMBL591773,SHINPTEROCARPIN
chembl:CHEMBL1255939,NALIDIXATE SODIUM
chembl:CHEMBL1317986,CHEMBL1317986
chembl:CHEMBL810,TEMOZOLOMIDE
RGD:1310823,Recql5
GO:0015304,glucose uniporter activity
chembl:CHEMBL276915,7-HYDROXYFLAVONE
chembl:CHEMBL1396,VARENICLINE
chembl:CHEMBL149082,TRAMIPROSATE
chembl:CHEMBL188641,CHEMBL188641
MONDO:0004766,status asthmaticus
MONDO:0006039,infectious colitis
PATO:0000389,acute
HGNC:18318,ASXL1
chembl:CHEMBL261919,PARATHION
HP:0001413,Micronodular cirrhosis
GO:0046449,creatinine metabolic process
MGI:1095409,Tuba1c
HGNC:9380,PRKACA
HP:0033643,Increased circulating very long-chain fatty acid concentration
HGNC:14180,PDIA2
chembl:CHEMBL1257,ENFLURANE
HGNC:443,ALS2
chembl:CHEMBL600090,CHEMBL600090
chembl:CHEMBL127,MEROPENEM
HP:0001332,Dystonia
HP:0006980,Progressive leukoencephalopathy
chembl:CHEMBL71,CHLORPROMAZINE
chembl:CHEMBL1200616,CHLOROTHIAZIDE SODIUM
chembl:CHEMBL1200967,BROMODIPHENHYDRAMINE HYDROCHLORIDE
HGNC:7414,MT-ATP6
HGNC:6859,MAP3K7
MGI:1921367,Actr3
HGNC:7758,NEU1
MONDO:0019046,leukodystrophy
HGNC:33911,RNASEK
HGNC:13575,BRD4
CHEBI:22729,benzoquinones
chembl:CHEMBL1428,NIMODIPINE
HGNC:4907,HIBADH
HP:0025430,High-pitched cry
HGNC:29827,MYL12B
chembl:CHEMBL1516474,TEGASEROD MALEATE
FB:FBgn0033194,Vps13
chembl:CHEMBL1523215,CHEMBL1523215
HGNC:285,ADRB1
chembl:CHEMBL51483,GOSSYPOL
HGNC:32069,LDLRAD1
chembl:CHEMBL1269845,CHEMBL1269845
chembl:CHEMBL1200762,BETAMETHASONE SODIUM PHOSPHATE
chembl:CHEMBL1189679,PALONOSETRON
HGNC:24648,ETAA1
chembl:CHEMBL268584,CHEMBL268584
HP:0032438,Platelet anisocytosis
chembl:CHEMBL237370,CINNAMIC ACID HYDROXAMATE
chembl:CHEMBL592068,CHEMBL592068
HGNC:17780,ACTBL2
chembl:CHEMBL1200851,HOMATROPINE METHYLBROMIDE
HGNC:11828,TJP2
UBERON:0001554,skin of hip
MONDO:0008734,"adrenocortical carcinoma, hereditary"
HGNC:17615,PCGF1
chembl:CHEMBL2109337,MDX-1342
HGNC:16187,SLC52A3
GO:0016068,type I hypersensitivity
chembl:CHEMBL1200606,MEXILETINE HYDROCHLORIDE
chembl:CHEMBL3,NICOTINE
HGNC:9587,PTDSS1
HGNC:11471,SUPV3L1
chembl:CHEMBL496999,FRANGULIN B
CHEBI:23888,drug
RGD:621281,Naip6
HP:0001987,Hyperammonemia
chembl:CHEMBL6206,BROMOENOL LACTONE
chembl:CHEMBL527586,CHEMBL527586
CHEBI:27405,streptidine
HGNC:843,ATP5MC3
HGNC:15912,NSFL1C
chembl:CHEMBL11359,CISPLATIN
HGNC:121,ACOX3
HGNC:9812,RAD23A
chembl:CHEMBL267099,TUBERCIDIN
chembl:CHEMBL389390,CHEMBL389390
MONDO:0009728,nephronophthisis 1
HGNC:18224,ZRANB1
chembl:CHEMBL1200334,MORICIZINE HYDROCHLORIDE
MONDO:0001617,transient global amnesia
HP:0003798,Nemaline bodies
HGNC:13666,AAAS
HGNC:11100,SMARCA4
chembl:CHEMBL52885,ENMD-981693
HP:0000473,Torticollis
HGNC:31677,ANO7
chembl:CHEMBL3301612,ENCORAFENIB
HGNC:4045,FZD7
HP:0000752,Hyperactivity
chembl:CHEMBL3989751,NEOMYCIN
chembl:CHEMBL1230020,PLX-4720
MGI:1914497,Mtarc2
HGNC:9554,PSMD1
MONDO:0011184,childhood apraxia of speech
chembl:CHEMBL582507,CHEMBL582507
chembl:CHEMBL401607,CHEMBL401607
chembl:CHEMBL596380,CHEMBL596380
chembl:CHEMBL928,DANTROLENE SODIUM
chembl:CHEMBL294747,CHEMBL294747
chembl:CHEMBL181,DIAZOXIDE
HGNC:12836,XRN2
MONDO:0002413,glycogen storage disease I
HGNC:493,ANK2
chembl:CHEMBL579957,CHEMBL579957
chembl:CHEMBL119625,ZONAMPANEL
chembl:CHEMBL2109608,L19IL2
MONDO:0020120,skeletal muscle disorder
CHEBI:4290,"1,1-dimethyl-4-phenylpiperazinium iodide"
wikidata:Q45071,PROGESTOGEN
HGNC:943,ADGRB1
chembl:CHEMBL475251,R-406
chembl:CHEMBL247484,TRICETIN
chembl:CHEMBL508425,LIPIDYL PSEUDOPTERANE A
MONDO:0005336,myopathy
HP:0001197,Abnormality of prenatal development or birth
HGNC:17847,STK38
Reactome:R-HSA-1614517,Sulfide oxidation to sulfate
chembl:CHEMBL1684097,CHEMBL1684097
CHEBI:47779,aminoglycoside
Reactome:R-MMU-390650,Histamine receptors
HP:0008897,Postnatal growth retardation
chembl:CHEMBL487046,CHEMBL487046
chembl:CHEMBL3545035,REVEXEPRIDE
chembl:CHEMBL1255654,TETRACAINE HYDROCHLORIDE
chembl:CHEMBL1643895,RAMOSETRON
CHEBI:167095,secondary fatty alcohol
MONDO:0858950,traumatic brain injury
HGNC:11075,NHERF1
GO:0032868,response to insulin
chembl:CHEMBL2105109,ITASETRON
HP:0002470,Nonprogressive cerebellar ataxia
chembl:CHEMBL591429,PAC-1
chembl:CHEMBL1308346,CHEMBL1308346
chembl:CHEMBL1650595,AR-12
chembl:CHEMBL1200789,TRICLOFOS SODIUM
chembl:CHEMBL1161866,CHEMBL1161866
chembl:CHEMBL1732,DIHYDROERGOTAMINE
chembl:CHEMBL3707356,SYL-1001
MONDO:0013978,autosomal recessive nonsyndromic hearing loss 70
GO:0018107,peptidyl-threonine phosphorylation
chembl:CHEMBL2386346,RO-5045337
HGNC:19316,P3H1
chembl:CHEMBL531268,CHEMBL531268
chembl:CHEMBL2364639,VALBENAZINE
HGNC:12649,VAPB
HP:0000478,Abnormality of the eye
HGNC:18514,SPART
MONDO:0014179,inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
HGNC:564,AP2M1
MONDO:0004836,intravascular fasciitis
HP:0031873,Early chronotype
HGNC:25084,TMEM116
CHEBI:26523,reactive oxygen species
HGNC:712,ARRB2
MONDO:0013645,autosomal recessive spinocerebellar ataxia 11
CHEBI:47788,3-oxo steroid
chembl:CHEMBL909,7-HYDROXYCHLORPROMAZINE
HGNC:1697,CD74
chembl:CHEMBL535331,CHEMBL535331
MONDO:0009258,classic galactosemia
HP:0001289,Confusion
wikidata:Q27285013,DEBIO-1347
chembl:CHEMBL363295,TERODILINE
MONDO:0009066,juvenile nephropathic cystinosis
HGNC:12117,TRAV20
chembl:CHEMBL3545313,BEMPEDOIC ACID
MONDO:0014796,autosomal recessive early-onset Parkinson disease 23
chembl:CHEMBL3545093,ZYH7
HGNC:30292,G3BP1
HGNC:9188,POLR2B
HGNC:12682,VEGFC
GO:0031045,dense core granule
chembl:CHEMBL4297417,"PHENSERINE, (+)-"
HGNC:28161,DUSP26
MGI:97138,Mpv17
GO:0004336,galactosylceramidase activity
chembl:CHEMBL1818143,FLUORESCEIN DIPHOSPHATE
chembl:CHEMBL9194,ATRASENTAN
CHEBI:17544,hydrogencarbonate
HP:0001355,Megalencephaly
chembl:CHEMBL1200847,HYDROXYSTILBAMIDINE ISETHIONATE
chembl:CHEMBL1371435,ISOEUGENITOL
chembl:CHEMBL3989695,REGADENOSON
chembl:CHEMBL316157,CEPHALORIDINE
MONDO:0021125,disease characteristic
HGNC:9008,PKD1
chembl:CHEMBL355014,FLUORANTHENE
HGNC:2519,CTPS1
chembl:CHEMBL1213257,AMOPYROQUINE
chembl:CHEMBL1736123,CINTAZONE
UBERON:0001233,right adrenal gland
chembl:CHEMBL131921,BIOCHANIN
MGI:1349765,Rcn2
chembl:CHEMBL1201607,NATALIZUMAB
MONDO:0018243,intellectual disability-hyperkinetic movement-truncal ataxia syndrome
chembl:CHEMBL66115,DEOXYCYTIDINE
CHEBI:87071,conazole antifungal drug
HGNC:9672,PTPRH
chembl:CHEMBL122701,CHEMBL122701
chembl:CHEMBL217899,TOFIMILAST
HGNC:855,ATP6V0C
HGNC:17296,RRM2B
chembl:CHEMBL1079742,ERLOTINIB HYDROCHLORIDE
chembl:CHEMBL607138,CHEMBL607138
chembl:CHEMBL527307,CHEMBL527307
HGNC:5021,FOXA1
chembl:CHEMBL1201342,METHIXENE
chembl:CHEMBL1908351,INTOPLICINE
HGNC:9285,PPP1R11
HGNC:2717,DDB1
HGNC:7672,NCOR1
HGNC:30185,CRBN
chembl:CHEMBL568,OXAZEPAM
chembl:CHEMBL1189150,LINSIDOMINE
HGNC:12034,TRAF4
chembl:CHEMBL2040682,CICLESONIDE
chembl:CHEMBL1254091,CHEMBL1254091
HGNC:591,BIRC3
HGNC:3724,FKBP8
chembl:CHEMBL310798,TYRPHOSTIN 25
MONDO:0020836,"autism, susceptiblity to"
chembl:CHEMBL2165191,AZD-6482
chembl:CHEMBL588327,CHEMBL588327
HGNC:29535,MTF2
HGNC:473,AMT
Reactome:R-HSA-3214841,PKMTs methylate histone lysines
HP:0005445,Enlarged posterior fossa
chembl:CHEMBL221542,BETA-SITOSTEROL
HGNC:11357,STAM
HGNC:10496,S100A6
chembl:CHEMBL934,METYRAPONE
chembl:CHEMBL328190,LASOFOXIFENE
FB:FBgn0027291,Idh3a
HGNC:2076,CLN5
chembl:CHEMBL1908312,MURABUTIDE
chembl:CHEMBL1382,TOLTERODINE
HGNC:5173,HRAS
chembl:CHEMBL2107332,DIAPLASININ
MONDO:0014389,polyglucosan body myopathy 1 with or without immunodeficiency
MGI:1918128,Ccdc136
chembl:CHEMBL574738,AST-487
chembl:CHEMBL2001019,PF-04217903
HGNC:10021,RIPK3
chembl:CHEMBL426559,LAROPIPRANT
chembl:CHEMBL93353,ARISTOLOCHIC ACID
MONDO:0012321,Alzheimer disease 10
MONDO:0800340,"seasonal affective disorder, susceptibility to"
GO:0005124,scavenger receptor binding
chembl:CHEMBL1200636,CYCLOBENZAPRINE HYDROCHLORIDE
chembl:CHEMBL31088,DEOXIEPINEPHRINE
chembl:CHEMBL1116,RALOXIFENE HYDROCHLORIDE
HGNC:20663,SLC25A25
chembl:CHEMBL299400,BUTORPHANOL TARTRATE
CHEBI:35343,17beta-hydroxy steroid
chembl:CHEMBL4297520,OGLEMILAST
chembl:CHEMBL286080,SKF-38393
chembl:CHEMBL1201244,ROCURONIUM
chembl:CHEMBL1256998,CHEMBL1256998
MONDO:0018053,trichothiodystrophy
HP:0000093,Proteinuria
HGNC:24969,NPRL2
HP:0007885,Slowed horizontal saccades
HGNC:16406,EFHC1
HGNC:4140,GAP43
HGNC:8091,OAT
HGNC:9822,RAD51B
chembl:CHEMBL2110581,BEVASIRANIB
GO:0097338,response to clozapine
GO:0010759,positive regulation of macrophage chemotaxis
chembl:CHEMBL214393,CHEMBL214393
chembl:CHEMBL104255,FLAVOKAWAIN B
chembl:CHEMBL52347,"1,2-NAPHTHOQUINONE"
chembl:CHEMBL1489223,SAPPANONE A DIMETHYL ETHER
chembl:CHEMBL2431768,LCL-161
chembl:CHEMBL599102,CHEMBL599102
chembl:CHEMBL192626,CHEMBL192626
HGNC:21157,GTF2H5
HP:0000124,Renal tubular dysfunction
chembl:CHEMBL296306,LACTULOSE
MONDO:0016621,juvenile Huntington disease
chembl:CHEMBL210411,CHEMBL210411
chembl:CHEMBL1742982,AFLIBERCEPT
HGNC:3596,FAT2
chembl:CHEMBL539027,FLUNARIZINE DIHYDROCHLORIDE
HGNC:5309,HUS1
NCBIGene:614700,COX6C
chembl:CHEMBL1224,ACRIVASTINE
chembl:CHEMBL114544,CHEMBL114544
chembl:CHEMBL660,AMANTADINE
chembl:CHEMBL806,FLUTAMIDE
GO:0015881,creatine transmembrane transport
HGNC:4324,GLP1R
chembl:CHEMBL266459,ZOMEPIRAC SODIUM
HGNC:22222,TTYH3
HGNC:17881,NRSN1
chembl:CHEMBL24072,PRENYLAMINE
chembl:CHEMBL152028,N- (9-FLUORENYLMETHOXYCARBONYL)-L-LEUCINE
chembl:CHEMBL1200689,NITRIC OXIDE
HGNC:29233,MAVS
chembl:CHEMBL90,HISTAMINE
HGNC:10990,SLC25A4
chembl:CHEMBL446,SULFAMETHAZINE
HP:0002600,Hyporeflexia of lower limbs
chembl:CHEMBL506,PRIMAQUINE
HGNC:3708,VEGFD
HGNC:9502,CYTH2
GO:0043279,response to alkaloid
HGNC:4378,GMPS
HP:0001348,Brisk reflexes
chembl:CHEMBL38,TRETINOIN
chembl:CHEMBL180239,CURCUMIN PYRAZOLE
chembl:CHEMBL532141,CHEMBL532141
HGNC:6845,MAP2K5
MONDO:0044705,paranasal sinus squamous cell carcinoma
chembl:CHEMBL1201594,RASBURICASE
GO:0001525,angiogenesis
GO:0005783,endoplasmic reticulum
chembl:CHEMBL1585652,CHEMBL1585652
chembl:CHEMBL576781,CHEMBL576781
CHEBI:17334,penicillin
HP:0001635,Congestive heart failure
chembl:CHEMBL4297236,LISOCABTAGENE MARALEUCEL
chembl:CHEMBL4243974,CP-461
chembl:CHEMBL911,ZOLPIDEM
chembl:CHEMBL235891,CHEMBL235891
chembl:CHEMBL4297574,TEPRASIRAN
chembl:CHEMBL600255,CHEMBL600255
HGNC:14895,ULBP3
HP:0011391,Morphological abnormality of the nerves of the inner ear
HGNC:6636,LMNA
HP:0007047,Atrophy of the dentate nucleus
chembl:CHEMBL8483,CHEMBL8483
chembl:CHEMBL1630084,CHEMBL1630084
chembl:CHEMBL1201573,OPRELVEKIN
chembl:CHEMBL579837,CHEMBL579837
chembl:CHEMBL2108266,CEDELIZUMAB
GO:0005929,cilium
chembl:CHEMBL2311194,CHEMBL2311194
chembl:CHEMBL2108628,PACLITAXEL POLIGLUMEX
chembl:CHEMBL250428,CHEMBL250428
HGNC:4601,GRN
chembl:CHEMBL525191,CHEMBL525191
chembl:CHEMBL601616,CHEMBL601616
HGNC:13178,IKZF3
chembl:CHEMBL83063,RITODRINE
chembl:CHEMBL601618,CHEMBL601618
chembl:CHEMBL1230065,BMS-582949
chembl:CHEMBL1200497,CYCLIZINE LACTATE
chembl:CHEMBL318782,DICHLON
MONDO:0002935,penis basal cell carcinoma
HGNC:2665,CD55
chembl:CHEMBL252921,BERKELEYACETAL B
HGNC:9783,RAB5A
HGNC:26941,UFC1
HP:0025190,Bilateral tonic-clonic seizure with generalized onset
chembl:CHEMBL3544914,TEZACAFTOR
chembl:CHEMBL283120,AXL-1717
chembl:CHEMBL3989868,TUCATINIB
chembl:CHEMBL600309,CHEMBL600309
chembl:CHEMBL589920,CHEMBL589920
chembl:CHEMBL601325,CHEMBL601325
MONDO:0008457,spinocerebellar ataxia type 6
chembl:CHEMBL3545327,TTP-607
UBERON:0000955,brain
HGNC:19836,KLHDC1
HP:0001884,Talipes calcaneovalgus
chembl:CHEMBL398363,CHEMBL398363
chembl:CHEMBL559612,CP-55940
HGNC:11140,SNCB
HGNC:26114,EDC3
CHEBI:35681,secondary alcohol
chembl:CHEMBL10316,IDAZOXAN
chembl:CHEMBL283754,CINALUKAST
HGNC:9217,POU3F4
chembl:CHEMBL1131,ACITRETIN
chembl:CHEMBL477396,CHEMBL477396
HP:0008765,Auditory hallucinations
chembl:CHEMBL1201822,GALSULFASE
CHEBI:24613,homodetic cyclic peptide
CHEBI:18249,"ergosta-5,7,22,24(28)-tetraen-3beta-ol"
HGNC:19317,P3H2
chembl:CHEMBL1834952,ELATOSIDE D
chembl:CHEMBL1201749,DIFLUPREDNATE
HGNC:19691,MECR
chembl:CHEMBL91829,RUBOXISTAURIN
chembl:CHEMBL249856,ENOXIMONE
HP:0006979,Sleep-wake cycle disturbance
MONDO:0005767,gas gangrene
chembl:CHEMBL487894,DIPYRONE SODIUM
UBERON:0001114,right lobe of liver
wikidata:Q410513,MEGESTROL
HP:0031879,Abnormal eyelid physiology
MONDO:0020674,vascular insufficiency disorder
HGNC:17287,SUV39H2
HGNC:28204,NTPCR
MONDO:0011551,TH-deficient dopa-responsive dystonia
chembl:CHEMBL1201618,GLUCAGON HYDROCHLORIDE
chembl:CHEMBL1200612,DIBUCAINE HYDROCHLORIDE
chembl:CHEMBL70159,CARMOXIROLE
chembl:CHEMBL269646,TIOTIDINE
HGNC:6677,LPL
Reactome:R-HSA-437239,Recycling pathway of L1
HGNC:11057,SLC7A1
chembl:CHEMBL480328,CHEMBL480328
MONDO:0005153,cervical adenocarcinoma
WB:WBGene00008278,npr-10
HP:0009589,Bilateral vestibular schwannoma
MONDO:0024278,proctocolitis
HP:0100716,Self-injurious behavior
chembl:CHEMBL147587,ISOQUINE
CHEBI:35618,aromatic ether
chembl:CHEMBL87285,ANDROSTERONE
CHEBI:67194,cannabinoid
MONDO:0011201,"tremor, hereditary essential, 2"
chembl:CHEMBL3039517,RABUSERTIB
HGNC:24876,GOLGA7
HP:0100951,Enlarged fossa interpeduncularis
chembl:CHEMBL2107787,TESETAXEL
chembl:CHEMBL799,CILOSTAZOL
chembl:CHEMBL4297903,PEPTIDE B27PD
CHEBI:456216,ADP(3-)
HGNC:4333,NOP53
chembl:CHEMBL192264,CHEMBL192264
MONDO:0007803,multiple system atrophy
HGNC:7427,MT-CYB
HP:0006934,Congenital nystagmus
chembl:CHEMBL1326758,CHEMBL1326758
chembl:CHEMBL1236924,INT131
chembl:CHEMBL2110730,POMAGLUMETAD METHIONIL
chembl:CHEMBL1082354,TENONITROZOLE
chembl:CHEMBL2108163,ULINASTATIN
chembl:CHEMBL3581647,BIRABRESIB
HGNC:634,AQP2
HP:0100539,Periorbital edema
HP:0000733,Abnormal repetitive mannerisms
chembl:CHEMBL1333189,PROPAZINE
chembl:CHEMBL1331521,"3,6-DIMETHOXYFLAVONE"
chembl:CHEMBL2348411,CHEMBL2348411
NCBIGene:615660,COX20
chembl:CHEMBL15750,NITROBENZENE
chembl:CHEMBL68810,THUNBERGINOL A
MONDO:0018208,neurofibromatosis type 1 due to NF1 mutation or intragenic deletion
chembl:CHEMBL2103741,LEVOTHYROXINE SODIUM
chembl:CHEMBL74121,CHEMBL74121
MONDO:0800064,osteogenesis imperfecta and a reduction of bone mineral density.
chembl:CHEMBL1142,4-AMINOPHENOL
chembl:CHEMBL1642,IMATINIB MESYLATE
chembl:CHEMBL1431017,CHEMBL1431017
chembl:CHEMBL1201012,FLURANDRENOLIDE
chembl:CHEMBL72631,INDOMETHACIN MORPHOLINYLAMIDE
chembl:CHEMBL2105804,IMPLITAPIDE
HGNC:29682,GFM2
chembl:CHEMBL3545055,INK-1117
chembl:CHEMBL336467,FUROXAN
MONDO:0034976,iatrogenic Creutzfeldt-Jakob disease
chembl:CHEMBL1201250,BENZQUINAMIDE
HP:0002145,Frontotemporal dementia
HGNC:18746,SLURP1
chembl:CHEMBL1722,METHYLPHENIDATE HYDROCHLORIDE
chembl:CHEMBL288114,GALLIC ACID
chembl:CHEMBL2017974,BUPARLISIB
chembl:CHEMBL575867,4-CHLOROMERCURIBENZOIC ACID
chembl:CHEMBL319244,CAFFEIC ACID PHENETHYL ESTER
chembl:CHEMBL2106841,NONABINE
chembl:CHEMBL534288,CHEMBL534288
chembl:CHEMBL925,TYROSINE
chembl:CHEMBL1200409,LIDOCAINE HYDROCHLORIDE
chembl:CHEMBL588234,CHEMBL588234
chembl:CHEMBL354077,AMIFAMPRIDINE
chembl:CHEMBL3545228,JTS-653
CHEBI:38824,fluorocarbon
MONDO:0024619,central nervous system infectious disorder
GO:0050782,galactose uniporter activity
HGNC:16496,ACSL6
chembl:CHEMBL3545283,RIVICICLIB
HP:0002138,Subarachnoid hemorrhage
chembl:CHEMBL4297700,BIMEKIZUMAB
chembl:CHEMBL404215,PRIDINOL
HGNC:23166,PNPT1
HGNC:282,ADRA2B
chembl:CHEMBL286494,HYPERICIN
HP:0011393,Aplasia of the vestibular nerve.
chembl:CHEMBL580340,CHEMBL580340
MONDO:0002235,eyelid neoplasm
chembl:CHEMBL1371756,GRAVEOLINE
MONDO:0011764,autosomal dominant Parkinson disease 8
CHEBI:35821,anticholesteremic drug
HGNC:14210,SUN2
HGNC:17169,PRDX4
HP:0002371,Loss of speech
chembl:CHEMBL288441,BOSUTINIB
wikidata:Q29006033,IRESSA
chembl:CHEMBL118478,ILEPCIMIDE
HGNC:3748,FLG
chembl:CHEMBL129529,BUTACAINE
HGNC:5387,IDI1
HP:0030219,Semantic dementia
MONDO:0002652,anus adenocarcinoma
GO:0008982,protein-N(PI)-phosphohistidine-sugar phosphotransferase activity
PR:000007495,fibroblast growth factor 4
chembl:CHEMBL4297900,AZD-4785
HGNC:16235,DNAJC5
HGNC:2553,CUL3
HGNC:12642,VAMP1
chembl:CHEMBL446315,ERGOCRISTINE
chembl:CHEMBL1797713,CHEMBL1797713
chembl:CHEMBL1201284,CINACALCET
chembl:CHEMBL222863,OUABAIN
chembl:CHEMBL2035187,PACRITINIB
chembl:CHEMBL52440,DEXTROMETHORPHAN
chembl:CHEMBL17157,TERFENADINE
chembl:CHEMBL592862,DIAZIRINE
CHEBI:42820,guanidine
HGNC:5293,HTR2A
chembl:CHEMBL1289,HALOPROGIN
chembl:CHEMBL2368925,DOLASETRON
HGNC:7704,NDUFB9
chembl:CHEMBL1576338,CHEMBL1576338
MONDO:0008735,adrenocortical unresponsiveness to ACTH with postreceptor defect
HGNC:9816,RAD50
HGNC:12032,TRAF2
chembl:CHEMBL3545412,K-877
CHEBI:16521,lanosterol
chembl:CHEMBL3545105,POL6326
HGNC:12667,VCX
MGI:1351617,Abca3
chembl:CHEMBL1835659,SPIRUCHOSTATIN C
MONDO:0019544,cocaine intoxication
MONDO:0016833,14q12 microdeletion syndrome
chembl:CHEMBL1201109,DESONIDE
chembl:CHEMBL1575,ESTRAMUSTINE
chembl:CHEMBL3545384,SB-85635
HGNC:28771,TMEM109
GO:0005515,protein binding
CHEBI:30920,3-hydroxy-3-methylglutarate(1-)
chembl:CHEMBL1229846,PHENOXYETHANOL
HGNC:29509,APH1A
chembl:CHEMBL221753,BENZETHONIUM CHLORIDE
MONDO:0016160,X-linked intellectual disability-epilepsy syndrome
MONDO:0019170,polyarteritis nodosa
chembl:CHEMBL1500740,CHEMBL1500740
MONDO:0956979,nocturnal asthma
chembl:CHEMBL548458,CHEMBL548458
HGNC:216,ADAM9
GO:0007507,heart development
MONDO:0044807,inherited dystonia
HGNC:8957,PIGA
MONDO:0005560,brain disorder
MONDO:0014688,short-rib thoracic dysplasia 14 with polydactyly
MONDO:0019202,myxofibrosarcoma
chembl:CHEMBL453863,TEROXIRONE
chembl:CHEMBL589366,3R14S-OCHRATOXIN A
HGNC:3763,FLT1
HGNC:18268,LMBR1L
HGNC:37276,CRPPA
MONDO:0020481,myotonia fluctuans
chembl:CHEMBL83,TAMOXIFEN
HP:0009916,Anisocoria
chembl:CHEMBL1775032,FERRUGINENE B
chembl:CHEMBL2108887,AFELIMOMAB
chembl:CHEMBL1230813,ALFADEX
chembl:CHEMBL1397833,VITAMIN B2
chembl:CHEMBL3545223,GW493838
chembl:CHEMBL473735,CHEMBL473735
MONDO:8000012,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1"
MONDO:0015003,"dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities"
HP:0000666,Horizontal nystagmus
GO:0097447,dendritic tree
chembl:CHEMBL107518,CHEMBL107518
chembl:CHEMBL3545346,AZD2516
HGNC:16178,BPIFB3
chembl:CHEMBL486706,CHEMBL486706
MONDO:0060671,"epilepsy, juvenile myoclonic, susceptibility to, 10"
chembl:CHEMBL72365,CHEMBL72365
chembl:CHEMBL1109,SULFAPHENAZOLE
chembl:CHEMBL2110814,DELUCEMINE
MONDO:0010823,rhizomelic chondrodysplasia punctata type 3
chembl:CHEMBL1576086,"2,4-HEXADIENAL"
chembl:CHEMBL1256786,FORMOTEROL
chembl:CHEMBL1076838,CYANOPEPTOLIN S
HGNC:4923,HK2
MONDO:0030815,"cholestasis, progressive familial intrahepatic, 11"
chembl:CHEMBL575924,PALBINONE
chembl:CHEMBL484928,CHEMBL484928
chembl:CHEMBL585045,CHEMBL585045
chembl:CHEMBL91163,CHEMBL91163
chembl:CHEMBL306280,DIFLOMOTECAN
HP:0000938,Osteopenia
chembl:CHEMBL1102,GLUTETHIMIDE
CHEBI:2639,amiloride
HGNC:11763,TFRC
chembl:CHEMBL3707219,REMETINOSTAT
chembl:CHEMBL464631,CHEMBL464631
HP:0030955,Alcoholism
chembl:CHEMBL297784,CHEMBL297784
MONDO:0001072,mild pre-eclampsia
chembl:CHEMBL583584,CHEMBL583584
chembl:CHEMBL1414154,ALACHLOR
HGNC:42,ABCB11
chembl:CHEMBL95,TACRINE
MONDO:0014698,microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome
HP:0012049,Laryngeal dystonia
chembl:CHEMBL1034,DICLOFENAC SODIUM
chembl:CHEMBL1200326,NICARDIPINE HYDROCHLORIDE
HP:0010677,Enuresis nocturna
chembl:CHEMBL3545280,EFATUTAZONE
chembl:CHEMBL259422,CHEMBL259422
chembl:CHEMBL1742988,BAMINERCEPT
HGNC:12403,TTN
HGNC:7805,NFYB
chembl:CHEMBL1530911,CHEMBL1530911
chembl:CHEMBL528245,CHEMBL528245
chembl:CHEMBL86715,PROCYCLIDINE
chembl:CHEMBL11608,TYRAMINE
chembl:CHEMBL3989911,VELDOREOTIDE
MONDO:0005070,neoplasm
chembl:CHEMBL1591080,METHOXYVONE
HP:0002510,Spastic tetraplegia
UBERON:0036214,rectosigmoid junction
chembl:CHEMBL4297354,AZD-7687
chembl:CHEMBL571228,CHEMBL571228
chembl:CHEMBL579550,CHEMBL579550
chembl:CHEMBL99779,PAULLONE
HGNC:9787,KIF20A
MONDO:0019218,inborn disorder of bile acid synthesis
chembl:CHEMBL437526,PRALNACASAN
chembl:CHEMBL462605,PITOLISANT
HGNC:6148,ITGAL
HP:0010943,Echogenic fetal bowel
chembl:CHEMBL24057,FURAMIDINE
chembl:CHEMBL450613,ZERANOL
chembl:CHEMBL4297410,IT-139
chembl:CHEMBL1086440,TRICLABENDAZOLE
HGNC:463,AMFR
chembl:CHEMBL2368924,DOLASETRON MESYLATE
chembl:CHEMBL458328,CHEMBL458328
chembl:CHEMBL190,THEOPHYLLINE
chembl:CHEMBL1697737,CLOTIAZEPAM
chembl:CHEMBL601918,CHEMBL601918
MONDO:0024888,mesonephric neoplasm
MONDO:0012789,dystonia 16
chembl:CHEMBL2108047,RINFABATE
chembl:CHEMBL191611,CHEMBL191611
chembl:CHEMBL1743006,DALOTUZUMAB
chembl:CHEMBL1528839,PHENFORMIN HYDROCHLORIDE
chembl:CHEMBL2105635,DAVALINTIDE
chembl:CHEMBL146506,MOFAROTENE
HP:0011710,Bundle branch block
MONDO:0012784,autosomal recessive ataxia due to ubiquinone deficiency
chembl:CHEMBL870,ALENDRONIC ACID
chembl:CHEMBL1168,RAMIPRIL
chembl:CHEMBL3545030,JNJ-17216498
chembl:CHEMBL705,ALITRETINOIN
chembl:CHEMBL2220486,LUCITANIB
chembl:CHEMBL2105731,ENCALERET SULFATE
HGNC:1461,CAMK2B
MONDO:0800351,left ventricular noncompaction 5
MONDO:0100056,exercise-induced anaphylaxis
HGNC:9395,PRKCB
HGNC:11275,SPTBN1
HGNC:7939,NPPA
chembl:CHEMBL2332119,VEGFRECINE
HP:0003577,Congenital onset
HP:0002093,Respiratory insufficiency
chembl:CHEMBL276473,4'-HYDROXYCHALCONE
HGNC:21906,CHCHD3
MGI:2156841,Recql5
chembl:CHEMBL1201117,METHOCARBAMOL
CHEBI:17833,gentamycin
MONDO:0001390,transient refractive change
CHEBI:28073,chromium atom
HGNC:1779,CDK8
MONDO:0013359,familial hyperaldosteronism type III
chembl:CHEMBL3707275,VORETIGENE NEPARVOVEC
chembl:CHEMBL3544946,PF-06291874
chembl:CHEMBL511,PYRILAMINE
chembl:CHEMBL3545002,MP-412
chembl:CHEMBL1288281,CHEMBL1288281
HP:0002334,Abnormal cerebellar vermis morphology
HP:0100820,Glomerulopathy
HP:0003542,Increased serum pyruvate
chembl:CHEMBL1201772,PRASUGREL
MONDO:0004329,pancreatic intraductal papillary-mucinous neoplasm with high grade dysplasia
MONDO:0005402,lymphoid leukemia
chembl:CHEMBL1040,CALCIFEDIOL
chembl:CHEMBL1370646,CHLORPYRIFOS-METHYL
chembl:CHEMBL491499,ZEARALANONE
HGNC:17358,TPK1
HGNC:10717,SEL1L
chembl:CHEMBL476302,CHEMBL476302
chembl:CHEMBL303933,PIPERAQUINE
chembl:CHEMBL3545331,RPR749
HGNC:12582,UQCRB
MONDO:0035713,FOXG1 syndrome due to intragenic alteration
HP:0002529,Neuronal loss in central nervous system
HP:0010576,Intracranial cystic lesion
HGNC:816,ATP2B3
HGNC:21208,WDR26
chembl:CHEMBL1489988,N-HISTIDYL-2-AMINONAPHTHALENE (BETANA)
chembl:CHEMBL2165615,PF-04937319
HP:0001691,Muscular subvalvular aortic stenosis
chembl:CHEMBL587714,"3',4' DICHLOROBENZAMIL"
HGNC:12643,VAMP2
chembl:CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE
chembl:CHEMBL545900,CHEMBL545900
chembl:CHEMBL55860,OCTADECYLAMINE
HGNC:3437,ERCC5
HGNC:12388,TST
HP:0033526,Limited ankle dorsiflexion
HGNC:3067,DUSP12
HGNC:6207,JUP
HGNC:21658,FBXL13
HP:0001291,Abnormal cranial nerve morphology
HGNC:9665,PTPRB
chembl:CHEMBL255033,(S)-NIMODIPINE
chembl:CHEMBL436,TOLRESTAT
CHEBI:4031,cyclosporin A
chembl:CHEMBL2177390,IPATASERTIB
HGNC:13408,PDCD11
chembl:CHEMBL2170369,CHEMBL2170369
chembl:CHEMBL3590674,ABT-639
GO:0031092,platelet alpha granule membrane
chembl:CHEMBL254649,COCHINCHINENIN C
chembl:CHEMBL2103840,DINACICLIB
chembl:CHEMBL442494,CHEMBL442494
HGNC:4658,GTF2H4
MONDO:0043543,iatrogenic disease
chembl:CHEMBL225071,RALTITREXED
CHEBI:48336,"(2R,4S)-ketoconazole"
MONDO:0041752,paucibacillary leprosy
HP:0002181,Cerebral edema
chembl:CHEMBL1200982,BUTABARBITAL SODIUM
MONDO:0014290,neurodegeneration with brain iron accumulation 6
HGNC:11138,SNCA
HGNC:9065,PLCG1
chembl:CHEMBL2107797,NORGESTREL
HP:0000252,Microcephaly
HGNC:17208,BICD2
chembl:CHEMBL4297289,IMG-7289
HP:0002131,Episodic ataxia
chembl:CHEMBL1256910,TREQUINSIN HYDROCHLORIDE
MONDO:0041086,mixed anxiety and depressive disorder
chembl:CHEMBL602940,CHEMBL602940
chembl:CHEMBL1668774,TUBERATOLIDE B
chembl:CHEMBL7002,CIGLITAZONE
chembl:CHEMBL453904,SULFOBROMOPHTHALEIN SODIUM
MONDO:0006552,folliculitis
HGNC:9137,EXOSC9
MONDO:0003646,rectum neuroendocrine neoplasm
HP:0001417,X-linked inheritance
chembl:CHEMBL487913,THIOCORALINE
HGNC:24927,CHP2
HP:0002010,Narrow maxilla
chembl:CHEMBL1743040,MILATUZUMAB
HGNC:21680,SIK2
CHEBI:25179,melanins
HP:0011976,Elevated urinary catecholamine level
GO:0019900,kinase binding
chembl:CHEMBL1607480,OXYTETRACYCLINE HYDROCHLORIDE
chembl:CHEMBL514201,TALMAPIMOD
chembl:CHEMBL3545113,PX-102
HGNC:10012,RHO
HGNC:33437,GSTT2B
chembl:CHEMBL504850,HARMAN-3-CARBOXYLIC ACID
chembl:CHEMBL3545368,PANOBINOSTAT LACTATE
chembl:CHEMBL3188386,WNT-974
chembl:CHEMBL487602,TOTAROL
chembl:CHEMBL513389,ICI-118551
chembl:CHEMBL1263,SALMETEROL
chembl:CHEMBL17331,PD-169316
chembl:CHEMBL982,NALMEFENE
chembl:CHEMBL1433,DOXYCYCLINE
MONDO:0018222,obsolete X-linked intellectual disability due to GRIA3 anomalies
chembl:CHEMBL12208,HYMECROMONE
HGNC:18212,HPCAL4
chembl:CHEMBL535,SUNITINIB
chembl:CHEMBL938,SARALASIN
chembl:CHEMBL3707399,CX1739
chembl:CHEMBL836,TAMSULOSIN
chembl:CHEMBL1397308,CHEMBL1397308
GO:0031252,cell leading edge
chembl:CHEMBL2106710,FADOLMIDINE HYDROCHLORIDE
CHEBI:28918,(R)-adrenaline
Reactome:R-HSA-2500257,Resolution of Sister Chromatid Cohesion
chembl:CHEMBL695,TRIMETHADIONE
RGD:71103,Slc27a2
UPHENO:0081740,increased biological_process in patella
MONDO:0002363,papilloma
CHEBI:32689,D-argininium(1+)
HGNC:3287,EIF4E
CHEBI:132124,"1,4-benzoquinones"
chembl:CHEMBL2208195,CHEMBL2208195
chembl:CHEMBL3545411,MF101
chembl:CHEMBL119264,GR-55562
HP:0012048,Oromandibular dystonia
chembl:CHEMBL1201218,CEFAMANDOLE NAFATE
chembl:CHEMBL1200968,HYDROCORTISONE SODIUM PHOSPHATE
HP:0004374,Hemiplegia/hemiparesis
chembl:CHEMBL260933,GS 6201
chembl:CHEMBL1782599,THEONELLASTEROL C
ZFIN:ZDB-GENE-040801-169,ndufa7
HGNC:9077,PLK1
MONDO:0014606,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome
HGNC:8853,PEX11B
MONDO:0014875,"hyperaldosteronism, familial, type IV"
chembl:CHEMBL35,FUROSEMIDE
HGNC:3607,FBP2
HGNC:18169,FKBP10
HGNC:2718,DDB2
